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During  fertilisation  the  sperm  causes  a  series  of [Ca2+]i  oscillations  in  the  egg  that  lead  to 
events such as cortical  granule exocytosis,  pronuclei  formation, exit from meiosis and entry 
into  mitosis.  These  events  are  collectively  termed  “egg  activation”  and  are  essential  for 
initiating  development  in  the  egg.  Injection  of PLC£  into  mouse  eggs  has  previously  been 
shown to cause [Ca2+]i oscillations, egg activation and development to the blastocyst stage. In 
this Thesis I show that injection of PLC£ cRNA also causes  [Ca2+]i oscillations  in pig eggs 
and  in  human  eggs  which  had  failed  to  fertilise  after  assisted  reproduction  technologies 
(ART).  The  human  eggs  were  shown to  undergo  further development  up  to  the  blastocyst 
stage.
The [Ca2+]i oscillations during egg activation are known to lead the immediate events 
of  egg  activation  but  the  role  of  these  [Ca2+]i  oscillations  on  later  preimplantation 
development  in  the  mouse  has  not  been  established.  The  work  presented  in  this  Thesis 
addresses  this  issue  by  comparing  differences  in  mouse  embryo  development  after 
parthenogenetic activation using stimuli that induce a [Ca2+]i increase (e.g. Sr2* and ethanol) 
with  those that do  not cause  any  [Ca2+]i  change  (e.g.  cycloheximide).  The data  shows  that 
parthenogenetic activation in the absence of a Ca2+ increase leads to embryo loss around the 
8-cell stage, and that any blastocysts that form in absence of a [Ca2+]i increase have a reduced 
inner cell mass and an increased incidence of apoptosis. [Ca2+]i oscillations during activation 
do  not  appear to  have an  effect on  the timing or amount of overall  global  gene expression 
during embryonic  genome  activation  (EGA).  However,  when  I  used microarray analysis  I 
found that a significant number of genes were differentially expressed in 8-cell stage embryos 
that were activated with a [Ca2+]i increases compared to those that activated in the absence of 
a [Ca2+]i change. These results provide evidence that [Ca2+]i increases at egg activation have 
an important role in regulating events during the later stages of preimplantation development.
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Chapter 1 
General Introduction
During mammalian fertilisation, a series of intracellular Ca2+ oscillations ([Ca  ]i) in the egg 
trigger the  transition  from  egg  to  embryo.  It  was  recently  discovered  that  a  proteinaceous 
“sperm factor” called Phospholipase C zeta (PLCQ is able to trigger these [Ca2+]i oscillations 
that are critical for development to proceed.  The experiments represented in this thesis were 
designed  to  examine  the  influence  these  [Ca2+]i  oscillations  have  upon  specific  aspects  of 
mammalian  preimplantation  embryo  development  such  as  embryonic  genome  activation 
(EGA), gene expression and blastocyst quality. This general introduction will act as a review 
of topics that are particularly relevant to these areas of study. I will begin with an overview of 
mammalian preimplantation development after which I will discuss the mechanisms of [Ca2+]i 
signalling  at  egg  activation.  This  will  be  followed  by  a  discussion  of EGA  and  how  it  is 
thought to impacts on embryo development. Finally I will discuss what is known about gene 
expression patterns in the preimplantation embryo.
1.1 Preimplantation embryo development
1.1.1  Oogenesis
Primordial germ cells develop in the foetus prior to birth. The mouse ovaries at birth contain 
only primordial follicles. The follicle is an essential functional unit of the ovary and the term 
folliculogenesis  refers  to  the  development  of follicles  from  the  primordial  stage through  a 
series  of  morphologically  defined  stages  that  culminate  in  the  formation  of  large  pre­
ovulatory follicles.  Over  half of the  primordial  follicles  present  in  the  ovaries  of newborn 
mice degenerate during the first few days after birth. Follicle formation in the mouse begins
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shortly after birth and by approximately 5  days after birth these  cells, which are known  as 
primary oocytes, are arrested in prophase 1   of meiosis 1. During meiotic arrest the size of the 
oocyte increases from a diameter of 15 to 85  pm and growth is complete within  10-18 days. 
The  growth  phase  is  accompanied by the  gradual  appearance of the zona pellucida (ZP),  a 
7pm layer of extracellular material synthesized by the oocyte (Wassarman,  1988; Greve and 
Wassarman,  1985). A major component of the ZP is the glycoprotein Zona Pellucida 3 (ZP3), 
which functions as a sperm receptor preventing cross-species fertilisation and a trigger for the 
acrosome reaction,  which  is essential  if fertilisation  is to take  place  (Bleil and  Wassarman, 
1980).  Oocyte  growth  is also characterised by the appearance of a  large  nucleus  called the 
germinal vesicle (GV) and the accumulation of molecules important for embryogenesis. Each 
oocyte  is initially contained within a follicle composed of a single  layer of granulosa cells. 
The granulosa cells that immediately surround the egg form gap junctions with each other and 
the oocyte that allow the transfer of metabolites and other low mass molecules, between the 
oocyte  and the  somatic  cells of the developing follicle.  Oocyte growth  is dependent on the 
communication between oocyte and granulosa cells, the growth rate depending on the number 
of granulosa cells in contact with the oocyte (Brower and Schultz,  1982). As the oocyte grows 
in size it acquires the competence to enter the last stages of meiosis in response to either the 
correct hormonal signal in vivo or release from the follicle in vitro.
In  female mice,  sexual  maturity occurs at  6 weeks of age and by this time each 
ovary contains approximately 104 oocytes that are at different stages of maturity (Hogan et al., 
1994).  In  a  natural  mouse  estrous  cycle,  6-15  follicles  respond  to  an  increase  in  Follicle 
Stimulating  Hormone  (FSH)  by accumulating  fluid  secreted  by  the  follicular  cells  (Gates, 
1971).  The  follicle,  now called a Graafian,  or Antral  follicle moves to the periphery of the 
ovary.  A  surge  in  Luteinising  hormone  (LH)  initiates  ovulation  by  causing  the  rupture  of 
several follicles (6-12 in the mouse) from the ovary (Gates,  1971). Large numbers of oocytes
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that  are  synchronous  in  their  development  can  be  stimulated  to  ovulate  artificially 
(superovulation) by administration of gonadotrophins. For experiments on mouse eggs 1  used 
Pregnant  Mare’s  Serum  Gonadotrophin  (PMSG)  to  mimic  FSH  and  human  Chorionic 
Gonadotrophin (hCG) to mimic LH (Hogan et al.,  1994). Typically 30-40 eggs were ovulated 
per mouse after this treatment (See materials and methods-Chapter 2). After LH stimulation 
the GV loses its membrane through a process known as germinal vesicle breakdown. At this 
stage, the chromosomes that have assembled on the spindle move towards the periphery of the 
cell  ready  for  the  first  meiotic  division  and  although  there  is  an  equal  division  of 
chromosomes into each daughter cell, the size of one daughter cell is about 30 times larger in 
volume than the other due to unequal division of the cytoplasm. The smaller cell, termed the 
1st  polar  body  degenerates  shortly  after  formation.  The  larger  cell  termed  the  secondary 
oocyte contains a full complement of chromosomes and the cell arrests at metaphase II (Mil) 
of the 2nd meiotic division.
Whilst remaining in meiotic arrest, the oocyte may eventually be released from its 
follicle by a process called ovulation. Each ovulated Mil-arrested oocyte is surrounded by a 
mass of follicle cells called the cumulus mass and can be referred to as an egg. The ovulated 
egg is swept into the infundibulum of the oviduct by the action of numerous cilia present on 
the oviduct epithelium. During ovulation, a section of the oviduct enlarges to form an ampulla 
where  fertilisation  will take  place.  In  mice,  around  6-12  eggs are  ovulated over a 2-3  hour 
period rather than in synchrony as may occur in other species (Hogan et al.,  1994).
1.1.2  Fertilisation
The stage of the cell cycle in which fertilisation takes place varies in different species. In the 
majority of mammals the egg arrests during Mil  and awaits fertilisation, there are however 
some  notable  exceptions.  Canine  oocytes  arrest  at  prophase  of the  1st  meiosis  (Holst  and
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Phemister,  1971), Ascidian and mollusc eggs arrest at Ml while sea urchins complete meiosis 
before  arresting.  Starfish  eggs  complete  Mil  without  arresting  and  can  be  fertilised  at  any 
time (Whitaker,  1996).
In  the  mouse  approximately  58  x  106  sperm  are  released  into  the  female 
reproductive tract upon ejaculation (Hogan et al.,  1994). Before the sperm can fertilise the egg 
it  must  undergo  a  specialised  process  of  maturation  known  as  capacitation.  Sperm 
capacitation  takes  about  1   hour,  although  its  molecular  nature  is  unclear  (Tulsiani  et  al., 
1997). The sperm has to penetrate through the cumulus cells and ZP before its head can bind 
to the glycoprotein ZP3. Once bound to ZP3, the sperm triggers the acrosome reaction (Bleil 
and Wassarman,  1980). During the acrosome reaction, hydrolytic enzymes are released from 
the  sperm head allowing  it to penetrate the ZP.  After penetration,  the posterior part of the 
sperm  head  fuses with the  egg membrane,  triggering  fertilisation.  In  normal  circumstances 
one sperm enters the egg and contributes it haploid nucleus, after which the centriole from the 
sperm divides and forms part of the spindle. The introduction of multiple sperm into the egg 
is known as polyspermy, this often causes multiple spindles in the egg and leads to abnormal 
cleavage and death in the embryo (Austin and Braden,  1953). Different mechanisms exist to 
prevent  polyspermy.  In  mammals,  cortical  granules  that  lie  directly  beneath  the  plasma 
membrane  are  released  in  a  Ca2+  dependent  manner.  This  process,  termed  cortical  granule 
exocytosis  (CGE),  initiates  the  zona reaction,  which  involves  modifications  of the  zona  so 
that sperm can no longer bind and trigger the acrosome reaction. In some species such as the 
sea  urchin  there  is  an  initial  fast  block  to  polyspermy  that  is  caused  by  a  change  in  the 
electrical potential of the egg plasma membrane. This block lasts for approximately 1   minute 
before  being  replaced  by  CGE.  Some  species  undergo  physiological  polyspermy  but  have 
unusual mechanisms to prevent more than one male pronucleus becoming involved in further 
development.  The  etenophore Beroe  Ovata  egg  for  example  can  be  fertilised  by  up  to  10
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sperm,  the  pronuclei  of the  sperm  remain however at the  sperm  entry site  beneath the  egg 
surface while the egg pronuclei migrates directly to a single chosen male pronucleus (Carre 
and Sardet,  1984).
In  mammals,  fertilisation  initiates  a  second  asymmetrical  meiotic  division, 
resulting in extrusion of the 2nd polar body. Nuclear proteins form around the maternal and 
paternal chromosomes resulting in separate haploid female and male pronuclei that both start 
to migrate towards the centre of the egg. During migration, DNA replication occurs  in both 
pronuclei. The nuclear membranes then break down and chromosomes align on the  spindle 
shortly before the first mitotic cell division occurs.
1.1.3  Preimplantation embryo development
Embryonic  cell  cleavages  in  mammals  are  the  slowest  in  the  animal  kingdom,  typically 
occurring  12 to 24 hours apart (Hogan et al.,  1994).  Mammalian embryonic cells divide by 
rotational cleavage whereby during the second cleavage one of the two blastomeres divides 
meridonally and  the  other divides  equatorially (Gulyas,  1975).  Mammalian  blastomeres  do 
not divide at the same time, they are diachronous and thus embryos often have odd numbers 
of cells.
In mice the first embryonic cell division begins  17-20 hours post-fertilisation and 
produces  an  embryo  with  two  identical  Blastomeres  (Hogan  et  al,  1994).  In  vivo,  the  2nd 
cleavage (3-4 cells) begins 46- 54 hours post fertilisation and the embryo typically reaches the 
8-cell  stage  by  60  hours.  Formation  of compacted  morula  occurs  by  60-75  hours  and 
blastocyst formation 84 -  96 hours (3.5-4 days) post fertilisation (Hogan et al.,  1994). During 
these early cell cleavages,  cilia and smooth muscle contractions of the oviduct wall help to 
push the embryo towards the uterus.  Following the third cleavage the blastomeres of the  8- 
cell embryo maximise their contact with one another,  forming a compact ball of cells.  This
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process marks the  start of compaction.  During compaction the  blastomeres adhere  together 
more tightly and this arrangement is stabilised by the formation of tight junctions that form 
between the outermost cells, sealing the inner cells off from the external environment (Pratt et 
al.,  1982).  This  arrangement  allows  the  cells  to  be  exposed  to  two  different 
microenvironments depending on their position within the embryo. The larger group of cells 
on the  outside  of the  embryo  are  exposed to  the  media  surrounding  the  embryo  while  the 
smaller group of inner cells do not have contact with the outside. Gap junctions form between 
the  inner  cells  allowing  small  molecules  to  pass  between  them.  The  Ca2+-dependent  cell 
adhesion molecule E-cadherin (Uvomorulin) appears at the time of compaction and causes the 
cells to adhere more closely. Antibodies to E-cadherin have been shown to reverse the process 
of compaction (Peyrieras et al.,  1983) revealing the importance of cadherins at this stage.
The  first cell differentiation event  in mammalian development  is the distinction 
between the trophectoderm (TE) and inner cell mass (ICM). This event allows the embryo to 
adhere  to  the  uterus.  The  descendents  of the  external  cells  of the  embryo  become  the 
Trophectoderm  (TE)  cells,  which  form  the  extra-embryonic  structures  such  as the  placenta 
(chorion). The fate of the inner cells of the embryo is to form the inner cell mass (ICM). The 
ICM gives rise to the embryo and  its associated allantois.  At the  16-32  cell  stage the  ICM 
cells  maintain  a  degree  of  plasticity  which  enables  them  to  differentiate  into  TE  cells 
(Fleming,  1986).  This  is  thought  to  enable  the  regulation  of the  ratio  of TE  to  ICM  cell 
number (Fleming,  1986).  At the 64 cell stage, the ICM consists of approximately 13 cells and 
is completely separate from the TE, thus neither group of internal or external cells contributes 
to the survival of the other. The embryo is now referred to as a morula.
Initially the  morula does not contain  a cavity after compaction  however the TE 
cells begin to secrete fluid into the morula. The resulting cavity is known as a blastocoel, this 
defines  the  formation  of  the  blastocyst.  The  cells  positioned  next  to  the  presumptive
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blastocoel have sodium (Na+) and potassium (K+) ion pumps that move sodium ions into the 
blastocoel, enlarging it by letting water flow in by osmosis (Watson and Barcroft, 2001). As 
the  blastocyst  continues  to  accumulate  blastocoelic  fluid,  it  increases  in  size  to  form  an 
expanded  blastocyst.  By  the  blastocyst  stage the  ICM  cells  have  lost  the  capacity  to  form 
extra-embryonic membranes but can contribute to any later embryonic tissue because they are 
still  totipotent  with  respect  to  embryonic  development.  At this  point the  blastocyst  cannot 
adhere to the oviduct wall due to the presence of the zona pellucida. Occasionally adherence 
does  occur  in  the  oviduct  and  this  can  result  in  ectopic  pregnancy,  a  potentially  life 
threatening  condition  that  can  lead  to  haemorrhage.  Ectopic  implantation  however  is  a 
common  occurrence  in  humans,  but  occurs  only  rarely  in  other  species  (Bronson  and 
Cunnane,  1975).  Once  the  blastocyst  reaches  the  uterus,  Strypsin,  a  trypsin  like  protease, 
which  is  present  on  the  cell  membranes  of the  outer  trophoblast  cells  helps  to  lyse  the 
fibrillase  matrix of the zona.  This causes an  opening  in  the zona pellucida from which  the 
blastocyst  can  be  easily  released.  The  blastocyst  adheres  to  the  uterine  wall  and  starts  to 
penetrate the  uterine epithelium  in a process mediated by TE  cells.  The  uterus  responds  to 
implantation with the  "decidual reaction," a process that allows the uterus to bring blood to 
the  developing  embryo  by  increasing  the  permeability  of blood  vessels  in  the  uterus  and 
allowing new blood vessels to be made (Psychoyos et al.,  1995).
1.1.4  Embryo developmental capacity
Embryos are routinely cultured until the blastocyst stage in vitro since most embryos cannot 
develop in the uterus before the morula or blastocyst stage. Primate embryos are an exception 
to this  rule and can be transferred  into the  uterus as early as the 4-8  cell  stage  resulting  in 
pregnancy in 20% of cases (Hunter,  1998).  This  is a considerable advantage to human  IVF 
since  detrimental  effects  associated  with  in  vitro  culture  can  be  kept  to  a  minimum.  The
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culturing of embryos to the blastocyst stage before implantation has however been shown to 
improve successful implantation by 30% to a 50% overall success rate (Gardner et al.,  1998). 
The ability to transfer only two blastocysts and still maintain high pregnancy rates will also 
facilitate the elimination of high order multiple  gestations.  The  in vitro  culture of embryos 
cannot  succeed past the blastocyst  stage  since embryos at this  stage  need to  implant  in  the 
uterus which is facilitated by in vivo conditions.
The  quality  of  the  blastocyst  is  imperative  to  high  implantation  rates  and 
development  to  full  term.  Specific  parameters  are  used  to  determine  the  viability  of 
preimplantation  embryos  (Bavister,  1995;  Van  Soom  et  al.,  1997).  The  timing  of  cell 
cleavages during early development has been reported to be a valuable parameter for intrinsic 
embryo  quality (Bavister,  1995;  Van  Soom  et al.,  1997).  Cinematographic analysis of cow 
embryos found that the faster the embryos cleaved into early stage embryos, the higher the 
probability  that  they  would  reach  the  morula  or  blastocyst  stage  (Grisart  et  al.,  1994). 
Approximately 70% of embryos reaching the 2-cell stage by 30-31  hours post insemination 
developed to these stages (Grisart et al.,  1994).
Assays based on nutrient uptake and subsequent utilisations as well as oxygen uptake 
and  enzyme  leakage  have  also  been  used  to  evaluate  embryo  viability  (Gardner,  1999). 
Assays  for  production  of growth  factors  such  as  trophoblast  interferon  have  been  used  to 
assess cow blastocyst quality (Hemandez-Ledezma et al.,  1993).
Scoring the percentages and rates of blastocysts hatching from the ZP can be a useful 
procedure  to  determine  blastocyst  quality  since  escape  from  the  ZP  is  essential  if  the 
blastocyst is to implant.  Differences in the timing, morphology and dynamics of ZP escape 
appear  however  to  exist  between  in  vivo  and  in  vitro  cultured  blastocysts  (Gonzales  and 
Bavister,  1995) . In vivo blastocysts escape the zona by global zona dissolution whereby the 
zona ‘dissolves’  evenly around the blastocyst. In contrast in vitro blastocysts escape through
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‘focal lysis’ by penetration of the zona by trophectodermal projections producing a small hole 
in the zona.
Invasive  techniques  to  study  the  internal  organelles,  DNA  quality,  microtubule 
assembly and cell number have been used to investigate embryo potential. Information on the 
distribution of ICM and TE cells in the blastocyst is valuable since a minimal number of ICM 
cells are required for a successful pregnancy. During normal development, optimal numbers 
of TE and ICM cells are present to ensure embryonic and fetal survival (Hardy et al.,  1989). 
The  ratio  of ICM  and TE  cell  numbers  is  particularly  important  since  a disproportionately 
large  ICM  has  been  associated  with  large-offspring  syndrome  (Leese  et  al.,  1998).  The 
determination of TE and  ICM allocation has proved to be an important measure of embryo 
viability and has thus attracted the development of a large number of procedures in order to 
distinguish the two cell types (Handyside and Hunter,  1984; Hardy et al.,  1989; De La Fuente 
and King,  1997; Thouas et al., 2001).
Apoptosis or cytoplasmic fragmentation has been commonly observed in mammalian 
blastocysts of excellent morphology. It has thus been suggested to play a role in the removal 
of defective cells as well as in the control of cell number and cell growth (Hardy et al., 2003). 
Extensive fragmentation is however associated with reduced blastocyst formation (Alikani et 
al., 2000; Hardy et al., 2003), reduced implantation potential (Alikani et al.,  1999) and lower 
blastocyst  cell  number,  especially  in  the  TE  (Hardy et  al.,  2003).  Apoptosis  has  also  been 
implicated  in  embryonic  arrest  (Jurisicova  et  al.,  1996).  The  detrimental  effects  of 
fragmentation  may  be  due  to  the  release  of toxins  that  damage  neighbouring  cells  or  the 
reduction in cytoplasm volume resulting in the loss of critical cellular components (Alikani et 
al.,  1999).  It has been demonstrated that extensive fragmentation results in the loss of whole 
blastomeres,  which  severely  reduces  blastocyst  formation  rate  (Hardy  et  al.,  2003).  It  has 
recently  been  proposed  using  a  mathematical  modelling  approach  that  an  embryos
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developmental competency is established before or at the zygotic  1-cell stage (Hardy et al.,
2001).  The majority of arrested embryos exhibit high  levels of chromosomal  abnormalities 
which  might  arise  because  of a  lack  of cell-cycle  checkpoints  before  embryonic  genome 
activation  (EGA)  (Handyside  and  Delhanty,  1997)  .  A  lack  of  functioning  cell-cycle 
checkpoints would allow apoptosis to  last till the eight-cell  stage when embryonic  arrest is 
first  observed  at  high  levels  (Hardy  et al.,  2001).  It  has  been  suggested  that  chromosomal 
abnormalities that arise after fertilisation could be due to lack of maternal transcripts during 
oocyte maturation (Hardy et al., 2001).
Apoptosis  has  been  detected  in  parthenogenetically  activated  preimplantation 
embryos, which shows that the initiation of apoptosis at this early stage does not require the 
paternal  genome(Liu et  al.,  2002).  The  initiation  of apoptosis  in  human  embryos coincides 
with the timing of compaction which occurs at the same time as gap junction formation. The 
presence of gap junctions on somatic cells has been reported to propagate apoptotic signals to 
their neighbouring cells suggesting that establishment of cell-cell communication may play an 
important role  in mediating apoptosis (Lin et al.,  1998).  It is unclear what process or signal 
initiates  apoptosis  in  preimplantation  embryos.  Fragmented  DNA  is  typically  detected  by 
terminal  deoxynucleotidyl  transferase  (TdT)  nick-end  labelling  (TUNEL)  and  been  widely 
used  to  detect  fragmentation  in  blastocysts  from  a  number  of  species  such  as  human 
(Jurisicova et al.,  1996; Spanos et al., 2000), cow (Fahrudin et al., 2002) (Neuber et al., 2002) 
and rat (Pampfer et al.,  1997).
It  is apparent that a plethora of strategies are  in  use to quantify and qualify embryo 
quality and viability, a process that is essential in order to increase successful pregnancies and 
reduce  the  risk of abnormalities.  These techniques  are  applicable  in  clinics  participating  in 
assisted  reproductive  technologies  (ART)  and  biotechnology  set  ups  carrying  out  nuclear 
transfer (NT) technology.
24Chapter 1: Introduction
1.2  [Ca2+]i signalling and fertilisation
1.2.1  [Ca2+]i signalling: a universal egg activation stimulus
An intracellular Ca2+ increase ([Ca2+]i) is an essential component of the fertilisation response 
in all plants and animals studied to date (Digonnet et al.,  1997).  In many eggs an increase in 
[Ca2+]i  is  triggered  at  the  point  of sperm  entry  before  being  propagated  as  a  global  wave 
across the whole egg (Strieker,  1999).  Some eggs such as those of the marine worm do not 
exhibit  [Ca2+]i  waves  but  [Ca2+]i  rises  simultaneously  around  the  egg  cortex  and  peaks 
slightly  later  in  the  nucleoplasm  (Stephano  and  Gould,  1997).  This  [Ca2+]i  signal  is 
responsible  for triggering  events  such  as  cortical  granule  exocytosis  (CGE),  completion  of 
meiosis (in mammals) and pronuclei formation. Collectively these processes are referred to as 
egg activation. In most mammals this [Ca2+]i signal takes on a distinct pattern in the form of 
repetitive  [Ca2+]i  transients  or  oscillations.  In  the  mouse  egg,  the  first  [Ca2+]i  transient  is 
longer in duration compared to subsequent transients and has smaller sinusoidal  [Ca2+]i rises 
at the peak. The following transients are of lower amplitude, shorter duration and occur at a 
frequency of several minutes from one another (Swann and Ozil,  1994). The [Ca2+]i transients 
continue for several hours and stop around the time of pronucleus formation (Kline and Kline, 
1992; Jones et al.,  1995a). The repetitive nature of the sperm-induced [Ca2+]i oscillations are 
essential for mammalian egg activation to be completed. Inhibition of these [Ca2+]i transients 
using the Ca2+ chelator BAPTA-AM completely blocks oocyte activation (Kline and  Kline,
1992)  and  premature  cessation  of  [Ca2+]i  oscillations  has  been  found  to  severely  retard 
pronucleus formation (Taylor et al.,  1993).
In most non-mammalians eggs such as frogs and sea urchins, the [Ca2+]i signal at 
fertilisation is in the form of a monotonic [Ca2+]i rise. During fertilisation in some species it is 
not the sperm that induces a [Ca2+]i increase in the egg, for example in the marine shrimp or
25Chapter 1: Introduction
zebrafish the [Ca2+]i increase is induced by ovulation or contact with sea or pond water (Lee 
et al.,  1999;  Lindsay et  al.,  1992).  These cases  are  unusual  however they are noteworthy 
exceptions since it relays the importance of the [Ca2+]i signal at fertilisation which appears to 
have  evolved  from  an  early  period  in  animal  natural  history  to  become  a  universal 
phenomenon.
1.2.2  Ca2+ release channels and intracellular stores
Ca2+ is responsible for stimulating a multitude of cellular processes from fertilisation to cell 
growth and adhesion (Berridge,  1993). The level of Ca2+ in the cytosol of a resting cell is very 
low (~100nM). Much higher concentrations of Ca2+ are found in the extracellular media (1- 
2mM)  and  specialised  Ca2+-sequestering compartments  (~600uM)  such  as the  endoplasmic 
reticulum (ER),  mitochondria and nuclear envelope (Rizzuto et al.,  1994;  Subramanian and 
Meyer,  1997).  The primary storage organelle for Ca  in most (non-muscle) cells  is the ER 
(Berridge and Irvine,  1989).
Ca2+ channels  on  the  plasma membrane  or membrane  of the  Ca2+  sequestering 
compartments can be stimulated to open by extracellular signal transduction. Ca2+ can rapidly 
move down its concentration gradient into the cell’s cytosol resulting in a dramatic increase in 
[Ca2+]i. A sudden rise in [Ca2+]i can stimulate a cascade of celluar events mediated by Ca2+- 
binding  proteins  and  protein  kinases.  In  order  for  [Ca2+]i  to  serve  as  an  intracellular 
messenger it must be present at very low concentrations in the cell’s cytosol. Many cells have 
ATP-dependent  Ca2+-ATPases  in  the  plasma  membranes  and  membranes  of  intracellular 
stores which act to pump Ca2+ from the cytosol to extraceullar media or intracellular stores, 
against  its concentration gradient (Fig  1.1).  The  uptake of Ca2+  into the  ER takes  place  via 
specialised Ca2+-ATPase pumps referred to as Sarcoplasmic/Endoplasmic Reticulum Calcium
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Figure 1.1  [Ca2+]i release via the  Inositol  1,4,5-Trisphosphate (InsP3) pathway during 
fertilisation. An active PLC  hydrolyzes phosphatidylinositol  bisphosphate (PIP2)  into the 
two secondary messengers inositol  1,4,5-trisphosphate (InsP3) and diacyl  glycerol (DAG). 
InsP3  then  diffuses  into  the  cytosol  and  activates  the  InsP3R  on  the  membrane  of the 
endoplasmic reticulum  (ER),  which subsequently releases Ca2+ from the  ER.  Further Ca2+ 
release  via the  lnsP3R is thought to  occur when  the  InsP3R is  stimulated  by Ca2+ binding 
during  a  process  called  calcium-induced  calcium-release  (CICR).  ATP-dependent  Ca2+- 
ATPases in the membrane of the ER allow Ca2+ to be pumped back into the  ER against a 
Ca2+ concentration gradient.
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ATPase (SERCA) pumps because they are also found in the sarcoplasmic reticulum (Lytton 
et al., 1992).
Two types of Ca2+ release channels have been identified on the endoplasmic reticulum 
plasma  membrane:  the  inositol  1,4,5-trisphosphate  receptor  (InsPsR)  and  the  ryanodine 
receptor  (RyR)  (Wagenknecht  et  al.,  1989).  The  RyR  is  the  Ca2+  release  channel  that 
dominates in the sarcomplasmic reticulum (muscle cells) however in all other cell types such 
as  the  mammalian  oocyte,  InsPaRs  predominate  (Berridge,  1993)  (Miyazaki  et  al.,  1993). 
RyRs  do  however exist  in  mammalian eggs  since  mouse  eggs have  been  found to  express 
mRNA for RYR isoforms type 2 and 3 and the proteins for these isoforms has been detected 
using western blots (Ayabe et al.,  1995). The role and mechanism of RyR at fertilisation is 
unclear.  Microinjection  or  external  addition  of ryanodine  has  been  shown  to  cause  [Ca" ]i 
increases and inhibit agonist induced [Ca2+]i oscillations in mouse eggs (Swann,  1992; Jones 
et al.,  1995b). This suggests that a RyR-sensitive mechanism is at play in mammals, although 
there  is  much  more  evidence  that  suggests  that  InsP3-induced  [Ca2+]i  release  is  the  main 
mechanism  by  which  regenerative  stimulation  of  [Ca2+]i  release  at  fertilisation  occurs 
(Miyazaki et al., 1993).
During fertilisation the hydrolysis of phosphatidylinositol 4,5 bisphosphate (PIP2) 
is  catalysed by a phospholipase C  which  results  in the generation of two  products,  Inositol 
1,4,5-trisphosphate  (InsP3) and  diacyl  glycerol  (Fig  1.1).  The  binding of InsP3  to  the  InsP3 
receptor (InsP3R)  situated on the ER causes  InsP3-induced  [Ca2+]i  release  (Miyazaki et al.,
1993). Monoclonal antibodies against the type  1   InsP3R revealed that InsP3Rs are present in 
the cytoplasm near the egg surface to initiate the InsP3-mediated signal and also in the deeper 
cytoplasm to propagate the waves of [Ca2+]i (Miyazaki et al.,  1992). This work also showed 
that type  1   but not the type  11  or  111  InsP3R were essential for mediating the InsP3-induced 
[Ca2+]i  release  (Miyazaki  et  al.,  1993).  In  addition,  the  microinjection  of  lnsP3  into
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unfertilised  mouse  eggs  has  been  found  to  trigger  [Ca2+]i  oscillations  (Swann,  1994). 
Inhibition  of  the  InsPsR  using  a  functionally  inhibitory  monoclonal  antibody  (18A10) 
inhibited sperm-induced  [Ca2+]i  oscillations  and  subsequent egg  activation  in  hamster eggs 
(Miyazaki  et  al.,  1992).  [Ca2+]i  oscillations  that  are  induced  during  fertilisation  or 
microinjection of adenophostin A are inhibited after the downregulation of InsPsR (Brind et 
al.,  2000).  Opening of the  IP3R, in the  presence  of IP3  is also thought to  be  stimulated  by 
calcium  binding  to  the  Ip3R causing  a  process  known  as  calcium-induced  calcium-release 
(CICR) (Jaffe, 1991).
In sea urchin eggs, which have both RyR and InsP3R, inhibition or either channel 
individually fails to prevent a [Ca2+]i rise at fertilisation, inhibition of both channels however 
completely inhibits Ca2+ release, indicating that InsP3R  and RyR have redundant mechanisms 
during  fertilisation  in the  sea urchin (Galione et al.,  1993).  It  is unclear  if RyR are  able to 
fully substitute for InsP3R’s since Ca2+ fluxes mediated by InsP3 were shown to be needed for 
normal cleavage in sea urchins (Ciapa et al.,  1994). InsP3 induced [Ca2+]i release mechanisms 
appear to also be necessary for normal starfish development (Strieker,  1995). Further studies 
on  different  species will  need to  be  carried out to  elucidate whether the  RyR plays  a vital 
function in fertilisation, the evidence so far suggests however that InsP3R is the main [Ca2+]i 
release channel mechanism.
1.2.3  Meiotic arrest is maintained by high MPF activity
Early  work  carried  out  on  frog  eggs  demonstrated  that  cytoplasm  transferred  from 
progesterone-treated  (maturing)  eggs caused  recipient  immature eggs to  undergo  premature 
maturation (Masui and Markert,  1971). The cytoplasmic substance responsible for this effect 
on  maturation  was  referred  to  as  Maturation-Promoting  Factor  (MPF).  MPF  was  found  to 
appear 6 hours after progesterone treatment and persist at high levels until fertilisation, after
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which  it declines to  low level during cell cleavage (Masui and Markert,  1971).  It was  also 
suggested that MPF played a role in cell cycle progression since it was also shown to appear 
in  frog  eggs  shortly  before  mitosis  (Wasserman  and  Smith,  1978).  MPF  is  now  known  to 
comprise of a regulatory cyclin B subunit (Evans et al.,  1983) and a cyclin dependent kinase 1  
(Cdkl)  (Doree  and  Hunt,  2002).  During  early egg  development the  levels of MPF  change 
dramatically.  In  frogs  Meiosis  I  is  activated  by  high  levels  of MPF that  are  stimulated  by 
progesterone secretion. MPF is at its highest at metaphase of meiosis I (MI) but falls briefly to 
cause the transition from MI to anaphase 1 and first polar body extrusion (Ledan et al., 2001). 
MPF activity rises again as the Mil spindle is reformed. Maintainance of high levels of MPF 
ensures the egg stays arrested at MIL A constant turnover of cyclin B occurs during Mil arrest 
and maintains a continuous equilibrium between cyclin B synthesis and degradation (Kubiak 
et al.,  1993). MPF activity is stabilised by a cytostatic factor (CSF) which acts to achieve cell 
cycle arrest prior to fertilisation. CSF was first discovered when cytoplasm from eggs at late 
stages  of maturation  were  found to  trigger metaphase  arrest  in the  blastomeres  of zygotes 
(Masui and Markert,  1971).  It is unclear what mechanism CSF employs to keep MPF  levels 
high,  it  is widely  believed however that the  Mos  protein,  mitogen-activated  protein  kinase 
(MAPK), early mitotic inhibitor  1   (Emil) and a recently discovered early mitotic inhibitor 2 
(Emi2) are involved. The injection of synthetic mos RNA into Xenopus blastomeres induces 
metaphase arrest. In contrast, immunodepletion of endogenous Mos from egg cytosol extracts 
prevented  meiotic  arrest  in  embryos  (Sagata  et  al.,  1989),  it  is  thus  clear  that  Mos  is  a 
component of CSF. Mos is not the sole component of CSF however since it is insufficient to 
maintain Mil arrest when acting alone and cyclin B is degraded before activation of the Mos 
pathway.
The 44-kDa protein Emil was recently proposed to be necessary and sufficient for 
causing  meiotic  arrest  (Reimann  and  Jackson,  2000).  The  addition  of extra  Emil  to  CSF-
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containing extracts prevented the destruction of cyclin B and mitotic exit whilst in contrast, 
CSF-extracts  immunodepleted  with  Emil  exit  from  mitosis  prematurely  in  the  absence  of 
[Ca2+]i  increases  (Reimann  and  Jackson,  2000).  Another  study  which  raised  an  antibody 
against  Emil  and  failed  to  detect  a  44-kDa  band  by  immunoblot  in  the Xenopus  egg  or 
embryo until gastrulation concluded that Emil  is unstable and cannot exist in the embryo until 
gastrulation and therefore is not required for CSF activity (Ohsumi et al., 2004) however no 
evidence exists to show that the 44kDa band observed at gastrulation was that of Em il.  Most 
recently an Emil  homologue identified as Emi2 has been put forward as a CSF maintenance 
protein  (Tung  et  al.,  2005).  Emi2  cross-reacts  with  antibodies  raised  against  Emil  which 
suggests  that  previous  Emil  immunoprecipitation  experiments  may  have  also  resulted  in 
inactivation  of Emi2,  a  possible  CSF  candidate.  Evidence  in  support  of Emi2  as  a  CSF 
candidate includes evidence it is an APC inhibitor and that Emi2 is targeted for destruction by 
Polo-like kinase 1  (Plxl) in response to [Ca2+]i signalling (Tung et al., 2005).
Mitogen-activated protein kinase (MAPK) has been  shown to  be  involved  in 
meiotic arrest although its role is unclear. Components of the MAPK pathway such as p90rsk 
were reported to cause metaphase arrest when injected into Xenopus blastomeres (Bhatt and 
Ferrell,  1999).  MAPK  is  capable  of  maintaining  meiotic  arrest  and  is  believed  to  act 
downstream of the Mos-pathway since MAPK fails to activate eggs in mos-/- mice (Verlhac 
et al.,  1996).  It is clear that a number of important components seem to be present in CSF the 
exact  mechanisms  by which  they  maintain  high  levels  of MPF  are  not  however known  at 
present.
1.2.4  [Ca  ]i signals release the egg from meiotic arrest
As discussed above, Mil arrest is characterised by biologically active levels of MPF and thus 
cyclin B must be continuously synthesized and destroyed to ensure the activity of MPF. Exit
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from meiotic arrest is caused by destruction of the cyclin B component which in turn greatly 
reduces the activity of MPF (Murray et al., 1989; Kubiak et al.,  1993). Cyclin B is targeted for 
proteolytic destruction by the anaphase promoting complex/cyclosome (APC/C). APC  is an 
E3 ligase complex that degrades its substrates (e.g. - cyclin B) by ligating them with ubiquitin 
which  serves  to  target  them  for  proteolysis  by  the  26S  proteosome.  Cyclin  B  contains  a 
RXXL  destruction-box  motif,  which  is  critical  for  ubiquitin  ligation  and  thus  proteolysis 
(Murray et al.,  1989; King et al., 1995).
[Ca2+]i  increases  during  fertilisation  or  parthenogenetic  activation  have  been 
reported to  induce  cyclin B  destruction and hence resumption of the  cell  cycle  in  frog  and 
mice (Lorca et al.,  1993; Winston et al.,  1995). Cyclin B destruction in the mouse requires the 
presence  of an  intact  spindle  since  exposure  to  nocodazole,  a  microtubule-depolymerising 
drug greatly reduced the rate of cyclin B degradation (Kubiak et al.,  1993). Consistent with 
this, egg activation with the parthenogenetic agent, thimerosal destroys the spindle and also 
prevents exit from Mil (Cheek et al., 1993).
One study monitored cyclin B activity during fertilisation using a cyclin B-GFP 
plasmid,  revealing  that  repetitive  [Ca2+]i  transients  are  necessary  for  the  continuous 
destruction of cyclin  B  (Nixon et al.,  2002).  Incremental  drops  in cyclin  B were associated 
with each [Ca2+]i transient when they were high in magnitude such as that of the first [Ca2+]i 
transient at fertilisation, (Nixon et al., 2002).
In  Xenopus,  cyclin  proteolysis  is  mediated  by  a  Ca2+-calmodulin  dependent 
process  (Lorca et  al.,  1991;  Lorca et al.,  1993).  Calmodulin  binds  Ca2+ and  functions  as  a 
multipurpose  intracellular Ca2+  receptor and  mediates  most Ca2+  regulated  processes.  Ca2+- 
calmodulin  does  not  have  enzymic  activity  itself but  becomes  active when  bound  to  other 
proteins. Ca  -Calmodulin dependent protein kinase II (CAMKII) has been revealed as being 
essential for meiotic resumption and cell cycle progression in amphibian and mammalian eggs
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(Lorca et al.,  1993;  Dupont,  1998).  It was reported in frog eggs that inhibitors of CAMKII 
prevent  Ca2+-induced  cyclin  degradation  and  constitutively  active  CAMKII  activates 
unfertilised eggs in the absence of any [Ca2+]i increase (Lorca et al.,  1993).
CAMKII  is  likely  to  have  a  similar  role  in  the  mouse  since  ethanol-induced 
parthenogenetic  activation  which  causes  a  single  [Ca2+]i  rise  induces  a  similar  rise  in 
CAMKII (Winston and Maro,  1995; Tatone et al.,  1999; Tatone et al., 2002). Monotonic rises 
in [Ca2+]i appear however to cause a  transient activation of CAMKII rather then a sustained 
activation (Winston and Maro,  1995;  Tatone  et al.,  2002).  Complete  egg activation  can  be 
hindered if the nature of the [Ca2+]i transient is insufficient to degrade cyclin B, for example, 
stopping  Ca  oscillations  prematurely  has  been  shown  to  severely  retard  pronucleus 
formation (Lawrence et al.,  1998). This suggests that the repetitive nature of sperm-induced 
[Ca2+]i oscillations in mammalian eggs act to activate CAMKII for a sustained time period to 
ensure progression through  the cell  cycle.  While  it  is accepted that the  immediate target of 
Ca2+-calmodulin  is  CAMKII the  exact  mechanism  of how  CAMKII  activates the  cyclin  B 
destruction pathway is unclear (Nixon et al., 2002).
Cyclin degradation is initiated by fertilisation-induced  [Ca2+]i oscillations and  is 
mediated via the Anaphase Promoting Complex (APC) pathway. Consistent with this, [Ca2+]i 
has  been  shown  to  induce  assembly  of the  26S  proteosome  from  the  20S  proteosome  in 
Xenopus  and  ascidian  eggs  (Kawahara  and  Yokosawa,  1994;  Aizawa  et  al.,  1996).  The 
switching-on of Ca2+-dependent APC pathway which leads to meiotic resumption is likely to 
be  triggered by CAMKII  however the  exact  mechanisms of action  are  presently unknown. 
Recently a constitutively active cRNA construct of CAMKIIa was reported to trigger meiotic 
resumption,  pronucleus  formation  and  2nd  polar  body  extrusion  when  microinjected  into 
mouse eggs (Madgwick et al., 2005). The spindle poison nocodazole but not the Ca2+ chelator 
BAPTA blocked CAMKII-induced meiotic resumption showing that CAMKII mediates cell-
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cycle  resumption  downstream  of  sperm-induced  Ca2+  release  but  upstream  of  the  APC 
(Madgwick et al., 2005).
1.2.5  Post-activation affects of [Ca2+]i signalling on preimplantation development
There  is mounting evidence that  [Ca2+]i oscillations at activation affect the development of 
the  embryo  after the  first cell  cycle.  [Ca2+]i  transients  can be  induced  and  manipulated  by 
means of electrical field pulse which allows complete control over the amplitude, frequency 
and  duration  of each  spike  (Ozil,  1990;  Ozil  and  Swann,  1995).  The  pattern  of  [Ca2+]i 
oscillations during egg activation has been shown to have a profound effect on the percentage 
of compacted embryos and blastocysts in rabbit (Ozil,  1990) and cow embryos (Collas et al., 
1993).  The  pattern  of  [Ca2+]i  oscillations  has  also  been  shown  to  affect  composition  of 
blastocysts  in  mouse  embryos  (Bos-Mikich  et  al.,  1997).  The  same  study  showed  that 
increasing  the  duration  of St2+-induced  [Ca2+]i  oscillations  from  two  to  four  to  six  hours 
caused an incremental increase in the number of cells in the ICM (Bos-Mikich et al., 1997).
Improved development has been reported when stimuli which cause an elevation
•  2+ in Ca  are  added to the  culture media of developing embryos.  The exposure  of morula to 
ethanol  or  Ca2+  ionophore  increases  the  rates  of  blastocyst  cavitations  and  expansion 
(Stacheki  et  al.,  1994a).  Blastocyst  exposure  to  the  same  Ca2+-inducing  stimuli  improves 
implantation and blastocyst outgrowth  in mouse embryos (Stacheki  et al.,  1994b).  In  post­
implantation development, manipulating the pattern of [Ca2+]i  transients has been shown  to 
optimise somite and heart development in rabbit embryos (Ozil and Huneau, 2001), moreover 
[Ca2+]i  elevations  have  been  reported  to  be  necessary  for normal  long-term  developmental 
changes in somatic cells such as cellular differentiation in embryonic neuronal cells (Spitzer 
et  al.,  1994).  The  mechanism  by  which  these  [Ca2+]i  signals  can  have  an  impact  on 
preimplantation development are unknown yet there is evidence to suggest the nature of the
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Ca2+ flux patterns can influence gene expression patterns. One report revealed that there was 
an optimal frequency of [Ca2+]i transients that was most efficient at driving gene expression 
(Li  et  al.,  1998).  This  is  consistent  with  other  reports  that  also  show  repetitive  [Ca  ]i 
oscillations are more efficient at inducing gene expression and were able to trigger expression 
of  a  higher  number  of  transcription  factors  compared  to  a  monotonic  rise  in  [Ca  ]i 
(Dolmetsch et al.,  1998). Mobilisation of Ca2+ has also been shown to be a major component 
in  the  activation  of the  transcription  factors fos  and jun  in  rat  fibroblasts  (Pribnow  et  al.,
1992).  Thus,  [Ca2+]i  oscillations  clearly  play  a  part  in  maintaining  normal  cellular 
development and at least in part by mediating changes in transcription factors.
1.2.6  Initiation of Ca2+ release by the sperm
Until recently the mechanism by which the sperm triggers Ca2+ release  in mammalian eggs 
has been a highly contentious issue. Three models were proposed to explain the Ca2+ release 
mechanism and were termed the conduit, contact and content models (Jaffe,  1991) (Fig  1.1). 
The content  (sperm  factor) theory  is now a widely accepted phenomenon  in  mammals  and 
ascidians  however  it  is  appropriate  to  describe  the  3  main  theories  to  provide  some 
background and understanding of what is known about [Ca2+]i  increases at egg activation.  I 
will discuss the conduit and contact (receptor-1 igand) theory briefly in turn before describing 
the “sperm factor” mechanism in more detail.
In the Ca2+ conduit hypothesis, the sperm was proposed to act like a channel or pipe, 
allowing  a continuous  influx of extracellular Ca2+  into  the  egg through  pores  in  the  sperm 
membrane  (Fig  1.1 A).  The  massive  rise  of [Ca2+]i  was  proposed  to  overload  intracellular 
stores,  triggering  calcium-induced  calcium-release  (CICR)  (Jaffe,  1991).  Support  for  this 
model  came  from  reports  which  showed  that  sperm-egg  fusion  was  a  prelude  to  [Ca2+]i 
increase at fertilisation (McCulloh and Chambers,  1992;  Lawrence et al.,  1997; Jones et al.,
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1998a)  and  Ca2+  injection  into  fish  and  frog  eggs  generated  a  single  [Ca2+]i  transient 
(Nuccitelli,  1991).  Subsequent  findings  did  not  provide  support  for this  model  since  Ca2+ 
influx  into  mammalian oocytes was  only  found to cause a single  [Ca2+]i  wave and did not 
produce the hallmark [Ca2+]i oscillations found at fertilisation (Swann and Ozil,  1994). It was 
also  demonstrated  that  a  very  low  concentration  of extracellular  Ca2+  of  13nM  in  culture 
media compared to  1.71mM did not prevent the initiation of [Ca2+]i transients at fertilisation 
(Jones etal.,  1998a).
The contact or receptor-ligand theory states that  [Ca2+]i oscillations are initiated 
through a signal transduction pathway involving the interaction of a sperm ligand to an oocyte 
plasma membrane receptor (Fig  1  .IB) (Foltz and  Shilling,  1993) (Schultz and Kopf,  1995). 
The  receptor theory was  proposed after studies  on  sea urchin  eggs revealed an  increase  in 
InsP3 turnover during fertilisation (Ciapa and Whitaker,  1986). The receptor was proposed to 
activate an egg derived PLC that in turn causes the hydrolysis of PIP2, which generates the 
Ca2+-releasing messenger InsP3  The oocyte receptor was proposed to be coupled to a tyrosine 
kinase  or  G  protein  signalling  pathway  which  triggers  the  [Ca2+]i  increase.  However, 
antibodies  to  the  Gq  family  of G-proteins  were  unable  to  prevent  sperm-induced  [Ca2+]i 
increase in mouse eggs (Williams et al.,  1998). Although there has been contention about the 
mechanism of activation at fertilisation it is now widely accepted that  InsP3  plays a role  in 
regulating [Ca2+]i oscillations at this time. Many studies have demonstrated that injection of 
InsP3 generates Ca2+ release in rabbit (Fissore and Robl,  1993), bovine (Fissore et al.,  1995) 
and hamster (Miyazaki et al.,  1992) eggs. Furthermore, sustained injection of lnsP3 has been 
shown to cause repetitive [Ca2+]i oscillations in mammalian oocytes (Swann and Ozil,  1994). 
Much  of this  evidence  has  been  used  to  validate  the  receptor-ligand  theory  rather  than 
supporting the role of InsP3 in sperm-induced Ca2+ release. Furthermore, the isolation of many 
surface  molecules  involved  in  sperm-egg  binding  has  not  produced  any  evidence  of  a
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membrane receptor that when activated by fertilisation can cause a [Ca2+]i increase. The most 
convincing piece of evidence against the receptor-ligand theory came from direct injection of 
the sperm (ICSI) which bypasses any interaction between the two gametes but results in egg 
activation and development to term (Kimura and Yanagimachi, 1995).
The  sperm  factor  theory  proposes  that  after  sperm-oocyte  fusion,  a  cytosolic 
sperm factor is introduced into the ooplasm and initiates [Ca2+]i release (Swann,  1990) (Fig 
1.1C). This hypothesis justifies many of the observations that could not be explained ffom the 
“Ca2+ conduit” or “receptor” models. The first substantiation of this model came from studies 
showing that  injection of sea urchin sperm extracts into unfertilised sea urchin eggs caused 
elevation of the fertilisation envelope; a sign that a [Ca2+]i increase had occurred (Dale et al., 
1985).  Consistent  with  the  sperm  factor  hypothesis,  in  mouse  eggs  fluorescent  dextrans 
(Lawrence et al.,  1997) and large molecular weight proteins (Jones et al.,  1998a) have been 
shown to diffuse between gametes prior to any observed [Ca2+]i changes.  Sperm-egg fusion 
has also been shown to precede the initial [Ca2+]i transient in sea urchin eggs (McCulloh and 
Chambers,  1992).
During  fertilisation  in  ascidian  eggs  the  sperm  triggers  two  phases  of  [Ca2+]i 
oscillations that are  separated by duration of approximately five mins. The  first few  [Ca2+]i 
waves triggered by fertilisation stimulate cortical contractions, which form a contraction pole. 
An  endoplasmic  reticulum-rich  domain  at  the  contraction  pole  becomes  a pacemaker  ffom 
which the 2nd phase of [Ca2+]i waves originates from (McDougall and Sardet,  1995). Injection 
of ascidian  sperm extract roughly equivalent to a single spermatozoon mimics the temporal 
(Kyozuka  et  al.,  1998)  and  spatial  (McDougall  et  al.,  2000)  pattern  of [Ca2+]i  oscillations 
triggered by the sperm. These data strongly supports the sperm factor model.
The  sperm  factor  has  been  reported  to  act  universally  across  species.  Injected 
porcine  sperm extracts have  been  shown  for example,  to cause  [Ca2+]i oscillations  in  cow,
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mouse (Wu et al.,  1997) and hamster (Swann,  1990) eggs. This Ca2+ releasing ability is not 
limited  to  mammalian  sperm  factors  since  microinjection  of  sperm  extracts  ffom  frogs, 
chickens (Dong et al., 2000) and fish (Coward et al., 2003) cause [Ca2+]i oscillations that are 
similar  in  pattern  to  fertilisation-induced  [Ca2+]i  oscillations  in  mouse  eggs  (Dong  et  al., 
2000).  Similarly  non-mammalian  species  eggs  respond  to  mammalian  sperm  factor  for 
example,  pig  sperm  extracts  induce  [Ca2+]i  oscillations  when  microinjected  into  the 
nemertean worm egg (Strieker et al., 2000). Cytosolic soluble extracts derived ffom flowering 
plant  pollen  in Brassica campestris  have  also  been  shown to  stimulate  [Ca2+]i  oscillations 
when micro injected  into  mouse eggs  (Li  et al.,  2001).  Cumulatively these  findings  suggest 
that the function of the sperm-factor is universally conserved not only across mammalian and 
non-mammalian species in the animal kingdom but also in the plant kingdom.
Mounting  evidence  implied that the  sperm  factor  is  proteinaceous  since  it  was
sensitive to both trypsin and heat and had a high molecular weight (30kDa) (Swann,  1990).
Another characteristic of the sperm factor was that it was tissue-specific.  When mRNA was
isolated  from  different  tissues  only  mRNA  from  spermatogenic  cells  appeared  to  trigger 
2+  . . .
[Ca  ]i  oscillations  after  microinjection  into  mouse  eggs,  which  suggested  that  mRNA 
encoding  the  sperm  factor  can  be  translated  into  an  active  protein  in  the  egg  cytoplasm 
(Parrington et al., 2000).
Further evidence for the sperm factor model comes from ISCI, which bypasses the 
normal  barrier  of sperm-egg  binding  but  has  been  shown  to  induce  [Ca2+]i  oscillations  in 
human and mouse eggs, which are similar to those seen at fertilisation (Tesarik et al.,  1994; 
Palermo  et  al.,  1997;  Nakano  et  al.,  1997).  The  biological  issues  of  ICSI  have  been 
controversial  (Ola  et  al.,  2001),  however  the  high  rates  of activation  and  resulting  births 
indicate  it  is  a  successful  Assisted  Reproduction  Technology  (ART)  for  couples  suffering 
from infertility problems (Palermo et al.,  1992; Palermo et al., 1995).
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One of the main criticisms of the sperm factor theory has been that large amounts 
of sperm extract, predicted to be more than a single sperm equivalent, are needed to cause egg 
activation (Swann,  1990;  Strieker,  1997).  However this prediction  is  likely to be due to the 
difficulty in extracting the protein  from a single sperm without a significant loss of activity 
during purification. One report indicated that between  1   and 8  sperm  is sufficient to trigger 
[Ca2+]i  oscillations  in a single  egg  (Nixon et al.,  2000).  The  adequacy  of a  single  sperm’s 
factor is however obvious since ICSI is sufficient to cause [Ca2+]i oscillations, egg activation 
and development to term (Palermo et al., 1992; Tesarik et al., 1994; Sato et al., 1999).
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Figure  1.2  Three  proposed  models  of  sperm-induced  Ca2+  release  at  fertilisation.  A)  The
conduit model describes the sperm as a channel that allows the flow of extracellular Ca2+  into the 
egg which in turn overloads the ER. Subsequent transients were hypothesised to some from Calcium 
induced-calcium  release  mechanisms.  B)  The  contact  model  proposes  that  Ca2+  increases  are 
initiated through a signal transduction pathways which is activated through contact between a sperm 
ligand and egg receptor. The egg receptor may be coupled to a G-protein or Tyrosine kinase which 
in turn activates a phospholipase C (PLC) which splits phosphatidylinositol 4,5-bisphosphate (P1P2) 
into  inositol  1,4,5-trisphosphate  (InsP3)  and  diacylglycerol  (DAG).  InsP3  binds  to  InsP3R’s 
stimulating InsP3-induced Ca2+ release. C) The content model proposes that a cytosolic sperm factor 
enters  the  egg  from  the  sperm  after  sperm-egg  fusion  and  induces  Ca2+  release  by  the  InsP3 
pathway. Recent evidence has put this model in favour and shown the sperm factor is in fact a PLC 
termed PLC£ (Saunders et al, 2002).
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1.2.7  Candidates for the title of the sperm factor
The  identity of the  sperm  factor was uncertain until recently and researchers  in 
fact  spent over a decade trying to  establish the  key molecule(s) that was the  sperm  factor. 
Early on  in the  investigation  it was  suggested that Ca2+ might  itself be responsible  for egg 
activation by entering the egg cytosol ffom the surrounding media (conduit theory). A protein 
binding assay revealed that the sperm contained enough  InsP3 to activate eggs and that the 
sperm factor only worked ffom inside the egg consistent with the primary messenger role of 
InsP3.  Injections of  a single bolus of Ca2+ or InsP3 however fail to cause sustained  [Ca2+]i 
oscillations  (Igusa  and  Miyazaki,  1983;  Mehlmann  and  Kline,  1994).  PLCs  are  directly 
responsible for the production of InsP3 and it has been suggested therefore that a PLC  must 
participate upstream in  inducing  [Ca2+]i  increases at fertilisation. This was demonstrated by 
the addition of boar sperm extracts to sea urchin homogenate which was shown to cause InsP3 
production  and  Ca2+  release  (Jones  et  al.,  1998b).  Moreover,  depleting the  homogenate  of 
PLC blocked InsP3 generation and [Ca2+]i increase
A  33kDa  glucosamine-6-phosphate  isomerase  was  identified  as  a  potential 
candidate sperm factor (Parrington et al.,  1996).  This protein termed “oscillin” was purified 
ffom  hamster  sperm  extracts  and  when  it  was  injected  into  mouse  eggs  it  correlated  with 
[Ca2+]i release. Injection of recombinant oscillin into eggs did not however cause any [Ca2+]i 
oscillations (Wolosker et al.,  1998).  Parrington’s group used SDS  gels to reveal that oscillin 
was present in  sperm extracts. The gel displayed a major band at 35kDa along with  several 
other lower weight bands. It has been suggested that since they used a Coomasie brilliant blue 
R-250 dye which is less sensitive than silver stains the Ca2+ releasing ability of the oscillin 
extract  was  not  directly  attributable  to  oscillin  but  other  proteins  present  in  the  extract 
(Wolosker et al., 1998).
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Another  possible  candidate  for  the  sperm  factor  is  a  truncated  form  of the  c-kit 
receptor named tr-kit. Injection of recombinent tr-kit protein or its complementary RNA into 
mouse eggs was reported to be sufficient to cause egg activation and 30% of embryos reached 
past  the  2-cell  stage  (Sette  et  al.,  1997).  There  were  however  a  number  of  different 
observations about tr-kit that did not fit into the sperm-factor theory,  for example tr-kit was 
predominantly  located  in  the  sperm  midpiece  and  not the  sperm  head,  which  is  known  to 
activate eggs after ICSI is performed. There was also no evidence that injection of tr-kit could 
induce [Ca2+]i oscillations in unfertilised eggs. A SH3 domain containing construct, inhibited 
activation in tr-kit injected eggs but did not block activation in fertilisation-induced activation 
suggesting  that  tr-kit  activates  eggs  by  a  different  mechanism  than  that  which  occurs  at 
fertilisation.
One group have reported that nitric oxide (NO) triggers [Ca2+]i oscillations and all the 
events associated with egg activation in sea urchin eggs (Kuo et al., 2000). The same group 
also  showed  that  the  NO-scavenger  oxyhaemoglobin  prevented  egg  activation  (Kuo  et  al.,
2000).  This  finding  is  not  however  supported  by  studies  on  mouse  and  ascidian  eggs  that 
show sperm-induced [Ca2+]i increases were not associated with any global or local change in 
NO  (Hyslop  et  al.,  2001).  Furthermore,  an  NO  synthase  inhibitor  failed  to  block  sperm- 
induced Ca2+ rises (Hyslop et al., 2001).
One  of the  definitive  tests  that  all  candidates  for  the  title  of the  sperm  factor 
should  be  tested  on  is  their  ability  to  reproduce  the  distinct  [Ca2+]i  oscillations  that  are 
observed  at fertilisation.  Until  recently all  candidates  put forward  for the title of the  sperm 
factor had failed to induce these hallmark repetitive [Ca2+]i oscillations.
A novel phospholipase C termed PLC^ (zeta) was recently identified as the sperm 
factor following a mouse testis Expressed Sequence Tag (EST) database searches (Saunders 
et  al.,  2002).  Injection  of cRNA  encoding  PLC£ was  found to trigger  long  lasting  [Ca2+]i
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oscillations that were  indistinguishable  from those observed at fertilisation.  Consistent with 
this, a recombinant PLC£ has also been shown to produce [Ca2+]i oscillations in mouse eggs 
that  are  indistinguishable  from  those  observed  at  fertilisation  (Kouchi  et  al.,  2004).  The 
amount of PLC£ required to  induce  [Ca2+]i  oscillations similar to those at fertilisation were 
assayed  and  found  to  be  equivalent  to  approximately  one  sperm’s  worth  (Saunders  et  al., 
2002).  Removal  of PLC£  ffom  sperm  extracts  using  antibodies  specific  to  PLC£  inhibited 
[Ca2+]i oscillations when microinjected into mouse eggs and this confirmed that PLC£ is the 
single responsible factor which induces egg activation (Saunders et al., 2002). Microinjection 
of PLC^ cRNA has also been shown to cause activation and development up till the blastocyst 
stage with success rates similar to those seen after IVF (Saunders et al., 2002).
PLC^  complements  previous  clues  about  the  nature  of the  sperm  factor.  The 
sperm  factor  was  proposed  to  be  a  universal  factor  which  acted  across  species.  This 
proposition  is  supported  by reports that  show that human and monkey PLC£ can  stimulate 
activation and development to the blastocyst stage in mouse eggs (Cox et al., 2002). Recent 
studies  have  also  demonstrated  that  a  PLC^  orthologue  is  present  in  a  non-mammalian 
vertebrate,  the  domestic  chicken.  Recombinant  chicken  PLC£  cRNA  can  stimulate  [Ca2+]i 
oscillations when microinjected into mouse eggs suggesting that PLC£ could be functionally 
conserved in other non-mammalian vertebrates (Coward et al., 2005).
1.2.8  [Ca2+]i releasing ability of PLC£
Five  isoforms of the PLC  family (|3, y, 8, £ and Q have been classified on the basis of their 
sequence homology. PLC^ is a unique PLC on the basis that it can induce Ca2+ oscillations in 
eggs at concentrations as low as  10 femtograms per egg (Saunders et al, 2002). PLC isoforms 
P,  y,  5  have  been  shown to  be  ineffective  at  inducing  [Ca2+]i  increases  when tested  in  sea 
urchin homogenate and mouse eggs (Jones et al., 2000). A much higher concentration (-20-
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fold)  of recombinant PLC5  protein was  shown to be required to  induce  [Ca2+]i  oscillations 
compared to PLC£, which had at least 100-fold higher Ca2+ sensitivity than PLC 5 (Kouchi et 
al., 2004).
Structural analysis reveals that PLCs comprise of a number of core domains such 
as X and Y  catalytic core domains which  forms the active  site where enzymic cleavage of 
PIP2 takes place. All PLCs also contain a lipid-binding C2 domain and Ca2+ binding EF-hand 
domains. PLC£ is distinct ffom other PLCs because it lacks a PH domain which targets the 
PLC to phosphoinositides.  Since all other PLC’s contain a PH domain and are incapable of 
causing  [Ca2+]i  oscillations  in  mouse  eggs,  the  lack  of a PH domain may be  an  important 
characteristic  of Ca2+  releasing  ability  in  PLC^ (Saunders et al.,  2002).  Studies  on  human, 
monkey, chicken and mouse PLC^ are consistent with this since they have all been found to 
lack the PH domain found on other PLC isoforms (Cox et al., 2002; Coward et al., 2005).
Two  recent  studies  examining  the  role  of  the  EF-hand  domains  used  PLC^ 
domain-deletion constructs to determine which domains were critical for PIP2 hydrolysis and 
inducing [Ca2+]i oscillations in mouse eggs (Kouchi et al., 2005; Nomikos et al., 2005). One
study showed that removal of either EF-hand domain did not affect PIP2 hydrolysis however
” 2+
Ca  sensitivity  was  greatly  reduced  (Nomikos  et  al.,  2005).  In  contrast  the  other  study 
revealed  that  deletions  of EF1  and  EF2  of the N-terminal  four EF-hand  domains  caused  a 
great reduction in PIP2 hydrolysis and complete loss of Ca2+ releasing ability (Kouchi et al., 
2005). Deletion of all four EF-hand domains caused complete inactivity of PLC^ (Kouchi et 
al.,  2005)  indicating that  both  domains  are  crucial  for the  activity of PLC^ (Kouchi  et  al., 
2005; Nomikos et al., 2005).
Comparisons of the cellular and molecular aspects of PLC£ ffom human (hPLCQ, 
cynomolgus monkey (cPLCQ and mouse (mPLCQ in their ability to cause [Ca2+]i oscillations 
in mouse eggs have recently been  investigated (Cox et al., 2002). Microinjection of hPLC£
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cRNA was found to be most effective at causing [Ca2+]i oscillations in mouse eggs compared 
to  microinjection  of cPLC£  or  mPLC^  (Cox  et  al.,  2002).The  reasons  for this  finding  are 
unclear, although a number of reasons have been proposed. Firstly, the domain structures of 
all  three  PLC’s  were  investigated  and  it  was  discovered  that  the  X-Y  linker  segment  (the 
region  between the  X  and Y catalytic domains) was  shortest  in the hPLC  and this  may be 
related to the  effectiveness  of this  PLC£.  Differences  in the  efficiency  of PLC^  at  causing 
[Ca2+]i oscillations may also reflect the variation in size of different species’ eggs. The human 
egg for example, is several times larger than that of a mouse egg and may thus require a more 
potent Ca2+-releasing PLC£.  Some species may alternatively have eggs which happen to be 
more sensitive to PLC£ than others, the hamster egg for example was found to be much less 
sensitive  to  sperm  extracts  compared  to  the  mouse  egg  (Parrington  et  al.,  1996).  PLC^ 
injection could in the  future become a possible treatment  for eggs that  fail to  fertilise after 
ART since it provides a natural Ca2+ signal to the egg which appears to be absent in the case 
of male  factor  infertility.  PLC£  may  also  be  used  as  an  alternative  activation  protocol  in 
nuclear transfer or for the parthenogenetic generation of embryonic stem cells.
1.2.9  Sperm-induced Ca2+ release is cell-cycle dependent.
The generation of [Ca2+]i transients is regulated in a cell-cycle dependent manner. The sperm 
triggers a series of [Ca2+]i oscillations that last for several hours and cease at the time of the 
formation  of pronuclei  and  the  entry  into  interphase  (Jones  et  al.,  1995a).  Interphase  is 
marked by a time when no [Ca2+]i increases occur.  Nuclear envelope breakdown (NEBD) at 
the first mitosis is associated with a single (Tombes et al.,  1992) or multiple [Ca2+]i transients 
(Kono et al.,  1996; Marangos et al., 2003; Larman et al., 2004).  Some studies have reported 
that InsPaR down-regulation occurs after fertilisation or sperm extract injection (Brind et al.,
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2000;  Jellerette  et  al.,  2000),  which  may explain  the  reduction  in egg  sensitivity to  InsP3- 
induced Ca2+ release during interphase.
These  findings  support  the  observations  that  [Ca2+]i  oscillations  cease  after 
duration  of several  hours  of fertilisation-induced  [Ca2+]i  oscillations,  however  it  does  not 
explain  why  this  correlates  with  pronuclei  formation  and  why  [Ca2+]i  increases  occur  at 
NEBD.  Accumulating  evidence  indicates  that  during  pronuclei  formation  a  Ca  releasing 
factor (PLCQ is sequestered into the pronuclei resulting in the cessation of [Ca2+]i oscillations 
(Marangos et  al.,  2003;  Larman et al.,  2004;  Yoda et al.,  2004). Nuclear  sequestration  has 
been supported using a number of different experimental approaches.
One  study  reported  that  inhibiting  pronucleus  formation  with  wheat  germ 
agglutinin  or  preventing  nuclear  import  prolonged  [Ca2+]i  oscillations  for  up  to  12  hours 
compared to  4  hours  in controls  (Marangos  et al.,  2003).  A  recent  key  study has  not  only 
added  support  to  the  nuclear  sequestration  hypothesis  but  also  provided  confirmation  that 
PLC£ is the Ca2+ releasing factor. PLC^-induced [Ca2+]i oscillations were revealed to have the 
same cell-cycle dependency during the first cell-cycle as fertilised eggs. A nuclear localisation 
factor (NLS) present on the PLC^ X-Y linker region led to nuclear sequestration and mutating 
the NLS to be non-functional greatly prolonged the [Ca2+]i oscillations, which continued into 
interphase (Larman et al., 2004). Preventing pronuclei formation also prolonged PLC-induced 
[Ca2+]i oscillations (Larman et al., 2004).  Mitotic [Ca2+]i transients have only been observed 
in  fertilised  but  not  parthenogenetic  embryos  which  was  interpreted  as  indicating  that  a 
paternally  derived  factor  ffom  the  sperm  was  responsible  for  stimulating  the  [Ca2+]i 
oscillations observed at fertilisation (Kono et al.,  1996).
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1.2.10  Ca2+-dependent parthenogenetic egg activation
As described above, the sperm provides a natural stimulus to the Mil arrested egg, which is 
responsible  for  ‘kick-starting’  egg  activation  and  embryo  development.  Parthenogenetic 
activation  is  defined  as  the  process  by which  egg activation  occurs  in  a  female  gamete  to 
which  there  has  been  no  contribution  ffom  the  male  genome  (Kaufman,  1979).  Induced 
parthenogenetic activation can be used as a model for studying the events of activation and 
early embryo development. Artificial activation can also be successfully applied clinically to 
facilitate  ART and  in a biotechnology  setting to  improve  nuclear transfer rates to  generate 
stem cells. Parthenogenetic activation is also particularly relevant to this thesis because I use 
this  method  as  a  main  tool  to  activate  eggs.  I  will  therefore  describe  and  explain  the 
advantages and disadvantages of various stimuli used to activate eggs.
Egg activation can be induced parthenogenetically by treating eggs with various 
chemical  or  physical  stimuli  that  trigger  single  or  multiple  [Ca2+]i  increases  (Fig  1.3A). 
Physical disruption by pricking the plasma membrane with a fine needle causes Ca2+  influx 
and has  been reported to efficiently activate Xenopus (Uehara and Yanagimachi,  1977) and 
hamster eggs (Kline and Nuccitelli,  1985; Kline and Nuccitelli,  1985). A simple injection of 
Ca2+ into the eggs of a number of species such as the sea urchin (Hamaguchi and Hiramoto,
1981), mouse (Fulton and Whittingham,  1978) and pig (Machaty et al.,  1996) has also been 
shown to induce all the events associated with egg activation (Fulton and Whittingham,  1978; 
Machaty et al., 1996).
Egg  activation  using  chemical  stimuli  has  commonly  involved  the  use  of 
treatments such as ethanol,  ionomycin and Ca2+  ionophore A23187,  which are  sufficient to 
trigger egg activation by means of inducing a single [Ca2+]i transient in the egg (Swann and 
Ozil,  1994;  Xu et al.,  1997).  Ethanol treatment causes the temporary opening of membrane 
calcium channels causing influx of extracellular Ca2+ as well as the formation of InsP3, which
47Chapter 1: Introduction
leads to release of Ca2+ from intracellular stores (Presicce and Yang,  1994). Ca2+ ionophore 
A23187  similarly  promotes  the  release  of Ca2+  from  intracellular  stores  and the  influx  of 
extracellular Ca2+ (Kline and Kline,  1992).  With increasing time after ovulation mammalian 
eggs  become  more  sensitive  to  artificial  stimuli  that  trigger  egg  activation.  The  rate  of 
activation  is  low  in  freshly  ovulated  eggs  that  are  treated  with  agents  that  induce  single 
transients compared to stimuli that induce multiple  [Ca2+]i transients (Ozil,  1990;  Xu et al., 
1997).  Although  agents  that  cause  a  monotonic  rise  in  [Ca2+]i  are  sufficient  to  cause 
activation, an initial rise in [Ca2+]i during mammalian fertilisation is followed by a series of 
repetitive [Ca2+]i transients. Thus, parthenogenetic agents that mimic the naturally occurring 
[Ca2+]i transients are often used as alternatives to agents that cause a single [Ca2+]i increase. 
Thimerosal,  a  thiol  reagent  that  probably  acts  by  oxidising  critical  sulphydryl  groups  on 
intracellular Ca2+ release proteins and induces [Ca2+]i transients that are remarkably similar to 
those  at  fertilisation  with  regard to their amplitude,  width  and  attack  (Cheek et  al.,  1993). 
Thimerosal  has  been  shown to  cause  [Ca2+]i  oscillations  in hamster (Swann,  1991),  human 
(Homa and Swann,  1994), mouse (Cheek et al.,  1993), bovine (Fissore et al.,  1995) and rabbit 
(Fissore and RobI,  1993) eggs. Although thimerosal treatment of eggs has also been reported 
to cause cortical granule exocytosis (CGE) it does not cause complete egg activation (Cheek 
et al.,  1993). Thimerosal has been shown to cause meiotic spindle disassembly and since an 
intact  spindle  is  required  for  transition  from  M-phase  to  interphase,  these  eggs  cannot  be 
released from Mil arrest. Disassembly of the meiotic spindle can however be reversed by the 
reducing  agent  dithiothreitol  (DTT)  so  that  a  combined  treatment  of thimerosal  and  DTT 
induces full activation and development to the blastocyst stage  in pig eggs (Machaty et al., 
1997).
Phorbol ester, an activator of protein kinase C (PKC) has been reported to cause
2+  .  ,
[Ca  ]i  oscillations  and  pronuclear  formation  in  mouse  eggs  (Cuthbertson  and  Cobbold,
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1985). Other studies have failed to measure any [Ca2+]i increase using phorbol ester and have 
concluded that  phorbol  ester can  activate  PKC  in the  absence  of Ca2+  and  upon  activation 
PKC  can  mediate  activation-associated  processes  such  as  cortical  granule  exocytosis  and 
cytokinesis (Bement and Capco,  1990).  Phorbol ester failed however to activate a significant 
proportion  of eggs,  with  very  few  reaching  the  blastocyst  stage  compared  to  when  Ca2+ 
ionophore was used as an activating agent (Uranga et al., 1996).
Incubating  mouse  oocytes  in  Ca2+-free  media  containing  strontium  ions  (Sr2+) 
•  2+   • induces  [Ca  ]i  oscillations  similar to  those  seen  at  fertilisation,  which  in  turn  causes  the 
associated  events  of egg  activation  to  occur  (Fraser,  1987;  Fraser,  1987).  SC+  like  Ca2+ 
probably mobilises Ca2+ from intracellular stores by increasing the affinity of InsPsR for InsP3 
(Marshall  and Taylor,  1994).  Sr2+  causes  the  sensitisation  of InsP3-stimulated  Ca2+  release 
with only three-fold less potency than Ca2+ (Marshall and Taylor, 1994). Sr2+ has been used in 
nuclear transfer technology to activate mice oocytes which have then successfully developed 
to term (Wakayama et al., 2005). Sr2* treatment does not however cause [Ca2+]i oscillations in 
human, pig (unpublished observations) and domestic animal eggs.
Electrical stimulation (electroporation) of mammalian oocytes has been shown to
2+   •  •
cause [Ca  ]i oscillations and a high proportion of activation. Electrical-field pulses cause the
formation of transient pores in the plasma membrane which allows Ca2+ ions present in the 
extracellular  media  to  enter  the  cell.  The  main  benefit  of this  technique  is  that  it  allows 
complete control over the  [Ca2+]i transients exhibited  by the eggs.  This technique has  been 
successfully  used  to  show  that  the  amplitude,  frequency  and  number  of [Ca2+]i  transients 
affect rabbit postimplantation embryo development (Ozil and Huneau, 2001).
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1.2.11  Ca2+-independent parthenogenetic egg activation
One  way  to  activate  eggs  in  a  Ca2+-independent  manner  is  to  inhibit  MPF  activity  using 
broad-range inhibitors of protein synthesis or protein phosphorylation (Fig  1.3B).  Incubation 
of Mil arrested eggs for 6 hours or longer in cyclohexamide (CX) or puromycin is sufficient 
to cause egg activation (Siracusa et al.,  1978; Moses and Kline,  1995). Pronuclear formation 
occurred when protein synthesis was almost totally inhibited and activation was induced when 
the  levels  of protein  synthesis  are  depressed  by  more  than  70%  (Siracusa  et  al.,  1978). 
Puromycin  has  also  been  reported  as  an  effective  inhibitor  of human  eggs  (Balakier  and 
Casper,  1993). In many species such as the pig, these inhibitors are not sufficient to cause egg 
activation when used alone (Nussbaum and Prather, 1995) but when used in combination with 
a Ca2+  inducing  stimulus  such  as  electrical-field  pulses,  egg activation  can  be  successfully 
accomplished  with  high  efficiency  (Nussbaum  and  Prather,  1995).  The  combination  of a 
protein synthesis inhibitor with a Ca2+ inducing stimulus is in fact commonly used in nuclear 
transfer (NT). Activation of bovine eggs with ethanol and CX after NT lead to activation and 
development  to  term  (Zakhartchenko  et  al.,  1999).  A  major  limitation  with  using  protein 
synthesis  inhibitors such as CX  is that they do not just deplete the cell of the proteins that 
maintain  MPF  but  also  from  proteins  that  function  in  critical  processes  such  as  cell  cycle 
progression.  A delay in the  initiation of protein  synthesis has  in fact been reported  in  eggs 
activated by ethanol and CX (Alberio et al.,  2001a).  It  is unsurprising that abnormalities  in 
postimplantation  development  such  as  skeletal  malformations,  hydroallantios  and  perinatal 
death have been shown to occur in embryos activated with CX (Zakhartchenko et al.,  1999).
The  inhibition  of MPF  can  be  carried  out  by  the  binding  of specific  cyclin- 
dependent  kinase  inhibitors  (cdkl).  The  non-specific  serine/  threonine  kinase  inhibitor  6- 
DMAP  for  example,  inhibits  the  phosphorylation  of  many  proteins.  Under  normal 
circumstances,  MPF  activity  is  kept  high  by the  action of various  kinases that  regulate  its
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phosphorylation status.  The cdc25  activates MPF by dephosphorylation of the tyr 15  site on 
cdkl. 6-DMAP inhibits the activation site of cdc25 which inactivates MPF and causes meiotic 
resumption.  6-DMAP treatment has  been  reported  however  as  an  ineffective  treatment  for 
activating many eggs such as those from the mouse and cow (Liu et al.,  1998; Szollosi et al.,
1993).  6-DMAP  has  been  reported  to  accelerate  many  post-fertilisation  events  such  as 
pronucleus formation and microtubule formation (Szollosi et al., 1993) and is very effective at 
artificial activation when used in combination with the Ca2+ ionophore ionomycin, which has 
lead to high rates of activation and blastocyst formation in sheep and cow eggs  (Loi et al., 
1998;  Liu et al.,  1998).  6-DMAP activation has however been associated with a number of 
placental and embryonic abnormalities suggesting that it may hinder a number of kinases that 
are important for development (Cibelli et al.,  1998).
Roscovitine  (6-benzylamino-9-isopropylpurine)  and  its  analogue  bohemine 
belong  to  a  group  of purine  derivatives,  which  specifically  inhibit  the  eye 1  in-dependent 
kinases cdc2, cdk2 and cdk5. Roscovitine inhibits MPF activity by targeting its ATP binding 
site (Meijer et al.,  1997)  and has thus been used to activate eggs artificially (Phillips et al., 
2002). Roscovitine treatment has been reported to cause high rates of egg activation in mouse 
eggs however very few of these parthenotes develop beyond the 8-cell stage (Phillips et al., 
2002).  This  suggests  that  the  developmental  competency  of  embryos  activated  by  the 
inhibition of these kinases is limited.
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Figurel.3  Mechanisms of inducing artificial egg activation. A) Egg activation  using Ca2+ 
dependent  means.  The  egg  is  arrested  in  Mil  by  active  MPF.  Ca2+  increases  triggered  by 
stimuli such as sperm, strontium ions or ionomycin are thought to activate CAMKII. CAMKII 
triggers the activation of the APC which targets cyclin B for destruction by the proteosome by 
polyubiquitination of its destruction-box. Cyclin proteolysis results in inactive MPF and release 
from  Mil arrest. B) Ca2+-independent activation can be induced using stimuli that cause MPF 
inactivation.  Cyclohexamide, a protein synthesis inhibitor works by preventing the synthesis of 
cyclin  B.  6-DMAP  inhibits  the  phosphatase  cdc25,  which  normally  acts  to  keep  MPF 
active.Roscovitine targets the ATP binding site on MPF
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1.3  Embryonic Genome Activation
1.3.1  A switch from maternal to embryonic dependency
The  immature  mouse  oocyte,  arrested  at  dictyate  of  its  first  meiotic  prophase,  is 
transcriptionally  active  (Wassarman  and  Letoumeau,  1976).  Immediate  translation  of 
accumulated  maternally  derived  mRNA’s  does  not  however occur  until  oocyte  maturation 
when it is needed to direct oocyte development (Bachvarova et al.,  1985). During the period 
that  encompasses  fertilisation,  the  egg/embryo  is  transcriptionally  silent  and  early 
development is directed by the complement of maternally derived mRNAs and proteins. The 
maternally derived mRNA’s, which are important to sustain development of the oocyte,  are 
progressively  degraded  after  fertilisation.  Maternal  mRNA  degradation  is  stimulated  by 
oocyte maturation and it is 90% completed in the mouse by the 2-cell stage although some 
maternal protein synthesis does occur until the 8-cell stage (Piko and Clegg,  1982;  Wang et 
al., 2004; Paynton et al.,  1988; Schultz, 1993).
The  time  that  the  embryonic  genome  becomes  transcriptionally  competent  is 
referred to as zygotic genome activation (ZGA) or embryonic genome activation (EGA).  In 
this  study we will refer to this switch as EGA as the majority of embryos discussed  in this 
thesis  are  parthenotes and not zygotes.  The  transition  from  maternal  to  embryonic  genome 
dependency has a number of functions that are critical for the continued development of the 
embryo (Schultz and Worrad,  1995). EGA replaces the degraded maternal transcripts that are 
common  to  both  the  oocyte  and  embryo,  with  zygotic  transcripts.  These  transcripts  are 
important  for  basic  cellular  functions  since  preventing  the  replenishment  of  maternal 
transcripts results in developmental arrest (Schultz and Worrad,  1995).  EGA is also  critical 
for the  generation  of novel  transcripts  that  are  not  present  in  the  oocyte  and  are  therefore
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unique to the embryo (Piko and Clegg,  1982; Bachvarova et al.,  1989). EGA is characterised 
by the sensitivity of the embryo to transcription. The treatment of fertilised embryos with a- 
amanatin,  a specific  inhibitor of RNA  polymerases  II  and  III,  result  in cell  cleavage  arrest 
usually within one cell division.
In the mouse EGA appears to  occur in two  phases  (Fig  1.4).  The  first phase  is 
evident  during  G2  of the  1st  cell  cycle  (Latham  et  al.,  1991)  and  directs  the  synthesis  of 
approximately  40  proteins  (Figure  1.3)  (Latham  et  al.,  1991;  Schultz,  1993).  This  ‘early’ 
phase involves the synthesis of a relatively small number of novel proteins and is referred to 
as  ‘minor EGA’.A much larger increase  in embryonic protein  synthesis occurs about  10-12 
hours  later than  the  minor  EGA  during the  G2  phase  of the  2-cell  embryos  (Flach  et  al.,
1982).  This  later  phase  is  termed  ‘major  EGA’  and  is  a  requirement  for  further  embryo 
development  (Latham  et  al.,  1991;  Christians  et  al.,  1995).  Many  species  have  a  biphasic 
EGA. The embryonic genome of the cow embryo is for example, fully activated by the 8-cell 
stage  although  this  is  preceded  by  a minor activation which  occurs  at the  late  1-cell  stage 
(Petzoldt and Muggleton-Harris,  1987).
1.3.2  The Zygotic Clock and initiation of EGA
The  onset of minor EGA  is  governed  by a time-dependent mechanism  (termed the zygotic 
clock) rather than by a particular cell cycle event. This is evident in the mouse embryo where 
minor EGA occurs around 24 hours after fertilisation,  independent of whether or not the  1- 
cell embryo has completed S phase and formed a 2-cell embryo (Schultz,  1993; Bolton et al., 
1984). When  1-cell embryos that have not yet formed pronuclei are incubated in aphidocolin 
(an inhibitor of replicative DNA polymerases),  they arrest development when they reach  S- 
phase but minor EGA still occurs at the time corresponding to when they would ordinarily
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Figure 1.4  Minor and major phases of embryonic genome activation. The egg is arrested at 
metaphase of the 2nd cell cycle (Mil).  If fertilisation occurs the egg is released from  Mil  and 
pronuclei  form.  During  the  G2  phase  of the  first  cell  cycle  the  egg  a  small  wave  of gene 
activation occurs. This marks the first event whereby the embryo is transcriptionally competent 
and is referred to as minor EGA. Minor EGA appears to be governed by a zygotic clock since it 
is independent of any cell division events. A much larger gene activation event occurs at G2 of 
the 2nd cell cycle and is referred to as Major EGA. This event is dependent on minor EGA and 
the first cell division event.
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have  become 2-cell  embryos.  In contrast to minor EGA,  major EGA  is  dependent on cell- 
cycle progression until the 2-cell stage in mice (Howlett, 1986).
It is now well documented that embryonic transcription begins at the G2 phase of 
the  1st cell cycle cell in the mouse embryo although results from early experiments suggested 
that  embryonic  transcription  was  first  initiated  at  the  2-cell  stage  (Nothias  et  al.,  1996; 
Meirelles et al., 2004). The synthesis of a family of structurally related proteins (Mr=70,000) 
termed  the  transcription-requiring  complex  (TRC)  for  example  was  frequently  used  as  a 
diagnostic marker for EGA in the mouse and was shown to be restricted to the 2-cell stage 
(Flach et al.,  1982). Endogenous RNA polymerase activity was also detected at the 2-cell but 
not the 1-cell stage using an assay that detects endogenous RNA polymerase activity (Moore, 
1975).  The  expression  of  an  hsp70-driven  beta  galactosidase  reporter  gene  was  also 
documented  after  microinjection  into  the  paternal  pronucleus  of cleavage  arrested  1-cell 
embryos  that  were  chronologically  at  the  2-cell  stage  (Schwartz  and  Schultz,  1992).  The 
insensitivity of the techniques described above was such that low levels of gene expression at 
G2 of the 1-cell stage could not be detected.
The development of highly sensitive techniques provided evidence in support of a 
transcriptionally  permissive  state  developing  at  the  1-cell  stage.  Expression  of  an  Spl- 
dependent  luciferase reporter gene was readily detected  for example  at the G2  stage  of the 
first  cell  cycle  (Ram  and  Schultz,  1993).  Consistent  with  this,  luciferase  transcripts  are 
detected  following  fertilisation at the  1-cell  stage after using transgenic  sperm  containing  a 
luciferase  transgene driven  by p-actin  expression  (Matsumoto et al.,  1994),  moreover TRC 
synthesis was detected at G2 of the  1st cell cycle following transplantation of a 2-cell embryo 
nucleus treated with a-amanitin into an enucleated  1-cell embryo (Latham et al.,  1992). The 
expression of TRC  genes was however much greater following transfer into late rather than 
early  1-cell stage recipient embryos (Latham et al.,  1992). The replacement of inactive RNA
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polymerase II from the 2-cell with functional RNA polymerase II from the enucleated  1-cell 
embryo is likely to be responsible for driving the transcription of TRC.
1.3.3  Measuring EGA
In the past gene expression during the matemal-to-embryonic transition was measured using 
plasmid-bome  reporter  genes  that  encode  either  luciferase  (Ram  and  Schultz,  1993; 
Wiekowski et al.,  1991)  or p-galactosidase (Vemet et al.,  1993).  The outcome drawn  from 
this method was consistent with the results obtained from expression of integrated transgenes 
(Christians  et al.,  1995;  Matsumoto  et  al.,  1994)  and  endogenous  genes  (Manejwala et  al., 
1991) regarding the onset of a transcriptionally permissive state. One major disadvantage of 
these gene expression assay systems is that they have to be measured by destructive analysis 
(lysis) of eggs taken from cohorts of treated eggs. This prevents a full profile of gene activity 
from an  individual embryo during developmental transition and cannot be measured in real­
time.  Real  time  imaging  of transcriptional  activity  has  been  carried  out  in  live  mouse 
preimplantation  embryos that carry a transgene encoding the  secreted  luminescent reporter, 
Vargula luciferase (Thompson et al.,  1995). In this study the culture medium was assayed for 
luciferase  activity  so  transfers  of an  embryo  to  new  drops  of culture  medium  for  each 
measurement were required.
Gene  expression  has  been  quantitatively  analysed  in  preimplantation  mouse 
embryos using the Green Fluorescent Protein (GFP) reporter gene (Medvedev et al.,  2002). 
GFP  is  advantageous  in  monitoring  embryos  because  it  requires  no  substrates  apart  from 
oxygen and it is essentially non-toxic and resistant to proteases.  The temporal  dynamics of 
gene expression can also be monitored and quantitatively measured in real time. This method 
is  limited  though,  because  UV  light  is  required  to  measure  GFP  fluorescence  and  this  is 
detrimental to the developmental capacity of the embryo. Only two recordings could therefore
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be taken every 24 hours, preventing a detailed study of gene expression during a critical time 
of development,  furthermore  gene  expression  could  only  be  detected  from  the  embryonic 
four-cell  stage  (Medvedev  et  al.,  2002).  In  Chapter  5  I  will  describe  a  highly  sensitive 
luminescent technique which I employed to measure gene expression in real time during EGA 
in mouse embryos.
1.3.4  Role of chromatin assembly during EGA
A number of studies have shown that functional differences exist between the maternal and 
paternal  pronuclei  to  support transcription  and which  are  likely to  be  due to  a  chromatin- 
mediated  repression.  The  maternal  pronucleus  inherits  repression  factors  from  the  oocyte 
which  are  absent  in  the  male  pronucleus.  A  number  of studies  support  the  idea  that  the 
maternally-derived  pronucleus  is  transcriptionally  repressed  in  comparison  to  the  paternal 
pronucleus. The Spl-dependent luciferase reporter gene is preferentially expressed in G2 of 
the  1st  cell  cycle  following  microinjection  of  the  paternal  pronucleus  compared  to 
microinjection  of the  maternal  pronucleus  (Ram  and  Schultz,  1993).  BrUTP  incorporation 
studies  similarly show that transcription  is  primarily  in the  paternal  pronucleus  during this 
time  period  (Aoki  et  al.,  1997).  These differences  in  transcriptional  activity are  concurrent 
with the  finding that nuclear concentration  of the transcription  factors  Spl  and TATA-box 
binding protein is greater in the male pronucleus as compared to that of the female pronucleus 
(Worrad et al.,  1994). The nuclear concentrations of these transcription factors increase  in a 
time-dependent fashion during the  1st cell cycle and are dependent on DNA synthesis but not 
transcription or cytokinesis (Worrad et al.,  1994).
The massive reprogramming of gene expression that is initiated at the late  1-cell 
stage  in  mice  is  followed  by  a transcriptionally repressive  state  (Wiekowski  et  al.,  1991) 
which is initiated at the 2-cell stage but increases as development proceeds to the 4-cell stage
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(Henery et al., 1995). When 1-cell embryos injected with reporter genes are developed to the 
2-cell stage the gene expression levels are reduced to less than 1% of that at S-phase in the  1  
cell  embryo  (Wiekowski  et  al.,  1991).  The  genes  of 2-cell  embryos  require  an  enhancer 
sequence for efficient gene expression in the 2-cell but not the  1-cell embryo (Wiekowski et 
al.,  1991;  Majumder  et  al.,  1993).  This  form  of repression  reduces  the  activity  of any 
promoter and is initiated sometime between S-phase of the  1st cell cycle and the 2-cell stage. 
The expression of endogenous genes such as the TRC increases from the  1-cell to late 2 cell 
but then decreases between the late 2 cell to 4 cell stage. This decrease in TRC expression can 
be prevented if histone hyperacelylation is induced by butyrate treatment (Davis et al., 1996). 
This demonstrates that this inhibition of TRC transcription is induced by chromatin-structure 
assembly.  Inhibiting  the  transcriptionally  repressive  state  by  inducing  histone 
hyperacelylation  prevents  development  beyond  the  2  cell  stage,  suggesting  that  the 
transcriptionally repressive state directs the correct pattern of gene expression that is vital for 
the continued development of the embryo. Some genes such as those of the TRC are required 
to overcome the effect of transcriptional inhibition and undergo expression at the 2-cell stage. 
It has been suggested that the presence of an enhancer sequence or unusually strong promoter 
may account for their expression (Schultz and Worrad, 1995).
1.3.5  Developmental block
The  embryonic  genome  of different  species  is  fully activated at different  stages  in  embryo 
development. In mice this occurs by the 2-cell stage (Flach et al.,  1982). In contrast, EGA is 
complete at the 4-8 cell stage in humans (Braude et al.,  1988) and pigs (Tomanek et al.,  1989) 
and at the 8-16 cell stage in sheep (Crosby et al.,  1988) and cows (Camous et al.,  1986). The 
timing of developmental block is species-specific and is generally correlated with the stage of 
development where major EGA begins (De Sousa et al., 1998). The developmental block thus
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occurs during the fourth cell cycle in cattle, second in mice and the third to fourth in humans 
and pigs (Memili and First, 2000).
As the timing of developmental block seems to coincide with the time major EGA 
begins it has often been assumed that the failure of in vitro cultured embryos to undergo EGA 
is causative of the developmental block. This idea was proposed by a group that demonstrated 
a  decrease  in  mRNA  levels  correlating  to  the  critical  period  for  2-cell  block  induced  by 
phosphate exposure during the time of EGA (Haraguchi et al.,  1999). A more recent study of 
protein  synthesis  patterns  by  two-dimensional  gel  electrophoresis  of  [35S]  Methionine 
radiolabeled  2-cell  embryos  has  however  shown  that  it  is  not  a  failure  but  a delay  in  the 
initiation of ZGA that may cause the 2-cell block in mice cultured in vitro (Qiu et al., 2003). 
Many mammalian embryos do not accomplish their preimplantation developmental potential 
when cultured in vitro (Yong et al., 2002). With the exception of some inbred and FI  hybrid 
mice, in vitro culture of 1-cell mouse embryos causes them to undergo a single cell division 
before  arresting at the 2-cell  stage. This  is referred to as the  2-cell  block.  Developmental 
block is a phenomenon that occurs when an embryo ceases to cleave during preimplantation 
development.
Mouse  strain,  medium  components  and  culture  conditions  have  been  shown  to 
affect the development of 1-cell embryos in vitro (Chatot et al.,  1989). Mouse embryos were 
first cultured from the 8-cell to blastocyst stage nearly fifty years ago, a simple defined media 
was used (Whitten,  1956).  As media improved  it became possible to culture embryos  from 
earlier stages. A simple mouse-designed medium termed CZB was the first media developed 
in  which  even  blocking  type  mouse  embryos  developed  from  the  fertilised  egg  to  the 
blastocyst  stage (Chatot et al.,  1989).  Simplex-optimized  media (SOM)  and  a  version  with 
higher  K+  (KSOM),  were  subsequently  demonstrated  to  be  very  successful  (Lawitts  and 
Biggers,  1991;  Lawitts  and  Biggers,  1993).  Changes  in  the  overall  osmolarity  or
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pyruvate:lactate ratio, decreased NaCl concentration and lowered glucose and phosphate were 
all factor in the media that were demonstrated to alleviate the 2-cell block in mouse embryos 
(Biggers,  1998). It is interesting however to note that the developmental block can be rescued 
by the transfer of cytoplasm from non-blocking strains and this indicates that a cytoplasmic 
component may be lacking in the ‘blocking’ strains of mice (Muggleton-Harris et al.,  1982).
The  inability  to  react  to  injuries  from  the  environment  and  failure  to  activate 
transcription  of important  developmental  genes  are  the  main  mechanisms  that  have  been 
suggested to cause embryonic developmental block in mammalian embryos (Betts and King,
2001).  The  mechanisms  behind  developmental  block  are  unclear  however  when  mouse 
embryos from the ‘blocking’  strain are developed in vivo until the 2-cell stage before further 
in vitro culture high numbers of them develop to the blastocyst stage (Whitten and Biggers, 
1968; Chatot et al., 1989)
1.4  Gene Expression in the preimplantation embryo
1.4.1  Monitoring global gene expression in the preimplantation embryo
Most  research  involving  gene  expression  analysis  focuses  on  genes  that  are  differentially 
expressed  between  different  cell  types  or  similar  cells  grown  in  varying  conditions.  Until 
relatively recently identification of differentially expressed genes in  preimplantation  embryos 
were  carried  out  using  complex  molecular  biology  techniques,  many  of which  have  major 
flaws.  Differential  display  for example,  was  recently used to  identify genes that were  highly 
expressed in either oocyte or 8-cell embryo, however it was found to produce a high  level of 
false positives and its detection system was biased towards the more abundant transcripts (Ma 
et al., 2001).
Expressed  Sequence  Tag  (EST)  projects  have  been  undertaken  with  the  purpose  to 
identify genes specifically expressed in egg and preimplantation stage embryos. Thousands of
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ESTs  have  been  stored  on  the  public  sequence  database  to  date  (Ko  et  al.,  2000).  One 
disadvantage of this system however is that it is limited to the quality of the cDNA library and 
therefore  some  rare  transcripts  are  likely  to  be  underestimated  (Sharov  et  al.,  2003). 
Quantitative analysis of 2-dimensional protein gels (Latham et al.,  1991) and Serial Analysis of 
Gene Expression (SAGE) (Blomberg le and Zuelke, 2004) have also been used to determine the 
levels  of  differentially  expressed  genes  in  cohorts  of  embryos.  One  relatively  new  and 
successful method of identifying specific differentially expressed genes is a PCR-based cDNA 
subtraction  strategy  called  suppression  subtractive  hybridization  (SSH)  (Diatchenko  et  al., 
1996).  SSH  is  advantageous  because  it  detects  transcripts  that  are  both  high  and  low  in 
abundance without  showing bias and  it gives  a low  incidence of false positives. The  system 
involves a linear amplification step so that even tissues with a relatively small mRNA yield can 
be  used.  SSH has  successfully been applied to  identify oocyte versus  8-cell-embryo-specific 
cDNA  clones  (Zeng  and  Schultz,  2003).  One  major  disadvantage  which  occurs  in  all  the 
methods  described  above  is  that  they  are  unable  to  measure  large  numbers  of  genes 
simultaneously.  The  recent development of large-scale  genomic  approaches  has  rescued  this 
problem. The development of large microarrays for example, has proved particularly useful for 
embryo development studies (Ko et al., 2000) and  has been used to identify global expression 
differences  in all stages of mouse preimplantation embryo development from the unfertilized 
egg to the late blastocyst stage (Wang et al., 2004; Hamatani et al., 2004a). Microarray analysis 
has been used to elucidate molecular pathways influencing blastocyst dormancy and activation 
(Hamatani et al., 2004b) as well as global gene expression differences between the morula and 
blastocyst stage (Tanaka and Ko, 2004).
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1.4.2  Preimplantation development is marked by phased gene expression
Two  separate  reports  recently  produced  the  first  detailed  studies  of global  gene  expression 
changes  during  each  stage  of  preimplantation  embryo  development  using  microarray 
technology (Wang et al., 2004; Hamatani et al., 2004a). Expression profiling revealed that two 
distinct waves of major gene expression occur in the preimplantation embryo. The first wave 
corresponds to EGA (described above) which reflects the time when transcription can first be 
supported  by  the  embryo.  The  second  wave  termed  Mid-preimplantation  Gene  Activation 
(MGA) occurs between the 4-cell to 8-cell stage and involves a significantly large increase in 
gene  expression  (Hamatani  et  al.,  2004a).  The  annotation  of many  genes  expressed  during 
MGA  appears  to  be  important  for  functions  relating  to  the  later  stages  of preimplantation 
development. For example, Na-K-ATPase and water channel genes are upregulated at this stage 
and are likely to influence the ionic gradient across the trophectoderm and the formation of the 
fluid-filled  blastocoel  (Watson  and  Barcroft,  2001).  Genes  involved  in  the  metabolic  switch 
from  pyruvate  to  glucose  dependency,  DNA  methylation  and  tight junction  formation  also 
appear to be expressed at this stage (Wang et al., 2004; Hamatani et al., 2004a).
The transient waves of expression of such large numbers of genes appear to be unique in 
the  preimplantation  embryo.  The  requirement  of the  embryo  to  have  fixed  waves  of gene 
expression could reflect the need for specific groups of genes to be expressed at certain times, 
furthermore when  genes have  fulfilled their function,  their expression  may be harmful  to the 
embryo so inactivation must take place to allow normal development. The waves of activation 
have also been proposed to act in a stepwise manner such that maternal transcripts and proteins 
trigger the onset of EGA and the proteins derived from EGA activate MGA (Hamatani et al., 
2004a).
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1.5  Synopsis
The aim of this thesis is to investigate the role of [Ca2+]i oscillations during egg activation on 
mammalian preimplantation development. The aim of Chapter 3 was to establish whether the 
recently  discovered  sperm  factor,  PLC£  can  cause  [Ca2+]i  oscillations,  egg  activation  and 
development to the blastocyst stage in pigs and humans since this has already been shown in 
mice. In Chapter 4 I investigate the role of [Ca2+]i oscillations more deeply and study how the 
effects of this signal can impact on embryo cleavage potential, cell allocation in the blastocyst 
and apoptosis.  Chapter  5  describes work using  luminescence techniques to  examine whether 
[Ca2+]i  signals  at  activation  may  be  having  an  effect  on  global  gene  expression  during 
embryonic  genome activation (EGA).  Continuing with this theme,  Chapter 6 describes  work
< •  04-
using microarray technology to examine how [Ca  ]i signals affect gene expression during the 
8-cell stage of embryo development.  Chapter 7 summarises the overall results from Chapters 3 
to  6  and  provides  a  detailed  discussion  of  the  findings  reported  in  this  thesis.
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Chapter 2 
Materials and methods
2.1 Mouse egg experiments
2.1.1 Mice
Mice were sourced from Harlan and all procedures were carried out in accordance with Home 
Office regulations. Ex-breeder FI  (C57xCBA) male mice of proven fertility were used for in 
vitro  fertilisation and  mating.  Oocytes  and embryos  from 21-24  day old MF1  female  mice 
were used for all other experiments, unless otherwise stated. Embryos and in vivo  fertilised 
oocytes were obtained from female mice that had been mated.
2.1.2 Oocyte and embryo collection
To induce ovulation, female mice were administered 7.5I.U pregnant mare serum 
gonadotrophin (PMSG; Intervet, Milton Keynes, UK) by intraperitoneal injection followed 48 
hours later by an injection of 7.5 I.U human chorionic gonadotrophin (hCG; Intervet). Mice 
were killed by cervical dislocation between  14 and 17 hours post-hCG and oviducts were 
removed with a fine pair of scissors and forceps. Oviducts were placed in warmed Hepes- 
buffered KSOM (HKSOM) media (Summers et al., 2000) containing 4mg/ml BSA (Sigma). 
Approximately 40 mg of BSA were added to 10 mis of HKSOM media to make a working 
stock of 4 mg/ml. See the appendices for a recipe of HKSOM and KSOM media. HKSOM 
was made as a 1  Ox stock for frozen storage at -20°C. When lOxHKSOM was removed from 
the freezer it was kept as a 1  Ox stock at 4°C for a maximum time of 5 days. Just prior to use
62Chapter 2: Materials and methods
the HKSOM was diluted to lx with fresenius water and amino acids and BSA were added 
accordingly. Cumulus masses were released into fresh media by tearing the ampulla region of 
the oviduct with a sterile pair of forceps. Cumulus cells were removed by addition of 
300ug/ml hyaluronidaise (Sigma) to the media for approximately 5 minutes. A 1500 Units/ml 
stock solution of hyaluronidaise was made by dissolving hyaluronidaise in HKSOM media 
without BSA. A working stock of 150 Units/ml was prepared by adding lOOul of stock 
solution to 900ul of HKSOM media.  Eggs were washed three times through fresh drops of 
media and left to recover from hyaluronidaise treatment for at least 10 minutes at 37°C before 
being used for experiments.
2.1.3  Parthenogenetic Activation
Parthenogenetic activation of Mil eggs was carried out using a number of different stimuli. 
Activation took place 15-18 hours post-hCG and all eggs were treated with 2pM cytochalasin 
D (Sigma) for 2 hours to prevent 2nd polar body extrusion.  Stocks of 2mM Cytochalasin D 
were  made  by  dissolving  0.0lg  Cytochalasin  D  powder  in  0.985  mL  DMSO.  Aliquots  of 
stock were stored at -20°C and were diluted  lOOOx with HKSOM media to make a working 
stock.
Eggs activated with strontium chloride (Sigma) were first washed three times in Ca2+- 
free HKSOM and then incubated in Ca2+ free HKSOM containing  lOmM Sr2+ for 2 hours at 
37°C.  A  Strontium  chloride  stock  solution was made  by adding  2.67g of S1 CI2  to  10ml  of 
fresenius water producing a 1M solution. The stock solution was diluted  lOOx with HKSOM 
to make a working stock of lOmM.
Ethanol activation was carried out by placing eggs in HKSOM containing 7% ethanol 
(Grade V; BDH Analar) for 7 minutes at room temperature.
63Chanter 2: Materials and methods
Artificial  activation  in  a  Ca2+  independent  manner  was  performed  using 
cycloheximide  (Sigma)  or  roscovitine  (Calbiochem).  Eggs  stimulated  with  cycloheximide 
were  incubated  for  a period  of 4  hours  in  HKSOM  containing  20ug/mL  cycloheximide  at 
37°C.  A  20mg/mL  cycloheximide  stock  solution  was  prepared  in  DMSO  and  was  diluted 
lOOOx in HKSOM to make a working stock of 20ug/mL.
Eggs  stimulated with roscovitine were  incubated  for 4 hours  in HKSOM  containing 
50pM roscovitine at 37°C.  Roscovitine was prepared as a 50mM stock in DMSO.
When a combined treatment was  carried  out with  Sr2+ and either cycloheximide  or 
roscovitine, oocytes were first incubated in cycloheximide or roscovitine alone for two hours 
followed  by  2  hours  incubation  in  Ca2+-ffee  HKSOM  containing  Sr2+  with  either 
cycloheximide or roscovitine.  Oocytes  activated with  ethanol and cycloheximide  were  first 
incubated in cycloheximide alone for 2 hours followed by 7% ethanol treatment for 7 mins, 
before being incubated in cycloheximide for the remaining 2 hours.
2.1.4  Mouse embryo development
Mouse embryos were cultured in vitro in drops of equilibrated potassium simplex optimised 
media  containing  essential  and  non-essential  amino  acids  (KSOM/AA)  (Summers  et  al., 
2000)  under  mineral  oil  (Sigma)  in  5%  C02  incubator  at  37°C.  KSOM  media  was  made 
weekly and stored at 4°C. See the appendices for details of the recipe. The sizes of the drops 
used  to  culture  embryos  were  governed  by  the  number  of embryos  in  each  drop,  with 
approximately 3pl of media per embryo. Eggs and embryos were cultured in drops on 30mm 
plastic  petri  dishes  (Falcon).  For  scoring  embryos  during  development,  embryos  were 
removed  briefly  from  the  incubator  24  hours  post-activation  (2-cell  stage),  48  hours  post­
activation  (4-cell  stage),  72  hours  post-activation  (8-cell  stage),  96  hours  post-activation 
(morula/early blastocyst stage) and 103 hours post-activation (blastocyst stage).
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2.1.5 In vitro fertilisation (IVF)
IVF was performed 16-18 hours after administration of hCG.  Epididymi were collected from 
FI  ex-breeder male  mice  by cutting the  vas  deferens  close to the  caudal  epididymis  using 
sterile  fine  scissors  and  forceps.  Sperm  were  squeezed  from  the  caudal  region  of  the 
epididymis into a petri-dish with 1ml T6 media (Quinn et al.,  1982) containing 15mg/ml BSA 
(Fraction V, Sigma) and which had been equilibrated in a 5% CO2 in air incubator overnight 
at 37°C to pH 7.6.  The sperm were given a 20-30 minute swim out period in the T6 media 
after which time 200pi drops of concentrated sperm media were made under oil and put in the 
incubator for three hours to allow capacitation of the sperm. In order to monitor Ca2+ changes 
in eggs during IVF,  eggs were  injected with  ImM Oregon Green BAPTA Dextran and the 
zona pellucidae were removed by brief exposure to acidified Tyrode’s solution (Sigma). The 
zona-free eggs were washed three times before being transferred to 0.5ml BSA-free HKSOM, 
which allowed the eggs to stick to the coverslip. After 15 minutes, when the eggs were firmly 
stuck to the coverslip, 0.5ml of BSA-containing media was added to the chamber. Then 20pl 
of the sperm-containing media was removed from the edges of the 200ul drops and added to 
the  chamber containing the  zona-free  eggs.  Ca2+  measurements  commenced when  the  first 
sperm was seen attaching to an egg.
2.1.6 Monitoring Embryonic Genome Activation (EGA) with a luciferase reporter gene
Embryonic  genome  activation  was  assayed  by  monitoring  luminescence  from  embryos 
injected with the firefly luciferase reporter gene pGL3  (Promega) (Ram and Schultz,  1993). 
Pronuclei of in vivo fertilized or in vitro activated parthenotes were injected with 50ng/ml of 
pGL3-control vector DNA (Promega)  in buffer containing  120mM KCL and 20mM Hepes. 
After  injection  the  pronucleate  embryos  were  incubated  in  HKSOM  media  containing 
luciferin (lOOpM).  Luciferin is a natural compound isolated from fireflies and is a substrate
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for the enzyme luciferase. Luciferase is encoded by the luc gene, which is widely used as a 
reporter  gene  in  a  variety  of  cells.  Due  to  the  intrinsic  low  background  of  the 
chemiluminescence technique, detection of the luc gene expression can be made at a very low 
level.  The  firefly  luciferase  enzyme  is  a  euglobulin  related  to  the  acyl-CoA  ligases.  It 
performs a ligase function in step I and an oxygenase function in step II of the assay described 
below.  Firefly  luciferin is a benzothiazole.  The role of ATP  is not as an energy source but 
instead  to  combine  with  luciferin  as  AMP  and  allow  the  formation  of the  dioxetanone 
intermediate by providing a leaving group and allowing electrophilic attack of the 4th carbon 
by  molecular  oxygen.  A  chemically  initiated  intramolecular  electron  exchange  process 
initiates the spontaneous breakdown of the dioxetanone ring and the formation of oxyluciferin 
bearing a singlet excited state electron. When this electron rapidly falls to the ground state it 
releases a photon of light in the process.
I
Luciferin + MgATP2’  ■   ►   adenyl-luciferin + PPi
II
Adenyl-luciferin + O2  ►   [peroxyluciferin] + AMP
[peroxyluciferin]  ►   [oxyluciferin] -1 - C02
[oxyluciferin]  *  oxyluciferin + light
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The  luminescence from cohorts of embryos was monitored continuously for up to 25  hours 
using  an  imaging  photon  detector  (1PD)  system  supplied  by  Science  Wares 
(www.sciencewares.com). The  IPD  consists of an  inverted Zeiss Axiovert microscope  with 
two attached cameras (see figure 2.1). The first is an IPD camera, which is sensitive enough 
to  detects  single  photon  events  using  a  cooled  (-10°C)  S20  photocathode,  a  microplate 
channel and  resistive  anode  (Photek Ltd,  St  Leonards  on  Sea,  UK).  The  second  is  a CCD 
camera that takes brightfield pictures so that cell morphology can be monitored over the time 
course of luminescence imaging. An integration time of 5 mins was sufficient to detect a clear 
photon signal above background for a single embryo when a 10 x 0.5NA objective was used.
2.1.7  Monitoring cyclin-luciferase in control and cycloheximide-treated eggs 
The Cyclin-luciferase mRNA was made entirely by Dr. Victoria Nixon and given as a gift. 
Luciferase cDNA from the pRL vector (Promega) was ligated to the C-terminus of the human 
form of cyclin B1  and the intact luciferase-cyclin fusion construct was cloned into the pCS2+ 
vector for in vitro mRNA synthesis using SP6 mMessage mMachine kit (Ambion). A poly-A 
tail was added using the mMessage kit and poly-A polymerase (Ambion). Cyclin-luciferase 
mRNA was injected at a pipette concentration of 2.7ug/ul into mouse eggs. The injection was 
3-5% of the egg total volume and was estimated from the displacement of a bolus injection. 
After injection the eggs were incubated in HKSOM media containing luciferin (lOOpM) for 2 
hours. Zonae pellucidae were removed prior to transfer of eggs to the IPD for luminescence 
measurements (see above and Fig 2.1  for more information on the IPD).  For cycloheximide 
treatment eggs were monitored in HKSOM media for 2  hours  followed by HKSOM media 
containing 20ug/ml cycloheximide. An integration time of 30 seconds was sufficient to detect 
a clear photon signal above background for a single embryo when a 20 x 0.5NA objective was 
used.
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Figure  2.1  Schematic  diagram  of a  Microscope-based  Imaging  Photon  Detector.
Photon  images  are  acquired  when  light  from  the  sample  passes  the  objective, 
microscope  tube  lens  and  a  reducing  lens  before  it  reaches  the  Resistive  anode-IPD 
input window. Transmitted or fluorescent light is acquired by the use of a  100% mirror 
which  is  placed  after the  tube  lens  to  reflect  light  up  to  the  trinoc,  where  it  is  then 
projected to the eyepiece or the CCD camera. Adapted from Sciencewares.com
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2.1.8  TUNEL labelling to assay apoptosis in mouse blastocysts
Mouse blastocysts (103 hours post-activation) were washed through three drops of Phosphate 
Buffered Saline (PBS) containing 1   mg/ml polyvinylpyrrolidone (PVP) and then fixed in 4% 
paraformaldehyde  (PFA)  in  PBS  for  20  mins  at  room  temperature.  Following  fixation, 
blastocysts were washed through four drops of PBS/PVP. In order to permeabilise the plasma 
membrane blastocysts were incubated in PBS containing 0.5% Triton-X (Sigma) for  1   hour. 
Positive controls were incubated in 5U/ml RQ1  DNase for 20 mins at 37°C. Blastocysts were 
then  washed  three  times  in  PBS/PVP  and  incubated  in  fluorescein-conjugated  dUTP  and 
terminal deoxynucleotidel transferase (TUNEL reagents; Roche diagnostics Ltd, East Sussex, 
UK) for 1   hour in the dark at 37°C. Blastocysts were washed through 2 drops of PBS/Triton- 
X and twice through PBS/PVP.  In order to count the number of cells  in the blastocyst,  the 
nuclei were stained by incubation in 0.05mg/ml Propidium Iodide (PI) and 50pg/ml RNase A 
for  1   hour in the dark at room temperature. Blastocysts were washed twice in PBS/Triton-X 
and twice in PBS/PVP before being mounted on a glass slide in  lOpl glycerol and covered 
with a coverslip.  Slides were viewed on a confocal microscope (model  LSM510; Carl Zeiss 
Microimaging Inc) using a 20x (0.75NA) lens. Cells labelled with TUNEL were excited by 
the 488nm line of an Argon laser, wavelength 450-490nm with a Dichroic mirror wavelength 
of 510nm and bandpass emission filter 505-530nm. Cells stained with PI were viewed using a 
He-Ne  543  laser with  bandpass  585-615.  Confocal  data were  analyzed using MetaMorph® 
(Universal  Imaging Corp.)  as  previously described (Halet  et al.,  2002).  FITC-labelled  cells 
were counted as apoptotic cells and PI  stained nuclei  were counted as total  number of live 
cells.  The  apoptotic  index was  calculated  by the  total  number of dead cells divided  by the 
total number of cells (dead cells and live cells) in each blastocyst.
69Chapter 2: Materials and methods
2.1.9  Differential staining of ICM and TE in mouse blastocysts
Zona pellucidae were removed from blastocysts (103 hours post-activation) by a 3-5  minute 
exposure  to  acidified  Tyrode’s  solution  (Sigma)  at  37°C.  Zona-free  blastocysts  were  then 
exposed to  lOOug/ml  fluorescein  isothiocyanate (FITC)-  labelled wheat germ  lectin  (WGA; 
Sigma)  for 20  min at 37°C  followed by  fixation  in 4% paraformaldehyde  in  PBS  at  room 
temperature  for  30  mins.  Blastocysts  were  exposed to  0.05%  Triton-X  in  PBS  for  1   hour 
followed  by  incubated  in  5pg/ml  propidium  iodide  for  1   hour.  After  permeabilisation  and 
staining blastocysts were washed through 3 drops of PBS before being viewed on a confocal 
microscope (model LSM510: Carl Zeiss Microimaging Inc) using a 20x (0.75NA) lens. Cells 
stained with PI were viewed using a HE-Ne 543  laser with bandpass 585-615. Cells labelled 
with FITC-WGA were excited by the 488nm line of an argon laser, wavelength 450-490nm, a 
dichroic mirror wavelength of 510nm and a bandpass emission filter 505-530nm.
2.2  Pig egg experiments
2.2.1 Collection of Ovaries
Pig ovaries were collected from an abattoir (Fowler Bros Ltd, Bumham-on-Crouch, UK) and 
transported to the laboratory in Dulbecco’s Phosphate Buffered Saline (PBS) (Unipath Ltd., 
Basingstoke, UK). The PBS was kept at 25-30°C by heated wheat bags in a thermo carrier and 
the transportation time was 2-3 hours. The ovaries were washed three times in PBS that was 
warmed to 37°C, before aspiration of the ovarian follicle cells.
2.2.2 Oocyte Collection
Cumulus oocyte complexes (COC’s) and pig follicular fluid (pff) were aspirated from ovarian 
follicles  that  were  3-6  mm  in  diameter  with  a  18  G  needle  fitted  to  a  10ml  syringe.  The 
COC’s  were  selected out of the pff by applying a thin  layer of follicular  fluid to  a 35mm
70Chapter 2: Materials and methods
petridish and removing them with a mouth pipette. The COC’s were collected in  1   ml drops 
of Hepes-buffered Tyrode  albumin  lactate  pyruvate  (PVA-TL-HEPES)  medium  containing 
0.1% polyvinylalcohol (PVA). The COC’s were washed through three drops PVA-TL-Hepes. 
COC’s  with  at  least  three  layers  of compact  cumulus  cells  and  uniform  cytoplasm  were 
selected for culture. The aspirated pff was collected in warm sterile  10ml falcon tubes during 
COC collection. Following this the pff was put in centrifugal tubes and spun at 3,000 for 30 
mins. The supernatant was collected from the tubes and equilibrated in a 35mm petridish at 
39°C in 5% C02 in air for 1  hour in preparation for in vitro maturation (1VM).
2.2.3 In vitro maturation of pig oocytes
IVM  of pig  oocytes  was  carried  out  in  North  Carolina  State  University  23  (NCSU-23) 
medium that had been equilibrated at 39°C  in 5% C02  in air for 5-6 hours. The NCSU-23 
media was supplemented with  10% pff which had been previously aspirated from the ovarian 
follicles,  1%  essential  amino  acids  (B-6766,  Sigma),  0.1%  non-essential  amino  acids  (M- 
7145,  Sigma),  10 IU/ml equine chorionic gonadotrophin (eCG) (Intervet,  Ireland),  10  IU/ml 
human  chorionic  gonadotrophin  (hCG)  (Intervet,  Ireland),  ImM  dibutyrl  cyclic  AMP, 
lOng/ml  Epidermal  growth  factor and  I mM cysteine.  The  oocytes were  washed through  3 
droplets of NCSU-23 and then kept in the same media for 22 hours in culture. After 22 hours 
the  oocytes  were  washed  three  times  in  fresh  equilibrated NCSU-23  with  all  supplements 
except hCG,  eCG  and db-cAMP.  They were  cultured  for a  further 22  hours  in  this  media. 
Only mature eggs, which had extruded the 1st polar body, were used for further experiments.
2.2.4 Pig embryo development
Pig embryos were cultured in NCSU-23 media containing  lOmg/ml BSA at 39°C in 5% CO2 
in air. Embryos were cultured in drops whose size was equivalent to approximately 3-5ul per
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embryo. Each day embryos were removed from the incubator briefly and their development 
was noted.
2.3  Human egg work
2.3.1  Patient treatment prior to oocyte collection
Human eggs were obtained from patients whose gametes had failed to fertilise following ICS1 
or  IVF.  Ethical  approval  for  the  project  was  obtained  from  St  Thomas’s  Hospital  Local 
Research  Ethics  Committee  and  from  the  Human  Fertilisation  and  Embryology  Authority 
(HFEA) who  issued a licence for the work (R0147).  Prior to their treatment patient’s  gave 
their consent for the use of all unfertilised eggs used in this research. For treatment patients 
underwent pituitary down regulation using buserelin (Suprefact; Hoechst UK Ltd, Middlesex, 
UK) in a mid-luteal start long protocol. Controlled ovarian hyperstimulation was performed 
using  gonadotrophins  following  satisfactory  pituitary  suppression  as  evidenced  by  a  thin 
endometrium  and  absence  of follicular  activity  or  ovarian  cysts.  Ovarian  stimulation  was 
achieved  using  a  daily  Follicle  Stimulating  Hormone  (FSH)  dose  of  150-450  IU  of 
recombinant  FSH  (Gonal  F;  Serono  Laboratories  Ltd,  Welwyn  Garden  City,  UK).  Human 
chorionic gonadotrophin (HCG)  10,000 IU ( Serono laboratories Ltd) was administered when 
at  least  3  follicles  had reached a mean diameter of 18mm  or more.  Transvaginal  follicular 
aspiration was performed 34-36 hours after HCG injection.
Cumulus-oocyte complexes (COC’s) were  isolated  from  follicular aspirates,  washed 
and  incubated  at  37°C  in  6%  C02  in  air.  3-6  hours  post  oocyte  recovery  oocytes  were 
prepared  for  IVF  or  ICS I  dependant  upon  earlier  semen  analysis.  Oocytes  for  IVF  were 
inseminated in a 4 well Nunc dish  in G-Fert media (Vitrolife,  Falmouth,  UK) with  100,000 
sperm per 1   ml well. Oocytes for ICSI had their surrounding cumulus cells removed with the 
minimal exposure to Hyase (Vitrolife) before being injected with a single sperm in G-MOPS
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(Vitrolife).  Following  IVF  insemination or ICSI oocytes were cultured overnight  in  G-Fert 
(IVF) or G-l  (ICSI) and checked for signs of fertilisation  19-20  hours later.  Those oocytes 
that  had  fertilised  normally  were  transferred  to  fresh  drops  of G-l  media  and  cultured  to 
embryo transfer. Those oocytes at the metaphase 2 stages that showed no signs of fertilisation 
were entered into the project.  Up until this stage all work on human eggs and oocytes were 
carried  out  by  embryologists  or  clinicians  at  Guys  Hospital.  These  unfertilised  eggs  were 
transferred from the Assisted Conception Unit at Guys Hospital to laboratories at University 
College London.  Eggs were kept in G-l  media warmed by heated  sterile sand  in a thermo 
carrier.  The  time  taken  for  the  transfer  of  oocytes  was  approximately  30  minutes.  All 
experiments  in  the  laboratory  were  carried  out  in  Hepes-KSOM  (HKSOM)  media  unless 
otherwise stated.
2.3.2  Embryo culture
Oocytes were cultured in Sydney IVF cleavage medium (COOK) from days  1-3 (up to 8-cell 
stage) before transfer to Sydney IVF blastocyst medium  (COOK)  for the remaining culture 
time. Oocytes were cultured in 20ul drops under mineral oil at 37°C in a 6% C02 incubator. 
Each day embryos were removed from the incubator briefly and their development was noted.
2.4  General Egg work
2.4.1  Egg loading and Microinjection.
Mouse eggs were loaded with 2pM Fura-2 (Molecular probes) for about 15 mins whereas pig 
eggs required a longer loading time of about 30-40 mins due to the larger size of the egg. The 
loading, manipulation and Ca2+ measurement were carried out in media containing 0.25mM 
sulfinpyrazone (Sigma) to prevent compartmentalisation of the Ca2+ indicator dye (Lawrence 
et al  1997).
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For PLC£ injections (Saunders et al., 2002) of mouse and pig eggs, injection pipettes
were  back-filled  with  varying  concentration  of  PLC^  cRNA  in  a  buffered  salt  solution
(120mM  KCL  and  20mM  Hepes,  pH  7.4)  that  had  been  treated  with  Chelex  100  beads
(Sigma) to remove divalent cations.  In  human eggs PLC^ cRNA was combined with  ImM
Oregon Green BAPTA dextran (Molecular Probes, Eugene, OR, USA) as an alternative way
to monitor Ca2+ changes without prior loading. PLC<^ cRNA was stored in aliquots at -80°C
2+   •  •
and thawed immediately before injection. For developmental purposes, when no Ca  imaging 
took place Oregon Green BAPTA was omitted from the injection and no prior loading of pig 
or  mouse  eggs  in  Fura-2  took  place.  All  eggs  were  also  placed  in  2pM  cytochalasin  D 
(Sigma) for approximately two hours to prevent second polar body extrusion.
Eggs were prepared for injection by transfer to a plastic petri dish with a fresh drop of 
media  covered  with  mineral  oil  (Sigma).  The  Petri-dish  was  placed  on  a Nikon  Diaphot 
microscope  stage  and  eggs  were  manipulated  using  a  micropipette  and  Narishige 
manipulators. Each egg was immobilized using a holding pipette and the injection pipette tip 
was pushed through the zona pellucida to the plasma membrane. Using the pressure injection 
system a dose of the PLC^ cRNA was injected into the oocyte.  The injection was 3-5% of the 
egg total volume and was estimated from the displacement of a bolus injection.
2.4.2  [Ca2+]i Measurements.
Loaded  pig  or mouse  eggs  were  transferred  to  a heated  chamber on  the  stage  of a Nikon 
Diaphot microscope. The heated chamber contained media absent of BSA to ensure the eggs 
remained stuck to the bottom of the chamber. A Xenon lamp was used to excite the Fura-2 at 
340  and 380nm.  Emission fluorescence was  collected using a 20 x 0.75  objective  lens  that 
passed through a 520 long pass filter and detected using a CCD camera. Ca2+ measurements 
of human eggs took place in a heated chamber on the stage of a Zeiss Axiovert microscope,
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which  was  equipped  with epifluorescence  optics  and  a 20 x  0.75NA  objective  lens.  Light 
from a halogen lamp passed through 490nm bandpass filter and emission was collected with a 
510nm long-pass filter. Fluorescence measurements were taken for individual eggs using an 
imaging  photon  detector  (IPD;  Photek  Ltd,  East  Sussex,  UK)  and  specialised  software 
developed by Science Wares (Falmouth, MA, USA).
2.5  Microarray work
2.5.1 Collection of 8-cell parthenotes for microarray work
Eggs were activated parthenogenetically using  Sr2+ or cycloheximide (See 2.1.4).  After 60 
hours  of culture  (See  2.1.5),  only  8-cell  embryos  exhibiting  excellent  morphology  were 
selected for collection. Batches of 34 8-cell embryos were washed four times through drops of 
M2 media and flash-frozen in 4ul of the same media. 8-cell embryos were shipped on dry ice 
to the National Institute on Aging (NLA), National Institute of Health (NIH), Baltimore, USA 
for RNA extraction, hybridisation and microarray analysis. The samples were stored at -80°C 
until further use.
2.5.2 Extraction and amplification of mRNA
Two collections of 34 x 8-cell embryos were collected for each group of cycloheximide and 
Sr2+ activated 8-cell embryos. Total mRNA was extracted from each group of embryos using 
a Quickprep micro poly-A RNA Extraction Kit (Amersham Biosciences, Piscataway, MJ) and 
linear  acrylamide  as  a  carrier  (Ambion,  Austin,  Texas).  Total  RNA  samples  from  each 
extraction were labeled with Cy3-dye by two-round linear amplification labelling reaction for 
cRNA targets using a Fluorescent Linear Amplification Kit (Agilent Technologies, Palo Alto, 
CA). Amplification was necessary due to the small amount of materials and starting mRNA 
we  had  extracted.  Compared  to  a  single  round  of amplification,  two-round  amplification
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reduces  the  sensitivity  of  differential  expression  detection  to  60%,  however  detection 
specificity was retained to 96% (Carter et al., 2003).
Quality  (purity)  and  size  distribution  of  cRNA  targets  was  determined  using  an 
Agilent  2100  Bioanalyzer  that  utilised  a  6000  Nano  lab-on-chip  Assay  (Agilent 
Technologies). Data was displayed as a gel  image or an electropherogram. The images and 
data provided  information about how well the  probes were  labelled, the  concentration  and 
quality of total RNA and any impurities that were present in the samples.
2.5.3 RNA labelling and hybridization on the N1A 22K 60-Mer Oligo Microarray
Universal mouse reference RNA (Stratagene, La Jolla, CA) was labelled with Cy5-dye by a 
one-round  amplification  labelling  reaction  and  used  as  a  control  for  all  hybridization 
reactions, allowing cross-comparisons between all data sets. The cRNA targets from both sets 
of  parthenogenetically  activated  embryos  and  universal  mouse  reference  RNA  were 
hybridized on the NIA 22k 60-mer oligo microarray (Carter et al., 2003). The NIA 22k 60- 
mer  oligo  microarray  is  enriched  with  genes  suitable  for  the  study  of  mouse  embryo 
development  and  is  compatible  with  the  small  amounts  of  RNA  extracted  from 
preimplantation mouse embryos (Ko et al., 2000).
2.5.4 Analysis of Microarray data
The  intensity  of 21,045  gene  features  per  array  were  extracted  from  scanned  microarray 
images  using  Feature  Extraction  5.1.1  software  (Agilent  Technologies),  which  performs 
background subtraction and dye normalization. Dye normalisation by Feature Extraction 5.1.1 
software is targeted at detecting changes in the relative expression of individual genes rather 
than global expression. Global gene expression was quantitatively analyzed using hierarchical 
clustering and Principle Component Analysis (PCA). A scatter plot showing the log-ratios of
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differentially  expressed  genes  in  both  groups  of  embryos  was  created  using  the  NIA 
microarray analysis tool (http://lgsun.grc.nia.nih.gov/ANOVAf).
Statistically  significant  genes  were  determined  quantitatively  using  the  analysis  of 
variance -  false discovery rate (ANOVA-FDR)  =  10%,  which minimises the occurrence of 
false positives (Sharov et al., 2005).  Assignment of gene function was carried out using Gene 
Ontology (GO) terms (Ashbumer et al.,  2000) which characterized genes  into basic  groups 
such  as  cell  cycle  and  cell  adhesion.  GO  terms  (Ashbumer  et  al.,  2000)  were  used  in 
conjunction  with  GenMapp/  MAPPFinder  (Doniger  et  al.,  2003)  to  find  the  genes  and 
functional  groups  associated  with  embryos  parthenogenetically  activated  with  Sr2+  or 
Cycloheximide.  The  microarray  data  are  available  from  the  public  databases  (GEO  and 
ArrayExpress) and the website: http://lgsun.grc.nia.nih.gov/microarray/data.html.
77Chapter 3: Introduction
Chapter 3 
PLCC ,;  a sperm specific protein that can activate 
development in mouse, pig and human eggs
3.1.1  Introduction
j
Fertilisation  in mammalian eggs triggers a series of long-lasting [Ca  ]i oscillations that are 
paramount  for  meiotic  resumption,  pronucleus  formation,  cortical  granule  exocytosis  and 
entry  into  the  first  mitotic  division  (Kline  and  Kline,  1992).  These  events  are  collectively 
referred to as egg activation (Lawrence et al., 1998). In mice, the [Ca2+]i oscillations continue 
for  about  4  hours  before  they  cease  at  a  time  corresponding  to  pronucleus  formation 
(Cuthbertson  and  Cobbold,  1985;  Jones  et  al.,  1995a).  The  exact  pattern  of these  sperm- 
induced [Ca2+]i oscillations is unique. Strontium ions (Sr2*) are one of a number of artificial 
stimuli  that  can  induce  [Ca2+]i  oscillations,  but  the  patterns  with  which  these  [Ca2+]i 
oscillations occur  is easily distinguishable  from the highly characteristic  oscillations which 
are  actually induced  at  fertilisation.  Many attempts have been made to  elucidate the  factor 
responsible  for  triggering  [Ca2+]i  oscillations,  egg  activation  and  embryo  development 
(Swann et al., 2004).
Recently a novel  phospholipase  C  (PLC),  termed  PLC^(zeta)  was  put  forward  as  a 
candidate  for the  sperm  factor  (Saunders  et  al.,  2002).  Microinjection  of mouse  PLC  zeta 
complementary  RNA  (mPLC£  cRNA)  into  mouse  eggs  triggered  a  pattern  of  [Ca2+]i 
oscillations that were  indistinguishable  from  those  induced by  fertilisation.  Preimplantation 
embryo  development  to  the  blastocyst  stage  has  been  triggered  in  mouse  eggs  after 
microinjection of mPLC£ with success rates similar to those after IVF (Saunders et al., 2002). 
Hamster  sperm  extracts  failed  to  induce  any  [Ca2+]i  oscillations,  egg  activation  or  later
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development  when  microinjected  into  mouse  eggs  if they  were  previously  subjected  to 
immunodepletion of PLC£ (Saunders et al., 2002). These results strongly suggest that PLC£ is 
the sperm factor responsible for activating egg development at fertilisation.
PLC^ genes have  been  identified  in mice,  humans,  monkeys,  chimpanzee,  cow,  rat, 
dog and chickens (Saunders et al., 2002; Cox et al., 2002; Coward et al., 2005). The different 
forms of PLC£ all  appear to have  a functional  similarity and can all cause Ca  release  in 
mouse eggs. One study has shown that differences exist between mice, human and monkey 
PLC£ (mPLC£, hPLC£ and cPLC^ respectively) with regards to their Ca2+-releasing potential 
in mouse eggs (Cox et al., 2002).  [Ca2+]i oscillations were generated more effectively from 
microinjection of hPLC£ cRNA than microinjection of mPLC£ or cPLC£ cRNA (Cox et al.,
2002). Studies have so far focused on the nature of different species PLC^ and their differing 
potential in causing [Ca2+]i oscillations (Saunders et al., 2002; Cox et al., 2002; Coward et al., 
2005)  or  on  the  functionality  of the  PLC£  molecule  as  an  enzyme  (Kouchi  et  al.,  2005; 
Nomikos et al., 2005). Whilst there have been investigations on the affect of PLC£ in mouse 
eggs,  no  studies have  investigated variation  in the  sensitivity of eggs from  other species to 
PLC£.
The aim of this chapter was to investigate the effectiveness of mPLC£ and hPLC£ in
‘ ji
triggering [Ca  ]i oscillations, egg activation and development in mouse, pig and aged human 
eggs.  To  my  knowledge  this  was  the  first  study  to  examine  the  effects  of PLC£  cRNA 
injection on pig and human eggs.  The experiments  presented here  show that differences  in 
sensitivity exist between mouse,  pig and human  eggs regarding their ability to release Ca2+ 
after stimulation by mPLC£ and hPLC£.
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3.2 Results
3.2.1  Sperm induce repetitive [Ca2+]i oscillations during IVF
In vitro fertilisation (IVF) of mouse eggs was carried out to monitor the different parameters 
of [Ca2+]i oscillations (frequency, mean interspike interval, amplitude and duration) induced 
by sperm. Mouse eggs were injected with Oregon green BAPTA Dextran (OGBD) and their 
Zona-Pellucidae  (ZP)  were  removed  prior  to  fertilisation  as  the  eggs  needed  to  be 
immobilised  before  [Ca2+]i  recording  could  begin.  [Ca2+]i  transients  were  monitored  by 
increases  in  OGBD  fluorescence.  Fluorescent  light  was  measured  on  an  Imaging  Photon 
Detector (IPD) which produced both a bright field and fluorescence  image of the eggs (Fig 
3.1Ci  and  ii).  The  range  of colours represented  fluorescence  intensity,  red  represents  high 
[Ca2+]i and blue represents basal levels of [Ca2+]i (Fig 3.1Cii).
[Ca2+]i oscillations began less than 5 minutes after adding the capacitated sperm to the 
media.  Initiation  of [Ca2+]i  oscillations  would  normally  take  longer  if the  ZP  was  intact 
because the sperm would need to trigger the acrosome reaction to permit ZP penetration. The 
sperm induced the characteristic pattern of [Ca2+]i oscillations previously reported to occur at 
fertilisation  (Fig  3.1A)  (Miyazaki  et  al.,  1993;  Swann  and  Ozil,  1994).  The  first  transient 
lasted approximately 6  minutes and at its peak,  it exhibited a series of small  superimposed 
high frequency [Ca2+]i spikes (Fig 3.IB). The first [Ca2+]i transient was also characterised by 
having a distinct shoulder during its rising phase. The subsequent [Ca2+]i oscillations were of 
much  shorter duration  (~ 60  seconds)  and were  of similar amplitude to  one  another.  Each 
regenerative [Ca2+]i transient began with a slow rise in [Ca2+]i from basal levels, followed by 
a swift attack to the peak. The five eggs monitored during IVF exhibited [Ca2+]i oscillations 
that had a mean interspike interval of 10.9 + 1.29 (standard error mean; s.e.m) mins.
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3.2.2  Mouse and human PLC£ triggers long lasting [Ca2+]i oscillations in mouse eggs 
PLC£ was used in the form of complementary RNA (cRNA), since it is rapidly translated into 
protein following microinjection into mouse eggs.  PLC£ protein was not used because  it  is 
unstable and was not available in a consistently active form. The protein form is also harder to 
microinject  into  eggs  and  can  easily  be  contaminated  by  other proteins  during  the  protein 
purification  stage.  PLC£ cRNA was  stored  in -80°C  and only thawed  immediately  prior to 
usage  to  prevent  degradation  of PLC^  by  RNAses.  Mouse  eggs  were  loaded  with  tura-2 
before  being  injected  with  various  concentrations  of mouse  or  human  PLC^  (mPLC£  and
hPLC£ respectively). Microinjection of mPLC£ or hPLC£ into mouse eggs triggered repetitive
2 1
[Ca  ]i  oscillations (Fig 3.2) which were indistinguishable from those  induced by IVF  (Fig
3.1).
The  frequency of the  [Ca2+]i  oscillations  was  determined  by the  concentration  and 
type of PLC^ cRNA microinjected into the mouse egg. The highest pipette concentration of 
mPLC^ used was 2mg/ml which corresponds to a concentration of <0.1 mg/ml in the mouse 
egg after a 3-5% injection volume. Nine eggs were injected with 2mg/ml hPLC£ cRNA and 
all eggs responded by exhibiting high frequency  [Ca2+]i oscillations with a mean interspike 
interval  of 8.8  1  0.52  (s.e.m)  mins  (Table  3.1)  that  commenced  within  20-30  minutes  of 
microinjection (Fig 3.2A). Many of the [Ca2+]i transients had a distinct shoulder during their 
rising phase.  Injecting a ten-fold lower pipette concentration of mPLC^ (200pg/ml) reduced 
the frequency of [Ca2+]i oscillations (Fig 3.2B) and gave a mean interspike frequency of 15.38 
1 2.12  (s.e.m) mins (Table 3.1).  Nine mouse eggs were  injected with this concentration  of 
mPLC^  and  eight  eggs  (89%)  exhibited  [Ca2+]i  oscillations.  Consistent with  the  pattern  of 
IVF-induced  [Ca2+]i  oscillations,  the  first  [Ca2+]i  transient  induced  by  mPLC^  lasted 
approximately 5 mins and had smaller [Ca2+]i rises superimposed on its peak (Fig 3.2C)
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Figure 3.1 Sperm induced [Ca2+]i Oscillations during IVF. A sample [Ca2+]i trace in a single 
Oregon Green BAPTA dextran (OGBD) loaded Mil mouse oocyte. OGBD fluorescence was in 
arbitrary units.  [Ca2+]i oscillations began less than 5  minutes after introduction of sperm  into 
the  media,  (indicated by the  red arrow).  The  black arrow  shows that the  [Ca2+]i  transient  is 
triggered by an initial gradual rise in basal [Ca2+]i. The first [Ca2+]i transient (B) had a duration 
of about  6.5  mins  and  contained  smaller  superimposed  increases  on  top  of it’s  peak.  Zona 
pellucida  were  removed  from  eggs  prior  to  IVF  as  shown  on  the  brightfield  image  (Ci). 
Fluorescence  was  monitored  in  mouse  eggs  over time  (ii).  The  range  of colours  reflect  the 
fluorescence  intensity  of [Ca2+]i  in  the  eggs  with  red  and  blue  indicating  high  and  basal 
cytosolic  [Ca2+]i  levels respectively. The middle  and  far right egg are  high  in cytosolic Ca2+ 
and probably at a peak in the  [Ca2+]i transient.  The egg above (blue) exhibits resting  [Ca2+]i 
levels and the egg below has rising [Ca2]i+ levels probably just prior to an upstroke in [Ca2+]i.
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type
PLC£
concentration
Mean Interspike interval
Human Eggs Mouse eggs Pig eggs
mPLC£ 1-2 mg/ml 15.8 ±10.0 (3) 8.8 ± 0.52 (9) No [Ca2+]i 
Oscillations
mPLC£ 100-200pg/ml 103.0 ±4.17 (4) 15.3 ±2.12 (9) No [Ca2+]i 
oscillations
hPLC£ 100-200pg/ml 24.0 ±4.82 (4) N/A 10.5 ±9.02 (6)
hPLC£ 10-20pg/ml 86.0 ±3.29 (9) 3.88 ±1.54 (12) 78.3 ± 2.4 (9)
hPLC£ 0.1-0.2pg/ml 109.0 ±4.49 (6) 11.5 ±2.29 (6) N/A
Table  3.1  Mean  interspike  intervals  of [Ca2+]i  oscillations  after  mPLC^  or  hPLC£ 
cRNA injection into  mouse, pig and  human eggs.  Brackets denote the  number of eggs 
tested for each concentration of PLC£. N/A applies to concentrations of PLC^ not tested in 
eggs
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Figure  3.2  Injection  of  mPLC£  cRNA  in  mouse  eggs.  2mg/ml  PLC£  initiated  high 
frequency  [Ca2+]i  transients  with  a  mean  interspike  interval  of  8.8  mins  and  which 
occurred approximately 20-30 mins after injection (A). Lowering he pipette concentration 
ofPLC^ 10-fold (200pg/ml) reduced the frequency of [Ca2+]i oscillations so that the mean 
interspike  interval  was  15.38  mins  and  [Ca2+]i  oscillations  began  45-60  mins  after 
injection (B). At this frequency the  [Ca2+]i oscillations take on a form  similar to  [Ca2+]i 
oscillations induced by fertilisation. The arrows show the gradual increase in basal [Ca2+]i 
initiating the next [Ca2+]i transient. The first [Ca2+]i transient was approximately 4.5  mins 
long and contained smaller superimposed increases on the top of the peak (C).
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Compared to the concentration of mPLC^ used,  much  lower concentrations of hPLC^ were 
required  to  induce  [Ca2+]i  transients  (Fig  3.3)  of similar  mean  interspike  interval.  When 
20pg/ml  hPLC^ was  microinjected  into  12  mouse  eggs  it  was  effective  in  causing  [Ca2+]i 
oscillations  in all  of them.  The  [Ca2+]i  oscillations were of very high  frequency  and  had  a 
mean interspike interval of 3.88 ±1.54  (s.e.m) mins (Table 3.1). After about  lhour from the 
time  the  [Ca2+]i  oscillations  commenced  the  amplitude  of  the  transients  decreased 
dramatically, although the frequency remained constant (Fig 3.3A).
Injection  of  a  100-fold  lower  concentration  hPLC^  (0.2pg/ml)  triggered  [Ca2+]i 
oscillations (Fig 3.3B) with a mean interspike interval of 11.53 ^-2.29 (s.e.m) mins (Table 3.1) 
which is of a similar frequency to that of IVF. This concentration of hPLC£ was effective in 
causing [Ca2+]i increases in all six eggs injected. The first [Ca2+]i transient induced by hPLC£ 
in mouse eggs was of duration of approximately 5 mins and it exhibit smaller superimposed 
[Ca2+]i  rises  on  the  top  of its  peak,  both  of which  are  consistent  with  the  initial  [Ca2+]i 
transient  during  IVF  or  following  injection  with  mPLC^  (Fig  3.3C).  The  main  effect  of 
increasing  the  concentration  of hPLC£  cRNA  was  the  increase  in  frequency  of  [Ca2+]i 
oscillations triggered. The amplitude and duration of each [Ca2+]i transient did not appear to 
change with an increase in concentration of hPLC^  or rnPLC^ cRNA microinjected in mouse 
eggs.
Microinjection  of  rnPLC^  or  hPLC£  triggered  [Ca2+]i  transients  that  gradually 
increased in [Ca2+]i followed by a swift rising phase before an abrupt decay to basal  levels. 
Another gradual  increase  in  [Ca2+]i  was observed before the next  [Ca2+]i  transient and  this 
suggested that a [Ca2+]i pacemaker was in action, leading to regular increases in [Ca2+]i over 
time (Fig 3.2 and 3.3).
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Figure 3.3 -  Injection  of human  PLC£ (hPLCQ  into  mouse eggs.  PLC£  was  injected at 
concentrations of A) 20pg/ml and B) 0.2pg/ml  in mouse eggs. The higher (A) concentration 
produced very high frequency [Ca2+]i oscillations that reduced in amplitude after the first  1.5 
hours.  Lowering  the  pipette  concentration  (100-fold)  of  hPLC£  (B)  triggered  [Ca2+]i 
oscillations that were  indistinguishable  from  those  at  IVF,  the  first  transient  was  longer  in 
duration (~ 5 mins) than the subsequent transients and had smaller peak [Ca2+]i increases on 
the top (C).
86Chapter 3: Results
3.2.3  hPLC£ but not mPLC£ is effective at triggering [Ca2+]i oscillations in pig eggs 
Immature  cumulus  enclosed  pig eggs  were  cultured  for  approximately 48  hours  until  they 
arrested at MIL Eggs were selected on the basis of whether 1st polar body extrusion had taken 
place  before  injecting  them  with  PLC^  cRNA  (Fig  3.4D).  The  microinjection  of mPLC^ 
cRNA into pig eggs at a variety of concentrations (0.2-2mg/ml) completely failed to trigger 
[Ca2+]i oscillations in pig eggs.  I have just shown that the potency of hPLC£ is higher than 
that of mPLC£ regarding the  ability to  cause  [Ca2+]i  release  in  mouse  eggs  so  changes  in 
intracellular  [Ca2+]i  were  monitored  in  pig  eggs  after  micro injection  of hPLC£  cRNA.  A 
concentration  of  20pg/ml  hPLC^  cRNA  only  stimulated  between  one  and  three  [Ca2+]i 
transients, which started approximately one to two hours after injection of hPLC£ cRNA (Fig 
3.4A). The [Ca2+]i transients had a mean interspike interval of 78.3 + 2.4 (s.e.m) mins (Table
3.1) and the amplitude of each [Ca2+]i transient decreased dramatically after each successive 
transient  (Fig  3.4A).  This concentration  of hPLC^  cRNA was  effective  at  causing  [Ca2+]i 
increase in 12 out of 16 (75%) eggs.
Injecting  a  higher  concentration  of hPLC£  cRNA  (ten-fold)  stimulated  the  [Ca2+]i 
oscillations to begin 30 -  60 mins after microinjection. The pig eggs displayed between four 
and eight [Ca2+]i  spikes with a mean  interspike  interval  of 10.5  + 9.02  (s.e.m) mins (Table
3.1)  and  like the  lower concentration there was  a  large  decrease  in  the  amplitude  of each 
successive  [Ca2+]i transient (Fig 3.4B). The [Ca2+]i oscillations were induced in 9 out of 12 
(75%) eggs after hPLC£ injection and in these eggs the oscillations lasted approximately one 
hour  before  cessation.  The  first  [Ca2+]i  transient  in  the  pig  egg  lasted  approximately  90 
seconds and did not appear to have any smaller spikes superimposed over the peak (Fig 3.4C).
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Figure  3.4  [Ca2+]i  oscillations  in  pig  eggs  triggered  by  microinjection  of  hPLC£ 
cRNA.  20pg/ml  hPLC£  cRNA  triggered  two  or  three  [Ca2+]i  transients  that  were 
approximately  60  mins  apart  (A).  200pg/ml  hPLC£  cRNA  triggered  multiple  [Ca2+]i 
oscillations, which lasted for about  1   hour before cessation (B). An arrow indicates the 
pacemaker  Ca2+  which  was  responsible  for  stimulating  sharp  [Ca2+]i  transients.  * 
indicates the time  the  Ca2+ pacemaker fails to  initiate  a  swift  increase  in  [Ca2+]i.  The 
first [Ca2+]i transient (C) lasted approximately 1.5 mins. Immature cumulus enclosed pig 
eggs  (D)  were  cultured  for  approximately  48  hours  until  they  arrested  at  Mil.  MII- 
arrested eggs were subsequently injected with hPLC£ cRNA.
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3.2.4  Mouse and human PLC£ induces [Ca2+]i oscillations in aged human eggs
I  wanted to  determine  if PLC£  would  be  effective  in  inducing  [Ca2+]i  oscillations  in  aged 
human eggs that had previously failed to activate following IVF or ICSI. Aged human eggs 
were co-injected with Oregon Green BAPTA Dextran (OGBD) and various concentrations of 
mPLC^ or hPLC^  cRNA.  OGBD  was used  as  a dye  instead of Fura-2  because  a different 
imaging  system was available at the time. An  Imaging Photon Detector (IPD) was  used to
9+
monitor fluorescence and this required a single wavelength [Ca  ]i indicator.
A  higher concentration  of rnPLC^ cRNA  was  required to  induce  similar  frequency 
[Ca2+]i  transients that were  induced by hPLCC, cRNA.  At  1  mg/ml  mPLC^ cRNA  triggered 
repetitive [Ca2+]i oscillations in all three human eggs injected. The [Ca2+]i oscillations began 
30 -  60 mins after microinjection (Fig 3.5A). The first [Ca2+]i transient was longer in duration 
than the  subsequent transients  and  lasted  approximately  5  mins  but  did  not  show  signs  of 
smaller spikes superimposed on the peak (Fig 3.5C). The first five to seven [Ca2+]i transients 
successively reduced  in  amplitude  but the  subsequent  [Ca2+]i  transients  were  of invariable 
amplitude. The  [Ca2+]i oscillations had a mean interspike interval  of 15.8 1  10 (s.e.m) mins 
(Table 3.1) which shortened successively with time. Decreasing the concentration of injected 
mPLC£ cRNA ten-fold (lOOpg/ml) triggered the  [Ca2+]i oscillations  in  all  four human eggs 
injected.  [Ca2+]i oscillations  started 60 -  90 mins after injection and had a mean  interspike 
interval  of  103  ± 4.17  (s.e.m)  mins  (Table  3.1).  The  mean  interspike  interval  appeared  to 
decrease after each [Ca2+]i transient.
Three different concentrations of hPLC£ cRNA were injected into aged human eggs. 
lOOpg/ml  hPLC£  cRNA  triggered  high  frequency  [Ca2+]i  oscillations  within  15  mins  of 
micro injection  (Fig  3.5A)  in  all  four  eggs  microinjected  at  this  concentration.  The  [Ca2+]i 
transients had a mean interspike frequency of 24 1 4.82 (s.e.m) mins (Table 3.1) and similar 
amplitude for each transient. A 10-fold decrease in the concentration of injected hPLC^ cRNA
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Figure 3.5 Injection of mPLC£ cRNA into aged  human eggs. Pipette concentrations of 
1  mg/ml mPLC£ cRNA triggered high frequency  [Ca2+]i oscillations that started about 30 
mins after injection (A).  lOOpg/ml mPLC£ cRNA triggered  [Ca2+]i oscillations that were 
much less frequenct and which started about 90 mins after injection (B). The first [Ca2+]i 
transient has a distinct peak and lasted for a duration of approximately 5  mins (C).  Eggs 
were  co-injected  with  PLC£  cRNA  and  Oregon  Green  BAPTA  dextran  (OGBD)  and 
[Ca2+]i was monitored using (OGBD) fluorescence.
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(lOpg/ml)  stimulated  [Ca2+]i  transients  in all nine  eggs microinjected  at this concentration. 
[Ca2+]i oscillations started after approximately an hour and had a mean interspike interval of 
86 1 3.29 (s.e.m) mins (Table 3.1, Fig 3.6B). A further  100-fold decrease in concentration of 
injected hPLC£ cRNA (O.lpg/ml) triggered [Ca2+]i transients with a mean interspike interval 
of 109 ±4.49 (s.e.m) mins (Table 3.1) and the first  [Ca2+]i transient began 30-60 mins after 
microinjection  of hPLC£ cRNA  (3.6C).  In  contrast to the  higher  concentrations  of hPLC£ 
cRNA, O.lpg/ml was only effective at inducing [Ca2+]i oscillations in 6 out of 13 eggs (46%). 
A definite trend existed towards the higher concentrations of hPLC£ cRNA triggering higher 
frequency [Ca2+]i oscillations. Injection of hPLC^ cRNA at concentrations of 1   or  10  pg/ml 
caused  [Ca2+]i  oscillations  that  initially  had  a  relatively  low  frequency  but  with  time  this 
frequency increased so that the final frequency was more similar to  [Ca2+]i  oscillations that
were  induced  by  higher  concentrations  of hPLC£  cRNA.  A  sustained  low  frequency  of
2+  .
[Ca  ]i  oscillations  was  only triggered  by using  a  low  pipette  concentration  (O.lpg/ml)  of 
hPLC£ cRNA.
3.2.5  The sensitivity of the [Ca2+]i release mechanism in mouse, pig and human eggs 
Different concentrations of  microinjected  PLC£ cRNA caused differences in the pattern of 
[Ca2+]i oscillations exhibited in eggs, mainly in regard to the frequency of [Ca2+]i transients. 
Table 3.1  provides information about the mean interspike intervals of [Ca2+]i oscillations after 
injection of different concentrations of mPLC^ or hPLC^ in mouse, human and pig eggs. Both 
mPLC£ and hPLC£ appeared to be effective in causing [Ca2+]i oscillations in the mouse and 
human egg. The human egg and the mouse egg appeared to be  less sensitive to mPLC^ and 
required  a  10-fold  increase  in  mPLC£  cRNA  concentration  to  produce  similar  frequency 
[Ca2+]i oscillations to those observed in the mouse egg when microinjected with rnPLC^. The
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Figure  3.6  [Ca2+]i  oscillations  triggered  by  hPLC^  cRNA  in  aged  human  eggs.  PLC^ 
cRNA  of concentration  lOOug/ml  (A)  ,  lOug/ml  (B)  and  0.lug/ml  (C)  were  injected  into 
human eggs. The frequency of [Ca2+]i oscillations increased with increased concentration of 
hPLC£ cRNA  injected.  The  frequency of [Ca2+]i  oscillations  also  increased with time  after 
injection  of  lOug/ml  hPLC£  cRNA.  [Ca2+]i  was  measured  using  Oregon  Green  BAPTA 
dextran  (OGBD)  fluorescence.  Eggs  were  co-injected  with  PLC£  cRNA  and  OGBD 
approximately 20 mins before the start of recording. OGBD Fluorescence were measured in 
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pig  egg  was  completely  unresponsive  to  injection  of mPLC^  cRNA  at  a  concentration  of 
2mg/ml.
The mouse egg was very sensitive to hPLC£ and produced very high frequency 
[Ca2+]i  oscillations  even  at  low  concentrations  of hPLC£  (100-0.lpg/ml).  The  mouse  egg 
appeared  to  be  at  least  1000-times  more  sensitive  to  hPLC£  than  the  human  egg,  since 
O.lpg/ml  hPLC£  in  the  mouse  egg  triggered  [Ca2+]i  oscillations  that  were  approximately 
double the  frequency of those  in human eggs that had been  injected with  lOOpg/ml hPLC£ 
cRNA.
The pig egg responded to hPLC£ by generating [Ca2+]i transients. Whilst the data in 
Table  3.1  shows that pig eggs exhibited  [Ca2+]i  oscillations at a  shorter  interspike  interval 
than  human  eggs  after micro injection  of 10-20  pg/ml  hPLC^  cRNA,  it  does  not  take  into 
account the short duration of [Ca2+]i oscillations in pig eggs. At lOpg/ml hPLC£ only induced 
two or three transients which were on average  78  mins apart.  Whilst  lOOpg/ml  hPLC^ did 
produce  a much  higher  frequency of [Ca2+]i  oscillations  (mean  interspike  interval  =  11.53 
mins) the duration only lasted about an hour. The amplitude of each transient also dampened 
rapidly after each successive [Ca2+]i spike in all pig eggs injected with hPLC£ cRNA..
3.2.6  Embryo development following injection of hPLC£ cRNA
Embryo development was monitored in mouse, pig and human eggs after injection of 
hPLC£  cRNA  (Table  3.2  and  Fig  3.8).  Changes  in  [Ca2+]i  were  not  monitored  in  these 
embryos  since  light  exposure  during  fluorescence  microscopy  can  impair  embryo 
development  and  eggs were  injected with  hPLC^ cRNA  alone.  All  eggs  were treated  with 
cytochalasin D to prevent 2nd polar body extrusion to ensure embryos were diploid.  Mouse 
eggs  were  injected  with  0.2pg/ml  hPLC^  cRNA  because  it  had  been  shown  that  this 
concentration of cRNA caused the highest number of embryos reaching the blastocyst stage
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of development (38.9%) (Cox et al., 2002). Consistent with this report, I found that 0.2pg/ml 
hPLC£ cRNA stimulated high percentages of mouse embryos to develop to the 2-cell (82%), 
4-cell (67%), 8-cell (55%) and blastocyst (53%) stage (Table 3.2 and Fig 3.8).
I  chose  to  inject  human  eggs  with  lOpg/ml  or  O.lpg/ml  to  determine  which 
concentration  would  generate  the  best  development.  14  human  eggs  were  injected  with 
lOpg/ml hPLC^ cRNA and whilst  10 (71%) formed pronuclei, only 2 (14%) reached the 2- 
cell stage and arrested development at this stage. A 100-fold decrease in hPLC^ concentration 
(O.lpg/ml)  had a dramatically different affect on embryo development and  stimulated  high 
numbers  of human  eggs  to  reach  the  2-cell  (75%),  4-cell  (42%),  8-cell  (21%)  and  the 
blastocyst (17%)  stage (Fig 3.7,  3.8  and Table  3.2).  Pig eggs were  injected with 200pg/ml 
hPLC£ cRNA because it triggered multiple [Ca2+]i oscillations in the eggs which could not be 
induced to occur with lesser concentrations (Fig 3.4B). Only 30% of these eggs developed to 
the 2-cell  stage whilst  10% reached the 4-cell  stage,  3% reached the  8-cell  stage  and none 
developed to the blastocyst stage (Table 3.2 and Fig 3.8).
94Figure  3.7  Parthenogenetic  human  embryos.  Human  eggs  that  were 
previously unsuccessful  in  fertilising during ICSI  or IVF were entered  into 
parthenogenetic activation studies using PLC£ cRNA injection, (i) Human 8- 
cell embryos (21%) and (ii) blastocyst stage embryos (17%) were generated 
from  eggs  injected  with  O.lpg/ml  hPLC£  cRNA.  Eggs  were  treated  with 
cytochalasin D for 2 hours after injection of PLC£ to prevent 2nd polar body 
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Figure  3.8  Developmental  scores  of  Mouse,  human  and  pig  embryos  following 
injection of hPLC£ cRNA. Mouse embryo development was the most successful with 
82% and 53% of embryos reaching the 2-cell  stage and blastocyst stage, respectively 
after  injection  of 0.2pg/ml  PLC£  cRNA.  Human  eggs  were  injected  with  O.lpg/ml 
hPLC£ which allowed 75% and  17% of human embryos to reach the 2-cell  stage  and 
blastocyst stage,  respectively.  200pg/ml  hPLC£ cRNA allowed only 30% and  3% of 
pig eggs to reached the 2-cell stage and 8-cell stage (3%) respectively. No pig embryos 
reached the blastocyst stage, n refers to the total number of embryos that were injected 
with hPLC£ cRNA in each species group. The number above each bars represents the 
number of embryos reaching the specified developmental stage. Numbers were derived 
from 3 or more experiments.
96Egg
type
hPLC£
concentration
No of 
embryos
% of embryos reaching stage of development
2-cell 4-cell 8-cell blastocyst
Mouse 0.2pg/ml 76 82 67 55 53
Human O.lpg/ml 24 75 42 21 17
Pig 200pg/ml 60 30 10 3 0
Table 3.2 Developmental scores of mouse, pig and human embryos derived from egg 
activation induced by hPLC£. The concentration of hPLCC, used to trigger development in 
each egg is stated. Development was scored for embryos developing from the 2-cell to the 
blastocyst stage.
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3.3 Discussion
It has previously been shown that mPLC^ and hPLC£ can cause activation and development 
to the blastocyst stage in mouse eggs (Saunders et al., 2002; Cox et al., 2002). In this Chapter 
I  show  for  the  first  time  that  PLC^  can  also  cause  [Ca2+]i  release  egg  activation  and 
development in human (Rogers et al., 2004) and pig eggs with different levels of success.  I 
establish  that  there  are  clear  differences  between  the  sensitivity  of different  mammalian 
(mouse, human and pig) eggs regarding PLC^-induced [Ca2+]i release and confirm previous 
reports that  show that differences  in the  potency of [Ca2+]i  releasing  ability exist  between 
mPLCC and hPLC^ (Cox et al., 2002).
3.3.1  Mouse and human PLC£ can effectively induce  [Ca2+]i oscillations in  mouse eggs 
but at different concentrations.
[Ca2+]i oscillations induced by sperm during IVF in mouse eggs were regular, repetitive and 
long-lasting (Fig 3.1). The first [Ca2+]i transient was about 6.5 mins in duration and contained 
smaller [Ca2+]i increases on its peak. The subsequent [Ca2+]i transients were much shorter in 
duration and a gradual increase in basal [Ca2+]i acted as a trigger to initiate the characteristic 
steep  upstroke  of  each  transient.  This  characteristic  pattern  of  [Ca2+]i  oscillations  was 
mimicked  by  PLC^  cRNA,  which  induced  [Ca2+]i  oscillations  that  were  indistinguishable 
from  those  induced  by  IVF.  Concentrations  of PLC£  cRNA  described  in  the  results  were 
injection pipette concentrations. Eggs were injected with pipette concentrations of 2mg/ml -  1  
x  104 mg/ml PLC£ cRNA, corresponding to <0.1 mg/ml -  5 x  106 mg/ml PLC£ cRNA in the 
egg after a 3-5% injection volume.
The  main  difference  between  the  [Ca2+]i  oscillations  induced  by  different  pipette 
concentrations of mPLC^ and hPLC^ was the frequency of the [Ca2+]i oscillations. The higher 
the  pipette  concentration  of PLC£  cRNA  injected  into  eggs,  the  higher  the  frequency  of
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[Ca2+]i oscillations induced and this matches the same phenomenon observed with different 
pipette concentrations of PLC£ (Saunders et al., 2002) or sperm extract (Swann,  1990). The 
amount  of  PLC£  protein  synthesized  in  mouse  eggs  has  previously  been  shown  to  be 
proportional to the concentration of PLC£ cRNA injected (Saunders et al., 2002). These data 
suggest that the concentration of PLC£ protein affects the frequency of PLC^-induced [Ca2+]i 
oscillations  (Rogers  et  al.,  2004).  Recently  the  minimum  concentration  of PLC£  protein 
required to  induce  [Ca2+]i oscillations has been estimated to  by different  studies to  be  300 
femptograms  (fg)/egg  (Kouchi  et  al.,  2004),  44-75  fg/egg  (Saunders  et  al.,  2002),  10-40 
fg/egg (Yoda et al., 2004) and 50 fg/egg (Nomikos et al., 2005).  Differences in the estimated 
concentrations  of  PLC£  protein  required  to  induce  [Ca2+]i  oscillations  may  be  due  to 
modifications  of the  PLC£ molecule to  a more  active  form  in  some  of the  eggs tested.  A 
pipette concentration of 0.02mg/ml mPLC^ cRNA which equates to 44-75fg/egg was reported 
to induce [Ca2+]i oscillations whose frequency was most like those that occur during IVF. A 
10-fold lower concentration (0.002mg/ml) which is equivalent to 4-8 fg/egg did however also 
cause [Ca2+]i oscillations with a lower frequency than those triggered by IVF (Saunders et al., 
2002). A single mouse sperm was calculated to contain about 20-50 fg PLC£ protein which is 
in the same range as the amount of rnPLC^ (4-75  fg of protein or 0.002-0.02 mg/ml cRNA) 
that is able to generate [Ca2+]i oscillations in a single mouse egg  (Saunders et al., 2002) and 
this is consistent with my data on mPLC^-induced [Ca2+]i release in mouse eggs.
Injecting a  1000-fold  lower pipette  concentration of hPLC£ was  needed  in to  cause
2” F   •  •  •
[Ca  ]i  oscillations  of a  similar  frequency  to  those  induced  by  mPLC£  in  mouse  eggs.  A 
concentration of 0.2pg/ml hPLC£ or 200pg/ml mPLC^ cRNA was sufficient to induce [Ca2+]i 
transients with a similar mean  interspike  interval to those  induced by  IVF  (table  3.1).  This 
data  is  supported  by  previous  reports  that  show  hPLC£  has  a  much  higher  potency  than 
mPLC£ with regard to [Ca2+]i releasing ability in mouse eggs (Cox et al., 2002).  The pipette
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concentration of hPLC£ and mPLC£ that triggered egg activation and development of mouse 
embryos  to  the  blastocyst  stage  in  these  experiments  were  similar  to  previous  reports 
(Saunders et al., 2002; Cox et al., 2002). The reasons for such a difference in [Ca2+]i releasing 
potency are unclear but it may be that as the volume of the human egg is greater than that of 
the mouse egg, The diameter of a human egg is approximately 150pm compared to the mouse 
egg which is approximately 80pm. This makes the human egg around seven times larger in 
volume than the mouse egg.  The dilution of PLC^ from the sperm into the cytoplasm would 
be larger and therefore may require a more vigorous PLC£ to trigger Ca2+ release (Cox et al.,
2002).  Differences  in  mouse  and  human  PLCC,  may  also  be  due  to  the  fact  that  different 
amounts of PLC£ may be present in human and mouse species sperm. The mouse and human 
egg  may  alternatively have  different  sensitivities  to  the  sperm  factor  as  is  the  case  in  the 
hamster egg  for example, where  it has been reported that the egg is much  less sensitive to 
sperm extract than the mouse egg (Parrington et al.,  1996). The sensitivities of mouse, pig and 
human  eggs  were  investigated  with  regard  to  [Ca2+]i  -releasing  ability  following 
microinjection of mPLC^ and hPLC£ cRNA. This was the first study carried out to investigate 
the effects of mPLC£ and hPLC£ on pig and human eggs.
3.3.2  Differences in sensitivity to different PLC^’s exist between mouse and human eggs 
The  concentration  of hPLC^  that  triggers  [Ca2+]i  oscillations  in  mouse  eggs  (0.2pg/ml)  is 
1000 times  lower than the  amount of hPLC£ (200pg/ml) that was  used to  generate  [Ca2+]i 
oscillations of a similar frequency in aged human eggs (table 3.1). This difference may in part 
be  due  to  the  fact  that  aged  human  eggs  may  not  translate  the  injected  PLC^  cRNA  into 
protein as efficiently as the freshly ovulated mouse eggs that were used.
The concentration of mPLC£ that triggers [Ca2+]i oscillations in human eggs (1 mg/ml) 
was only five times higher than the amount used to produce  [Ca2+]i oscillations of a similar 
frequency  in  mouse  eggs  (200ug/ml)  so  any  inefficiency  of aged  human  eggs  to  translate
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cRNA to protein must be minimal (figs 3.2  and 3.5). These results show that whilst mouse 
eggs are much more sensitive to hPLC£ than human eggs (-1000 times), mouse eggs are only 
slightly more sensitive to mPLC£ than human eggs (-5  times). This  suggests that the eggs 
have  different thresholds  of sensitivity  for different  PLC^’s  since the  mouse  egg  is  highly 
sensitive to hPLC£ but only slightly more sensitive to mPLC£ compared to that of the human 
egg-
There appears to be a fine balance between the amount and type (species) of PLC£ and 
type (species) of egg required to effectively induce [Ca2+]i oscillations. The injection of some 
intermediate concentrations of hPLC^ cRNA into aged human eggs caused [Ca2+]i oscillations 
that  increased  in  frequency  over  time.  This  is  probably  due  to  the  gradual  increase  of 
translated PLC£ protein over time that in turn causes a frequency of [Ca2+]i oscillations that 
would normally be observed when higher concentrations of PLC£ cRNA are injected into an
egg.
The human eggs used in these experiments were either failed-ICSI or failed-IVF eggs 
which lead to a number of limitations that must be discussed. Firstly, the procedure of ICSI 
involves the injection of a single sperm into an egg and this procedure could therefore lead to 
parthenogenetic  activation  of the  egg  since  disruption  of the  egg  membrane  can  cause  an 
increase  in  [Ca2+]i.  This  could  mean  that  injection  of PLC^  into  the  human  eggs  may  be 
required  in  a  bigger  dose  to  initiate  further  [Ca2+]i  transients  following  the  initial 
parthenogenetic activation after ICSI.
It  is  also  possible that  some  of the  eggs  that  failed  to  fertilise  after  ICSI/IVF  were 
diploid. A number of studies have shown that eggs that have failed to fertilise contain both 
female  and  male  chromosomes  (Kunathikom  et  al,  2001;  Zhivkova,  2003).  One  study  has 
shown  that  in many failed  IVF  eggs  either decondensed  sperm  heads  (-5%  of eggs)  were 
present  or  premature  sperm  chromosome  condensation  (~  34%  of  eggs)  had  occurred
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(Kunathikom  et  al,  2001).  Approximately  18%  of failed-ICSI  eggs  were  found  to  contain 
decondensed  sperm  heads  and  57%  showed  intact  sperm  heads  (Kunathikom  et  al,  2001). 
These results show that many eggs that have failed to fertilise with IVF or ICSI are diploid 
and this  is  likely to be reflected  in my  studies on human eggs.  Eggs were  checked  for the 
presence  of a  single  pronucleus  or  two  pronuclei  approximately  17  hours  post  ICSI/IVF 
which would indicate if parthogenetic activation due to the ICSI procedure or fertilisation due 
to  ICSI/IVF  had  occurred.  Any  embryos  with  a  single  pronucleus  or  two  pronuclei  were 
destroyed immediately in ethanol. The age of the human eggs (>17 hours post ICSI/IVF) may 
also have been a factor that impeded the development of human eggs after injection of PLCC,. 
It would be interesting to carry out these same experiments on freshly ovulated human eggs to 
determine how affective PLC£ is at triggering development to the blastocyst stage in human 
embryos.
3.3.3  Rapid cessation of [Ca2+]i transients may reflect faulty Ca2+-release mechanism in 
IVM pig eggs
hPLC£  but  not  mPLC^  was  effective  in  causing  [Ca2+]i  oscillations  and  triggering 
development in pig eggs. The potency of hPLC£ has been reported to be higher than mPLC£ 
with regard to causing [Ca2+]i release in mouse eggs (Cox et al., 2002) so it is likely that this 
is the case in pig eggs.
The highest concentration of mPLC^ cRNA  injected  into  pig eggs was  2mg/ml  and 
this did not trigger a [Ca2+]i response.  Pig eggs did respond to hPLC£ cRNA by exhibiting
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[Ca  ]i  oscillations,  although they were  characteristically  short  in  duration  (lasting  about  1  
hour)  and  the  amplitude  of  each  [Ca2+]i  transient  was  shortened  successively  until  the 
transients ceased. A gradual increase in basal [Ca2+]i was observed before each [Ca2+]i spike 
in pig eggs and it appeared that a spike was triggered only when the basal  [Ca2+]i reached a 
threshold level. This is a characteristic that has been previously reported in pig eggs (Sun et
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al.,  1992).  As the  PLC^-induced  [Ca2+]i  oscillations  gradually decreased  in  amplitude  they 
also exhibited a slower rate of rise, until eventually the increase in basal [Ca2+]i still occurred 
but was not sufficient to initiate a full [Ca2+]i spike (Fig 3.4A and B). The [Ca2+]i oscillations 
then  ceased.  The  short  duration  of hPLC^-induced  [Ca2+]i  oscillations  in  pig  eggs  was  in 
contrast to the hPLC^-induced [Ca2+]i oscillations in human and mouse eggs that continued 
for more than 3 hours. [Ca2+]i recordings of fertilisation in pig eggs has previously shown that 
sperm-induced  [Ca2+]i oscillations last for more than 3  hours and exhibit regular amplitude 
and frequency [Ca2+]i oscillations (Sun et al.,  1992). [Ca2+]i oscillations in pig eggs that had 
been triggered following injection of crude extract isolated from boar sperm were similar to 
those seen at fertilisation and the transients did not exhibit rapid reduction in the amplitude of 
[Ca2+]i transients, instead the time leading to each transient increased until  [Ca2+]i transients 
ceased about 90 mins after injection (Machaty et al., 2000). Recently it has been established 
that pig sperm have a greater ability to induce [Ca2+]i oscillations in mouse eggs than mouse 
sperm (Kurokawa et al., 2005) so it would seem reasonable to suggest that the pig egg is more 
insensitive than the mouse egg. This does not, however account for the fact that the pig eggs 
exhibited [Ca2+]i oscillations that were both short in duration and showed a rapid decrease in 
amplitude following each successive [Ca2+]i transient.
The  rapidly  diminishing  hPLC^-induced  [Ca2+]i  rises  in  pig  eggs  could  be  due  to 
incomplete  oocyte  maturation.  Dramatic  changes  in  [Ca2+]i  release  mechanisms  have  been 
reported  to  occur  during  oocyte  maturation  (Mehlmann  and  Kline,  1994;  Fujiwara  et  al., 
1993;  Carroll et al.,  1994;  Jones et al.,  1995b)  and the  ability of eggs to  generate multiple 
long-lasting  [Ca2+]i  oscillations  is  dependent  on  successful  progression  through  oocyte 
maturation (Jones et al.,  1995b). Fertilization of immature oocytes induces [Ca2+]i transients 
that are significantly less in number, are markedly smaller and have a slower rate of rise than 
mature eggs (Jones et al.,  1995b; Cheung et al., 2000; Jones et al.,  1995b).  These affects are
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consistent with the [Ca2+]i response of the IVM pig eggs to hPLC^ cRNA in the experiments 
presented.  This  suggests  that  the  pig  eggs  have  not  undergone  complete  development  of 
[Ca2+]i release mechanisms due to poor cytoplasmic maturation.
It has been demonstrated that the ability of a spermatozoa to cause [Ca2+]i oscillations 
is dependent on the stage of maturation of the oocyte. This was first observed in the starfish 
oocyte, where the Ca2+ release in response to ten fertilizing sperm was less than that seen after 
a single sperm entry in a mature starfish egg (Chiba et al.,  1990). Around  100 times as much 
InsP3 was required to generate the same Ca2+ release in immature oocytes as mature starfish 
eggs however saturating InsP3 levels caused a the same Ca2+ release in both immature oocyte 
and  mature  egg  (Chiba  et  al.,  1990).  Studies  on  hamster  oocytes  showed  that  oocyte 
maturation caused an increased sensitivity to InsP3 and that mature eggs had an all-or-nothing 
[Ca2+]i  release  in  response  to  low  InsP3  levels  (Fujiwara  et  al.,  1993).  The  pig  eggs  did 
respond to PLC£ albeit not as strongly as human or mouse eggs, which suggests that whilst 
[Ca2+]i  release  mechanisms  were  in  place  they  had  a  weakened  ability  to  release  [Ca2+]i 
causing a rapid damping of each successive [Ca2+]i transient (fig 3.4). Immature pig oocytes 
were selected for maturation based on exhibition of a uniform cytoplasm  and at  least three 
layers  of  compact  cumulus  cells  around  them.  Pig  eggs  were  only  selected  for  hPLC^ 
microinjection  if  1st  polar  body  extrusion  had  occurred,  however  more  selectivity  may  be 
necessary to determine how high quality pig eggs respond to PLC^ with respect to  [Ca2+]i- 
releasing ability.
The amount of Ca2+ released after stimulation  with  spermatozoa,  ionomycin,  InsP3t 
ryanodine  and  the  Ca2+-ATPase  inhibitor  thapsigargin,  has  been  shown  to  increase  during 
oocyte maturation (Tombes et al.,  1992;  Jones et al.,  1995b;  Carroll  et al.,  1996).  Previous 
reports have shown that immature mouse oocytes respond to sperm fusion by generating two 
to three successful [Ca2+]i transients before [Ca2+]i flux ceases in less than an hour (Jones et
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al.,  1995b).  This  is  consistent with  the  results  obtained  from  injection  of 20pg/ml  hPLC£ 
cRNA  into  pig  eggs.  [Ca2+]i  can  cause  regenerative  [Ca2+]i  increases  by  activating 
neighboring Ca2+ channels to release  [Ca2+]i  by a process called Calcium-Induced Calcium 
Release  (CICR).  The  gradual  reduction  of [Ca2+]i  being  released  from  the  stores  may  be 
hindering further  [Ca2+]i uptake and hence  [Ca2+]i  release.  The duration of the  first  [Ca2+]i 
transient in the pig egg was approximately 90 seconds, which is of much shorter duration than 
the first transient exhibited in [Ca2+]i oscillations of the human or mouse egg which  lasted 
around five to six minutes. Failure of intracellular [Ca2+]i stores to sequester [Ca2+]i may have 
caused fast [Ca2+]i depletion during the first [Ca2+]i transient.
The experiments carried out on pig eggs were subject to a number of limitations other 
than that of the detrimental affects of in vitro maturation. The pig oocytes had for example to 
remain in the ovary for at least 2 hours during transportation of the ovaries from the slaughter­
house to the lab. A previous study investigating how temperature changes and time intervals 
caused by handling and transport of mare ovaries from the slaughterhouse to the laboratory 
revealed  an  adverse  affect  on  the  rate  of oocyte  recovery  and  their  quality  after  IVF  and 
maturation  (Guignot et al,  1999).  It therefore  seems  likely that the  development of the  pig 
eggs and embryos following activation with PLC^ may be influenced by the stress placed on 
the oocytes during the time following slaughter of the corresponding gilts.
Another factor affecting the pig eggs’ ability to respond to PLC£ mRNA may be their 
ability to translate  mRNA.  It  is  unclear how the translational  efficiency of pig  eggs  varies 
from that of human and mouse eggs but this may be significantly different. One way to test 
this hypothesis would be to inject the PLC^ protein rather than the mRNA form into the pig, 
human and mouse eggs.
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3.3.4  hPLC£ can trigger development to the blastocyst stage in human and mouse eggs.
It has previously been shown that hPLC£ cRNA can cause Ca2+ oscillations and development 
to the blastocyst stage when injected into mouse eggs (Cox et al., 2002). Here I confirm that 
the same concentration of hPLC£ cRNA (0.2pg/ml) can trigger development to the blastocyst 
stage  (53%)  in  mice  with  high  success  (fig  3.8).  This  finding  also  demonstrates  that  the 
pattern  of  [Ca2+]i  oscillations  induced  by  PLC£  is  efficient  in  causing  high  levels  of 
development.
A number of chemical treatments have been used to successfully parthenogenetically 
activate mouse  eggs,  but human  eggs appear to  be  insensitive  to  most of these treatments. 
Artificial  stimuli  have  been  reported  to  trigger  egg  activation  and  development  up  to  the 
blastocyst stage in freshly ovulated eggs but not in aged human eggs. Ca2+ ionophore A23187 
and puromycin have for example been shown to trigger activation in aged human eggs with 
20%  of eggs  reaching  development  to  the  four-cell  stage  however  no  development  was 
observed beyond this stage  in this study (Nakagawa et al.,  2001).  Other studies using aged 
human  eggs  reported  cell  cleavages  after  parthenogenetic  activation  but  not  blastocyst 
formation (Winston et al.,  1991;  Balakier and Casper,  1993).  Freshly ovulated human eggs 
have  in  contrast  been  reported  to  reach  the  eight-ten  cell  stage  (Cibelli  et  al.,  2001)  and 
blastocyst stage (Lin et al., 2003; Hwang et al., 2004) after artificial activation stimulated by 
Ca2+ ionophore and 6-DMAP.
To my knowledge this  is the  first  study to  show blastocyst  stage development after 
parthenogenetic activation of aged human eggs. The overall number of human eggs that were 
used  for  developmental  studies  were  small  however,  development  to  the  blastocyst  stage 
occurred in  17% of aged human eggs artificially activated with O.lpg/ml hPLC^ (Rogers et 
al.,  2004).  Successful development of human embryos was dependent on a narrow range of 
hPLC£ cRNA concentration. The  lowest concentration (O.lpg/ml) was effective at inducing
106Chapter 3: Discussion
[Ca2+]i oscillations in only 46% of eggs although this concentration was particularly effective 
at  causing  high  numbers  of embryos  to  cleave  and  reach  later  stages  of preimplantation 
development  up  the  blastocyst  stage  (Fig  3.7  and  Table  3.2).  A  100-fold  increase  in  the 
concentration of injected hPLC^ (lOpg/ml) triggered high frequency [Ca2+]i oscillations in all 
eggs  injected, however this concentration was detrimental to embryo development since no 
embryos developed past the two-cell stage (data not shown). This result is consistent with a 
previous  study which  showed high  frequency  [Ca2+]i  oscillations  are  detrimental  to  mouse 
embryo development, especially after the two-cell stage (Cox et al., 2002).
[Ca2+]i oscillations were first measured  in human eggs during fertilization using the 
calcium-sensitive photo-protein aequorin and this study showed that the Ca2+ transients were 
of  low  frequency  and  occurred  at  different  frequencies  in  different  eggs  but  at  regular 
frequency in individual eggs (Taylor et al., 1993). It is likely therefore that low concentrations 
of hPLC£ which  induce low frequency [Ca2+]i oscillations are more effective at  stimulating 
development of human eggs to the blastocyst stage (Rogers et al., 2004).
One explanation of the success in developing the human eggs to blastocyst stage may 
lie in the nature of the activation stimulus. Repetitive  [Ca2+]i oscillations can be induced by 
PLC£  in  human  eggs  (Rogers  et  al.,  2004)  and  these  are  similar  to  those  that  have  been 
observed previously during fertilization in human eggs (Taylor et al.,  1993) (Fig 3.6). Many 
stimuli  that  cause  multiple  [Ca2+]i  transients  in  other  species  eggs  (such  as  Sr2+)  are 
ineffective in human eggs. I exposed human (n = 2 eggs) and pig (n = 5 eggs) to  10 mM Sr2* 
and  found  that  neither  egg  exhibited  any  [Ca2+]i  oscillations  with  this  treatment  (data  not 
shown).  Artificial  stimuli  that  cause  a  single  [Ca2+]i  wave  are  commonly  used  to  activate 
human and pig eggs for this reason.
Studies  on  rabbit  eggs  where  the  number  of [Ca2+]i  increases  were  controlled  by 
electrical pulsing have shown that repetitive  [Ca2+]i oscillations can improve the  success  of
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preimplantation  (Ozil,  1990)  and  postimplantation  (Ozil  and  Huneau,  2001)  development 
compared to a single [Ca2+]i increase. Results from a separate study also using electrical-field 
pulses to induce [Ca2+]i transients in human eggs that failed to fertilize after ICSI, found that 
the frequency of [Ca2+]i transients applied had an affect on fertilization efficiency as well as 
embryo development (Zhang et al., 1999).
One  study  showed  that  fertilization  failure  after  Intracytoplasmic  Sperm  Injection 
(ICSI)  was  due  to  incomplete  egg activation  in  approximately 40%  of cases  (Rawe  et  al., 
2000).  This  suggests  that  an  inactive  factor  in  the  sperm  (potentially  PLCQ  may  be 
responsible  for  fertilization failure.  The  fact that  hPLC£ cRNA microinjection  caused  high 
rates of egg activation (75%) and development to the blastocyst stage (17%) in human eggs 
that previously failed to fertilize after Assisted Reproduction Technologies (ART)  including 
ICSI suggests that hPLC£ cRNA could have clinical implications for couples suffering from 
this form of infertility, called male factor infertility. A small number of cases have shown that 
egg activation,  successful pregnancy and development to term can be achieved in situations 
where failed fertilization repeatedly occurs after ICSI,  by inducing a single  [Ca2+]i  increase 
using Ca2+ ionophore following the ICSI procedure (Murase et al.,  2004;  Eldar-Geva et al.,
2003).  One of the pregnancies did however end with a second trimester miscarriage due to 
fetal anomaly (Eldar-Geva et al.,  2003) which suggests that Ca2+  ionophore activation may 
cause defects  later on  in  embryo development.  It  is also unclear as to how efficiently Ca2+ 
ionophore works to facilitate later development in human embryos.
These  experiments  demonstrate  that  hPLC£  has  the  ability to  trigger activation  and 
development of human eggs at high efficiency and could be used specifically in this way to 
ensure  high  levels  of egg  activation.  PLC£  may  also  be  applied  as  a  method  to  activate 
recipient  eggs  during  Nuclear  Transfer  (NT)  since  it  provides  a  ‘natural’  mechanism  of
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[Ca  ]i release and may therefore be effective at activating a wide range of mammalian eggs.
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Generation  of parthenogenetic  human  embryos  for the  production  of totipotent  stem  cells 
using hPLC£ could  provide  a more  ethically acceptable  way of producing  stem  cells  from 
human embryos (Lin et al., 2003).
3.3.5  Summary
In  this  Chapter  I  have  demonstrated  that  PLC£  can  be  used  to  effectively  cause  [Ca2+]i 
oscillations, activation and development in human, mouse and pig eggs. Clear differences in 
sensitivity  exist  between  the  three  types  of eggs  and  this  was  observed  by  the  different 
amounts and types (mouse or human) of PLC£ needed to cause [Ca2+]i release in these eggs. 
Mouse eggs appeared to be the most sensitive egg. I have shown for the first time that aged 
human eggs that had failed to fertilize through ICSI or IVF can be effectively stimulated to 
activate and develop with reasonable success to the blastocyst stage by injecting them with 
hPLC£ cRNA.  Lower scores of successful development were observed  in pig eggs  injected 
with hPLC£ cRNA and this is probably because of incomplete development of [Ca2+]i release 
mechanisms during oocyte maturation. I have also confirmed the findings of previous reports 
that  show  hPLC£  is  a  more  potent  Ca2+  releasing  PLC  then  rnPLC^  (Cox  et  al.,  2002).
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Chapter 4 
[Ca2+ ]i oscillations during egg activation affect 
preimplantation development and blastocyst quality
4.1 Introduction
In Chapter 3 I showed that PLC£ the natural proteinaceous factor found in the sperm, induces 
repetitive [Ca2+]i oscillations in mice, pigs and human eggs. In this Chapter I demonstrate that 
repetitive  [Ca2+]i  oscillations  at  egg  activation  have  important  post-activation  effects  on 
preimplantation development.
A number of studies have concluded that [Ca2+]i oscillations at egg activation have a 
role  in  longer  term  embryonic  events.  Manipulation  of  [Ca2+]i  transients  (controlled  by 
electrical field pulse) has been used to show that the pattern of [Ca2+]i transients influence the 
number of embryos undergoing compaction, forming blastocysts and implanting (Ozil,  1990; 
Ozil and Huneau, 2001). Blastocyst composition has been shown to be affected by the pattern 
of [Ca2+]i oscillations during egg activation.  Increasing the duration of Sr2+-induced  [Ca2+]i 
oscillations during parthenogenetic activation from two to four to twenty-four hours increased 
the  Inner  Cell  Mass  (ICM)  cell  number  sequentially  (Bos-Mikich  et  al.,  1997).  Ethanol 
activation which induces a single [Ca2+]i transient was shown to generate blastocysts with the 
lowest  ICM  and  the  highest  Trophectoderm  (TE)  cell  number  compared  to  IVF  or  Sr2+- 
activated embryos (Bos-Mikich et al.,  1997) and this suggests that [Ca2+]i oscillations have an 
important role beyond  stimulating meiotic resumption.  At present  it  is unclear how  [Ca2+]i 
oscillations during egg activation can  influence embryos several cell divisions later then the 
blastocyst stage
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Improved mouse embryo development has been observed when stimuli that increase 
basal [Ca2+]i levels are added to culture media. The addition of 0.1% ethanol in culture media 
during  the  one  or  two-cell  stage  has  been  shown  to  significantly  increase  blastocyst  cell 
numbers,  rates  of blastocyst  formation,  numbers  of successfully  hatching  blastocysts  and 
earlier formation of adhesive trophoblasts (Leach et al.,  1993). Stimulation of mouse morulae 
with  ethanol  or  Ca2+  ionophore  was  similarly  reported  to  accelerate  the  rate  of  fluid 
accumulation during blastocyst cavitation (Stacheki et al.,  1994a) and this was interpreted as 
an  indication  that  fluctuations  in  [Ca2+]i  may  act  as  a  signal  to  promote  cell  growth  and 
differentiation as well as to regulate preimplantation embryo development. Studies on somatic 
cells  have  shown  that  the  [Ca2+]i  oscillations  reduce  the  effective  [Ca2+]i  threshold  for
activating transcription  factors  (Dolmetsch  et  al.,  1998;  Li  et al.,  1998).  The  frequency  of
2+ [Ca  ]i oscillations has been reported to increase gene expression specificity so  while rapid 
[Ca2+]i oscillations may stimulate a large number of transcription factors,  infrequent  [Ca2+]i 
oscillations may stimulate only a small number (Dolmetsch et al., 1998).
The aim  of this Chapter was to examine the role of [Ca2+]i  oscillations during post­
activation preimplantation development. One major hurdle in attempting to study the affects 
of [Ca  ]i oscillations on later development is the fact that the earlier events associated with
egg activation are dependent on  [Ca2+]i  increases.  One  method  of separating the  affects  of
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[Ca  ]i oscillations on activation from the affects on  later embryo development is to trigger 
egg activation by Ca2+-independent means. Protein synthesis inhibitors such as cycloheximide 
do not induce a [Ca2+]i increase (Moses and Kline,  1995) but stimulate meiotic resumption by 
blocking the  otherwise continuous  synthesis  of cyclin  B,  which  is  essential  for stimulating 
cyclin dependent kinase (cdkl) and ensuring cell-cycle arrest. The protein synthesis inhibitors 
cycloheximide and puromycin have both been used to successfully activate mouse eggs in the 
past and have been reported to cause pronuclei formation and cell cleavage in mouse embryos
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(Siracusa et al.,  1978). Protein kinase inhibitors such as roscovitine (Phillips et al., 2002) have 
also been used to activate mouse eggs without stimulating a [Ca2+]i increase. The long-term 
development of embryos activated with protein  synthesis  or protein kinase  inhibitors  alone 
has not been monitored.  In this  study  I  used cycloheximide  or roscovitine to  activate  eggs 
without  a  [Ca2+]i  increase.  Cycloheximide  was  chosen  to  activate  eggs  because  it  is  a 
commonly used agent for activating eggs (although it is almost always used in combination 
with an agent that induces a [Ca2+]i increase). As cycloheximide inhibits the synthesis of all 
proteins  in  the  cell  it was  a  possibility  that  it  may  have  caused  long  term  developmental 
damage regardless of the fact that its effects are reversible after its removal.  I chose to use 
roscovitine as an another way of activating eggs in a Ca2+ independent manner to safeguard 
against any detrimental affects on development that may have occurred with cycloheximide 
treatment.  Roscovitine  is  an  inhibior  of cyclin-dependent  kinase  1   (cdkl)  and  to  a  lesser 
extent  of cyclin-dependent  kinase  5  (cdk5)  and  was  therefore  used  because  of its  higher 
specificity in translational  inhibition than that of cycloheximide.  The development of these 
eggs  was  compared  to  eggs  that  were  parthenogenetically  activated  using  strontium  ions 
(Sr2*),  ethanol or a combination of Sr2* plus cycloheximide,  ethanol plus cycloheximide or 
roscovitine plus Sr2+ (See Fig 4.4 for experimental design). In this Chapter I show that [Ca2+]i 
increases at egg activation play an important role in cell-cleavage events up to the blastocyst 
stage and may mediate processes important in establishing blastocyst composition.
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4.2 Results
4.2.1  [Ca2+]i measurements during parthenogenetic activation in mouse eggs 
To stimulate parthenogenetic  activation,  eggs were treated  using cycloheximide  alone or in 
combination with Sr2* or ethanol, roscovitine alone or in combination with Sr2+, Sr2+ alone or 
ethanol  alone.  All  Sr2+  treatments  were  carried  out  in  Ca2+-free  media.  Sr2+  treatment 
triggered  a  series  of repetitive  [Ca2+]i  oscillations  that  did  not  change  in  frequency  or 
amplitude  over the  duration of two  hours  in  13/14  eggs tested  (Fig  4.1 A).  Cycloheximide 
treatment alone did not cause any [Ca2+]i  change whatsoever  in any of the  14 mouse  eggs 
treated (Fig 4. IB). Treatment of eggs for 2 hours with cycloheximide followed by a further 2 
hours  treatment  in  cycloheximide  and  Sr2+  caused  repetitive  [Ca2+]i  oscillations  that  were 
similar to those caused by Sr2* alone (Fig 4.1C).  [Ca2+]i transients of a similar nature were 
observed in all  16 eggs tested with this treatment.
In contrast to  Sr2+ treatment, ethanol (7%) treatment triggered a large single  [Ca2+]i 
transient (Fig 4.ID). The single transient consisted of an initial rapid rise in [Ca2+]i followed 
by  a  steady peak  before  a  gradual  drop  back to  basal  [Ca2+]i  as  ethanol  was  replaced  by 
regular HKSOM media. The gradual decrease was likely to be due to the slow replacement of 
ethanol with media. For developmental studies eggs were removed rapidly from the ethanol- 
containing media into regular media which in theory causes a more rapid decline in [Ca2+]i.
Roscovitine  treatment  alone  did  not  induce  any  [Ca2+]i  changes  whatsoever  in  all 
mouse eggs tested (Fig 4.2A). Treatment of eggs for 2 hours with roscovitine followed by a 
further 2  hours  treatment  in  roscovitine  and  Sr2+  caused  repetitive  [Ca2+]i  oscillations  that 
were similar to those caused by Sr2+ alone (Fig 4.2B).
113A   Sr2* (n=l 3/14) g   CX (n=14/14)
0  4
0.2
30 mins 30 mins
C   CX + Sr2* (n=16/16)
1 2
_o
cd U,
<7  0.8 as i— i
3 Lu
0.4
L j L—
Ethanol (n=5/5)
0 
•—>
cd
(N 1
g
3 L u
30 mins
1.5
1.0
30 mins
Figure 4.1  [Ca2+]i changes during parthenogenetic activation. [Ca2+]i was monitored in 
eggs by changes in the fura-2 fluorescence ratio.  In (A) a sample trace is shown of an egg 
undergoing  [Ca2+]i oscillations when  incubated in media containing  lOmM  Sr^from the 
start  of recording.  (B)  is  an  example  of an  egg  showing  no  [Ca2+]i  changes  in  media 
containing  20pg/ml  cycloheximide  (CX),  in  (C)  an  egg  had  been  exposed  to  CX  for  2 
hours before being placed in media containing both Sr2+ and CX at the start of recording. 
(D) is a sample trace of an egg exposed to 7% ethanol for 7 mins. The ethanol-containing 
media  was  slowly pipetted off after the  7  min  treatment  and  replaced  with  fresh  media 
causing a gradual decrease in  [Ca2+]i. The n  in each sample trace refers to the number of 
eggs exhibiting [Ca2+]i changes similar to that of the sample trace.
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Figure  4.2  [Ca2+]i  changes  during  roscovitine  treatment.  [Ca2+]i  was 
monitored  in  eggs  by changes  in  the  fiira-2  fluorescence  ratio.  (A)  is  a  sample 
traces  of  an  egg  exhibiting  no  [Ca2+]i  changes  in  media  containing  50pM 
roscovitine  (ROS).  In  (B)  an  egg  had  been  exposed  to  50pM  ROS  for  2  hours 
before  being  placed  in  media  containing  roscovitine  and  Sr2+  at  the  start  of 
recording.  The  N  in  each  sample  trace  refers  to  the  number  of eggs  exhibiting 
[Ca2+]i changes similar to that of the sample trace
115Chapter 4: Results
4.2.2 Pronuclear formation in embryos generated from parthenogenetic activation
The timing of egg activation  in parthenogenetically activated eggs  was judged  by the time 
taken for pronuclear formation  (Table,  4.1,  Fig 4.3).  The  overall  amount  of egg  activation 
after 6 hours from the start of activation was found to be similar in all eggs stimulated. After 4 
hours from the start of activation, eggs treated with Sr2+ showed a significantly higher degree 
of activation (58%) than eggs activated with cycloheximide (26%) or ethanol (26%). A high 
percentage  of eggs  (78  -  95%)  had  two  fully  formed  pronuclei  in  all  of the  groups  of 
parthenogenetically stimulated eggs by 6 hours after the start of the activation treatment (table 
4.1, Fig 4.3). At the same time point many (86%) of the  1-cell embryos induced to activate 
using cycloheximide underwent a temporary phenotypic stage where they developed irregular 
shapes  and  furrows.  This  phenotype  persisted  for  1-2  hours  before  the  cycloheximide- 
activated embryos returned to their normal, well-defined spherical shape. Eggs activated with 
other  parthenogenetic  stimuli  (ethanol  and  Sr2*  alone)  did  not  develop  this  temporary 
phenotype.
4.2.3  Cycloheximide  treatment  and  in  vitro  fertilisation  diminishes  cyclin  B1  levels  in 
mouse eggs
Mouse  eggs  were  injected  with  cyclin-luciferase  mRNA,  factors  affecting  changes  in  the 
translation of wild-type cyclin will also affect change in the translation of the fusion mRNA. 
The levels of cyclin-luciferase protein in a single egg were measured by the amount of light 
output  from  a  single  egg.  The  levels  of cyclin-luciferase  in  control  eggs  (n  =  19  eggs) 
remained  in  general very steady, often with a slight decrease  in cyclin-luciferase over time 
(Fig 4.4A).  Eggs treated with cycloheximide exhibited a rapid decrease in  cyclin-luciferase 
during the  first 2 hours of treatment and the  levels continued to drop  gradually to  baseline 
levels during the last 2 hours of the 4-hour treatment (Fig 4.4B). A time of 57.4 + 3.1 minutes 
(s.e.m) from the start of cycloheximide treatment was required for 90% cyclin-luciferase
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Figure 4.3. Rate of pronuclei formation during parthenogenetic activation. The timing 
of pronucleus  formation  from  the  start  of activation  treatment  with  Sr2*,  cycloheximide 
(CX), CX+ Sr2^ Ethanol and CX + Ethanol.  The number of embryos with pronuclei were 
scored  every  hour  from  3  to  6  hours  after  activation  treatment  began.  Sr2+  treatment 
involved  a  2  hour  incubation  in  lOmM  Sr2*,  CX  treatment  was  a  4  hour  incubation  in 
20pg/ml  CX.  The combined  Sr2+ + CX treatment began with  2  hour  incubation  in  CX- 
containing  media  followed  by  2  hour  incubation  in  media  containing  both  CX  +  Sr2+. 
Ethanol  treatment  was  a  7  minute  exposure  to  7%  ethanol  at  room  temperature.  The 
combined CX and ethanol treatment involved ethanol exposure  in the middle of a 4 hour 
treatment in CX. All eggs were cultured in media containing 2pg/ml cytochalasin D for 2 
hours during their activation protocol to ensure parthenotes were diploid.  The data in the 
brackets  denote  the  total  number  of eggs  used  for  each  activation  protocol.  At  least  10 
biological replicates were used for each egg activation protocol.
117Activation
Treatment
Number 
of eggs
Pronuclear formation rate (hours post-treatment)
3 4 5 6
Sr2* 505 92(18) 294 (58) 377 (75) 438 (87)
CX 575 61(11) 151 (26) 359 (62) 447 (78)
Sr2+ + CX 321 33 (10) 81 (25) 224 (70) 281 (88)
Ethanol 290 11(4) 76 (26) 202 (70) 252 (87)
Ethanol + CX 270 28 (10) 68 (25) 212 (78) 256 (95)
Table  4.1  Pronuclear  formation  rates  after  parthenogenetic  egg  activation.
Pronuclear formation  was assessed  3-6 hours after the  start of egg  activation.  The 
numbers in brackets indicate the % of eggs with 2  fully formed pronuclei.  Embryos 
were used from 10 biological replicates. CX = cycloheximide
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Figure  4.4  Cyclin-luciferase  measurements  in  control  and  cycloheximide  treated 
mouse  eggs.  Cyclin-luciferase  levels  were  monitored  in  control  (A)  and  cycloheximide 
treated  (B)  Mil  mouse  eggs  (A).  Control  eggs  exhibited  levels  of cyclin-luciferase  that 
remained high during a four hour period although a gradually reduction in cyclin B  levels 
did  occur  in  the  first  hour  of monitoring.  Cycloheximide  treatment  caused  the  levels  of 
cyclin-luciferase  to  decrease  drastically  in  the  first  hour  and  these  levels  continued  to 
reduce during the four hour incubation.  The red arrow  indicates the  point eggs were  first 
exposed to  cycloheximide.  An  integration time of 10  seconds was used  to collect  photon
counts and a 20 x 0.5NA objective was used.
119Figure  4.5  Monitoring  cyclin-luciferase  synthesis  in  control  and  cycloheximide- 
treated Mil eggs. Mil eggs were injected with 2.7ng/pl of cyclin-luciferase mRNA and 
incubated in  lOOpM luciferin for 2 hours prior to luminescent imaging. Image (i) shows a 
brightfield  image  of the  zona  pellucidae-free  mouse  eggs  that  were  imaged.  Image  ii 
shows  a  luminescence  image  of the  same  eggs just  prior  to  cycloheximide  exposure. 
Image  (iii)  shows  a  luminescence  image  of  the  eggs  after  1   hour  exposure  to 
cycloheximide and (iv) after 4 hours of exposure to cycloheximide. An integration time 
of 10 seconds was used to collect photons when a 20 x 0.5NA objective was used.  The 
egg in the middle right of the image did not luminesce as it was dying.
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Fig 4.6 Cyclin-luciferase  measurements in  fertilised  mouse eggs.  Cyclin-luciferase 
levels were monitored in mouse eggs undergoing IVF. Cyclin-luciferase measurements 
were taken in eggs for approximately 2 hours prior to addition of  sperm to the media. 
After sperm-egg fusion the levels of cyclin-luciferase decreased drastically during the 
first 30-40 minutes and then remained at a constant level  for the next few hours. The 
red arrow indicates the time of fertilisation. An integration time of 10 seconds was used 
to collect photon counts and a 20 x 0.5NA objective was used.
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degradation (n = 19 eggs). Fig 4.5 shows luminescence images of single eggs during different 
time-points during treatment with cycloheximide. Prior to cycloheximide treatment the eggs 
exhibited  high  amounts  of  cyclin-luciferase  protein  (Fig  4.5  ii)  but  after  1   hour  of 
cycloheximide  treatment,  the  amount  of  luminescence  is  reduced  (Fig  4.5  iii).  The 
luminescent intensity of each egg can be seen to be further reduced after the 4-hour treatment 
with  cycloheximide  (Fig 4.5  iv).  As  an  indication of the typical  photon  counts  per  second 
(pcs) per egg I have selected the top middle.  This egg exhibits approximately 611  pcs just 
prior to cycloheximide treatment, 227 pcs after 1 hour of cycloheximide treatment and 87 pcs 
after 4 hours of cycloheximide treatment. Eggs undergoing IVF (experiments carried out by 
Dr.  Victoria  Nixon)  exhibited  a  rapid  decrease  in  cyclin  luciferase  during  the  first  30-40 
minutes  after  sperm-egg  fusion  (Fig  4.6).  A  time  of 36.1  +  6.9  minutes  (s.e.m.)  from  the 
approximate start of fertilisation was required for 90% cyclin-luciferase  degradation (n = 4 
eggs).
4.2.4  The relationship between [Ca2+]i increase(s) and developmental success in 
preimplantation embryos.
Parthenogenetic activation was carried out using different combinations of stimuli (See Fig 
4.7 for experimental design). Development of parthenogenetically activated eggs was scored 
from the egg to the blastocyst stage. Sr2+-activation triggered a high percentage of embryos to 
reach the blastocyst stage and confocal imaging showed that most of these embryos were of 
good-excellent  morphology  (Fig  4.8).  DNA  staining  using  Hoechst  dye  also  revealed  that 
large nuclei were present  in each of the blastomeres of these embryos and that compaction 
occurred at approximately the  16-cell  stage. Around 36% of blastocysts that had previously 
undergone Sr2+ induced egg activation were recorded as hatching.
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Figure  4.7  Experimental  design  for  parthenogenetic  egg  activation  protocol.  Eggs 
were  activated  in  a  Ca2+  dependent  manner  with  a  two  hour  incubation  in  media 
containing  (a)  Sr2*  or  a  7  minute  exposure  to  media  containing  (b)  7%  ethanol  (Eth). 
Eggs  were  activated  in  a Ca2+  independent  manner with  a 4  hour  incubation  in  media 
containing  either (c) cycloheximide (CX) or (d) roscovitine (ROS). Combined treatments 
were carried out by exposing eggs to media containing (e) CX for 4 hours with a 7 min 
exposure to Eth after 2 hours from the start of CX treatment. Eggs were also incubated in 
media containing (f) CX for 2 hours followed by treatment in CX plus Sr*+ for a further 2 
hours. This same treatment was also carried out in eggs but where (g) ROS replaced CX 
treatment.H
Figure  4.8  Preimplantation  stage  parthenogenetic  embryos  generated  from  Sr2+ 
activation. Brightfield images (A, C, E,G and I) and their corresponding Hoechst (DNA 
specific images (B,D,F,H) taken by confocal microscopy. Pronuclei form  3-6 hours after 
Sr2* treatment (A.B). The first and second cell cleavage occurred  18-20 and 45-50 (C.D) 
hours post-activation. The 8-cell embryo was formed 60-65  hours post-activation  (E,F). 
Approximately  72  hours post activation the  embryo  formed  a compact  ball  of cells  so 
that  the  cells  were  no  longer  distinguishable  from  one  another  (G,H).  Formation  of a 
blastocoel is first observed about 96 hours after activation and the embryo is now called a 
blastocyst.  As  the  blastocoel  enlarges  the  blastocyst  expands.  The  final  stage  of 
development  in  vitro  is  blastocyst  hatching  (I)  when  the  blastocyst  escapes  its  zona 
pellucida through a small hole that it has lysed through a process called focal lysis.
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A similar percentage of all parthenotes activated using various stimuli (see above) reached the 
2 -cell stage of development (Table 4.2, Fig 4.9). Eggs activated with Sr2+, cycloheximide and 
ethanol reached the 2-cell stage with a success of 90%, 90% and 89%, respectively. Similarly 
high  percentages  of these  groups  reached  the  4-cell  stage.  A  significant  difference  in 
developmental growth was however observed when embryos were cultured beyond the 4-cell 
stage.  The  percentage  of  cycloheximide-activated  eggs  reaching  the  8-cell  stage  was 
dramatically  lower  than  eggs  activated  with  Sr2+  and  ethanol.  Whilst  only  38%  of 
cycloheximide-activated  eggs  reached the  8-cell  stage,  Sr2+  and  ethanol  eggs  reached  this 
stage with a success of 74% and 70% respectively (Fig 4.9).
To  test whether the  occurrence  of [Ca2+]i  increases  could  improve  development  of 
cycloheximide-activated  embryos  I  monitored  development  in  embryos  activated  with  a 
combination of cycloheximide plus Sr2+ or cycloheximide plus ethanol. The effectiveness of 
Sr2+ to induce [Ca2+]i oscillations has been reported to decrease as the egg completes its first 
cell cycle. Consistent with this I found that Sr2* was unable to induce [Ca2+]i oscillations in 
eggs that had been incubated in cycloheximide for 4 hours prior to exposure to Sr2+. Sr2+ was 
however effective in triggering [Ca2+]i oscillations, in eggs that had previously been exposed 
to cycloheximide for just 2 hours (Fig 4.1C) and thus this combined activation method was 
employed to activate eggs. Eggs activated with cycloheximide and Sr2+ or ethanol exhibited 
similar levels of activation and development to the 2-cell (96% and 94% respectively) and 4- 
cell (88% and 80% respectively) stage (Fig 4.9). Treatment of eggs with cycloheximide for 2 
hours  followed  by  Sr2+  plus  cycloheximide  for  2  hours  caused  the  number  of  embryos 
developing to the 8-cell stage (77%) to be comparable to embryos activated with Sr2+ (74%) 
alone. Parthenogenetic egg activation using cycloheximide plus ethanol also produced similar 
success to the 8-cell stage (75%). The developmental success of embryos beyond the 4-cell 
stage was much higher in eggs activated with these combined [Ca2+]i dependent treatments
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Figure 4.9  Developmental  stages  reached  by  eggs  parthenogenetically  activated 
by different stimuli. Stacked bar chart showing developmental phases from egg to the 
blastocyst  stage  that  embryos  reach  after  each  type  of  parthenogenetic  activation 
treatment. The black section of each bar represents the % of eggs that did not undergo 
1st  cell  cleavage  to  the  2-cell  stage.  The  combined  activation  treatment  of Sr24  and 
cycloheximide (CX) was the most successful activation  stimulus with regard to % of 
successful egg activation and blastocyst formation. The number of embryos reaching 
the  8-cell  stage  dropped  dramatically  in  CX-activated  embryos  when  compared  to 
embryos that had been activated by other stimuli.  Total  number of mouse eggs used 
for  each  treatment  are  denoted  over  each  of  the  bars.  CM  represents  compacted 
morulae and B refers to blastocysts.
126Time post egg activation (hours) and corresponding 
developmental stage
Activation
Treatment
24 hours 
2-cell
48 hours 
4-cell
72 hours 
8-cell
96 hours 
Morula
103 hours 
Blastocyst
Sr2+
454
417(92) 374 (82) 357 (79) 323 (71)
CX 519 432 (83) 221 (43)* 183 (35)* 126 (24)*
Sr2+ + CX 307 281 (92) 248 (81) 223 (73) 209 (68)
Ethanol 258 224 (87) 204 (79) 204 (79) 184 (71)
Ethanol + CX 253 217(86) 203 (80) 193 (76) 160 (63)
ROS 278 200 (72)* 132 (47)* 83 (30)* 39 (14)*
Sr^ + ROS 236 197 (83) 148 (63) 98 (42) 66 (28)
Table 4.2 Developmental scores of embryos derived from different parthenogenetic 
stimuli.  The  numbers  in  brackets  indicate  the  %  of  embryos  that  reached  each 
developmental  stage.  Embryos  were  scored  for  developmental  stage  after  the  time 
(hours post-activation)  indicated in the table.  Embryos were used from  10  biological 
replicates. * denotes a significant difference in the group of activated embryos compared 
to groups without a *. CX= cycloheximide and ROS = roscovitine
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than activation using cycloheximide alone. This data shows that [Ca2+]i elevation during egg 
activation appears to first show a real developmental effect during the 3rd cell cleavage, some 
time between the 4 and 8-cell stage.  Only 22% of cycloheximide-activated eggs developed to 
the blastocyst stage compared to 65% of Sr2+ plus cycloheximide and 59% of cycloheximide 
plus ethanol activated eggs.
The  development  of  embryos  derived  from  egg  activation  using  roscovitine  or 
roscovitine  plus  Sr2" 1 "   was  also  compared  (table  4.2).  Roscovitine-induced  egg  activation 
allowed 72% of eggs to develop to the 2-cell stage, 47% to the 4-cell stage, 30% to the 8-cell 
stage and  14% to the blastocyst stage. The combined activation treatment of roscovitine plus 
Sr2+ allowed a significantly higher number of embryos to develop to the 2-cell (83%), 4-cell 
(63%), 8-cell (42%) and blastocyst stage (28%).
4.2.5  Blastocyst composition after parthenogenetic egg activation with Sr2+ or 
cycloheximide
The  numbers  of cells  in the  inner cell  mass  (ICM)  and  trophectoderm  (TE)  of blastocysts 
generated from cycloheximide and Sr2+-induced parthenogenetic egg activation were assessed 
using  a  differential  staining  technique.  The  outer  cells  (TE)  of live  Zona  Pellucida-free 
blastocysts were  artificially labelled with  fluorescein-5-isothiocynate  (FITC)-labeled Wheat 
Germ Agglutinin (WGA). The blastocysts were subsequently fixed, permeabilised and stained 
with propidium iodide (PI). The TE cells fluoresce with green cytoplasm and cell surface and 
red nuclei whereas the ICM cells will only exhibit red nuclei. Blastocysts were viewed on a 
confocal microscope and images of 3 pm slices were taken from the top to the bottom of each 
blastocyst  in  order  to  carry  out  cell  counts.  An  example  of sections  though  differentially 
stained parthenogenetic blastocysts can be seen in Fig 4.10.
The  mean  total  cell  number,  ICM  number,  TE  number  and  TE/ICM  ratio  were 
calculated (table 4.3, Fig 4.11) in 22 blastocysts generated from Sr2+-induced activation and
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Figure  4.10  Confocal  images  of  differentially  stained  blastocysts  derived  from 
parthenogenetically  activated  eggs.  Exposure  of live  zona-free  blastocysts to  FITC- 
labeled WGA causes the exclusive labeling of the TE cell surface. Phagocytic activity in 
TE cells also contributes to the FITC labeling on the TE epithelium. Blastocysts are then 
fixed and permeabilised before being counterstained with Propidium Iodide (PI),  which 
stains  the  nuclei  of  both  ICM  and  TE  red.  The  TE  cell  surface  and  cytoplasm 
consequently fluoresces green and the nuclei red from PI staining. Blastomeres allocated 
to the ICM were readily distinguishable as they were exclusively labeled by the PI and 
had  no  green  fluorescence.  Images  I-III  show  5pm  sections  taken  from  the  top  and 
middle of a blastocyst generated from Sr2+-induced egg activation. At the top TE can be 
seen  and  consist  of red  nuclei  with  green  cytoplasm  surrounding  it  (I).  Through  the 
middle  of the  blastocyst,  the  ICM  can  be  seen  in  the  middle  of the  blastocyst  and  is 
exclusively labeled red (II). Past the ICM another section shows a large cavity and only 
TE cells can be  seen  (III).  Images  IV-VI  show  sections through  a different blastocyst 
derived from an egg activated by cycloheximide. The red and green colours representing 
PI  and  FITC-WGA  staining,  respectively  can  be  selectively  highlighted  or  removed 
using  MetaMorph  2  imaging  software  in  order  to  easily  establish  the  cell-type  of 
individual cells.
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Figure  4.11  Blastocyst  composition  in  blastocysts  derived  from  cycloheximide 
and  Sr^-induced  egg activation.  Bar charts with  standard error mean  (s.e.m)  bars 
showing differences in mean ICM (A), mean TE (B), Mean total cell number (C) and 
ratio of TE/ICM (D) in blastocysts generated from either Sr2* or cycloheximide (CX)- 
induced  parthenogenetic  activation.  *  indicates  that  Sr2*  and  CX  groups  are 
significantly  different  (student’s  t  test,  P<0.01).  B).  The  data  represents  mean 
numbers for 4 replicate experiments.
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Fig 4.11
130Treatment No of 
blastocysts
Mean ICM 
number *
Mean TE 
number
Mean Total
cell number
*
Mean 
TE/ICM 
ratio *
Cycloheximide
(CX)
21 8 (0.62) 45(1.16) 53 (1.27) 6.3 (0.48)
Strontium
(Sr2+)
22 14 (0.76) 49(1.52) 63(1.8) 3.67 (0.22)
Table  4.3  Composition  of  blastocysts  resulting  from  cycloheximide  or  Sr2*- 
induced  egg  activation.  Parthenote  blastocysts  which  were  generated  by 
cycloheximide (CX) or Sr2* activation  were differentially stained using FITC-WGA 
labelling and the mean ICM, TE, total cell number and ICM/TE ratio  was calculated. 
*  denotes a significant difference between the  Sr2+ and CX treated group.  Brackets 
show the standard error of each group.
Treatment No of 
Blastocysts
Mean no of 
cells *
Mean no of apoptotic 
cells per blastocyst x
Apoptotic 
index x
Cycloheximide
(CX)
26 46.77(1.17) 6.42 (0.62) 0.14(0.01)
Strontium
(Sr2")
19 62.68 (3.52) 3.00 (0.37) 0.05 (0.01)
Table 4.4. Apoptotic index in  blastocysts derived  from  cycloheximide or Sr2*- 
induced egg activation. Table of results showing mean numbers of cells, apoptotic 
cells and apoptotic index. Apoptotic index (%) is calculated by the equation -  (dead 
cells)/  (live cells  + dead  cells)  x  100.  *  represents  significant  difference  between 
Sr2+ and CX activated groups of blastocysts (calculated by students t test, P<0.05).
131Chapter 4: Results
21  blastocysts  generated  from  cycloheximide-induced  egg  activation.  Blastocysts  were 
obtained from 4 treatment groups. The total cell number was significantly smaller (Fig 4.11C) 
in the blastocysts produced from cycloheximide-induced egg activation (53  cells) compared 
to  those  produced  from  Sr2+-induced  egg  activation  (63  cells).  The  difference  in  TE  cell 
numbers in blastocysts generated from cycloheximide (45 cells) and Sr2+ - activated (49 cells) 
eggs were not significant (Fig 4.1 IB). A significant difference was observed however in the 
number  of  cells  in  the  ICM  where  blastocysts  produced  from  cycloheximide-induced 
activation  had  an  average  of  8  ICM  cells  and  blastocysts  generated  from  Sr2+-induced 
activation had 14 ICM cells (Fig 4.11 A). Analysis of the ratio of TE to the ICM cells revealed
I
that blastocysts derived from eggs activated by Sr  had 3.67 times more TE than ICM cells. 
Blastocysts derived from eggs activated by cycloheximide had 6.3 times more TE than ICM 
(table 4.3, Fig 4.1 ID).
4.2.6  Apoptosis in blastocysts derived from eggs activated with Sr2+ or cycloheximide
TUNEL  (Terminal  deoxynucleotidyl Transferase  Biotin-dUTP Nick End  Labeling)  staining 
was  used  to  assay the  degree  of apoptosis  in blastocysts  derived  from  eggs  activated  with 
cycloheximide or Sr2+. Extensive DNA degradation is a characteristic event that occurs in the 
late stages of apoptosis. DNA cleavage or degradation leads to strand breaks within the DNA. 
The TUNEL method identifies apoptotic cells by using terminal deoxynucleotidyl transferase 
(TdT) to transfer fluorescein-dUTP to the free 3’-OH termini on the strand breaks of cleaved 
DNA.  Blastocysts were  imaged under a fluorescence  microscope to  detect cells  with  DNA 
breaks. A total cell count was made possible by exposing blastocysts to Propidium Iodide (PI) 
which stains the nuclei of each cell.  Cells that contained green fragments were classified as 
apoptotic.
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Fig  4.12A  shows  examples  of  blastocysts  that  have  been  stained  with  TUNEL 
reagents and PI. The apoptotic index was calculated by dividing the number of apoptotic cells 
by the  number of total  cells  (apoptotic  and  healthy)  (table  4.4,  fig  4.12B).  The  degree  of 
apoptosis  (apoptotic  index)  in  blastocysts  derived  from  eggs  after  cycloheximide-induced 
activation was almost 3 times higher than when blastocysts were derived from  Sr2+-induced 
egg  activation.  The  mean  number  of  apoptotic  cells  per  blastocyst  generated  from 
cycloheximide activation was 6.42 compared to a significantly lower 3.0 apoptotic cells per 
blastocyst generated from Sr2+ activation. Significantly more cells were present in blastocysts 
derived from Sr2+ compared to cycloheximide-induced egg activation and this was consistent 
with  previous  results  from  the  differential  staining  protocol  (Fig  4.11C).
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Figure 4.12 Measuring apoptosis in blastocysts. Blastocysts were fixed, permeabilised 
and  incubated  in  fluorescein-conjugated  dUTP  and  Terminal  Deoxynucleotidyl 
Transferase Biotin-dUTP Nick End Labeling (TUNEL). In order to assess the proportion 
of apoptosis in the blastocyst all cell nuclei were stained red with propidium iodide (PI) 
which  counted  as  the  total  number  of cells.  Fluorescein-labelled  cells  (green)  were 
counted as apoptotic cells. Slices (5pM) through the blastocyst from the top to bottom 
were  imaged.  Compressed  images  of TUNEL  stained  blastocysts  derived  from  eggs 
activated with (AI) Sr2+ and (All) Cycloheximide (CX).  (B)  Bar chat representing the 
apoptotic index of blastocyst parthenotes. A significantly larger apoptotic  index occurs 
in  blastocysts derived from  CX compared to  Sr2* activation  (denoted  by  *).  Numbers 
above the standard error mean (s.e.m) bars show the number of blastocysts used for each 
treatment group. Blastocysts from 3 biological replicates were used.
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4.3 Discussion
The  experiments  presented  in  this  Chapter  were  designed  to  determine  the  long-term 
developmental  role  of [Ca2+]i  oscillations  at  egg  activation  in  mouse  embryos.  In  order to 
address this,  embryo  development was  compared  in embryos  derived  from  eggs  that  were 
activated parthenogenetically by stimuli that do or do not trigger [Ca2+]i increase(s). The main 
interpretation from this work was that [Ca2+]i oscillations or a single [Ca2+]i increase at egg 
activation  increase the potential of embryos to develop beyond the 4-cell  stage by rescuing 
embryos which would otherwise arrest prematurely.  This  suggests that  [Ca2+]i  increases  at 
egg  activation have a developmental role beyond the  immediate effect of inducing  meiotic 
resumption.  [Ca2+]i oscillations at egg activation also appear to influence embryo quality in 
terms of their long term survival. Ca2+-independent parthenogenetic egg activation using the 
protein synthesis inhibitor cycloheximide caused a significantly reduced total cell number and 
inner cell mass  (ICM)  number compared to Ca2+-dependent egg  activation  using  strontium
*  2*f”  • ions  (Sr  ).  Blastocysts  derived  from  cycloheximide-induced  egg  activation  also  had  a 
significantly larger degree  of apoptosis which can be  construed  as  a negative  influence  on 
embryo survival.
2+
4.3.1  [Ca  ]i changes during parthenogenetic egg activation
Sr2+ treatment has been shown to induce repetitive [Ca2+]i oscillations in mouse eggs that are 
similar but distinguishable to those that occur  at  fertilisation  (Kline  and  Kline,  1992;  Bos- 
Mikich et al., 1997) and my data is consistent with these observations. Sr2+ treatment has been 
reported to be less effective in triggering [Ca2+]i oscillations as embryos develop through the 
1st cell cycle. I found that prior treatment of eggs with cycloheximide for 4 hours prevented
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[Ca2+]i oscillations from occurring when eggs were then treated with Sr2+ (data not shown). 
The  prior  treatment  of eggs  for  2  hours  in  cycloheximide  did  not  however  prevent  the 
generation of [Ca2+]i oscillations after exposure of eggs to Sr2+. This infers that eggs become 
insensitive to stimuli that cause  [Ca2+]i release if treated with cycloheximide for between 2 
and  4  hours.  It  has  previously  been  shown  that  at  fertilisation  sperm-induced  [Ca2+]i 
oscillations  are  cell-cycle  dependent  and  cease  when  the  egg  enters  interphase  and  form 
pronuclei  (Jones  et  al.,  1995a).  It  therefore  appears  that  sperm  can  only  induce  [Ca2+]i 
oscillations during metaphase and not interphase. My results show that a 4 hour treatment of 
eggs in cycloheximide is sufficient to cause pronuclei formation  in 26% of parthenotes and 
therefore this time correlates with the time eggs are entering interphase.
According to  Bos-Mikich et al,  exposure  of mouse  eggs  for 2  hours  in  lOmM  Sr2+ 
caused  96% of eggs to  activate (Bos-Mikich et al.,  1995).  The  activation  success  rate  was 
slightly higher than that which  I obtained (87%) using the  same protocol.  Activation using 
Sr2+ plus cycloheximide triggered a very similar activation rate (88%).
The effectiveness of parthenogenetic agents depends heavily on the post-ovulatory age of the 
egg and  freshly ovulated eggs  for example are normally activated at lower rates than  aged 
oocytes  (Siracusa et  al.,  1978;  Swann  and  Ozil,  1994).  A  combined  treatment  of Sr2+  and 
cycloheximide has  previously been shown to  significantly increase the rate of activation  in 
freshly ovulated eggs compared to Sr2+-treatment alone (Bos-Mikich et al.,  1995).  It has been 
shown that cycloheximide reduces Maturation Promoting Factor (MPF)  (Bos-Mikich et al., 
1995)  and  since  MPF  decreases  spontaneously during  aging  in  eggs  it  is  probable that the 
eggs I used (16 hours post-hCG) for Sr2+ activation did not require an extra stimulus such as 
cycloheximide to decrease MPF levels further.  Cycloheximide has previously been shown to 
activate  eggs  without  inducing  a  [Ca2+]i  increase  (Siracusa et  al.,  1978;  Moses  and  Kline, 
1995; Moos et al.,  1996). In support of these findings I found that mouse eggs incubated in
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cycloheximide  for 4 hours  formed pronuclei  but  failed to  exhibit any  [Ca2+]i  changes  (Fig 
4.IB).
4.3.2  Cycloheximide  and  sperm-induced  egg  activation  efficiently  cause  cyclin 
degradation
I used cyclin-luciferase mRNA to give an indication of what affect cycloheximide would have 
on endogenous cyclin B1  in mouse eggs.  Cycloheximide is a non-specific eukaryotic protein 
synthesis  inhibitor which works by inhibiting the  ribozyme peptidlytransferase an  essential 
enzyme  in  the  elongation  reaction  during  protein  synthesis.  The  amount  of  cyclin  Bl- 
luciferase  protein  being translated from  cyclin-luciferase  mRNA  in  single  mouse  eggs was 
related  to  the  amount  of light  output  during  luminescence  imaging.  The  levels  of cyclin- 
luciferase protein were fairly steady in control mouse eggs although many eggs exhibited a 
slight decrease in the levels of protein over time. This was probably due to a small amount of 
degradation of cyclin Bl-luciferase mRNA over time and therefore a smaller yield of overall 
translated cyclin-luciferase protein. Cycloheximide caused a rapid decline  in the  amount of 
cyclin-luciferase protein. These experiments show that cycloheximide can effectively inhibit 
the  levels  of cyclin-luciferase  synthesis  in  eggs  over  the  time  course  of 4  hours.  Prior  to 
cycloheximide exposure eggs exhibited luminescence at approximately 10 photon counts per 
second  which  corresponds  to  about  1-2  pg  of luciferase  protein  (personal  communication 
from  Nixon  and  Swann).  It  has  previously  been  estimated  that  approximately  10  pg  of 
endogenous cyclin B exist in meiotically competent eggs (Kanatsu-Shinohara et al., 2000).
Reduced levels of cyclin are required for egg activation to occur and it is through the 
prevention  of the  synthesis of this  protein  that  cycloheximide  appears  to  be  effective  as  a 
Ca  -independent  mediator  of  parthenogenetic  activation  of  eggs.  The  effects  of 
cycloheximide  are  reversible  and  when  the  eggs  are  no  longer exposed  to  it,  they  resume 
protein  synthesis.  Cycloheximide  treatment  of metaphase II-arrested  mouse  eggs  has  been
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shown to result in similar temporal decreases in both cdc2/cyclin B1  kinase and MAP kinase 
activities that also occur following fertilization (Moos et al.,  1996). Whilst the use of a cyclin 
based reporter system  demonstrates that the  protein  inhibitor acts  specifically upon  cyclin, 
cycloheximide inhibits all translational activity and changes in the levels of cyclin-luciferase 
during cycloheximide exposure probably represent the relative changes  in the translation of 
many other proteins in the same cell. Fertilisation of mouse eggs caused a more rapid decline 
in the amount of cyclin-luciferase protein than cycloheximide treatment with the time taken 
for 90%  degradation of cyclin-luciferase protein being  36.1  ± 6.9  and  57.4  + 3.1  minutes
I
(s.e.m.) respectively. This difference in time indicates that the presence of [Ca  ]i oscillations 
during fertilisation increases the rate of cyclin-luciferase degradation. A GFP-based approach 
to  examine  real-time  cyclin  destruction  in  mouse  eggs  has  previously  revealed  that  the 
presence of sperm-induced  [Ca2+]i oscillations cause a 6-fold  increase  in cyclin destruction 
when  [Ca2+]i  levels are raised above 600nM compared to cyclin degradation  in  unfertilised 
eggs (Nixon et al., 2002). This report also showed that discrete drops in cyclin B levels were 
associated with [Ca2+]i spikes when these spikes were as large as the first [Ca2+]i rise; this did 
not occur when the  subsequent  [Ca2+]I  spikes were  of a smaller magnitude.  A progressive 
decrease in cyclin B did occur in eggs regardless of the magnitude of [Ca2+]i oscillations. I did 
not monitor changes in [Ca2+]i during the monitoring of cyclin luciferase but I would expect 
to  make  similar observations to those described by Nixon  et al,  2002.  The  time  taken  for 
cyclin B  levels to fall to their lowest levels during fertilisation was comparable in the GFP- 
based study (Nixon et al., 2002) and in the luciferase-based work I describe in this thesis.
Eggs  are  activated  and  pronuclei  formation  occurs  when  cycloheximide  treatment 
reduces  protein  synthesis  by more than  70% (Siracusa et al.,  1978).  If fertilisation-induced 
[Ca  ]i oscillations do indeed increase the rate of cyclin B degradation, then it is likely that 
Sr2+ treatment (which also induces [Ca2+]i oscillations) will have the same affect and this may
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also  explain the  reason  for an  increased  rate of pronuclei  formation  in  Sr2+  activated  eggs 
compared to cycloheximide treatment (which causes no [Ca2+]I oscillations) (Fig 4.3).  Whilst 
the rate of cyclin B decrease may impact on early developmental events (pronuclei formation) 
it is unlikely that it would have an affect on later preimplantation development.
4.3.3  [Ca2+]i oscillations and preimplantation embryo development
The  importance  of  [Ca2+]i  oscillations  during  mammalian  egg  activation  has  been  well 
documented  with  respect  to  successful  egg  activation.  The  necessity  for  repetitive  [Ca  ]i 
oscillations is demonstrated by the finding that at fertilisation at least 9 Ca2+ transients were 
required  for the  formation  of 2  pronuclei  in  mouse  embryos  (Lawrence  et  al.,  1998).  The 
frequency  of [Ca2+]i  transients  has  also  been  shown  to  correlate  with  pronuclei  formation 
(Vitullo  and  Ozil,  1992;  Lawrence  et  al.,  1998).  A  single  [Ca2+]i  transient  which  can  be 
induced by agents such as ethanol or Ca2+ ionophore can be sufficient to cause egg activation 
although the activation success is low in freshly ovulated eggs compared to aged eggs (Xu et 
al.,  1997). A monotonic [Ca2+]i change in sheep (Loi et al.,  1998) and cow (Fukui et al.,  1992) 
eggs is also sufficient to promote some postimplantation developmental events. Whilst these 
data demonstrate the usefulness of the monotonic [Ca2+]i transient in activating development 
in some mammalian species it does not provide information about how the dynamics of the 
Ca  signal  influence long-term embryo development. A number of studies have shown that 
the  pattern  of  [Ca2+]i  oscillations  at  egg  activation  can  have  a  profound  affect  on  the 
development of the embryo. One study showed that compared with a single [Ca2+]i transient, 
experimentally controlled [Ca2+]i oscillations with a fertilisation-like frequency significantly 
increase the extent of development in preimplantation embryos (Ozil,  1990).
All studies investigating the developmental impact of [Ca2+]i oscillations have so far 
only  slightly  altered  the  parameters  of  [Ca2+]i  oscillations  in  terms  of  the  frequency,
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amplitude and number of [Ca2+]i transients allowed to take place. The experiments conducted
2+ • in  this  work  were  extreme  in  order  to  discover  what  affect  the  absence  of any  [Ca  ]i 
increases  would  have  on  embryo  development.  The  development  of embryos  derived  by 
means  of Ca2+  dependent and Ca2+  independent parthenogenetic  egg activation  was  scored 
according  to  the  developmental  stage  reached  by  each  embryo.  This  method  provided  a 
simple,  effective  and  reproducible  way  of studying  any  possible  influences  of [Ca  ]i  on 
development and these developmental affects could be separated by any affect of [Ca2+]i upon 
egg activation. It is well known that diploid parthenotes are less apoptotic and have a greater 
developmental  capacity compared to haploid parthenotes  (Liu  et  al.,  2002).  All  eggs  were 
treated  during  activation with  Cytochalasin  D,  this  prevents  2nd  polar  body  extrusion  and 
hence  chromosome expulsion, causing eggs to remain  diploid.  Haploidy therefore  does  not 
explain  any  differences  in  developmental  potential  between  different  cohorts  of 
parthenogenetically activated embryos.
In vitro cultured parthenogenetic embryos cannot develop beyond the blastocyst stage 
since later stages of development require the expression of paternally derived imprinted genes 
which  are  essential  for  the  normal  development  of extra-embryonic  membranes  and  the 
trophoblast (Surani  et al.,  1984).  During one  study Ca2+ or heavy-metal-ion  chelators  were 
used to control the number of spontaneous [Ca2+]i transients at fertilisation (Lawrence et al., 
1998) but I required complete abolishment of [Ca2+]i  oscillations during egg activation  and 
this  technique  would  not  be  sufficient  to  cause  egg  activation  without  causing  [Ca2+]i 
increases. For this reason activating eggs using cycloheximide appeared to be one of the most 
effective ways of causing egg activation without inducing [Ca2+]i oscillations.
The degree of successful egg activation was determined by the proportion of eggs that 
formed pronuclei and this was similar in eggs that were examined after activation with the 
five different treatments (Fig 4.3). At 4 hours after activation treatments began, a significantly
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higher proportion of Sr2+-activated embryos had 2 pronuclei compared to cycloheximide and 
ethanol-activated embryos. The reason for there being significantly less eggs with pronuclei 
after  2  hours  from  the  start  of activation  with  cycloheximide  plus  Sr2+  compared  to  Sr2+ 
activation alone is unclear. The cycloheximide treatment may inhibit proteins that are required 
for  pronuclei  formation.  By  6  hours  from  the  start  of activation  embryos  from  all  five 
treatment  groups had similar percentages  of embryos with  2  pronuclei  and thus  successful 
activation.
The results from these experiments show that [Ca2+]i rises are not necessary to trigger 
egg activation and preimplantation embryo development since activation with cycloheximide 
or  roscovitine  alone  did  trigger  cell  cleavages  to  occur  albeit  with  reduced  success  rates 
compared  to  embryos  generated  from  egg  activation  with  Ca2+-releasing  stimuli  (Sr2+  and 
ethanol).  More notably a significantly larger group  of embryos developed to the  8-cell  and 
blastocyst stages after egg activation with stimuli that cause either single or multiple [Ca2+]i 
transients.
It  could  be  argued  that  egg  activation  by  inhibitors  of protein  synthesis  may  have 
detrimental  affects  on embryo development. The  data from  embryo  culture  shows however 
that  when  used  in  combination  with  Sr2*,  cycloheximide  does  not  have  a  significantly 
detrimental  affect  on  the  number  of embryos  forming  8-cell  embryos  compared  to  eggs 
activated in Sr2+ alone. This shows that cycloheximide does not have a detrimental affect on 
early stage embryos with regard to cell cleavage  but  instead  it suggests that there  in a link 
between  the  induction  of  [Ca2+]i  oscillations  at  egg  activation  and  better  developmental 
potential.
The protein kinase inhibitor roscovitine was found to be sufficient at activating eggs 
with  a  similar  efficiency  to  other  stimuli  (-72%)  however  further  preimplantation 
development was severely impaired with only  14% of roscovitine-activated eggs developing
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to  the  blastocyst  stage.  Consistent  with  my  data,  results  from  a  published  study  showed 
roscovitine-induced  egg  activation  caused  similar  numbers  of embryos  to  develop  to  each 
preimplantation stage, although this study did not report any blastocyst formation (Phillips et 
al., 2002). The addition of Sr2+ treatment to roscovitine-treated eggs improved the numbers of 
embryos developing from the 2-cell to the blastocyst stage. This improvement was however 
not as pronounced as that of Sr2+ and cycloheximide treatment which suggests that roscovitine 
may cause  inhibition of kinases that function around the time of egg activation and which 
may as a result of inhibition impact detrimentally on early preimplantation development. For 
this reason roscovitine-induced egg activation was not used for further studies.
4.3.4  Differential staining
Monochromatic or fluorochrome staining is a commonly used method for assessing total cell 
numbers  in  blastocysts.  Further  developmental  information  can  however  be  obtained  by 
assessing the relative numbers ICM and TE cells in blastocysts (Van Soom et al., 2001). I will 
briefly explain  some  of the  methods that have  previously  been  used  to  differentially  stain 
blastocysts and explain the reasons  for the staining protocol  I  used. The  first approach that 
allowed selective  labelling of TE  and ICM used antibody complement-mediated membrane 
lysis (Handyside and Hunter,  1984). The outer TE cells form tight junctions to one another 
and are lysed by complement after being labelled with antibodies and PI whilst ICM cells are 
protected from lysis by the TE cells. The embryos are then fixed and all nuclei labelled with 
bisbenzimide. This technique is labour intensive and somewhat tedious as the antiserum must 
be prepared and tested for variability. A different method which involves labelling the outer 
cell surface proteins with benzenesulphonic acid (TNBS) has been used and is advantageous 
since  the  TNBS-labelled  cells  are  recognised  by  antiserum  that  is  commercially  available 
(Hardy  et  al.,  1989).  I  tested  this  procedure  on  mouse  blastocysts  and  found  that  the
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complement activity was highly variable and often resulted  in  incomplete  lysis of the outer 
cells.  TE cells can be permeabilised by rapid treatment with the ionic detergent Triton X-100 
in  combination  with  PI,  followed  by  fixation  in  ethanol  and  bisbenzimide  (Thouas  et  al., 
2001). I used this technique but found that slight overexposure of blastocysts to Triton X-100 
for  even  a  few  seconds  caused  permeabilisation  of the  ICM  cells.  The  most  successful 
technique  I  used  involved  labelling  the  outer  cells  of zona-free  mouse  blastocysts  with 
fluorescein-5-isothiocynate (FlTC)-labeled  Wheat  Germ  Agglutinin (WGA)  which  binds to 
saccharide  residues  on the  plasma membrane  of TE  cells.  The  blastocysts  are  then  fixed, 
permeabilised and stained with PI.  The cytoplasm of the TE cells fluoresce green and nuclei 
stain red whereas the  ICM nuclei only show red  (Fig 4.10).  This technique has been  used 
successfully in mouse blastocysts (De La Fuente and King, 1998). I found this technique to be 
very  simple  to  carry  out,  fast,  effective  and  accurate  in  differentially  staining  mouse 
blastocysts.
4.3.5  [Ca2+]i oscillations at egg activation influence blastocyst composition
Analysis  of total  cell  number,  inner  cell  mass  (ICM)  and  trophectoderm  (TE)  number  in 
blastocysts  are  an  accurate  indicator  of embryo  quality  in  terms  of implantation  viability 
(Thouas et al.,  2001).  A significant number of cow blastocysts with low ICM cell numbers 
have been shown to be derived from embryos of poor morphology (Van  Soom et al.,  1997) 
and  increases  in  the  number of ICM  and  total  cells  have  been  reported  in  cattle  embryos 
cultured under favourable conditions (Narula et al., 1996).
The  total  number of cells  in  my  Sr2+  and cycloheximide  activated  blastocysts  (103 
hours post-activation) were 63  and  53  cells respectively.  There  appears to be considerable 
variation  between  reported  total  cell  numbers  in  parthenogenetic  activated  with  various 
studies reporting 46 cells (Bos-Mikich et al,  1997), 62 cells (Brison and Schultz,  1997) and
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104 cells (Liu et al,  1998)  96  hours  post-egg activation. The variation  in total cell number 
may reflect the differences in mouse strain, culture conditions and also the time point at which 
total cell numbers were evaluated post-egg activation. The parthenogenetic blastocysts in my 
experiments were within the  reported range of total  cell  number described  in  other  studies 
although  it  is  hard  to  make  direct  comparisons  with  other  studies  when  blastocyst  cell 
numbers from my experiments were evaluated  at different times  post- egg activation.  The 
total  cell  numbers of in vivo  fertilised mouse  blastocysts  have  also  been  reported  in  many 
published papers but again variation  is observed  in different studies  and means of 65  cells 
(Jurisicova et al,  1998), 69 cells (Brison and Schultz,  1997) and 73 cells (Lin et al, 2003) have 
been reported in different studies on mouse blastocysts (96 hours post-hCG injection).
My results show that the nature of the activation stimulus during egg activation also 
has an impact on cell allocation in the blastocyst. I found that the total and ICM cell numbers 
were significantly reduced in blastocysts derived from eggs activated in a Ca2+-independent 
manner compared to eggs activated  in  a Ca2+-dependent manner. This  suggests that  [Ca2+]i 
increases during egg activation don’t just influence egg activation but also events that take 
place a number of cell divisions later at the blastocyst stage. The pattern of [Ca2+]i oscillations 
at  egg  activation  has  previously  been  shown  to  affect  blastocyst  composition.  One  study 
reported that increasing the duration of Sr2+-induced [Ca2+]i oscillations increased the number 
of ICM cells  in mouse blastocysts (Bos-Mikich  et al.,  1997).  Egg activation using different 
concentrations  of Sr2+  or  duration  of treatment  has  also  been  shown  to  affect  blastocyst 
formation and composition (Ma et al., 2005). An optimised treatment of lOmM Sr2+ for 2.5 
hours was shown to be the most effective at generating high numbers of blastocysts with large 
ICM and total cell numbers (Ma et al.,  2005).  Both total and ICM cell numbers have been 
shown  to  be  significantly  lower  in  diploid  parthenogenetic  blastocysts  derived  from  Sr2+ - 
induced egg activation than fertilised embryos that had been cultured in vivo or in vitro (Ma et
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al.,  2005).  It would therefore  be  useful  to  compare  the  composition  of blastocysts  derived 
from  PLC^-induced  egg  activation  with  Sr2+-induced  egg  activation.  The  sperm-specific 
protein PLC£ induces Ca2+ oscillations with a pattern indistinguishable from those induced by 
sperm  (Saunders  et  al.,  2002).  Sr2+-induced  [Ca2+]i  responses  are  not  equivalent  to  those 
induced by fertilisation, which  suggests that difference  in  stimulation  of the  egg  activation 
signalling  pathway  can  modify  cellular  and  molecular  events  that  impact  upon  later 
developmental events.
Knowledge of how different activation stimuli will affect cell allocation in blastocysts 
is of considerable importance since a minimal number of ICM cells are required to obtain a 
pregnancy.  It has also been  suggested that allocation of a disproportionate number of ICM 
cells could result in an abnormally large foetus  and  large-offspring syndrome (Leese  et al.,
1998).
4.3.6  Apoptotic index is reduced in blastocysts derived from Sr2+ compared to 
cycloheximide-induced activation.
The lower cell number in blastocysts generated from cycloheximide compared to Sr2+-induced 
egg activation may be due to higher levels of apoptosis. Apoptosis is an important mechanism 
for removing  defective  cells  that would  otherwise  be  detrimental  to  the  embryos  survival. 
High  levels  of apoptosis  have  also  been  observed  in  embryos  of excellent  morphology, 
suggesting that apoptosis may control embryo cell number (Hardy et al., 2003). It has recently 
been  reported  that  minimal  and  moderate  levels  of  fragmentation  in  human  blastocysts 
reduced  cell  numbers  in  blastocysts  but  this  was  mainly  confined  to  TE  cells  since  an 
invariable number of ICM cells were  maintained (Hardy et al.,  2003).  The  same  study did 
however  show that extensive  fragmentation  (>25%)  causes  cell  numbers  to reduce  in  both 
lineages. The findings presented in this chapter indicate that apoptosis may have a different
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affect  on  TE/ICM  cell  numbers  since  blastocysts  derived  from  egg  activation  by 
cycloheximide have around three times as much apoptosis compared to blastocysts  derived 
from  Sr2+-activation  but this  appears  to  only  cause  a reduced  ICM  cell  number  and  not  a 
reduced  TE  cell  number.  It  is  unclear  however  if  apoptosis  in  these  parthenogenetic 
blastocysts is the major factor contributing to a reduction in ICM cell number. A combined 
differential  staining and  apoptosis assay would determine  if apoptosis  is  more prevalent  in 
ICM cells than TE cells. One way of investigating if the blastocyst composition and degree of 
apoptosis are due to a positive effect by Sr2+ or a negative affect by cycloheximide would be 
to study blastocysts derived from egg activation treatment using a combination of Sr2+ plus 
cycloheximide compared with blastocysts generated from cycloheximide treatment alone.  A 
number of previously published reports have revealed the level of apoptosis in in vivo and in 
vitro cultured mouse embryos. One study showed that mouse blastocysts cultured in vivo or 
in vitro  from the 2-cell  stage  showed approximately 2% and  6% of dead  cells respectively 
(Brison and Schultz,  1997). Other studies have shown that blastocysts that have been derived 
from  culture  in vitro  contain approximately 3-8% apoptotic nuclei  (Handyside  and Hunter, 
1986; Fabian et al,  2003;  Fabian et al,  2004) whereas a  1-5  % occurrence of apoptosis has 
been documented from  in vivo derived mouse blastocysts (Jurisicova et al,  1998;  Liu et al,
1999).  In comparison to these data the incidence of apoptosis in my in vitro cultured  Sr  - 
activated blastocysts appears to be comparable to blastocysts derived from in vitro culture in 
other  studies.  The  blastocysts  derived  from  cycloheximide-activation  in  my  experiments 
exhibited  14%  apoptotic  cells,  which  appears  to  be  higher  than  has  been  observed  in 
previously  published  reports  on  in  vitro  cultured  blastocysts.  This  suggests  that  the 
mechanism  of parthenogenetic  egg  activation  may  later  influence the  level  of apoptosis  in 
embryos. A previous study has shown however that the level of apoptosis in blastocysts is not 
increased in parthenogenetically activated blastocysts but by haploidy (Liu et al,  1998). In this
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elegant study, the level of apoptosis in diploid Sr2+-activated blastocysts (4% apoptotic cells) 
was not found to be significantly different from blastocysts derived from in-vitro fertilisation 
(3% apoptotic  cells) but both groups were  found to  be  significantly different  from  haploid 
S reactivated blastocysts (7% apoptotic cells).
It is unclear how [Ca2+]i rises may positively affect embryo development. It has been
2+  #
suggested  that  developmentally-important  information  is  encoded  in  the  pattern  of [Ca  ]i 
oscillations  imparted  into the egg by the  activating  sperm  factor.  Consistent with this  idea, 
rapid superfusion of immobilized Ca2+- and calmodulin-dependent protein kinase II (CaMKII) 
in  vitro  showed  that  the  enzyme  can  decode  the  frequency  of [Ca2+]i  spikes  into  distinct 
amounts  of  kinase  activity  (De  Koninck  and  Schulman,  1998).  The  pattern  of  [Ca2+]i 
oscillations has also been shown to modify gene expression (Dolmetsch et al.,  1998; Li et al., 
1998)  although transcriptional  activity  in mammalian  embryos  is  minor at the  time  of egg 
activation.  [Ca2+]i  rises  may  induce  a  long-term  affect  on  gene  expression  by  altering  the 
chromatin  structure,  which  may  in  turn  promote  expression  of developmentally-important 
genes  (Ozil  and  Huneau,  2001).  [Ca2+]i  oscillations  may  also  modify  gene  expression  by 
affecting protein synthesis during the 1st cell cycle. Recruitment of maternal mRNA and post- 
translational protein modifications are characteristic of fertilisation (Howlett,  1986) and it is 
therefore likely that frequency and duration of fertilisation-induced [Ca2+]i oscillations act to 
modify protein synthesis machinery. In support of this idea, data from a recent study showed 
that  the  number  of [Ca2+]i  transients  at  fertilisation  determines  the  translation  of specific 
proteins  (Ducibella  et  al.,  2002).  In  Chapter  6  I  investigate  what  impact  the  presence  or 
absence of [Ca2+]i oscillations has on gene expression levels in preimplantation stage embryos 
Abnormalities  in  postimplantation  development  such  as  skeletal  malformation  and 
hydroallantois have been reported to occur in a high number of nuclear transfer (NT) embryos 
activated with cycloheximide (Zakhartchenko et al.,  1999).  Initiation of DNA synthesis and
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cell cleavage have also been reported to be delayed in NT embryos activated with ethanol and 
cycloheximide  (Alberio  et  al.,  2001a;  Wang  and  Latham,  1997)  and  it  is  feasible  that the 
activating agents used may contribute to  later embryonic abnormalities.  Most abnormalities 
associated  with  NT  are  likely  however  to  be  associated  with  inaccurate  nuclear 
reprogramming  of  the  injected  nuclei.  The  studies  that  showed  a  delay  in  embryonic 
transcription used cycloheximide treatments for duration of 6-14 hours whereas in this study I 
only exposed eggs to cycloheximide  for 4  hours.  More  importantly I  showed that  inducing 
single  or  multiple  Ca  increases  can  reverse  the  poor  development  observed  in  embryos
derived from  egg activation with cx alone.  In Chapter 5  I  examine whether egg activation
•  2+ with Sr  or cycloheximide affects the onset of embryonic transcription or embryonic genome 
activation  (EGA)  and  amount  of global  gene  expression  that  takes  place  at  this  time  to 
determine whether cycloheximide  affects the timing  or amount of embryonic transcription.
148Chapter 5: Introduction
Chapter 5 
Embryonic Genome Activation in parthenogenetic 
embryos
5.1  Introduction
In  order  for  an  embryo  to  progress  through  preimplantation  development  it  must  become 
transcriptionally active. The acquisition of transcriptional competency occurs when there is a 
switch  from  maternal  to  embryonic  transcriptional  dependency  and  this  is  referred  to  as 
Embryonic Genome Activation (EGA).  EGA has a number of crucial functions  such as the 
replacement of degraded maternal transcripts, expression of which are common to both egg 
and embryo with transcripts of embryonic origin. Preventing the occurrence of EGA results in 
a  developmental  block,  usually  within  one  cell  division  (Schultz  and  Worrad,  1995),  this 
demonstrates  that  early  embryonic  transcripts  encode  proteins  that  have  a  basic  cellular 
function. EGA also triggers the synthesis of novel transcripts that are not present in the egg 
prior  to  EGA  but  are  required  for  later  embryo  development  (Piko  and  Clegg,  1982; 
Bachvarova et al., 1989).
EGA in many species is biphasic. In the mouse embryo a ‘minor’ phase of activation 
occurs during the late one-cell stage (Latham et al.,  1991; Ram and Schultz,  1993; Latham et 
al.,  1992) and is characterised by a low level of gene activation. At this stage approximately 
40 proteins are synthesized (Latham et al.,  1991). The onset of the minor EGA is controlled 
by a time-dependent mechanism known as the zygotic clock and not by any particular cell-
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cycle event.  EGA begins approximately 24 hours after activation regardless of whether the 
one-cell embryo has divided to form a two-cell embryo (Bolton et al.,  1984; Schultz,  1993).
A ‘major’ phase of EGA is initiated during the late two-cell stage and involves a much 
larger burst of gene activation which is necessary for further embryo development (Latham et 
al.,  1991).  In contrast to the minor phase, the major phase of EGA is cell-cycle dependent 
and does not occur unless a two-cell embryo has formed (Howlett, 1986).
In  this  Chapter  I  assay  gene  expression  during  EGA  in  parthenogenetic  embryos. 
Previous  assays  of gene  expression  in  embryos  have  included  the  monitoring  of plasmid- 
borne reporter genes (Wiekowski et al.,  1991;  Ram and Schultz,  1993; Vemet et al.,  1993), 
integrated transgenes (Christians et al.,  1995) and endogenous genes (Manejwala et al., 1991). 
The methods described there  involved the destructive analysis of embryos taken  from  large 
cohorts  and  as  a result  of the methods  used  a full  profile  of gene  expression  in  individual 
embryos could not be generated.
The temporal dynamics of gene expression have been quantitatively measured using a 
Green  Fluorescent  Protein  (GFP)  reporter  gene  (Medvedev  et  al.,  2002),  which  is 
advantageous  since  it  does  not  require  destruction  of the  embryo.  GFP  gives  a much  less 
sensitive  measure  of gene  expression  than  reporter  systems  based  upon  firefly  luciferase 
expression and gene expression could not be detected until the embryonic 4-cell stage when 
using GFP. This makes GFP unsuitable for the monitoring of EGA.
To monitor global gene expression during EGA I have combined aspects of previous 
assays  and  injected  the  pGL3-control  vector  DNA  (Promega,  Madison,  Wisconsin)  into  a 
single  pronucleus  of  in  vivo  fertilised  or  in  vitro  parthenogenetically  activated  one-cell 
embryos  (Ram  and  Schultz,  1993).  This  plasmid  contains  the  luciferase  gene  and  SV40 
enhancer and SV40 promoter sequences. The replication and expression of genes encoded in 
extra-chromosomal  DNA  respond  to  the  same  signals  that  regulate  these  processes  in
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endogenous  DNA  (Majumder  et  al.,  1993)  and  the  expression  of the  embryonic  genome 
consequently initiates the transcription of the luciferase from the vector template. Luciferase 
assays involve the oxidation of luciferin by the enzyme  luciferase, the product of which  is 
oxyluciferin which bears an excited electron. When the electron falls to the ground state the 
molecule loses the energy in the form of light. The quantum yield of the reaction is very high 
(-90%), with around one photon being released  for every molecule of luciferin  undergoing 
oxidation.  The luciferin can simply be added to the culture media rather than injected into the 
egg since it is membrane permeable. It is the esterification of the D-luciferin carboxyl group 
as an ethyl ester that allows the uptake of the substrate by the egg. After entering the egg, the 
ethyl ester is quickly removed by ubiquitous esterase  activity inside the  egg,  rendering the 
molecule incapable of leaving the egg. We can measure the extent of transcription by the rate 
at which photons are emitted from the reaction. The Imaging Photon Detector (IPD, Photek, 
St  Leonard-on-sea,  UK)  was  suitable  for  measuring  gene  expression  during  EGA  as  it  is 
sensitive  enough  to  detect  luminescence  over  a  dynamic  range  of  50  -  5  x  104 
photons/second/pixel (See Fig 2.1  for schematic diagram of IPD). Gene expression could also 
be  monitored  continuously  since  no  destructive  analysis  was  required  for  luminescent 
measurements on the IPD, thus allowing a full gene activity profile of individual embryos to 
be made.
The  embryos  of  many  species  are  subject  to  a  time  during  preimplantation 
development when they are vulnerable to developmental arrest. Developmental arrest occurs 
when  preimplantation  embryonic  cells  fail  to  cleave  and  is  often  referred  to  as  the 
developmental block. Developmental block normally correlates with the time that major EGA 
is  initiated  in that  species  (De  Sousa et  al.,  1998)  and by way of an example,(Memili  and 
First, 2000) developmental block occurs in mice at the two-cell stage. It has been suggested 
that embryos undergo developmental block as a result of failure to complete EGA (Haraguchi
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et al., 1999) though more recent evidence suggests that a delay, rather than a failure of EGA is 
more  likely to  be  causative  of the  developmental  block  (Qiu  et  al.,  2003).  Developmental 
block can be alleviated by alteration of the culture media (Biggers,  1998) but the mechanisms 
regulating this phenomenon remain unclear.
EGA is one of the major molecular events to occur (<24 hours) following the [Ca2+]i 
signals  that  trigger  egg  activation.  The  purpose  of this  work  was  to  determine  if [Ca2+]i 
oscillations at egg activation influence the onset and amount of gene expression during EGA. 
Gene expression was monitored in parthenogenetic embryos generated from eggs activated by 
triggering  Sr^-induced  [Ca2+]i  oscillations  or  without  any  [Ca2+]i  changes  by  using  the 
protein synthesis inhibitor, cycloheximide.  The data from  luminescent imaging experiments 
described in this chapter revealed that  [Ca2+]i  oscillations at egg activation are not required 
for the onset of,  or affect the duration or total amount of gene expression occurring during 
EGA.
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5.2 Results
5.2.1  EGA can be measured with luciferase reporter genes and an Imaging Photon 
detector.
Gene expression during Embryonic Genome Activation (EGA) was monitored continuously 
by luminescence  imaging of one-cell  embryos  using an  Imaging  Photon Detector (IPD).  A 
single pronucleus was  injected  in pronuclear stage  1-cell  embryos with a mixture  of pGL3 
luciferase  reporter  gene  and  fluorescein  dextran.  Fluorescein  dextran  was  a  necessary 
constituent of the injection mixture since I could verify that the injection mixture had entered 
the pronucleus by exciting the injected egg with fluorescent light. Fig 5.1 A shows an example 
of a bright-field (i) and fluorescent (ii)  image of an injected  1-cell pronucleate embryo. The 
pronuclei  can  be  difficult  to  identify  under  bright-field  imaging.  The  fluorescent  image 
reveals however that whilst a small  amount of injection mixture has entered the  cytoplasm 
from  the  microinjection  pipette  (faint  green  background)  one  pronucleus  has  clearly  been 
microinjected successfully since it fluoresces a much brighter colour of green. The dark circle 
on  the  far  right  of the  fluorescence  micrograph  represents  the  uninjected  pronucleus.  In 
parthenogenetic  embryos  a  single  pronucleus  was  choosen  at  random  for  injection.  In 
fertilised embryos  it was the  female pronucleus that was  injected as transcriptional  activity 
could  be  compared to  the  pronuclei  in  parthenogenetic  embryos  that were  both  maternally 
derived.  It  is  also  known  that  the  male  pronucleus  has  a  different  level  of transcriptional 
activity  than  the  female  pronucleus  and  therefore  injection  of the  male  pronucleus  would 
prevent  an  accurate  comparison  of transcriptional  activity  in  fertilised  and parthenogenetic 
embryos.
The IPD was used to measure changes in luminescence of embryos injected with the 
luciferase reporter gene. An integration time of five minutes was sufficient to produce a clear
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luminescence signal above background noise.  Typical  luminescence  (Fig 5.1Bi)  and bright- 
field (Fig  5.IBii)  images  of one-cell  parthenogenetic  embryos  derived  from  Sr  -activation 
can be observed in Fig 5.IB. The light emission intensity is represented by the colours on the 
luminescence image which are proportional to the level of gene expression. When no photon 
signal above background noise can be observed this means that no gene expression is taking 
place,  blue  signals  (~30  photon  counts  /min)  show  that  low/moderate  amounts  of  gene 
expression are taking place and a yellow-red signal (-100-120 photon counts/ min) indicate a 
high level of gene  expression  is taking place.  The  IPD  is  a very  sensitive  photon  detector 
because of the very low background photon count. I measured the background photon count 
of an area the same size as an egg from a sample data set and found that this area exhibited 
-10 photons /min.  The bright-field  images could be overlaid on the  luminescent  images  in 
order to monitor any morphological  changes  in embryo  development (such as cell  death or 
cleavage) whilst measuring gene expression in the same embryos. Luminescence in embryos 
was measured for duration of approximately 25 hours to capture the time of gene expression 
during EGA.
5.2.2  Minor and major EGA in  in vivo fertilised embryos
The time  of onset of gene  expression  in  fertilised  1-cell  embryos  varied  between  different 
embryos although it always began in the time frame of 15-21  hours post-fertilisation (Table 
5.1,  Fig  5.2)  in all embryos tested  [n=14  embryos].  The timing of fertilisation can  only be 
approximated  since  variations  of a  few  hours  exist  in  the  timing  of mating  and  ovulation. 
Gene expression  in  all  fertilised embryos occurred with an  initial  slow increase which was 
then  followed  by  a  swift  attack  to  the  maximum  peak.  The  decrease  in  gene  expression 
following the peak of expression exhibited a lower gradient than that of the attack phase.
154A)
Figure  5.1  Monitoring  EGA  using  firefly  luciferase  reporter  gene  pGL3- 
control vector DNA. (Ai) The pronuclei of  in vivo fertilized or in vitro activated 
parthenotes  were  injected  with  50ng/ml  of pGL3-control  vector  DNA  and  (Aii) 
fluorescein  dextran  in  order to  check  pronuclei  were  injected  successfully  using 
fluorescence microscopy. After injection, the pronucleate embryos were incubated 
in  HKSOM  media  containing  luciferin  (lOOpM).  (Bi)  The  luminescence  from 
embryos  was  measured  for  approximately  25  mins  using  an  Imaging  Photon 
detector  (IPD).  The  luminescent  image  represents  the  photon  count  during  an 
integration time of  Brightfield images were taken throughout recording to monitor 
development (Bii)
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Minor EGA  lasted  approximately 20  hours  (Fig  5.2).  The  peak  of expression  in  embryos 
derived from in vivo fertilisation ranged from 36-64 photons/ min (Fig 5.2)
Gene expression was also monitored during the major phase of EGA.  Embryos ( n= 9 
embryos) at the 2-cell stage were obtained from pregnant female mice approximately 38 hours 
after  fertilisation.  The  nucleus  from  one  blastomere  was  microinjected  with  the  luciferase 
reporter gene prior to imaging the embryo on the IPD. The onset of major EGA began about 
40 hours post-fertilisation and lasted for approximately 20 hours  in all nine embryos tested 
(Table 5.1, Fig 5.3). The maximum peak of expression was up to ten times higher in embryos 
during the major EGA compared to embryos during minor EGA however the maximum peak 
of  expression  varied  widely  in  different  embryos.  Gene  expression  during  major  EGA 
occurred in a wave-like pattern which was similar to that observed during minor EGA.
5.2.3  Minor EGA is similar in parthenotes and fertilised embryos
Parthenotes  were  derived  from  egg  activation with  strontium  ions  (Sr2 *)  or  cycloheximide 
treatment. I wanted to investigate whether [Ca2+]i oscillations were necessary for the initiation 
of minor EGA or if they had an affect on the global pattern or amount of gene  expression 
taking place at this phase. In order to do this I compared eggs that were activated by means of 
inducing  [Ca2+]i  oscillations  (Sr2+ treatment)  or  by  means  of inducing  no  [Ca2+]i  change 
whatsoever  using  cycloheximide.  This  method  was  used  in  the  experiments  described  in 
Chapter 4 to investigate whether [Ca2+]i oscillations affect development and embryo quality 
during preimplantation development.
A  2  hour  treatment  in  cytochalasin  D  was  used  during  artificial  egg  activation  to 
prevent extrusion of the 2nd polar body and therefore allow formation of 2  pronuclei.  Sr2+- 
activated embryos [n = 32 embryos] and cycloheximide-activated embryos (n = 35 embryos) 
were microinjected approximately 6 hours after the start of development of pronuclei (-12
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Figure  5.2  Minor  EGA  measurements  in  5  in  vivo  fertilised  embryos.  The
overall  peak of expression varied  widely amongst different eggs  although  EGA 
onset began in all eggs 15-21 hours post-fertilisation and lasted for approximately 
20 hours. Gene expression increased gradually to begin with and then at began to 
rise very rapidly. A more gradual decrease in expression occurred following peak 
gene  expression.  An  integration  time  of 5  minutes  was  sufficient  to  collect  a 
photon  signal  above  background  signals.  Maximum  peaks  ranged  from  36-62 
photon counts/ min.
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Figure  5.3  Major  EGA  measurements  in  5  in  vivo  fertilised  2-cell  mouse 
embryos.  The  degree  of gene  expression  varied  largely  between  individual  2-cell 
mouse embryos however the onset of major EGA was very similar in different eggs 
and  occurred  approximately  40  hours  post-fertilisation.  The  onset  of  EGA  was 
marked  by  a  steep  rise  in  expression  to  the  peak  followed  by  a  slower  decline. 
Maximal peak  expressions ranged  from  160-700  photon counts / min.  Major EGA 
lasted about 20 hours.
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hours  post-treatment).  Gene  expression  in  twenty-three  1-cell  embryos  derived  from  Sr2+ 
induced  egg  activation  and  twenty-two  embryos  derived  from  cycloheximide-induced 
activation  was  initiated  approximately  18  hours  after the  start  of parthenogenetic  treatment. 
The  pattern  of  gene  expression  during  minor  EGA  in  Sr2+  and  cycloheximide  activated 
parthenotes was wave-like and the onset was initiated by a sharp rise in gene expression that 
continued to the maximum peak. A decrease in gene expression was observed in nineteen Sr2+ 
induced embryos and eighteen cycloheximide-activated embryos.  It was noted that some Sr2+ 
activated  embryos  (n  =  5  embryos)  and  cycloheximide-activated  embryos  (n  =  4  embryos) 
exhibited an increase in gene expression that remained high and did not decrease (Table 5.1). 
This generally occurred when embryos were incubated in media that had fluctuated in optimal 
temperature  (37°C)  over  time  or  if embryos  exhibited  aberrant  morphology  shortly  after 
microinjection  of the  reporter plasmid.  The  minor phase  of EGA  in  both  cohorts  lasted  for 
about  20  hours  (Fig  5.4).  Some  parthenotes  exhibited  a  slow  gradual  decrease  in  gene 
expression  following the maximum  peak of expression while others exhibited a much  faster 
decrease (Fig 5.4). The maximum peak of expression reached by embryos activated with Sr2+ 
varied considerably between embryos (Fig 5.4) and this was also the case for cycloheximide- 
activated embryos. The maximum peak of expression in embryos derived from egg activation 
with  Sr~  ranged  from  36-100  photons/  min  (Fig  5.4).  The  timing  of gene  expression  in 
embryos  activated  with  cycloheximide  was  not  significantly  different  to  embryos  activated 
with Sr2+ (see section 5.2.4 for details).
I  attempted  to  monitor  major  EGA  in  parthenotes  derived  from  Sr2+  and 
cycloheximide  to  determine  if differences  in  the  pattern  of expression  could  be  determined 
during this phase of higher gene expression levels. Whilst the onset of gene expression during 
major  EGA  was  recorded  in  all  parthenogenetic  Sr2+-activated  (N  =  8  embryos)  and 
cycloheximide  (N  =11  embryos)  2-cell  stage  embryos,  a  decrease  in  gene  expression  was
159P
h
o
t
o
n
 
C
o
u
n
t
/
 
m
i
n
120
100
40
0 20 30 40
Time (hours) post-strontium treatment
Figure 5.4 Minor EGA in embryos generated from Sr2 *-induced egg activation.
The  degree  of gene  expression during  EGA  varied  largely amongst eggs activated 
with  Sr^with  the  maximal  peaks  of gene  expression  ranging  from  32-104  photon 
counts/ min.  Minor EGA lasted for approximately 20 hours. In general the pattern of 
gene expression was similar to that of a bell-shaped  curve.  Some eggs exhibited a 
rapid increase in gene expression to the peak followed by a slower decline (blue and 
red  curve)  whilst  others  showed  a  more-or-less  similar  rate  of attack  and  decay 
producing a more symmetrical curve (green and navy curve).
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observed  in only two Sr2+-activated embryos and 4 cycloheximide embryos.  None of these 
2-cell embryos cleaved to the 4-cell stage (Table 5.1).
5.2.4  The  time  of  EGA  onset  and  duration  is  similar  in  embryos  derived  from 
cycloheximide and Sr2+ induced egg activation
The time of EGA onset, duration,  total  amount of gene expression and time  it took to reach 
half the  maximum  peak were  noted  (Fig  5.6).  The  time  of onset  and  the  duration  of gene 
expression  during  EGA were very’ similar  in  embryos activated with  cycloheximide  or  Sr2+ 
(Fig  5.5).  Gene  expression  in  both cohorts of embryos  began  approximately  18  hours  post­
activation.  peaked  at  25-28  hours  post-activation  and decreased  gradually before reaching  a 
basal gene expression levels by 40 hours post-activation (Fig 5.5).
The total area under the curve of gene expression w as used as a measure of the amount 
of gene expression that took place during EGA (Fig 5.6 and Table 5.2). An average of 1.7 + 
0.7 standard error mean (s.e.m) x  103  photons was calculated from Sr2+-activated embryos (n 
=  19  embryos)  and  an  average  of  1.5  +  0.8  (s.e.m)  x  105   photons  was  calculated  from 
cycloheximide-activated  embryos  (n  =  18).  The  differences  in  total  amount  of  gene 
expression  between  the  embryos derived  by  cycloheximide  and  Sr2+-induced  egg  activation 
were not statistically significant.
The  time  it  took  to  reach  half the  maximum  peak  of luminescence  was  used  as  a 
measure  of the  rate of EGA  onset  (Fig  5.6  and  Table  5.2)  as this  point  represents the  best 
measure of the effective gradient of the  initiation of transcription. The time  it took to reach 
half the maximum peak of EGA was 9.6 + 0.8 (s.e.m) hours for Sr2+ activated embryos (n = 
19  embryos)  and  10.9  +  0.9  (s.e.m)  hours  for  cycloheximide-activated  embryos  (n  =  18 
embryos). The time it took to reach half the maximum peak of gene expression during EGA 
in  cohorts  that  were  generated  by  Sr2+  or  cycloheximide-induced  egg  activation  was  not 
significantly different.
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Figure  5.5  Minor  EGA  in  embryos  derived  from  fertilisation,  Sr2*  or 
cycloheximide-induced  egg  activation.  The  graphs  show  that  minor  EGA  begins 
approximately 20  hours post-activation or  fertilisation  and the  duration  of which  lasts 
for about 20 hours. The shapes of the curves are similar to bell-shaped curves. The onset 
of EGA  appears to occur at  a  faster rate  than the  rate of decrease  as  gene expression 
levels fall. Cycloheximide = CX.  ^Peak(P)
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Figure 5.6 Estimation of the total amount of gene expression and time to reach 
half the maximum peak during EGA. The total light output can be calculated by 
measuring  the  area  under the  curve  (using  Sigma  Plot  8).  The  total  light  output 
provides a good indication of the total amount of gene expression taking place. The 
rate of onset of EGA was calculated by measuring the time required to allow half 
the maximum peak of gene expression to occur.
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egg
activation
Minor or 
major EGA 
being 
monitored
No of
embryos
tested
No of embryos 
showing an 
increase in 
gene expression
No of embryos 
showing an 
decrease in gene 
expression
No of 
embryos 
that cleaved 
to 2 or 4-cell
Fertilisation Minor EGA 14 14 14 5
St2*
activation
Minor EGA 32 24 19 5
CX
activation
Minor EGA 35 22 18 6
Fertilisation Major EGA 9 9 9 2
St2*
activation
Major EGA 8 8 2 0
CX
activation
Major EGA 11 11 4 0
Table 5.1 Summary of response of embryos monitored for minor and major EGA. Fertilised 
and Sr2+ and CX -  induced parthenogenetic embryos were monitored for gene expression 
during minor and major EGA. CX = cycloheximide.
Treatment Number 
of eggs
Total time to V a 
peak (hours)
Total gene expression (Photon 
Counts/ mins) (x105)
St 2* 19 9.6 0.34
SE = 0.8 SE = 0.14
CX 18 10.9 0.3
SE = 0.9 SE = 0.16
P value 0.89 0.27
Table 5.2 Rate of EGA onset and total gene expression during minor EGA in embryos 
derived from parthenogenetic egg activation using Sr2* and Cycloheximide. SE denotes 
standard  error.  The  total  gene  expression  was  measured  as  total  photon  counts  over  an 
integration  time  of  1   minute.  P  values  from  student  unpaired  ttest  show  that  there  is  no 
significant difference (P<0.05) between cycloheximide (CX) and Sr2+  activated eggs.
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5.3 Discussion
Embryonic  genome  activation  (EGA)  marks  the  switch  of an  embryo’s  dependency  from 
maternally derived transcripts to embryonic transcripts. The occurrence of EGA at the correct 
time  is  essential  for the embryo’s developmental  progression.  In this Chapter  I  demonstrate 
that  low  levels of gene  expression  during  EGA can be  monitored continuously  in  real  time 
without  the  destruction  of the  embryo  using  a  plasmid  bome  firefly  luciferase  enhancer- 
promoter- reporter gene assay and an Imaging Photon Detector (IPD).
EGA  is  one  of the  first  major  molecular  events  that  occurs  after  the  fertilisation- 
induced [Ca‘  ]i signal during egg activation. The purpose of the experiments described in this 
chapter was to elucidate whether [Ca2+]i increases at egg activation are essential for initiating 
EGA. The data from this work shows that minor EGA does not have a strict requirement for 
the occurrence of [Ca2+]i oscillations at egg activation since EGA occurred in the same time 
frame and in a similar amount in parthenogenetic embryos activated in a [Ca2+]i independent 
or [Ca2^]i dependent manner.
5.3.1  EGA occurs in waves of gene expression
Measurements  of minor  and  major phases  of EGA  (Fig  5.2  and  5.3)  in  fertilised  embryos 
revealed that changes  in the  levels of gene expression occurred  in a bell-shaped pattern  and 
each phase lasted approximately 20 hours. The onset of minor EGA began  15-21  hours post- 
fertilisation  and  major  EGA  began  at  approximately  40  hours  post-fertilisation.  The  main 
difference between the two phases of EGA in fertilised embryos was the that the peak of gene 
expression  was  up to ten times higher  in  the  major phase of EGA than  the  minor phase  of 
EGA. This data complements previously reported data that has shown that the minor phase of 
EGA  involves a limited amount of transcription  (resulting in the synthesis of approximately
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40  proteins) whilst the major phase of EGA  involves a much  larger amount of transcription 
(Latham et al.,  1991; Bolton et al.,  1984; Christians et al.,  1995).
The time that  a  photon  signal  was  first  detected  in  fertilised  embryos  during  minor 
EGA  ranged  from  15-21  hours  post-fertilisation  between  different  in  vivo  fertilised  mouse 
embryos.  This  probably  reflects  the  fact  that  in  the  mouse,  eggs  are  ovulated  over  a  time 
period of 2-3  hours, so the timing of fertilisation will vary among eggs  in the same mouse. 
Eggs were also obtained from a number of female mice that were introduced to different male 
mice at the  same time so variations  in the timing of mating and ovulation in different mice 
may also add to the variation in fertilisation times.
The  onset  of major  EGA  appeared  to  be  much  more  synchronous  than  the onset of 
minor EGA in different in vivo fertilised embryos although the reasons for this are unclear. In 
vivo  signalling  mechanisms  may play a role  in  synchronising early embryo  development at 
this stage.
5.3.2  Parthenotes  and  fertilised  embryos  have a  similar gene expression  phase  during 
EGA.
To my knowledge this is the first time EGA has been monitored in parthenogenetic embryos. 
The onset of EGA in Sr2* activated parthenotes was over a very narrow time frame (Fig 3.4) 
and occurred about  18 hours after Sr2+ treatment began. This is likely to be due to the fact that 
eggs  were  all  exposed  to  Sr2+  treatment  at  precisely  the  same  time  and  therefore  activated 
simultaneously in contrast to in vivo fertilised eggs (Fig 3.2). The timing of gene expression 
during minor EGA was however similar in parthenotes compared to embryos which had been 
fertilised.  This data clearly demonstrates  that the  paternal  genome  is  not  required  for EGA 
although  this  information  is also clear from  previous  studies that show parthenogenetic  egg 
activation  can  trigger  embryo  development  up  to  the  blastocyst  stage  as  exemplified  by 
Kaufman (Kaufman.  1979).
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The  pattern  of global  gene  expression  during  the  rising  phase  of minor  EGA  did 
appear to differ between  fertilised embryos and  parthenogenetically activated embryos. The 
gene expression in zygotes began with a slow but gradual  increase in expression which was 
followed by a rapid increase to the peak (Fig 5.2). The pattern of gene expression during EGA 
in zygotes appeared to be dependent on a minimum threshold level of global gene expression 
in order for a much higher level of expression to be triggered. There was no initial slow rising 
phase  in  parthenotes  during  EGA  but a  steep  increase  in expression  from  the  beginning  of 
EGA onset.  It is unclear why there appears to be a difference in the pattern of onset of gene 
expression between fertilised and parthenogenetic embryos. The pattern of [Ca2+]i oscillations 
has  been  shown  to  determine  expression  levels  and  gene  specificity  in  somatic  cells 
(Dolmetsch  et  al.,  1998).  The  [Ca2+]i  oscillations  triggered  by  Sr2+-activation  are 
distinguishable  from  those  of  fertilisation  and  it  may  be  that  specific  patterns  of  sperm 
induced  [Ca2+]i  oscillations  encode  information  for  the  egg  that  changes  the  degree  of 
expression  and  specificity  of genes expression  during  early  EGA.  In  order  to  test  out  this 
theory individual genes that are known to be expressed during minor EGA, such as heat shock 
protein  70  (Christians  et  al.,  1995)  could  be  monitored  to  determine  how  their  expression 
patterns  change  over  the  time  course  of EGA  in  fertilised  and  parthenogenetic  embryos. 
Paternal  influences  may also  be  involved  in  changing the pattern  of gene expression  at this 
stage and although these differences are clearly not required  for the progression of embryos 
through  the  preimplantation  stages of development, their affects  may  be exerted  some time 
after this  stage during postimplantation development.  A  number of studies have shown that 
the maternally-derived pronucleus is transcriptionally repressed in comparison to the paternal 
pronucleus because the maternal pronucleus inherits repression factors from the oocyte which 
are absent in the male pronucleus. For this reason, only the maternal pronucleus (and not the 
male  pronucleus which  is visibly  larger  in  size)  was  injected with the  pGL3-control  vector
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DNA when minor EGA was monitored so that comparisons could be made between  in-vivo 
fertilised and parthenogenetic embryos.
5.3.3  EGA is not dependent on (Ca2+]i increases during egg activation
EGA  is a major molecular event during preimplantation development and as it is a proximal 
event  to  [Ca2+]i  signalling at egg activation,  it  is  logical  to explore any affects that  [Ca2+]i 
oscillations  may have on this phase.  In order to  investigate whether  [Ca2+]i  oscillations  are 
essential for EGA, I compared EGA in embryos activated by Ca2+-dependent (Sr2+-activation) 
means  to  those  activated  by  Ca2+-  independent  (cycloheximide  activation)  means.  These 
methods of activation have been used as a basis for artificially activating eggs in much of the 
work described in this thesis and can be read in detail in Chapter 4.
Luminescence measurements revealed that minor EGA lasted for the same duration (~ 
20  hours)  in  both  cycloheximide  and  Sr2+-activated  parthenogenetic  embryos  and  fertilised 
embryos.  The  time  of  onset  of  minor  EGA  was  also  similar  in  the  two  groups  of 
parthenogenetic embryos and this correlated with the onset of EGA in fertilised embryos. This 
data clearly  shows  that  the  initiation  and timings of EGA  are  not  strictly dependent on  the 
presence of [Ca2+]i oscillations during egg activation since parthenotes activated dependently 
or independently of [Ca2+]i appeared to exhibit similar patterns of gene expression.
To further investigate the affects of [Ca2+]i on the global pattern of gene expression in 
these  parthenogenetic  embryos,  I  calculated  the  overall  photon  signal  which  gives  a  good 
indication  of the  total  amount  of gene expression and  I  also  determined  the time  it took to 
reach half the maximum peak and compared these parameters in both groups of parthenotes. 
The values for the total photon signal and time taken to reach the peak were not significantly 
different  between  the  two  groups,  indicating  again  that  [Ca2+]i  does  not  exert  any  global 
affects  on  gene  expression  during  minor  EGA.  Considerable  variation  did  however  exist
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between eggs from the same cohorts regarding the degree of expression and rate of onset of 
EGA,  so  small  differences  in  EGA  between  the  two  cohorts  cannot  be  excluded  without 
further analysis and larger numbers of embryos. This data demonstrates that the initiation of 
EGA  is  not  the  result  of a  [Ca2+]i  signalling  pathway  and  may  be  due  to  a  genome-wide 
release  of gene  expression  from  inhibition  of transcription  (Schultz,  1993)  by  some  other 
factor.
As a much  larger degree of gene expression occurs during the major phase of EGA 
compared to the minor phase, it was possible that any large difference may become apparent 
at this stage.  I attempted to monitor major EGA in parthenotes to determine if differences in 
the global pattern of expression could be determined during major EGA. In contrast to in vivo 
fertilised embryos  which exhibited wave-like  gene  expression  that  fell to  baseline  levels  as 
major EGA finished, in the majority of parthenogenetic 2-cell stage embryos gene expression 
increased  to  high  levels  but  then  failed  to  decrease  back  to  baseline  levels.  I  previously 
observed this pattern of gene expression  in morphologically impaired embryos or those that 
were  cultured  under  sub-optimal  conditions.  It  may be argued that gene  expression  did  not 
decrease back to baseline levels during major EGA in parthenotes because they have a weaker 
developmental  potential  than  those  of in  vivo  fertilised  embryos.  This  is  unlikely  though, 
since completion of major EGA  is necessary for development to progress beyond the 2-cell 
stage  and  under optimised  in vitro culture  conditions  many parthenotes  do  develop  beyond 
this  stage  and  up  to  the  blastocyst  stage.  A  failure  of  gene  expression  to  decrease  in 
parthenotes  is probably due to the fact that parthenogenetic 2-cell embryos were cultured in 
vitro  from the Mil stage egg and they may therefore have a reduced developmental capacity 
compared  to  fertilised embryos  that were  not  removed  from  female mice  until a  few hours 
prior to  the  monitoring of major EGA  onset  and did exhibit a decrease  in  gene  expression 
after  peak  expression  (Fig  5.3).  To  test  out  this  theory  in  vivo  fertilised  embryo  could  be
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removed  from  oviducts  and  cultured  in  vitro  prior  to  imaging  for  gene  expression  during 
major EGA. The imaging of parthenogenetic 2-cell embryos in KSOM culture media with the 
use  of  a  CO2  chamber  would  enable  longer-term  studies  to  be  carried  out  and  as  the 
conditions  would  be  more  optimal  in  KSOM  than  HKSOM  media  it  is  likely  that  these 
embryos  would  exhibit wave-like  gene  expression  that  falls  back to  baseline  levels  during 
major EGA and be of a high quality with regards to developmental potential.
Previous  work  from  Chapter  4  demonstrated  that  embryos  derived  from 
cycloheximide-induced  egg  activation  had  a  reduced  developmental  capacity  compared  to 
those  derived  from  Sr2+-induced  egg  activation;  that  work  also  showed  however  that  the 
addition of Sr^-induced  [Ca2+]i oscillations significantly improved successful cleavages and 
development from the 4-cell to the blastocyst stage in embryos activated with cycloheximide. 
This  indicated  that  it  was  a  lack  of  [Ca2+]i  oscillations  that  had  a  negative  impact  on 
development  rather  than  detrimental  affects  caused  by  cycloheximide-activation.  Previous 
reports  have  in  contrast  shown that parthenogenetic egg activation  involving cycloheximide 
causes a delay in the initiation of DNA synthesis and cell division during the first cell cycle 
(Wang  and  Latham.  1997;  Alberio  et  al.,  2001a)  and  it  has  also  been  suggested  that 
postimplantation abnormalities in cycloheximide-activated embryos may be due to this early 
delay in transcriptional activity (Zakhartchenko et al.,  1999). My results do not support these 
findings since no significant difference in the timing of EGA were recorded between embryos 
derived  from  cycloheximide-induced  egg  activation  and  Sr2+-induced  egg  activation  or 
fertilisation.
A major limitation with the luminescent reporter gene technique used to measure EGA 
was that only  global  measures of gene expression could  be taken.  This does  not reveal  any 
information about the changing patterns of specific genes that occur in embryos during EGA. 
Changes  in  the  expression  levels  of genes  having  an  important  affect  can  be  masked  by
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balancing changes  in other genes. Genes expressed at  low  levels which are highly potent  in 
their effect or highly expressed yet relatively impotent genes can also cause problems when 
only  global  expression  changes  are  monitored.  The  differential  expression  of some  genes 
may  be causing the developmental arrest observed at the 4-cell  stage  in the cycloheximide- 
activated eggs and which is described in Chapter 4.  In Chapter 6  I  investigate differences  in 
gene  expression  between  Sr2*  and  cycloheximide-activated  parthenotes  during  the  8-cell 
embryo stage.  Instead of monitoring global gene expression which has limitations regarding 
the  absence  of  information  on  individual  gene  activity,  I  used  microarray  technology  to 
monitor the activity of 21,045  genes specific to stem cells and preimplantation development 
embryonic cells.
5.3.4  Summary
In this Chapter I have, for the first time used a plasmid borne firefly luciferase reporter gene 
assay to  monitor  EGA  in  parthenotes.  This assay provided a sensitive,  accurate and  simple 
means  of monitoring  gene  expression  during  EGA.  My  data  clearly  shows  that  a  similar 
pattern of gene expression during EGA occurs in fertilised and parthenogenetically activated 
embryos.  More  significantly  in  regard  to  previous  work  carried  out  in  this  thesis,  I  have 
demonstrated that EGA  is not strictly dependent on the  [Ca2+]i oscillations that occur at egg 
activation.  A  more  detailed  examination  of specific  genes  during  both  phases  of EGA  will 
help  to  elucidate  whether  [Ca2+]i  oscillations  have  an  impact  on  a  small  number  of 
developmentally  important genes,  which would  not  be notable  in whole genome expression 
studies.
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Chapter 6
Gene expression in 8-cell mouse embryos derived 
from strontium or cycloheximide-induced egg
activation.
6.1  Introduction
In this Chapter I determine whether [Ca2+]i  oscillations at egg activation have any influence on 
the expression of specific genes during preimplantation development. A number of studies have 
shown  that  the  pattern  of  [Ca2+]i  oscillations  can  exert  specific  affects  on  gene  expression. 
Repetitive [Ca2+]i oscillations in somatic cells for example have been shown to be more efficient 
at  inducing  gene  expression  and  were  able  to  trigger  expression  of  a  higher  number  of 
transcription  factors  compared  to  a  monotonic  rise  in  [Ca2+]i  (Dolmetsch  et  al.,  1998).  The 
optimisation  of gene  expression  in  somatic  cells  has  also  been  shown  to  be  dependent  on  the 
frequency of [Ca2+]i oscillations (Li et al.,  1998) but no data reported so far has shown that the 
pattern  of  [Ca2+]i  oscillations  at  egg  activation  can  affect  the  pattern  of gene  expression  in 
mammalian embryonic cells.
In order to investigate whether [Ca2+]i oscillations affect gene expression in embryos I 
utilised  strontium  ions (Sr2+) and the protein synthesis inhibitor cycloheximide.  Both chemicals 
are  capable  of  activating  eggs  but  whilst  Sr2+  ions  induce  repetitive  [Ca2+]i  oscillations, 
cycloheximide  does  not  induce  any  [Ca2+]i  changes  in  eggs  (Fig  4.2).  I  chose  to  investigate 
differences  in  the expression of individual  genes at the embryonic  8-cell  stage,  mainly because 
the differential expression of genes at this stage should reflect some of the major events that take 
place at the blastocyst stage and genes involved in apoptosis and cell differentiation were likely 
to be of particular interest.
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A  recent  study  investigating  phased  gene  expression  in  the  preimplantation  embryo 
reported that the transition from the 4 to 8-cell embryo is characterised by a period in which an 
enormous  number  of genes  undergo  a  dramatic  change  in  gene  expression  (Hamatani  et  al., 
2004a).  Studying  embryos  at  this  stage  is  likely  to  reveal  more  notable  differences  in  gene 
expression  between  the  two  groups  of embryos  than  would  be  seen  at  any  other  stage  of 
preimplantation embryo development
Until  relatively  recently  the  isolation  of differentially  expressed  genes  in  early  stage 
embryos was elucidated using differential display technology (Ma et al., 2001), EST projects (Ko 
et al., 2000), 2-dimensional protein gels (Latham et al.,  1991) Serial Analysis of Gene Expression 
(SAGE)  (Blomberg  le  and  Zuelke,  2004)  and  a  PCR-based  cDNA  subtraction  strategy  called 
Suppression  Subtractive  Hybridization  (SSH)  (Diatchenko  et  al.,  1996).  These methods  are  all 
limited  because  they  cannot  measure  large  numbers  of  genes  simultaneously.  The  use  of 
microarray technology solves this problem and has very rapidly become an invaluable tool in the 
study  of developmental  genomics  (Ko  et  al.,  2000).  Microarrays  have  been  used  to  determine 
patterns  of gene  expression  during  different  phases  of preimplantation  embryo  development 
(Wang et al., 2004; Hamatani et al., 2004a). I utilised microarray analysis to quantify differences 
in  gene  expression  between  Sr2+  and  cycloheximide-activated  8-cell  parthenogenetic  embryos. 
Gene expression  studies  on  early stage mammalian  embryo development have  previously been 
hindered  by  the  difficulties  in  obtaining  large  numbers  of  embryos  to  produce  sufficient 
quantities of mRNA. This hurdle was crossed by using an optimized labelling reaction with two 
rounds of cRNA linear amplification suitable for tiny amounts of extracted mRNA (Carter et al., 
2003).  The  lack  of  available  microarray  platforms  containing  genes  unique  to  early  stage 
embryos  has  also  been  a  hindrance.  A  60-mer  oligo  microarray  platform  enriched  in  genes 
expressed  in  stem  cells  and  preimplantation  stage  embryonic  cells  was  recently  produced
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(Hamatani  et al.,  2004a)  and  I  was  given  access to this  microarray  by  Dr Ko,  of the National 
Institute of Aging (NIA), National Institute of Health (NIH), Baltimore.
Here  I  show that gene expression  in  8-cell embryos derived  from parthenogenetic egg 
activation  using  either  Sr2*  or  cycloheximide  exhibit  differences  in  the  expression  levels  of 
specific  genes.  Differentially expressed  genes were clustered  into  functional  groups  in order to 
obtain  some  idea  of the  biological  significance  of these  changes.  High  expression  of genes 
associated with the cell-cycle, apoptosis and cell differentiation were found to be characteristic of 
8-cell  embryos  generated  from  cycloheximide-induced  parthenogenetic  egg  activation.  High
expression of genes associated with  ion transport,  cell adhesion and cell  proliferation pathways 
were  found  to  be  characteristic  of 8-cell  embryos  generated  from  Sr2+-induced  egg  activation. 
The  results  from  this  study on gene expression  suggest that the  presence  or absence  of [Ca2+]i 
oscillations  during  egg  activation  have  an  affect  on  developmentally  important  genes  and 
pathways during preimplantation embryo development.
These experiments were carried out in the laboratories of the NIA, NIH,  Baltimore and 
were  in  collaboration  with  Dr  Minoru  Ko,  Dr  Yulan  Piao,  Dr  Kazuhiro  Aiba  and  Dr  Alexi 
Sharov.
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6.2 Results
6.2.1  Experimental design for cRNA microarray work
Embryos that were activated using cycloheximide or Sr2+ were developed to the 8-cell stage 
and  collected  in  groups  of 34  before  being  frozen  at  -80°C.  Experiments  were  done  in 
duplicate.  The  mRNAs from cycloheximide and  Sr2+ activated  8-cell embryos were  labeled 
with Cyanine 5 (Cy5) fluorochrome by fluorescent linear amplification (Fig 6.1a). In order to 
identify’   differential  gene  expression  using  microarray  platforms,  an  experimental  design  is 
required which  is suitable for the type of samples being tested. Two types of 2-colour array 
experimental  designs exist and are referred  to  as the  "loop"  and  "reference"  designs.  In  the 
"loop" design,  samples are compared to one another in circular or multiple-pairwise fashion. 
This  is  a  useful  design  when  small  numbers  of samples  are  being  compared  however  it 
becomes inefficient with large numbers of samples.  In the  "reference" design each sample is 
compared  to  a  common  RNA  reference  sample  which  serves  as  a  common  denominator 
between  different  microarray  hybridizations  (Fig  6.1b).  Reference  markers  also  reduce  the 
incidence of laboratory mistakes because each  sample  is handled the same way and thus all 
comparisons are made with equal efficiency.
Microarray analyses of cycloheximide and Sr2+ -activated 8-cell embryos were carried 
out  using  a  reference  design  based  upon  the  Universal  Mouse  Reference  RNA  (UMRR; 
Strategene).  This  is  comprised of total  RNA  from  11  pooled  mouse  cell  lines of different 
tissue origins including embryo, testis, kidney and mammary gland. UMRR was labeled with 
Cyanine 3 (Cy3) fluorochrome and upon stimulation the Cy5/Cy3 intensities from each of the 
4 microarray platforms (cycloheximide duplicates CXI, CX2 and Sr2+ duplicates Sr2+1, Sr2+2)
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Fig  6.1  Experimental  design  for  microarray  work.  Comparison  of gene  expression  in 
S t2*  and  cycloheximide  (CX)-activated  8-cell  embryos  using  universal  mouse  reference 
RNA  (UMRR)  as  a common  reference  sample.  Total  RNA  isolated  from  8-cell  embryos 
was  labeled  with  Cy5  during  cRNA  synthesis.  UMRR  cRNA  was  labeled  with  Cy3  (a) 
Each  experimental  Cy5-labeled  cRNA  was  co-hybridized  with  Cy3-labeled  cRNA  from 
UMRR  onto  a  22,000-spot  cRNA  microarray  (b).  Ratios  of Cy5/Cy3  intensities  were 
compared to each other and differentially expressed genes tabulated (c).
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were compared to one another.  Differentially expressed  genes from  each  group  of embryos 
were tabulated (Fig 6.1c).
6.2.2  Determination of cRNA Quality and integrity using a lab-on-chip assay, Nanodrop 
spectrophotometer and Agilent 2100 Bioanaylzer.
The  quality of the  microarray data  is  related  to  the  quality  (purity)  and  amount  of mRNA 
present  in  the  sample  and  since  array experiments  are  time  consuming  and  expensive  it  is 
important to analyze the mRNA quality before proceeding with the hybridization  reactions. 
Following probe labeling with Cy5-dye the quality of the cRNA probes was measured using 
an Agilent 2100 Bioanalyzer (Agilent Technologies) with a Nano lab-on-chip Assay (Mueller 
et  al.,  2000).  Each  chip  contains  an  interconnected  set  of gel-filled  channels  that  allows 
molecular sieving of nucleic acids  in a way that  is effectively a microscale electrophoresis. 
The chip assay provides a more sensitive alternative to polyacrylamide gels and is suitable for 
work with minuscule amounts of mRNA as it only requires approximately 5ng of nucleic acid 
as  a  starting  material.  A  customised microarray molecular weight  marker that consists of 6 
well  defined transcripts of lengths  in the optimal  range  necessary to  be hybridised onto the 
microarray are integrated into the chip.
Data was presented as electropherograms  in the forms of both a faux gel  image  (Fig 
6.2A)  and  an  actual  fluorescence  trace  (Fig  6.2Bi/ii).  This  graphically  depicts  spikes  in
A  .
fluorescence over time.  Four samples (cycloheximide  1/ 2 and Sr  1/2) were loaded into the 
chip wells and allowed to run for 3 minutes. A high number of cRNA transcripts with lengths 
similar to  that  of the  customised  molecular weight  markers were  observed  (Fig  6.2A).  The 
large  number  of cRNA  transcripts  all  of which  were  of different  lengths  in  the  samples 
prevented  visualisation  of distinct  bands  in  the  gel.  The  gel  did  confirm  however  that  the 
cRNA  transcripts  were  fragmented  to  suitable  lengths  that  were  in  the  optimal  range  for 
hybridization onto the microarray platform.
177Chapter 6: Results
Degradation of total RNA by RNAases can be easily detected by a shift in the RNA 
transcript size distribution towards smaller fragments.  Inspection of each sample  lane on the 
gel  showed that there was no  increase  in the amount of smaller fragments in any of the  gel 
lanes and this indicated that mRNA degradation was minimal.
The Agilent 2100 bioanalyzer software automatically detects ribosomal RNA (rRNA) 
contamination  by  looking  for bands  of characteristic  size  which  represent the  major rRNA 
species (18S and 28S) which tend to electrophorese  in a characteristic pattern.  Results from 
the bioanalyzer show that there was no rRNA contamination in any of the samples.
The Agilent 2100 bioanalyzer produced an electropherogram of cRNAs derived from 
each sample (See Fig 6.2Bi and ii for examples from Sr2+1   and cycloheximide2 respectively). 
The  area  under  the  curve  is  directly  proportional  to  the  amount  of cRNA  although  the 
relationship is only semi-quantitative due to the nature of the assay and the non-representative 
nature  of such  a  small  test  volume  of macromolecules.  The  total  amounts  of mRNA  for 
cycloheximide 1,  cycloheximide  2,  Sr^l  and  Si^+2  were  as  follows;  607ng/pl,  670ng/|il, 
478ng/pl and 430 ng/pl respectively. The cRNA obtained from each sample was in sufficient 
quantities to allow efficient hybridisation.
The  cRNA  from  each  sample  was  labelled  with  Cy5  and  co-hybridised  with  Cy3- 
labelled  UMRR  onto  the  NIA  22k  microarray.  Ratios  of Cy5  and  Cy3  intensities  were 
compared to one another.  Fig 6.3  shows an example of a scanned  image  from  a microarray 
platform  after  hybridisation  of  cRNA  obtained  from  the  Sr2+1   cohort  of  embryos.  The 
intensity of the  colour of each  spot reflects the  amount of expression occurring  in  the  gene 
represented by each spot; the higher the intensity of red in a spot, the higher the expression of 
the  represented  gene  in  the  test  sample  compared  to  that  of the  UMRR.  The  higher  the 
intensity of green in a spot the higher the expression of the represented gene in the UMRR
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Figure  6.2.  Determination  of  cRNA  quality  and  quantity  prior  to  hybridisation.
Digitally  generated  gel  image of Cy3-labelled  cRNA’s  from  the  4  samples  (CXI,  CX2, 
SH^l  and Sr2^ )  (A). The lengths of cRNA transcripts in all samples are of similar size to 
that  of  the  ladder  (L)  indicating  their  suitability  for  microarray  work.  Bioanalyzer 
electropherograms  of cRNA  from  St2+1   (Bi)  and  CXI  (Bii)  samples  were carried  out  to 
analyze the integrity of cRNA. To calculate the concentration of total RNA, the area under 
the entire RNA electropherogram is determined and compared to the area under the ladder 
and this value is directly related to the cRNA concentration. CX = cycloheximide.
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179Figure  6.3  NIA  22K  60-Mer  Oligo  Microarray.  Image  of a  whole  microarray  after 
hybridisation of cy3-labeled cRNA from Sr2*!  sample group and cy5-Iabeled UMRR (i). 
Magnification of a small area of the microarray showing distinct green, red and yellow 
spots  that  vary  in  intensity  (ii).  A  red  spot  indicates  that  the  represented  gene  in  the 
cohort of embryos is more highly expressed compared to the expression of the gene  in 
the UMRR A green spot indicates that the represented gene in the UMRR is more highly 
expressed compared to the gene in the cohort of embryos. A yellow spot indicates that 
there  is no significant differences  in gene expression levels of the represented gene  in 
either the cohort of embryos or UMRR.
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compared  to that  of the  test  sample.  When  the  spot  is  yellow  it  indicates  that the  gene  is 
expressed in similar amounts in both the UMRR and the treated sample.
It  is  important  to  analyse  the  scanned  images  of  each  microarray  during  data 
collection, this is to ensure that the scanner laser has been correctly aligned to the centre of 
the  spots  and  there  have  been  no  power  fluctuations.  Minor variations  in  laser  power  will 
result  in apparent brightness variations  in the  images and obvious streaks appear across the 
whole image. No streaks were present on any of the arrays in my experiments (Fig 6.3).
6.2.3  Pairwise comparison of 8-cell embryos activated with Sr2+ or cycloheximide.
The  8-cell  embryos  generated  from  parthenogenetic  activation  with  Sr2+ or  cycloheximide 
were  used  for  expression  profiling.  A  pairwise  comparison  of  gene  expression  using 
microarray data was carried out to highlight differentially expressed genes between the two 
cohorts of 8-cell embry os.
Genes expressed in the Sr2* and cycloheximide groups were described as differentially 
expressed  when  they  exhibited  a  1.5-fold  higher  expression  than  cycloheximide  and  Sr2* 
groups,  respectively.  Quantitative  statistical  analysis  identified  807  genes  that  were 
differentially  expressed  between  the  two  groups  of embryos.  239  genes  were  identified  as 
being  highly  expressed  in  the  Sr2+-  activated  group  of embryos  whereas  568  genes  were 
identified as highly expressed in the cycloheximide-activated group of embryos. The majority 
of differentially expressed genes in both groups had a log intensity of approximately 2.5-3.5 
and  a  log-ratio  value  of 0.4-0.6  which  revealed  that  most  differentially  expressed  genes 
exhibited  a  1.5-2  fold  difference  in  gene  expression  (Fig  6.4).  As  the  comparison  of gene 
expression  between  the  two  groups  of embryos  was  a  pairwise  comparison  genes  were 
described as highly expressed with respect to the other group and could not be described as 
under expressed  with  respect to the  same  group.  A  table  of all  the  differentially expressed
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genes (fold changes >  1.5) and their fold-changes can be observed in the appendices (Tables
8.1  and 8.2).
A scatter plot of the log intensities versus log ratio was generated using the NIA array 
analysis  tool  (http://lgsun.grc.nia.nih.gov/ANOVA/)  (Fig  6.4).  Each  differentially expressed 
gene  was  represented  by  a  single  point  on  the  scatter  plot.  The  log  intensity  refers  to  the 
logarithm  of intensity of fluorescent  light for each dye on each spot of the array.  Log-ratios 
are usually used for microarray data analysis to facilitate the calculation of fold change, where 
a 2 fold up-regulation of a gene corresponds to a log ratio of 1. Highly variable genes that had 
a high signal to noise ratio were treated with caution.
6.2.4  A perspective on global gene expression by Principle Component Analysis
I used Principle Component Analysis (PCA), a common tool used in microarray analysis, as a 
cluster  analysis  tool  to  compare  common  global  gene  expression  patterns  in  datasets  of 
cycloheximide  and  Sr2+  activated  parthenogenetic  eggs  to  unfertilized  eggs  and  fertilised 
embryos at the  1   cell, 2 cell, 4 cell, 8 cell, morula and blastocyst stages. I used the NIA array 
analysis  tool  (http://lgsun.grc.nia.nih.gov/ANOVA/)  to  identify  any  common  global  theme 
that  might  be  representative  of my  treated  embryos  during  preimplantation  development 
(Sharov et al., 2005).  PCA is useful because it breaks down the complexity of large datasets 
and characterizes the most abundant themes of gene expression.
In a situation where two variables are to be compared, we would normally draw a two 
dimensional chart or graph where the first variable represents the first dimension (x) and the 
second  variable  represents the  second  dimension  (y).  If we  were  comparing  three  variables 
simultaneously we  could  still  draw a graph  including  a third dimension  (z).  Each covariate 
point in this three dimensional space has a co-ordinate value (x,y,z). The addition of a fourth 
variable in the comparison causes problems as we cannot perceive or draw a fourth spatial
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Figure 6.4  Scatter plot  showing  log  intensity'  and  ratio  of differentially  expressed 
genes.  The  horizontal  axis  represents  the  averaged  log  (intensity)  of genes  and  the 
vertical axis represents the log-ratio of signal intensity for each genes. The coloured dots 
represent genes that have passed statistical analysis by false rate discovery (FDR) =10%. 
Highly expressed genes from Sr2* activated 8-cell embryos are denoted by red dots and 
those from  cycloheximide (CX)- activated embryos are denoted by green dots.  Highly 
variable  (noisy)  genes  (shown  in  a  lighter  green  or  red  colour)  were  present  in  our 
results and were treated with caution.  In  total  807 genes were differentially expressed 
between the 2 groups of parthenogenetic 8-cell embryos.
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dimension;  this  does  not  however  prevent  the  plotting  of a  four  point  co-ordinate  value 
(x,y,z,a).  With n variables,  this  principle  is extrapolated  into n dimensional  space and  each 
point  in this space  is described by an n dimensional coordinate value (x,y,z,a,b,c...n).  Each 
dimension  thus  corresponds  to  a  different  gene.  The  microarrays  utilized  for  this  work 
contained  21,045  gene  features  which  would  therefore  correlate  to  a  21,045  dimensional 
coordinate  value.  Just  as  in  3D  space,  the  values  of the  points  in  the  co-ordinate  are 
representations  of variance  along  a  single  dimension,  or  in  the  case  of micro-array  data 
analysis variations in the expression of different genes. Principle Component Analysis allows 
us to transpose  high dimensional  space  into a normal  3D  space. This allows us to visualize 
and analyze extremely complex data sets  in a very simple way and simultaneously analyzes 
all of the data.
The first step of PCA is to plot all of the covariates in to the high dimensional space. 
This would look like a cloud of points floating in n dimensions. A hyper-axis (something like 
an  n  dimensional  line  of best  fit)  is  drawn  through  this  space.  This  axis  is  the  single  line 
which can be drawn through the cloud that gives us the best one dimensional idea of the shape 
of the  cloud  in  that  it  passes  through  more  points  than  any  other  line,  this  is  Principle 
Component  1   (PCI). The next step is to draw a second hyper-axis at right angles (just like in 
normal co-ordinates) to PC 1  and this gives us the next best, one-dimensional idea of the shape 
of the cloud and is Principle Component 2. By plotting PCI  against PC2 we now can identify 
the basic two-dimensional outline of the cloud as if its shadow had been cast on a wall. This 
principle can be continued until such a point as most of the variation has been described by 
the  principle  components  used  (i.e.  one  of the  principle  components  passes  through  the 
majority  of points  in  the  cloud.  In  normal  situations  we  would  hope  that  almost  all  of the 
variation would  be described by the  first three  principal  components as they can  be  simply 
graphed  in normal space. The principle components are averages of the summative effect of
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all of the covariates. The final stage of PCA is to plot each individual set of covariates (i.e. the 
data from each developmental stage, see Fig 6.5) individually onto the principle components 
and assess how they vary from the average. For any given grouping (here the type of embryos 
used),  small differences  in any number of dimensions  in the co-ordinate  system will  have a 
knock-on effect on the position of the point representing that grouping along the axes of the 
principle  components.  The  result  is  a  graph  that  shows  how  the  gene  expression  at  each 
developmental stage varies from the average and is without scale or value. The proximity of 
each set of covariates to one another when graphed along the Principle Components describes 
in a low dimensional form how they compare to one another in the high dimensional form. In 
these experiments we can describe how the different sets of embryos compare to one another 
in terms of the expression of many genes, but in a simple two-dimensional form that describes 
all, or most of the expression data from the micro-array simultaneously.
PCA revealed that 8-cell embryos generated by activation with Sr2+ or cycloheximide 
followed a similar developmental path to that of the In vivo fertilised embryos (Fig 6.5A). Fig 
6.5A  shows  that  the  gene  expression  of unfertilized  and  fertilised oocytes  is  very different 
from  the  gene  expression  of 2-cell,  4-cell,  8-cell,  morulae  and  blastocyst  stages.  This  has 
previously been  described  (Hamatani et al., 2004a).  Both groups of 8-cell  parthenogenetic 
embryos exhibited an expression pattern that was in a phase between that of the 4-cell and 8- 
cell/morula stages of in vivo fertilised embryos (Fig 6.5A).  Further analysis of PCI  and PC2 
revealed  that  subtle  differences  existed  between  S r+   and  cycloheximide-activated  embryos 
(Fig  6.5B).  PCI,  which  represented  the  most  common  global  gene  expression  patterns, 
revealed that Sr2* activated 8-cell embryos showed more resemblance to In v/'vo-fertilised 8- 
cell, morula and blastocyst stage embryos than any other preimplantation stage (Fig 6.5  Bi). 
Cycloheximide-activated 8-cell embryos had expression patterns that were most similar to a
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phase between the 4 and 8-cell preimplantation stages of In vivo- fertilised embryos (Fig 6.5 
Bi).
PC2  analysis  which  represented  the  2nd  most  common  gene  expression  pattern, 
demonstrated  that  Sr2*  and  cycloheximide-activated  embryos  were  more  similar  to  one 
another than to any stage of in v/vo-fertilised preimplantation embryos (Fig 6.5ii).
6.2.5  Assignment of functional categories to differentially expressed genes.
MAPPFinder  (Doniger  et  al.,  2003)  was  used  in  conjunction  with  GenMAPP  in  order  to 
assign  functional categories to differentially expressed genes by identifying the major Gene 
Ontology (GO) terms (Ashburner et al., 2000) associated with them. The microarray data are 
available  from  the  public  databases  (GEO  and  ArrayExpress)  and  the  website 
http://lgsun.grc.nia.nih.gov/microarrav.data.html.
To assess possible biological significance, only functional categories that had three or 
more  differentially  expressed  genes  in  either  the  Sr2+  or  cycloheximide-activated  group  of 
embryos  were  selected.  Overall  functional  groupings  were quite  different  between  embryos 
generated from cycloheximide and Sr^-induced egg activation.  8-cell  embryos  derived 
from cycloheximide-activation were characterized by genes such as those associated with the 
GO-terms  “cell  cycle,  microtubule-based  processes,  ATP  binding,  apoptosis  and  cell 
differentiation’*   (Table  6.1).  The  8-cell  embryos  resulting  from  Sr2+  activation  were 
represented  by  genes  such  as  those  associated  with  the  GO-terms  "‘cell  proliferation,  cell 
adhesion  and  ion  transport"  (Table  6.2).  It  is  important  to  note  that  a  single  gene  can  be 
common to more than one biological process, for example RAD21  is associated with both the 
cell  cycle  and  apoptosis  pathways  and  Gadd45g  is  associated  with  apoptosis  and  cell 
differentiation.
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Table 6.1  - Genes more highly expressed  in 8-cell cycloheximide-activated embryos 
compared to Sr2* activated 8-cell embryos.
Gene Ontology 
classification
Gene Name  Protein Name Fold
change
Cell cycle
Microtubule
based
processes
Cytoskeleton
dependent
intracellular
transport
Microtubule motor 
activity
Apoptosis
Cell growth
Cell proliferation 
Organic acid 
transporter 
activity
Morphogenesis of 
epithelium
Protein
phosphorylation
Spin
Ccnb3
Cdc6
Cdk7
Cdk9
Cdkn2d
Mapk4
Plk4
Rad21
Dnclcl
Kifll
KifJb
Kif2c
Kif3c
Tuba4
Tubb3
Bicd2
Dnclicl
Bicd2
Dnclcl
Dnclicl
Tuba4
Kifll
Kiflb
Faf-1
Dapk2
Jak2
Rad21
Zfp346
Gadd45g
Cebpb
Card4
Socsl
Socs2
Socs3
Cdk9
Sicla7
Slc38a4
Slcla3
Xdh 
Celsrl 
Jag I
Akt3
Cdk7
Cdk9
Dapk2
spindlin  2.092
cyclin B3  1.883
cell division cycle 6  1.858
eye 1  in-dependent kinase 7  2.225
cyclin-dependent kinase 9  1.961
eye 1  in-dependent kinase inhibitor 2D  1.711
mitogen-activated protein kinase 4  1.786
polo-like kinase 4  1.731
Double-strand-break repair protein rad21   homolog  1.716
cytoplasmic , light chain 1   1.739
kinesin family member 11  2.399
kinesin family member lb  1.772
kinesin family member 2c  1.879
kinesin family member 3C  1.704
tubulin, alpha 4  1.81
tubulin, beta 3  2.097
bicaudal D homolog 2  2.093
dynein, light intermediate chain 1   1.951
bicaudal D homolog 2  2.093
Dynein, cytoplasmic . light chain 1   1.739
dynein, light intermediate chain 1   1.951
tubulin, alpha 4  1.81
kinesin family member 11  2.399
kinesin family member lb  1.772
Fas-associated factor 1   2.421
Death associated protein kinase 2  1.691
Janus kinase 2  1.778
Double-strand-break repair protein rad21  homolog  1.716
zinc finger protein 346  1.752
growth arrest and DNA-damage-inducible 45 gamma.  2.358
CCAAT/enhancer binding protein (C/EBP), beta  1.871
caspase recruitment domain 4  1.841
suppressor of cytokine signaling  1   1.772
Suppressor of cytokine signaling 2  1.919
Suppressor of cytokine signal ing 3  1.942
cyclin-dependent kinase 9  1.961
Solute carrier family  1   (glutamate transporter), member 3  1.753
Solute carrier family 38. member 4  2.033
Solute carrier family  1  (glial high affinity glutamate  1.913
transporter), 
member 3
Xanthine dehydrogenase  1.778
Cadherin EGF LAG seven-pass G-type  receptor 1   precursor  1.889
Jagged 1   2.07
Thymoma viral proto-oncogene 3  1.751
cyclin-dependent kinase 7  2.225
cyclin-dependent kinase 9  1.961
Death associated kinase 2  1.691
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Ddrl  discoidin domain receptor family, member 1   2.007
EifakS  eukaryotic translation initiation factor 2 alpha kinase 3  2.054
JAK2  Janus kinase 2  1.778
Mapkl4  mitogen activated protein kinase 14  1.937
Mapk4  mitogen-activated protein kinase 4  1.786
Nek4  N1MA (never in mitosis gene a)-related expressed kinase 4  2.357
Prkcb  protein kinase C, beta  1.882
Prkar2a  protein kinase. cAMP dependent regulatory, type 11 alpha  1.77
PLK4  polo-like kinase 4  1.731
Abcb9  ATP-binding cassette, sub-family B (MDR/TAP). member 9  2.031
AbcclO  ATP-binding cassette, sub-family C  1.726
Acly  ATP citrate lyase  1.705
Akt3  thymoma viral proto-oncogene 3  1.751
DlPasl  DNA segment, Chr 1, Pasteur Institute 1   1.666
ATP binding  Dapk2  Death associated kinase 2  1.691
Dck  deoxycytidine kinase  2.059
Ddrl  discoidin domain receptor family, memberl  2.007
Ddx27  DEAD box polypeptide 27  1.857
Ddx28  DEAD box polypeptide 28  1.976
Cdc6  cell division cycle 6,  1.858
Cdk7  cyclin-dependent kinase 7  2.225
Cdk9  cyclin-dependent kinase 9  1.961
Edaradd  ectodysplasin-A receptor  2.129
Cell  Gadd45g  growth arrest and DNA-damage-inducible 45 gamma.  2.358
differentiation  Jak2  Janus kinase 2  1.778
Xdh  xanthine dehydrogenase  1.254
Sp3  Trans-acting transcription factor 3  1.884
Icsbpl  interferon consensus sequence binding protein 1   1.808
Cebpb  CCAAT/enhancer binding protein, beta  1.871
Socs2  Suppressor of cytokine signaling 2  2.118
Mrap  melanocortin 2 receptor accessory protein  1.7
Integral to  1300007B12Rik  R1KEN cDNA 1300007B12 gene  2.222
1700018018Rik  RIKEN cDNA 1700018018 gene  2.403
mem  181005SG02Rik  RIKEN cDNA 1810055G02 gene  2.399
4732495E13Rik  RIKEN cDNA 4732495E13 gene  1.959
5031400M07Rik  RIKEN cDNA 5031400M07 gene  2.045
Extracellular Space  Art5  ADP-ribosyltransferase 5  1.873
Morphogenesis of  Celsrl  Cadherin EGF LAG seven-pass G-type  1.889
an epithelium  Ja81  Jagged 1   2.07
Ankl  ankyrin.l erythriod  1.803
Edaradd  EDAR  (ectodvplasin-A receptor-associated death domain  2.129
j  Fgfl8  Fibroblast growth factor 18  2.274
n^.  Gng7  G protein, gamma 7 subunit  1.908
transduction  Hivep2  Human immunodeficiency virus type enhancer protein 2  2.328
Prkar2a  protein Protein kinase, cAMP dependent regulatory, type II  1.77
Rgsl7  alpha  1.916
Rtkn  regulator of G-protein signaling  17  2.115
Socsl  Rhotekin  1.772
Socs2  Suppressor of cytokine signalling 1   1.919
Socs3  Suppressor of cytokine signaling 2  1.942
Suppressor of cytokine signaling 3 
2410005k20Rik  RIKEN cDNA 2410005K20  1.749
Protein  Eif2ak3  Eurakyotic translation initiation factor 2 alpha kinase 3  2.054
hincvnthf»«‘«  Gadd45g  growth arrest and DNA-damage-inducible 45 gamma  1.894
^   1   Rad21  Double-strand-break repair protein rad21 homolog  1.716
Rps271  ribosomal protein S27-like  1.993
RpL17  ribosomal protein L17  1.706
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Table 6.2 Genes more highly expressed in Sr^-activated 8-cell embryos than in CX activated 8- 
cell embryos
Fold
Gene Ontology 
classification
Apoptosis 
Cell proliferation
Organic acid transporter 
activity 
ATP binding 
Cell differentiation
Cell adhesion
Ion transport 
Signal
Transduction
Protein
biosynthesis
Gene Name Protein (or gene) of interest chan
Muc 2 mucin 2 1.81
Nfkbl Nuclear factor of kappa light chain gene 2.208
Btgl B-cell translocation gene 1, anti-proliferative 2.015
Pdgfa platelet derived growth factor, alpha 1.681
Prkarla Protein kinase, cAMP dependent regulatory, type 1, alpha 2.001
Uhrfl ubiquitin-like, containing PHD and RING finger domains 1.763
Slcl2a7 solute carrier family  12, member 7 1.831
Axl AXL receptor tyrosine kinase 1.612
Mdfi MyoD family inhibitor 1.886
DOCK2 dedicator of cyto-kinesis 2 2.089
Tgfbr2 transforming growth factor, beta receptor II 2.679
CD36 CD36 antigen 1.801
Cntnap2 Contactin associated protein  1 2.039
Dscl Dermatopontin 3.477
Gpnmb Glycoprotein (transmembrane) nmb 2.114
Pcdh7 Protocadherin 7 1.875
Pcdhal Protocadherin  alpha 1 1.677
Trpc7 transient receptor potential cation channel, subfamily C, 3.698
Sic 12a 7 member 7 1.831
Scn8a solute carrier family  12, member 7 2.295
Kcnjll sodium channel, voltage-gated, type VIII, alpha polypeptide 
potassium inwardly rectifying channel J  11
1.967
Rgs9 regulator of G-protein signaling 9 1.935
Nfkbl Nuclear factor of kappa light chain gene 2.208
Gabl growth factor receptor bound protein 2-associated protein  1 2.434
Prkarla Protein kinase, cAMP dependent regulatory, type I, alpha 2.001
Ei/3sl0 Eurakyotic translation initiation factor 3,subunit 10 (theta) 3.271
MrpllS mitochondrial ribosomal protein L15 1.886
RpllO ribosomal protein L10 2.32
Rpl9 ribosomal protein L9 2.628
Rpl29 ribosomal protein L29 2.031
Rp9 ribosomal protein L9 2.628
Scyel small inducible cytokine subfamily E, member 1 1.956
Rps3a ribosomal protein S3a 1.946
Rps27a ribosomal protein S27a 2.35
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6.3 Discussion
The aim of the work presented in this chapter was to investigate whether [Ca2+]i oscillations 
at  egg  activation  have  an  impact  on  gene  expression  during  preimplantation  embryo 
development.  To  further examine  the  affects  of [Ca2+]i  oscillations  on  development  I  used 
embryos  obtained  from  parthenogenetic  activation  using  Sr2+  (which  induces  activation  by 
inducing  [Ca2+]i  oscillations)  and cycloheximide  (does not cause any  [Ca2+]i  changes). The 
data  from  microarray analysis reveals that the occurrence of [Ca2+]i  oscillations during egg 
activation  may  affect  the  expression  of genes  associated with  biological  processes  such  as 
apoptosis, cell cycle, ion transport, cell proliferation, cell differentiation and cell adhesion.
6.3.1  High  expression  of  genes  associated  with  the  cell-cycle,  apoptosis  and  cell 
differentiation are characteristic of cycloheximide-activated 8-cell embryos.
Microarray analysis data revealed that 8 genes associated with the cell cycle (Table 6.1) were
more highly expressed in 8-cell embryos generated from cycloheximide-activation compared
to Sr2+ activation. Of particular interest was the high expression of Ccnb3, which codes for the
regulatory protein subunit cyclin B3. Cyclins are commonly known to be positive regulatory
subunits of the cyclin-dependent kinases (cdks) which regulate mitotic cell cycle transitions.
The degradation of cyclins is necessary for the progression of the cell cycle through mitosis.
Preventing cyclin  B3  degradation by using a stable version of the protein has been shown to
prevent  normal  spindle  organization  and  blocks  other  events  such  as  chromosome
decondensation  (Parry,  2001).  High  expression  of non-degradable  cyclin  B3  has  also  been
reported to cause cell-cycle arrest in anaphase and at higher doses interferes with progression
through G1  and entry into  S  phase (Nguyen et al., 2002).  It  is evident that high expression
levels of cyclin B3 may have detrimental effects on the cell cycle and this may therefore be an
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explanation  of why  premature  developmental  arrest  occurs  in  many of the  cycloheximide- 
activated 4-cell embryos (Chapter 4).
Cycloheximide-activated  8-cell  embryos  were  also  characterised  by  the  high 
expression of Spin, which encodes the protein Spindlin. Spin is involved in the progression of 
the meiotic and first mitotic cell cycles and it is highly expressed in the growing oocyte where 
it persists through embryogenesis until the 4-cell stage after which time it degrades (Oh et al., 
2005).  Under  normal  circumstances  8-cell  embryos  would  not  express  Spin,  in 
cycloheximide-activated 8-cell embryos however. Spin is overexpressed 2.1  fold compared to 
Sr2*  activated  8-cells.  It  appears  that  there  is  no  requirement  for  the  expression  of Spin 
following  the  first  mitotic  cell  cycle  and  that  a  high  level  probably  interferes  with 
developmental  progression  through  later  mitotic  cell-cycles,  which  is  consistent  with  the 
observations made in cycloheximide-activated embryos.
Cell cycle arrest has also been reported to occur in cells after overexpression of other 
cell  cycle  related  genes  which  were  highly  expressed  in  cycloheximide-activated  8-cell 
embryos. Cdk7 (Nishiwaki et al., 2000) and Cdkn2d (Okuda et al., 1995) overexpression for 
example causes premature cell cycle arrest in different somatic cell types. There was no high 
expression  of  cell-cycle  related  genes  in  Sr2+-activated  8-cell  embryos  compared  to 
cycloheximide-activated  embryos.  Previous  experiments  have  shown  that  Sr2+-activated 
embryos  progress  through  preimplantation  development  to  the  blastocyst  stage  without  any 
major  hurdles  (Chapter  4)  and  since  cycloheximide-activated  embryos  (which  often  arrest 
prematurely) exhibit high levels of cell-cycle related gene expression, this suggests that high 
levels of expression of these genes has a detrimental effect on embryo development.
Apoptosis  related  genes  were  found  to  be  differentially  expressed  in  both 
cycloheximide  and  Sr2+  activated  embryos.  Only  two  apoptosis-related  genes,  Muc  2  and 
Nfkbl  (Table 6.2) were  found to be highly expressed in 8-cell embryos generated from  Sr2+
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activation.  More  apoptosis-related  genes  were  however  discovered  to  be  more  highly 
expressed  in  8-cell embryos activated by cycloheximide (Table 6.1).  High expression  levels 
of DAPK2 (Death Associated Kinase 2) were present in cycloheximide-activated embryos and 
have  been  reported  to  significantly  induce  the  morphological  changes  characteristic  of 
apoptosis in skeletal muscle cells (Kawai et al., 1999). DAPK2 binds directly to calmodulin 
and  is  activated  in  a  Ca2+/Calmodulin-dependent  manner.  It  is  surprising  that  DAPK2  is 
overexpressed  in  cycloheximide-activated  embryos  because  cycloheximide-induced  egg 
activation occurs in the absence of [Ca2+]i oscillations.
A number of genes which were found to be more highly expressed in cycloheximide- 
activated embryos and whose function is associated with apoptosis also appear to be related to 
the cell cycle. In fact there is mounting evidence that apoptosis regulatory proteins themselves 
can  directly  impinge  on  the  cell-cycle  machinery.  The  gene  Rad21  (Double-strand-break 
repair protein  21)  for  example  plays  a  critical  role  in  cell  division  by  regulating  sister 
chromatid cohesion  and  separation  at  the  metaphase-to-anaphase  transition  but  also  has  a 
further  role  in  the  regulation  of apoptosis  by  repairing  double-strand  DNA  breaks.  High 
expression levels of Rad21 cause an increased incidence of apoptosis in Molt4 and 293T cells 
(Pari  et  al.,  2002)  and  could  mean  that  RAD21  overexpression  leads  to  an  increase  in 
apoptosis  in other cell  types.  The 8-cell embryos activated with cycloheximide were  indeed 
found to have a  1.7-fold  increase  in RAD21  expression compared to those embryos derived 
from  Sr2+ activation which may account for the higher degree of apoptosis observed in these 
parthenogenetic embryos.
Gadd45g  is  another  gene  which  was  originally  identified  to  be  a  gene  involved  in 
negative regulation of the cell cycle and growth control however over expression of this gene 
has  recently been  shown  to  cause  apoptosis  and  cell  cycle  arrest In  vitro  (Mak and Kultz, 
2004).  Gadd45g is also expressed approximately 2.4  fold higher in cycloheximide-activated
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embryos than in Sr2* activated embryos. The Cdk9 protein which  is associated with the cell 
division phase of the cell cycle has also been shown to render cells lines sensitive to apoptosis 
when  expressed  in high  levels (Foskett et al., 2001). The highest  incidence of apoptosis  in 
blastocysts  as  determined  by  TUNEL  occurred  in  embryos  generated  from  cycloheximide 
compared  to  Sr2+  activation  and  high  levels  of cell  cycle  and  apoptosis-related  genes  may 
therefore  induce this effect.  Further work will  be needed to elucidate  any  apoptosis-related 
pathways that may be in action and are triggered by the lack of [Ca2+]i signals at activation. 
Unfortunately it is still unclear how most apoptosis genes work and how high expression can 
lead  to  eventual  programmed  cell  death.  It  was  surprising  that  some  genes  known  to  be 
activated via classical effector pathways such as the pro-apoptotic bcl-2 family members, bax 
and  caspase-1  were  not  found  to  be highly expressed  in  cycloheximide when  compared  to 
Sr2+-activated embryos.  It has been suggested that various apoptosis regulatory factors may 
enhance or inhibit the function of a gene and  in this way the ratio of activators to  inhibitors 
may determine if the cell undergoes apoptosis or not (korsmeyer et al,  1995).
The  8-cell  embryos  generated  with  cycloheximide  had  high  expression  of  genes 
associated with the GO-term “cell differentiation” (Table 6.1). Overexpression of Sp3 (Trans­
acting transcription factor 3)  was  particularly  interesting  as  it  has  been  reported  to  cause 
down-regulation  of  N-cadherin  expression  in  human  osteoblasts  (Le  Mee  et  al.,  2005). 
Members  of the  cadherin  family  function  by  facilitating  cell-cell  adhesion,  which  is  a  vital 
process  for  preimplantation  stage  embryos,  especially  during  the  process  of compaction. 
Socs2 (Suppressor of cytokine signaling 2)  is a growth control gene with inhibitory functions 
and  therefore  high  expression  of this  gene would  lead  to  a  growth  inhibiting affect  on  the 
embryo, which may explain the incidence of less Inner Cell Mass (ICM) cells  in blastocysts 
derived from cycloheximide-activation.
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6.3.2  High  expression  of  genes  associated  with  ion  transport,  cell  adhesion  and  cell 
proliferation pathways are characteristic of Sreactivated 8-cell embryos.
8-cell embryos resulting from Sr2+-induced egg activation has differential expression of genes
associated  with  the  GO  term  “ion  transport”  (Table  6.2).  The  overexpression  of  Trpc7
(Transient receptor potential cation channel,  subfamily C,  member  7)  was  interesting  as  it
functions as a Ca2+ permeable cation channel which is activated by diacyglycerol (DAG) and
Ca2+ store depletion (Hoffmann et al.,  1999). The [Ca2+]i rises that are stimulated by Sr2+ lead
to the synthesis of DAG which  in turn may lead to activation of the channel. Egg activation
by  cycloheximide-stimulation  in  contrast,  occurs  in  a  Ca2+  dependent  manner  without  the
production of DAG, which may prevent activation of the channels.
The  expression  of Scn8a  and  kcnjll,  which  code  for  a  voltage  gated  Na+  and  K+ 
channel respectively may be relevant to the formation of the blastocoel cavity.  Although the 
exact  mechanisms  of blastocoel  formation  are  unclear  it  appears  to  be  mediated  by Na/K- 
ATPase-generated trans-trophectoderm ion gradient that promotes the accumulation of water 
across the epithelium (Watson and Barcroff,  2001). The expression of genes associated with 
Na+  and  K+  ion  channels  appears  to  have  an  important  role  in  the  maintenance  and  later 
development  of  the  embryo  during  preimplantation  development,  especially  during  the 
blastocyst stage.
Genes  associated  with  the  GO-term  “cell  adhesion”  were  identified  as  being 
differentially expressed in Sr2+ and cycloheximide-activated groups of 8-cell embryos. The 8- 
cell embryos derived  from  cycloheximide-induced egg activation were characteristed by the 
high expression  levels of 3  cell adhesion  related genes (Table 6.1) however 6  cell adhesion 
related  genes  (Table  6.2)  were  highly  expressed  in  8-cell  embryos  resulting  from  Sr2+- 
induced  activation.  The  two  protocadherins  Pcdh7  (Protocadherin  7)  and  Pcdhal 
(Protocadherin  alpha 1) which work by Ca2+-dependent cell-cell adhesion were both highly 
expressed  in  8-cell  embryos  activated  by  Sr2+  and  their  overexpression  may  aid  the  cell
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adhesion events in the 8-cell embryo. Further analysis by antibody staining or protein assays 
is  necessary  to  be  clearer  about  the  exact  function  of  these  adhesion  genes  in  the 
preimplantation embryo.
Overexpression of genes relating to cell proliferation was found in 8-cell embryos that 
were  generated  by  Sr2* and cycloheximide activation.  Only  1   cell  proliferation  gene (cdk.9) 
was found to be highly expressed in the cycloheximide-activated group (Table 6.1) whereas 4 
genes  (Table  6.2)  were  found  to  be  highly  expressed  in  the  Sr2+-activated  group.  Pdgfa 
(Platelet derived growth factor alpha)  is  a  potent  mitogen  that  has  a  major role  in  wound 
healing by stimulating neighboring cells to grow.  Uhrfl  (Ubiquitin-like, containing PHD and 
RING finger domains)  which  has  been  shown  to  suppress  expression  of tumor  suppressor 
genes  in  breast  cancer  cells  has  also  been  reported  to  be  involved  in  cell  proliferation- 
associated events (Unoki et al., 2004).  High expression levels of these proliferation genes in 
Sr2* activated embryos may explain why the resulting blastocysts have an  increased number 
of cells in their ICM.
The majority of differentially expressed genes in both cohorts of embryos were only 
differentially expressed  1.5 -  2.5 fold however it is becoming widely accepted that even small 
differences  in  gene  expression  can  have  profound  consequences  for  the  cell.  Expression 
studies  on  human  breast  cancer  for  example,  revealed  that  as  little  as  a  1.25-  to  2.5-fold 
increase  in  expression  of RAD21  was  present  in  several  human  breast  cancer  cell  lines  as 
compared  with  normal  breast cell  lines (Atienza et al.,  2005),  although this may not  be the 
only aberrant gene in these cancerous cells.
6.3.3  Experimental limitations and future directions
Analysis  of gene  expression  in cycloheximide  and  Sr2+-activated  parthenotes would  ideally 
not have been restricted to the 8-cell stage but extended through all stages of preimplantation
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development from the  1-cell pronucleate to the blastocyst stage. This would have provided a 
much  more  detailed  view  of  how  [Ca2+]i  oscillations  at  egg  activation  can  change  the 
expression  patterns  of  individual  genes  throughout  preimplantation  development.  During 
development in the fertilised embryo for example, the gene Spin is only expressed until the 4- 
cell stage after which time the protein is degraded (Oh et al., 2005). High expression levels of 
Spin occur however in 8-cell embryos generated from cycloheximide-induced activation. The 
opportunity to follow the expression pattern of Spin throughout preimplantation development 
would  reveal  when  this  gene  first  becomes  differentially  expressed  with  respect  to  Sr2+ 
activated  parthenotes  or  fertilised  embryos.  The  high  costs  (-$1000  per  array)  and  time 
associated with this work prevented me from examining the different cohorts of parthenotes 
during  each  stage  of preimplantation  development.  The  8-cell  stage  of development  was 
however a suitable stage to examine gene expression in the groups of parthenotes since any 
major events taking place around the time of blastocyst  formation,  such  as compaction  and 
cell differentiation would be reflected by the pattern of gene expression at this stage.
It could be argued that any deleterious affects on gene expression could be due to the 
affect  of  cycloheximide  which  has  previously  been  shown  to  delay  cell  division  and 
embryonic transcription (Zakhartchenko et al.,  1999; Alberio et al., 2001b). I have previously 
shown however that cycloheximide does not affect the timing or amount of gene expression 
that  occurs  during  minor embryonic  genome  activation  (Chapter  5)  and  moreover,  it  is the 
advantageous affect of S r+  and not the detrimental affect of cycloheximide that causes a high 
number  of embryos  to  reach  the  blastocyst  stage  after  egg  activation  when  a  combined 
treatment  of cycloheximide  plus  Sr2*  is  used  (Chapter  4).  It  will  be  useful  to  carry  out 
microarray  analysis  of  embryos  treated  with  the  combined  treatment  (Sr2+  plus 
cycloheximide)  to  rule  out  the  possibility  that  differential  gene  expression  was  due  to  the 
detrimental  affects  of cycloheximide rather than  by the  [Ca2+]i  oscillations  induced  by  Sr2+
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activation.  Again  it  was  the  high  costs  of  testing  a  larger  number  of  microarrays  that 
prevented me from testing the combined activation treatment.
PC A  was  performed  to  compare  global  gene  expression  patterns  in  the  8-cell 
parthenogenetic  embryos  with  fertilised  embryos  from  all  stages  of  preimplantation 
development (Fig 6.5). I compared the results from the gene expression database from 8-cell 
parthenotes  in  my  experiments with the  results  of gene  expression  datasets  from  fertilised 
embryos  which  have  been  published  previously  (Hamatani  et  al.,  2004a).  Two  main 
differences between the cohorts of embryos from each database prevented me from being able 
to  make  direct  comparisons  between  the  two  datasets.  Firstly,  I  had  to  compare  my  global 
gene  expression  results  from  parthenogenetic  embryos  with  fertilised  embryos,  so  any 
influence the sperm or its DNA has over gene expression during preimplantation development 
would not be observed in parthenogenetic 8-cell embryos. In the future it may be possible to 
inject a male pronucleus into each egg prior to parthenogenetic activation to ensure complete 
paternal input. This was however unnecessary as the main aim of the work was to investigate 
the affect [Ca2+]i signaling had on gene expression by comparing eggs that had been activated 
in a [Ca2+]i dependent or independent manner.
The second parameter that prevented me from making direct comparisons of my 8-cell 
embryos  with the  fertilised  embryo  gene expression datasets was the  fact that the  fertilised 
embryos  were  developed  under  In  vivo  conditions  and  only  removed  prior  to  microarray 
analysis. The 8-cell parthenotes from my work on the other hand were cultured in vitro from 
the time of activation.  The environmental conditions that the embryo is subjected to are a big 
determinant of embryo quality and viability. Many studies have concluded that it is during the 
first few cleavages of preimplantation development that the embryo is particularly sensitive to 
environmental  conditions,  which  have  been  reported to  influence  the  relative  abundance  of 
embryonic  transcripts at these  stages  (Rizos  et  al.,  2003).  Studies  on bovine  embryos have
198Chapter 6: Discussion
shown that In v/Yro-cultured embryos have a higher incidence of chromosomal abnormalities 
(Viuff  et  al.,  1999)  compared  to  embryos  cultured  In  vivo.  In  fact  even  altering  the 
supplemental ingredients of cell culture media such as amino acids has been shown to have an 
effect on the gene expression and cavitation rates of blastocysts (Rinaudo and Schultz, 2004). 
Analysis  of Principle  Component  1   (PCI)  from  the  Principle  Component  Analysis  (PCA) 
results  nevertheless  revealed  that  embryos  from  the  two  groups  of parthenotes  were  more 
similar to other preimplantation stages of in vivo fertilised embryos than to one another (Fig 
6.5Bi). The gene expression of cycloheximide-activated 8-cell embryos were most similar to a 
stage between the 4 and 8-cell stage of in vivo fertilised embryos and the gene expression of 
Sr2+  activated  8-cell  embryos  were  most  similar to  a  time  between  the  8-cell,  morula  and 
blastocyst development of in vivo fertilised embryos (Fig 6.5i). This global gene expression 
data  indicates  that  cycloheximide-activated  8-cell  embryos  were  developmentally  less 
advanced  then  Sr2+  activated  embryos  and  that  the  method  of activation  and  possibly  the 
presence  or  absence  of [Ca2+]i  oscillations at this time  has  important  implications  for  gene 
expression and perhaps more so than the extent of in vitro culture systems.
The  analysis  of PC2  from  the  PCA  revealed  there  were  similar  patterns  of gene 
expression  between  the  2  sets  of parthenotes  compared  to  other  stages  of in vivo  fertilised 
embryos.  This  is  likely to  reflect the  fact that the embryos were cultured  under identical in 
vitro conditions that were very different from  the optimal in vivo conditions that the in vivo 
fertilised embryos were subject to.
One  interesting result from the analysis of gene expression was the larger number of 
highly expressed  genes  in the cycloheximide-activated group  (568)  compared to that of the
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Sr  -activated group (239). This could be happening for a number of reasons.  Firstly, a large 
number  of  overexpressed  genes  in  cycloheximide-activated  embryos  may  be  negative 
regulators of important processes such as the cell cycle and cell growth, which may explain
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why many of the embryos arrest development prematurely and have a smaller blastocyst cell 
number  (See  Chapter  4).  Secondly,  if 8-cell  embryos  activated  with  Sr2+  were  at  a  more 
advanced  stage  of development  than  embryos  activated  with  cycloheximide,  the  maternal 
mRNA that exists in the embryos until degradation some time during the 8-cell stage may the 
cause the amount of gene expression in many genes to be higher. Choosing a single time point 
to  study  gene  expression  is  not  as  accurate  as  using  different  time  points  to  make  direct 
conclusions about gene expression activity.  In the future an investigation of gene expression 
after  parallel  morphological  stages  rather  than  specific  times  may  provide  better  quality 
results.
6.3.4  Summary
The work described in this chapter provided  information on gene activity during a snapshot 
moment of development during the 8-cell  stage  in parthenotes activated with cycloheximide 
and  Sr2+.  The  data  from  these  results  demonstrate  that  the  methods  used  for  artificial  egg 
activation  can  have  profound  implications  for  the  embryo  with  regards  to  specific  gene 
expression.  The  results  also  imply  that  the  occurrence  of  [Ca2+]i  oscillations  during  egg 
activation may influence gene expression which is associated with biological processes such 
as apoptosis, cell differentiation and the cell cycle.
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Chapter 7 
General Conclusions
In this thesis  I have presented the data from a number of studies that have  investigated the 
occurrence  of  [Ca2+]i  oscillations  at  egg  activation  and  their  impact  on  preimplantation 
development. A number of original findings have resulted from this work. I have shown that 
the human form of phospholipase C zeta (hPLCQ cRNA can be used to activate aged human 
eggs that have previously failed to fertilise after ICSI or IVF and that this procedure permits 
development  up  to  the  blastocyst  stage.  1   have  shown  that  hPLC£  cRNA  can  be  used  to 
activate  pig  eggs,  which  as  a  consequence  can  develop  up  to  the  8-cell  stage.  I  have 
demonstrated  that  [Ca2+]i  oscillations  or  a  single  [Ca2+]i  increase  at  egg  activation  vastly 
improves the number of parthenogenetic embryos cleaving beyond the 4-cell stage compared 
to embryos derived from [Ca2+]i independent egg activation. This shows that the nature of the 
parthenogenetic stimulus has an affect on the cellular composition and degree of apoptosis in 
blastocysts  and  there  are  indications,  although  not  conclusive  proof,  that  the  presence  of 
[Ca2+]i oscillations at egg activation influences these events. I have also demonstrated that the 
initiation  and  degree  of gene  expression  during  the  minor  phase  of  Embryonic  Genome 
Activation  (EGA)  is  independent  of the  presence  of [Ca2+]i  oscillations  at  egg  activation. 
Finally,  1   have  revealed  that  [Ca2+]i  oscillations  at  egg  activation  are  likely  to  influence 
specific  expression  of genes  during  the  embryonic  8-cell  stage.  Fig  7.1  is  a  diagrammatic 
representation  of the  novel  findings  I  have  presented  in  this  thesis.  These  findings  are  of 
particular  relevance  to  understanding  the  relationship  between  [Ca2+]i  oscillations  and 
preimplantation embryo development. This final chapter will discuss a number of important
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Figure 7.1  Overall conclusions about the affect of |Ca2+]i oscillations on  preimplantation development. The human form of PLC£ 
(hPLCQ can trigger [Ca2+]i oscillations and egg activation in pig, mouse and human eggs. There does not appear to be a requirement for 
the presence of [Ca2+]i oscillations at egg activation for the initiation and amount of global gene expression during the minor phase of 
Embryonic  Genome  Activation  (EGA).  Using  different  parthenogenetic  activation  stimuli  to  induce  [Ca2+]i  oscillations  or  a  single 
[Ca2+]i  increase,  I demonstrated that [Ca2+]i  increases at egg activation improves the developmental success of embryos beyond the 4- 
cell stage compared to embryos that are activated independently of [Ca2+]i. Microarray analysis of gene expression in embryos activated 
by Sr2*  or Cycloheximide revealed that  [Ca2+]i  oscillations affect the expression of genes associated  with processes such as apoptosis 
and the cell-cycle at the 8-cell stage. The results from TUNEL staining and differential staining also indicate that the presence of [Ca2*]i 
oscillations  at  egg  activation  affect  the  degree  of apoptosis  and  cellular  composition  of blastocysts,  respectively.  Cycloheximide- 
activation caused blastocysts to have a significantly larger degree of apoptotic cells and a smaller total and Inner Cell Mass cell number.
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developmental  processes  which  I  have  indicated  that  [Ca2+]i  oscillations  may  have  an 
influence on during preimplantation development.
7.1.1  PLC£  appears  to  be  a  universal  mammalian  sperm  factor  which  triggers  egg 
activation.
During fertilisation  in mammals, egg activation  is triggered by a series of distinctively long- 
lasting [Ca2+]i oscillations. The frequency of [Ca2+]i oscillations at fertilisation varies between 
different species and can range from a [Ca2+]i  increase every few minutes to one that occurs 
every  hour.  Sperm-induced  [Ca2+]i  oscillations  in  mice  cease  around  the  time  of pronuclei 
formation when the egg is entering interphase. There has been much controversy in the field 
of fertilisation about how the sperm activates the egg.  Mounting evidence supports the idea 
that  the  sperm  induces  a  soluble  proteinaceous  factor  into  the  egg,  which  in  turn  causes 
[Ca2+]i oscillations to occur. A search of the mouse and human testis Expressed Sequence Tag 
(EST)  database  revealed  the  existence  of a  novel  PLC  referred  to  as  PLC£.  The  defining 
characteristic of the sperm factor is that it can cause fertilisation-like [Ca2+]i oscillations when 
it is injected in the form of sperm extracts into eggs. Injecting the mouse form of PLC^ cRNA 
in mouse eggs triggered  [Ca2+]i oscillations that were of a pattern indistinguishable from the 
[Ca2+]i oscillations induced by fertilisation (Saunders et al.. 2002). The more PLC^ cRNA that 
was  injected  into  mouse  eggs,  the  higher  the  frequency  of  [Ca2+]i  oscillations  induced 
(Saunders et al., 2002). This is consistent with the work I presented in Chapter 3 which shows 
that  increasing the concentration of the human or mouse form of PLC£ cRNA  increases the 
frequency of [Ca2+]i  oscillations  in mouse,  human  (Rogers  et al.,  2004)  and  pig eggs.  It  is 
clear  that  PLC^-induced  [Ca2+]i  oscillations  require  the  synthesis  of PLC£  protein  since 
[Ca2+]i  oscillations are prevented when eggs are  incubated  in the protein  synthesis inhibitor 
cycloheximide  after  injection  of PLC£  cRNA  (Saunders  et  al.,  2002).  In  the  experiments 
presented  in  Chapter  3  I  did  not  quantify the  amount  of PLC^ protein  synthesis  following
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injection  of PLC£  cRNA  however  other  groups  have  done  so  by using  PLC^  tagged  with 
Venus fluorescent protein (Yoda et al., 2004) or luciferase (Nomikos et al., 2005) to show ~50 
pg/egg PLC£ protein causes a series of [Ca2+]i oscillations. Recently a study has shown that 
reducing  sperm  PLC£  protein  by  transgenic  RNA  interference  significantly  perturbs  the 
[Ca2+]i oscillations exhibited by eggs after insemination of these sperm (Knott et al., 2005). 
This data provided the first direct evidence that PLC£ works as the physiological sperm factor 
in vivo.
The discovery of PLC£ has prompted further functional studies on the PLC£ molecule 
(Kouchi et al., 2005; Nomikos et al., 2005) and investigations on how effective the PLC£ is at 
causing  [Ca2+]i  oscillations  and  egg  activation  in  other  species  (Cox  et  al.,  2002).  Sperm 
extract has previously been documented to trigger [Ca2+]i oscillations across a broad range of 
species (Dong et al., 2000; Jones et al., 1998b; Knott et al., 2002; Wu et al.,  1997) and support 
for PLC^ as the sperm factor is galvanised by the work presented in this thesis, showing that 
hPLC£ is effective at causing [Ca2+]i oscillations in pig and mice eggs and that mPLC£ can 
effectively cause  [Ca2+]i oscillations in human eggs.  There  is evidence for the existence of 
the PLC£ gene in many species including humans, mice, rats, chimpanzee, pigs, dogs, cows, 
monkeys and chickens. This data indicates that different versions of mammalian PLC£ would 
cause  fertilisation-like  [Ca2+]i  oscillations  in  all mammalian  eggs.  Recent reports  have  also 
demonstrated  that  chicken  PLC£  cRNA  can  trigger  [Ca2+]i  oscillations  when  injected  into 
mouse  eggs  (Coward  et  al.,  2005)  indicating  that  PLC£  may  have  a  universal  role  in 
stimulating egg activation in vertebrates.
It has recently been  shown that pig and bull  sperm contain significantly more PLC£ 
than  mouse  sperm  (Kurokawa  et  al.,  2005)  which  suggests  that  pig  eggs  require  a  larger 
amount of PLC£. My findings support this idea because a higher concentration of hPLC£ was 
required to  induce [Ca2+]i oscillations in pig eggs than in mouse eggs.  Studies on pig sperm
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have shown that PLC^ is present in cytosolic sperm extracts as well as the pellets of extracts 
that contain the sperm heads. The 70kD full length version of PLC£ was found not to correlate 
with PLC^’s ability to cause [Ca2+]i oscillations in eggs. This suggests that a proteolytically 
cleaved version of PLC^ may exist in pigs (Kurokawa et al., 2005).  I have demonstrated that 
differences in the potency of hPLC£ and rnPLC^ with regard to causing [Ca2+]i release in eggs 
exist,  since  -1000  times  less  hPLC£  than  mPLC£  cRNA  was  required  to  induce  similar- 
ffequency [Ca2+]i oscillations in mouse eggs. Differences in the degree of solubility, amount 
and potency  of PLC£ with regard to Ca2+-releasing ability appear to  occur in the  sperm  of 
different species. I have demonstrated that eggs from different species (human, mouse and pig 
eggs) also vary in their ability to exhibit PLC^-induced  [Ca2+]i  oscillations and this may be 
due to  the  differing  sensitivities of the different eggs to  PLC£ since  it has  previously been 
shown  that  the  hamster  egg  is  much  less  sensitive  to  sperm  extracts  than  the  mouse  egg 
(Parrington  et  al.,  1996).  The  variation  in  size  of  different  species’  eggs  will  reflect 
differences  in  the  efficiency  of PLC£  at  causing  [Ca2+]i  oscillations;  the  human  egg  for 
example  is several  times  larger than that of a mouse egg and this may be the reason  for the 
hPLC£ being  more potent  in  its Ca2+-releasing ability than rnPLC^.  The  fine-tuning of the 
effective dose of PLC£ during fertilisation thus appears to be species-specific and appropriate 
to match the size and sensitivity of the egg so that the sperm can induce robust,  long-lasting 
[Ca2+]i oscillations.
The  experiments  I  have  presented  in  chapter  3  indicated  that  pig  eggs  were  more 
insensitive to PLC£ than either the mouse or human egg and mPLC^ was  in  fact completely 
ineffective  at triggering  [Ca2+]i  oscillations  in  pig eggs. The  [Ca2+]i  oscillations  in  pig eggs 
that  were triggered  by hPLC£ were  short-lived and  successively  reduced  in  amplitude after 
each [Ca2+]i transient. The inability of hPLC£ to induce long-lasting, higher frequency [Ca2+]i 
oscillations in pig eggs could be due to the developmental failure of Ca2+ release machinery,
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hindered  by the  process of in vitro  maturation  (IVM).  Despite  advances  of in vitro  culture 
techniques,  IVM has been shown to reduce the quality of the oocyte drastically. A previous 
investigation  studying  the  developmental  competency  of IVM  pig  oocytes  after  subzonal 
sperm  injection  concluded  that  ooplasmic  incompetence  was  the  major  cause  of  limited 
developmental  competence  (Nagashima  et  al.,  1996).  In  order  to  best  study  the  affects  of 
PLC£ on  pig embryo development,  IVM techniques will need to be drastically improved to 
ensure  successful  development  of  Ca2+  stores  and  release  mechanisms.  Measuring  the 
effectiveness of pig PLC£ in inducing [Ca2+]i transients in mouse and human eggs would also 
help to elucidate what level of potency is required to effectively induce [Ca2+]i oscillations in 
pig eggs  and  this would also reflect the relative  sensitivity of the pig  egg compared to the 
human and mouse egg.
7.2  [Ca2+]i oscillations and preimplantation embryo development
Pre and post-implantation studies have shown that the pattern of the activating [Ca2+]i signal 
has an  impact on the developmental potential of mouse and rabbit embryos (Ozil,  1990; Ozil 
and Huneau, 2001; Bos-Mikich et al.,  1997; Vitullo and Ozil,  1992). Increasing the frequency 
of  [Ca2+]i  oscillations  has  for  example  been  shown  to  increase  the  number  of embryos 
successfully undergoing compaction (Ozil,  1990) and [Ca2+]i transients can be manipulated in 
rabbit  eggs  to  optimize  postimplantation  embryo  development  such  as  the extent  of somite 
and  heart  formation  (Ozil  and  Huneau,  2001).  The  pattern  of [Ca2+]i  oscillations  has  been 
reported  to  change  the  cellular  composition  of developing  blastocysts  (Bos-Mikich  et  al.,
1997)  with an increasing duration from 2 to 4 to 6 hours causing a successive increase in the 
ICM cell number in blastocysts. A recent study was undertaken to investigate whether or not 
ICSI-initiated fertilisation causes alterations in [Ca2+]i responses and affects pre-implantation 
development  compared  to  IVF-initiated  fertilisation.  ICSI-induced  [Ca2+]i  oscillations
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occurred  more  infrequently  and  ceased  significantly  earlier  compared  with  IVF-induced 
[Ca2+]i oscillations and were also associated with a reduced developmental capacity to reach 
the blastocyst stage and reduced blastocyst cell numbers (Kurokawa et al., 2005). In the work 
presented  in  this  thesis  I  have  shown  that  the  short-lived  [Ca2+]i  oscillations  induced  by 
hPLC£ in pig eggs leads to the poor development of pig embryos with only 3% progressing to 
the 8-cell  stage. This is in contrast to the much more successful development of human and 
mouse  embryos  that  exhibited  long-lasting  PLC^-induced  [Ca2+]i  oscillations.  This  data 
indicates  that  the  duration  of  [Ca2+]i  oscillations  at  egg  activation  correlates  with  the 
developmental  success  of  the  embryo  and  supports  the  data  of  Kurokawa  et  al,  2005 
(Kurokawa et al., 2005). A transgenic RNAi approach was used to reduce production of the 
sperm-specific  PLC£  protein  during  spermatogenesis  showed  that  sperm  extracts  from 
transgenic  male  mice  contained  approximately  60%  of the  amount  of PLC£  compared  to 
sperm  extract  from  non-transgenic  littermates.  More  importantly  the  pattern  of  [Ca2+]i 
oscillations  was  different  in  eggs  fertilised with  sperm  from  transgenic  and  non-transgenic 
mice, for example  eggs fertilised with sperm ffom transgenic mice oscillated for substantially 
shorter  periods  of  time  than  fertilised  control  eggs.  The  reduced  duration  of  [Ca2+]i 
oscillations  induced  by  sperm  from  transgenic  mice  also  caused  a  significantly  lower 
incidence of egg activation as monitored by the incidence of pronuclei formation compared to 
the longer duration  [Ca2+]I oscillations induced by sperm  ffom non-transgenic mice and as a 
consequence of this,  fewer  1-cell embryos cleaved and formed blastocysts.  PLC£ also plays 
an  important  role  in  shaping  the  amplitude  and  duration  of  the  [Ca:+]i  transients  at 
fertilisation.  Genotypic  analysis  of the offspring  of the  transgenic  founder revealed  that  no 
transgenic offspring were bom, suggesting that the eggs fertilised by transgenic sperm (which 
fail to exhibit normal [Ca2+]i oscillations) do not develop to term. This is supportive of other
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data which has been  interpreted as  indicating that the oscillatory behaviour of [Ca2+]i has a 
long-term role in development (Ozil and Huneau, 2001).
Whilst  parthenogenetic  stimuli  such  as  Sr2+ trigger repetitive  [Ca2+]i  oscillations  in 
eggs they are distinguishable from those at fertilisation and probably lack the ability to encode 
specific  information that may influence gene expression or the activation of certain kinases 
that play a role in embryo development. More studies are required to elucidate the real long­
term affects of the fertilisation-like [Ca2+]i  signal compared to the [Ca2+]i  signal induced by 
other parthenogenetic agents.
Human eggs that have previously failed to activate during ART due to a faulty sperm 
factor  are  often  activated  with  chemicals  (such  as  ionomycin)  that  induce  a  single  [Ca2+]i 
transient.  Previous  studies  have  shown  that  parthenogenetic  activation  of freshly  ovulated 
human eggs by inducing a single [Ca2+]i transient can result in development to the blastocyst 
stage (Cibelli  et al.,  2001;  Lin et al.,  2003).  Parthenogenetic activation of aged human eggs 
using a protein synthesis  inhibitor such as cycloheximide or puromycin  in conjunction with 
stimuli that cause a single [Ca2+]i transient can stimulate early cleavage events but has never 
been reported to cause development to the blastocyst stage (Winston et al.,  1991; Nakagawa 
et  al.,  2001).  In  this  thesis  I  showed  for  the  first  time  that  aged  human  eggs  can  be 
parthenogenetically activated and induced to develop to the blastocyst stage following PLC^ 
cRNA  injection  (Rogers  et al.,  2004).  It  is  possible  that the repetitive  nature of the  [Ca2+]i 
signal  which  was  induced  by  PLC£  and  which  is  exhibited  normally  during  human  egg 
fertilization may have been causative of higher success of parthenogenetic development in the 
embryos.  More extensive studies are required to elucidate any influence that [Ca2+]i patterns 
(oscillations versus single transient) at egg activation can have on the developmental potential 
of human embryos. The single [Ca2+]i increase that can be used to induce egg activation may 
also have consequences  for sheep, pig or cattle embryo development since these stimuli are
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used  frequently  on  these  animals  during  the  Nuclear  Transfer  (NT)  procedure.  Whilst  the 
activation  of cattle  eggs  using  single  [Ca2+]i  wave  stimuli  has  been  shown  to  work  with 
moderate efficiency if used in conjunction with a protein synthesis inhibitor, the efficiency of 
NT technology is still very low and the long term consequences of this activation method are 
unclear. Artificial stimuli that cause single [Ca2+]i transients will need to be studied further to 
establish what long-term affects it may be triggering
Details  of  the  downstream  targets  of  [Ca2+]i  oscillations  are  unclear,  however 
mounting evidence suggests that [Ca2+]i oscillations activate a number of protein kinases that 
are relevant to embryo development and they are Calmodulin-dependent Kinase II (CAMKII) 
and  Protein  Kinase  C  (PKC).  The  process  of  egg  activation  is  dependent  on  [Ca2+]i 
oscillations  which  act to  destroy maturation  promoting  factor (MPF)  and the  cohesion  that 
holds the two sister chromatids together (Madgwick et al., 2004) and this is achieved by the 
destruction of cyclin B and securin respectively.  [Ca2+]i oscillations activate CAMKII which 
stimulates ubiquitin-dependent degradation of Cyclin B (Lorca et al.,  1993) by targeting it for 
destruction by the proteasome, allowing the egg to be released from meiotic arrest. CAMKII 
is present in all mammalian eggs studied to date and  its activity increases immediately after 
each  [Ca2+]i  rise  associated  with  fertilization  or  parthenogenetic  activation  (Winston  and 
Maro,  1995; Tatone et al., 2002). There is a tight correlation between the [Ca2+]i increase and 
CAMKII activity with the amplitude of the  [Ca2+]i  spike determining the relative activity of 
CAMKII  (Markoulaki  et  al.,  2004).  CAMKII  which  has  been  reported  to  be  the  primary 
downstream  target  of  [Ca2+]i  signalling  (Madgwick  et  al.,  2005)and  has  been  shown  to 
regulate the activity of more than 20 enzymes such as calcineurin and nitric oxide synthase 
(Means  et  al.,  1991;  Lu  and  Means,  1993).  It  is  through  the  action  of these  enzymes  that 
CAMKII is thought to control a number of critical cellular processes in the early embryo such 
as cell cycle progression, microtubule formation, cell motility and metabolism (Chafouleas et
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al.,  1982;  Johnson  et  al.,  1998).  CAMKII  co-localizes  with  calmodulin  (CAM)  and  MAP 
kinase following egg activation (Hatch and Capco, 2001). CAM has been found on the mitotic 
apparatus of yeast cells and mutations in this protein have been reported to cause spindle body 
defects  as  well  as  abnormal  chromosome  segregation  (Davis,  1992).  CAM  has  also  been 
documented to intervene with the cell cycle during the G1 to S boundary, G2 to mitosis phase 
and  the  anaphase-metaphase  transition  (Rasmussen  and  Means,  1989).  Cycloheximide- 
induced  egg  activation bypasses the  need  for any  [Ca2+]i  rises  because  it  causes  the  direct 
degradation of Cyclin B, this however prevents the activation of CAMKII and the regulation 
of calmodulin-dependent enzymes and may prove detrimental to processes required for cell 
cycle  progression  and  microtubule  associated  events.  This  idea  is  consistent  with  my 
microarray  and  experimental  data  that  reveal  high  incidence  of premature  developmental 
arrest  and  high  differential  gene  expression  of cell-cycle  and  microtubule  related  genes  in 
cycloheximide-activated  embryos  compared  to  S r+-activated  embryos.  In  recent  work 
investigating the  role  of CAMKII during meiotic  resumption,  a constitutively active  cRNA 
construct of CAMKII was shown to induce the same effects on the resumption of meiosis as 
sperm, since pronucleus formation and 2nd polar body extrusion both occurred, along with the 
destruction of cyclin  B  and  securin (Madgwick et al.,  2005).  The use of the  spindle poison
■n  i
nocodazole was also shown to block meiotic resumption however the Ca  chelator BAPTA 
did  not,  showing  that  CAMKII  lies  downstream  of sperm  induced  [Ca  ]i  oscillations  but 
upstream of the spindle check point (Madgwick et al., 2005).  In order to study the affects of 
[Ca2+]i  oscillations  on  embryo  development  in  the  future,  it  would  be  an  idea  to  inject  a 
constitutively active form of CAMKII which bypasses the need for [Ca2+]i oscillations but is 
not associated with the detrimental affects of cycloheximide.
Embryonic  development  requires  signals  that  are  transduced  through  cell  surface 
receptors which upon binding to their ligand initiate signal transduction cascades which alter
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the phosphorylation of intracellular components via kinases and phosphatases. The PKC’s are 
a major signal transducer made up of eleven different kinases, many of which are [Ca2+]i and 
DAG dependent. Some PKC  isoforms may in fact serve to decode  [Ca2+]i oscillations since 
stimulation  of repetitive  [Ca2+]i  transients  has  been  shown  to  cause  a  parallel  repetitive 
translocation  of GFP-tagged  PKC  gamma  to  the  plasma  membrane  (Oancea  and  Meyer, 
1998).  Recent work using a constitutively active cRNA construct of PKC  has revealed that 
PKC is not a trigger for meiotic resumption (as CAMKII is), but rather has a role in sustaining 
long-lasting [Ca2+]i oscillations at fertilisation by facilitating store-operated [Ca2+]i entry. In a 
different study it was also concluded that PKC promotes store refilling and it was shown that 
PKC  overexpression  leads  to  an  increased  frequency  of [Ca2+]i  oscillations  (Halet  et  al.,
2004).
PKC's  may  also  have  a role  in  later preimplantation development  since  it  has  been 
shown to be involved in mouse embryo compaction since activation of PKC by phorbol ester 
causes  premature  compaction  of 4-cell  embryos  within  minutes  of addition  of the  ester 
(Winkel  et  al.,  1990).  PKC  activation  also  causes  a  rapid  shift  of antibodies  to  E-cadherin 
which  coincides  with  the  timing  of compaction  (Winkel  et  al.,  1990).  PKC  has  also  been 
linked  to  blastocoel  formation.  Blastocoel  formation  is  dependent  on  Na2+/K+  ATPase 
activities which  help to drive the osmotic transport of water across the epithelium.  Na2+/K+ 
activities are believed to be mediated by [Ca2+]i and Ca2+-modulating activities, all of which 
interact with PKC pathways. While these data suggest that [Ca2+]i rises are responsible for the 
activation of PKC's,  it is unclear if it is these [Ca2+]i rises during activation that function to 
facilitate  blastocoel  formation  and  compaction.  The  full  extent  of the  role  of PKC  during 
preimplantation development has yet to be determined.
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7.3  Embryo developmental potential
Developmental arrest is a phenomenon observed in embryos in almost all mammalian species. 
Suboptimal conditions have often  been  suggested as the cause of embryonic arrest however 
one study utilised mathematical modelling and data ffom experiments to conclude that while 
environmental factors can influence developmental progression to a limited degree, there will 
always  be  a  group  of  embryos  that  arrest  and  a  group  that  survives  when  cultured  in 
suboptimal  conditions  (Hardy  et  al.,  2001).  The  mechanisms  which  cause  developmental 
arrest are unclear however the embryonic stages at which transcription-dependent proteins are 
first made coincide with the highest incidence of cleavage arrest in most species, suggesting 
that  a  delay  or  failure  in the  onset  of transcription  is  causative  of developmental  arrest.  A 
wide  range  of  cellular  defects  have  been  observed  during  cleavage  arrest,  such  as  the 
redistribution of mitochondria (Acton et al., 2004) and abnormal localisation of proteins such 
as those from the Bcl-2 family.
The developmental  progression of fertilised mammalian oocytes  is  dependent  to  the 
successful  implementation  of  specific  genetic  and  developmental  programmes.  It  is  not 
surprising therefore that factors which predispose an embryo to develop normally or to arrest 
have been suggested to be  largely determined at or before the  1-cell zygote stage (Hardy et 
al.,  2001).  Chromosomal  abnormalities  (Munne  et  al.,  1995)  and  inadequate  oocyte 
maturation  (Moor  et  al.,  1998)  are  some  of the  commonly  suggested  causative  factors  for 
early embryonic abnormalities (Hardy et al., 2001). The results ffom studies presented in this 
thesis reveal that the presence of [Ca2+]i oscillations or a single  [Ca2+]i transient during egg 
activation  improve the developmental potential  of resulting embryos progressing past the 4- 
cell  stage  (See  Chapter  4).  A  recent  study  has  shown  that  the  implantation  success  of 
blastocysts  are  significantly  better  after  oscillatory  [Ca2+]i  signals  rather  than  a  single 
sustained [Ca2+]i transient during egg activation (Ozil et al., 2005). Whilst I have shown that 
the presence of [Ca2+]i oscillations at egg activation does not appear to be a requirement for
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the initiation of Embryonic Genome Activation (Chapter 5) other processes such as chromatin 
remodelling may be affected by the presence or absence of oscillatory [Ca“  ]i signals
7.4  Apoptosis and cell allocation in mammalian blastocysts
The  degree  of fragmentation  in  blastocysts  has  been  used  as  a  good  indicator  of embryo 
quality. The presence of minor fragmentation (<10%) has been shown to commonly occur in 
healthy human embryos which implant and develop to term with a similar success as embryos 
exhibiting  no  signs  of fragmentation,  indicating  that  the  occurrence  of fragmentation  is  a 
normal  process  during  development.  A  higher  degree  of  fragmentation  (>10-15%)  has 
however  has  been  reported  to  significantly  reduce  implantation  and  pregnancy  rates  in  a 
number of different studies (Giorgetti et al.,  1995; Ziebe et al.,  1997). Many factors other than 
fragmentation have been shown to significantly decrease implantation rates and they include 
the age of the mother (Giorgetti et al.,  1995), embryo growth rate (Cummins et al.,  1986), and 
the number of cells of the Inner Cell Mass (ICM) of blastocysts (Richter et al., 2001). I have 
demonstrated  that  the  method  of  parthenogenetic  mouse  egg  activation  (Sr2+  or 
cycloheximide-induced  egg  activation)  significantly  affects  the  degree  of  apoptosis  in 
blastocysts since Sr2* and cycloheximide-induced activation resulted in blastocysts with a 5% 
and  14%  degree  of  apoptosis  respectively.  As  Sr2*  triggers  [Ca2+]i  oscillations  and 
cycloheximide  does  not  induce  any  [Ca2+]i  changes,  it  can  be  ascertained  that  [Ca2+]i 
signalling may be responsible, at least in part,  for determining the level  of fragmentation  in 
blastocysts.  Whilst  cycloheximide-activated  blastocysts  did  exhibit  a  significantly  larger 
degree of apoptosis, these blastocysts were still only characterised by an intermediate level of 
apoptosis (14%). A 10-15% degree of apoptosis has been reported as the threshold of whether 
apoptosis will reduce the implantation potential of the human embryo or not, so it is unclear if
213Chapter 7: General Conclusions
cycloheximide-derived mouse blastocysts would have a reduced potential to  implant due to 
apoptosis, compared to Sr2+-activated mouse blastocysts.
Parthenogenetic  activation  of  eggs  using  cycloheximide  and  Sr2*  also  had  a 
differential  affect on the number of cells  forming the  1CM  and TE  in  resulting blastocysts. 
Blastocysts derived ffom Sr2* activation had significantly larger cell numbers in the ICM but 
not the TE compared to those activated by cycloheximide. The larger ICM cell number may 
be due to the occurrence of [Ca2+]i oscillations induced by Sr2* activation. Previous findings 
have shown that increasing the length of time S r+-induced [Ca2+]i oscillations persisted ffom 
2 to 4 to 6 hours successively increased the  ICM cell number in blastocysts (Bos-Mikich et 
al.,  1997). The same study did not investigate the cellular composition of blastocysts after egg 
activation  by  [Ca2+]i  dependent  means.  Larger  ICM  cell  numbers  have  been  reported  to 
increase the success of implantation and pregnancy potential.
As  the  ICM  but  not  the  TE  cell  numbers  were  significantly  different  between 
cycloheximide and Sr2+-activated embryos, apoptosis may be occurring predominantly in the 
ICM group of embryos. This could be quantitatively determined in the future by using a dual- 
purpose differential staining and apoptosis assay as has previously been described for bovine 
blastocysts  (Fouladi-Nashta et al.,  2005).  In  a number of studies the  incidence of apoptosis 
has been shown to be more prevalent in the ICM when compared to the TE in in vivo and in 
vz/ro-derived mouse blastocysts (Copp,  1978; Brison and Schultz,  1997; Fouladi-Nashta et al.,
2005).  Minimal and moderate levels of ffagmentation in human blastocysts have  in contrast 
been  shown to cause a reduction  in cell numbers that is largely confined to the TE, whilst a 
steady  number  of ICM  cells  are  maintained  and  only  drop  in  blastocysts  exhibiting  gross 
(>25%) ffagmentation (Hardy et al., 2003). A homeostatic mechanism in human embryos thus 
appears  to  control  the  numbers  of ICM  cells  up  to  moderate  ffagmentation  (<25%)  levels. 
Apoptosis  has  a  clear  role  in  regulating  ICM  cell  number  in  the  human  blastocyst  since
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blastocysts with excellent morphology and high cell numbers have higher levels of apoptosis 
in the ICM than blastocysts of poor morphology with fewer cell numbers (Hardy et al., 2003). 
It is unclear if this protective mechanism to ensure sufficient ICM cell numbers is specific to 
some species and not others since  it has not been observed  in mouse blastocysts. The early 
mouse  embryo  has  been  shown  to  be  equipped  with  a  self-regulating  mechanism  to 
stringently maintain the ICM to TE cell ratio and this has been shown to be mediated by a 
combination of cell interactions, mitotic spindle orientation and changes  in cell morphology 
(Fleming,  1987). The allocation of cell numbers during development is clearly an important 
factor in development and since the stem cell pool for foetal and extra-embryonic lineages is 
limited, a depletion of either TE or ICM could influence the pattern of later development.
7.5  (Ca2+]i oscillations and gene expression
Previous studies on somatic cells have demonstrated that changes in [Ca2+]i have an effect on 
the levels of gene expression in a cell. One study using caged InsP3 to induce [Ca2+]i changes 
concluded  that  repetitive  [Ca2+]i  transients  at  1   minute  intervals  causes  significantly  more 
gene expression than transients at  intervals of 0.5  or more than 2  minutes (Li  et al.,  1998). 
The same study also revealed that a single [Ca2+]i transient causes less gene expression than 
repetitive transients (Li et al.,  1998). A [Ca2+]i clamp technique has previously been used to 
investigate  the  effect  of the  frequency  of [Ca2+]i  transients on  gene  expression  and  it  was 
concluded  that  repetitive  [Ca2+]i  oscillations  were  much  more  effective  at  driving  gene 
expression  in  the  transcription  factors  that  were  studied  (Dolmetsch  et  al..  1998).  High 
frequency oscillations were also  shown to  stimulate  more transcription  factors  and  increase 
the  specificity  of gene  expression  compared  to  infrequent  oscillations  (Dolmetsch  et  al.,
1998). The complete absence of increases in [Ca2+]i during cycloheximide-induced activation
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is therefore likely to prevent the expression of genes that may play an important role in later 
embryo development.
In  the  future  a  comparison  of gene  expression  following  the  use  of other  artificial 
activation  stimuli would be an  interesting  study to carry out  because  of its  implications  for 
nuclear transfer and assisted reproductive technologies (ART).  Analysis  of gene  expression 
following egg activation  induced by PLC£ for example,  would be valuable for a number of 
reasons.  PLC£  stimulates  [Ca2+]i  oscillations  that  are  of a  pattern  that  is  indistinguishable 
from those at fertilization (Saunders et al., 2002) and is characterised by features such as the 
first [Ca2+]i transient being much longer in duration than the proceeding transients and by the 
presence  of smaller  sinusoidal  [Ca2+]i  spikes  on  top  of  it.  PLC^-induced  activation,  like 
fertilization  also causes  mitotic Ca2+ transients that occur shortly after pronuclear envelope 
breakdown  is  initiated  (Larman  et  al.,  2004;  Marangos  et  al.,  2003)  and  the  cell-cycle 
dependent  manner  in  which  these  mitotic  [Ca2+]i  transients  occur  could  be  important  in 
regulating the time-dependent  manner  in which  specific  genes  are  expressed.  PLC£,  which 
provides  a  natural  stimulus  to  activate  eggs,  would  be  a  good  control  for  future  gene 
expression experiments conducted on parthenogenetic embryos.
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KSOM (simplex optimised media: Summers et al.,  1995; Lawitts and Biggers, 1998; 
Summers et al., 2000).
HEPES-KSOM:  For embryo collection and stage work 
Composition
lx stock  lOx stock
Ingredient___________________  mM  g/L_____   ml/L_______ g/0.5L____   ml/0.5L
1 NaCl 95 5.55 N/A 27.75 N/A
2 KCI 2.5 0.185 N/A 0.925 N/A
3 KH2P04 0.35 0.0476 N/A 0.238 N/A
4 Sodium Pyruvate 0.2 0.022 N/A 0.11 N/A
5 L-Glutamine 1 0.146 N/A 0.73 N/A
6 Streptomycin Sulfate N/A 0.05 N/A 0.25 N/A
7 Penicillin G N/A 0.063 N/A 0.315 N/A
8
EDTA (tetrasodium 
salt) 0.01 0.0038 N/A 0.019 N/A
9 MgS04.7H20 0.2 0.0493 N/A 0.2465 N/A
10 Sodium Lactate (Syrup) 10 N/A 1.474 N/A 7.37
11 NaHC03 4 0.0336 N/A 1.68 N/A
12 Phenol Red N/A 0.011 N/A 0.055 N/A
13 HEPES 20 4.76 N/A 23.8 N/A
14 CaC1.2H20 1.71 0.251 N/A N/A N/A
15 Glucose 0.2 0.036 N/A N/A N/A
16 BSA N/A N/A 1 N/A N/A
lOx stocks containing components 1-13 were prepared, pH was adjusted to 7.3-7.4 using 200- 
220 pi of 0.5 M NaOH and solution was filter sterilised through a pre-soaked 0.45pM filter.
lOx solutions were stored at -20°C. Components 14-16 were added on preparation of lx 
working solutions.
1.71  M stocks ofCaC1.2H20 were stored -20°C and dilution  1/1000 in final  IX working 
solutions.
0.2 M Glucose solutions were made weekly and stored at 4-8°C. BSA stocks were kept at 4 
mg ml"1
242Appendices
KSOM: used for culturing embryos
lx stock  lOx stock
Ingredient_______  mM  g/L_______  ml/L_________g/0.5L  ml/0.5L
1 NaCl 95 5.55 N/A 27.75 N/A
2 KCI 2.5 0.185 N/A 0.925 N/A
3 KH2P04 0.35 0.0476 N/A 0.238 N/A
4
Sodium
Pyruvate 0.2 0.022 N/A 0.11 N/A
5 L-Glutamine 1 0.146 N/A 0.73 N/A
6
Streptomycin
Sulfate N/A 0.05 N/A 0.25 N/A
7 Penicillin G N/A 0.063 N/A 0.315 N/A
8
EDTA
(tetrasodium
salt) 0.01 0.0038 N/A 0.019 N/A
9 MgS04.7H20 0.2 0.0493 N/A 0.2465 N/A
10
Sodium Lactate 
(Syrup) 11.8 N/A 1.74 N/A 8.7
11 NaHC03 25 2.1 N/A 10.5 N/A
12 Phenol Red N/A 0.011 N/A 0.055 N/A
13 CaC1.2H20 1.71 0.251 N/A N/A N/A
14 Glucose 0.2 0.036 N/A N/A N/A
15 BSA N/A N/A 1 N/A N/A
16
Essential amino 
acids (50x 
concentrate) 10
17
Nonessential 
amino acids 
(lOOx 
concentrate) 5
For embryo development in 5% CO2 environment
lx  stocks  (made  every  week)  containing  components  1-12  were  prepared  and  pH  was 
adjusted to 7.6 using  10-20 pL of 0.5  M NaOH.  Solution was filter sterilised through a pre­
soaked 0.45pM filter and left to equilibrate to pH 7.4 overnight in a CO2 incubator.
Components  13-17 were added during the preparation of lx working solutions.  1.71  M stocks 
of CaC1.2H20 were  stored -20°C and dilution  1/1000  in  final  IX working solutions.  0.2  M 
Glucose solutions were made weekly and stored at 4-8°C. BSA stocks were kept at 4 mg ml1 .  
Essential and nonessential amino acids stocks were from Gibco
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Table 8.1 Genes overexpressed (>1.5 fold) in 8-cell embryos after parthenogenetic egg 
activation with Sr2+
i
nge
Common
symbol
Gene Name
6.297 3632440L23 Rik RIKEN  cD N A  3 63 24 40 L 23  g en e
4.848 1500009C09Rik M us m u scu lu s cD N A  clon e IM A G E :4951210,  partial cds.
3.776 A430069L09 Rik RIKEN cD N A :A 430069L 09 g en e
3.698 Trpc7 transient recep to r poten tial cation channel,  su bfam ily C,  m em b er 7
3.477 Dsc1 D erm atopontin
3.271 Eif3s10 E urakyotic translation initiation factor 3, su bu n it 10 (theta)
3.229 S100a11 S 1 0 0  calcium  binding protein  A 11  (calizzarin)
3.111 LOC328660 sim ilar to C atech ol O -m eth yltran sferase
3.025 Kera keratocan
2.947 Htrlf 5-h ydroxytryptam in e (serotonin) recep to r 1F
2.901 Prtn3 p ro tein ase 3
2.857 1700019B01Rik RIKEN  cD N A   1 70 00 1 9B 01  g en e
2.795 Pigf phosph atidylin ositol glycan,  cla ss F
2.679 Tgfbr2 Transform ing grow th factor,  b eta  recep to r II
2.656 Cd97 C D 97 antigen
2.65 Pinkl PT E N  in du ced pu tative kin ase  1
2.628 Rpl29 ribosom al protein L29
2.627 2900097C17Rik R IKEN  cD N A   2 9 0 0 0 9 7 C 1 7  g en e
2.61 Set S E T  translocation
2.593 Clmn calm in
2.569 Sqle squ a len e ep o x id a se
2.553 1190002C06Rik R IK E N cD N A   119 0 0 0 2 C 0 6  g en e
2.55 Pcp4l1 Purkinje cell protein 4-like  1
2.539 Gabrp gam m a-am in obu tyric a cid (G A B A-A) receptor, p i
2.476 Ysg2 yolk sa c  g en e 2
2.455 HdacIO h iston e d e a cetyla se  10
2.436 Sema6b sem a  dom ain,  tran sm em bran e dom ain (TM),  a n d  cytoplasm ic dom ain  6B
2.435 Hsd17b4 h ydroxysteroid (17-beta) d eh yd ro g en a se 4
2.434 Gab1 grow th factor recep to r bou n d protein  2 -a sso cia ted  protein  1
2.423 Did dihydrolipoam ide d eh yd ro g en a se
2.421 Tm4sf1 tran sm em bran e 4 su perfam ily m em b er 1
2.418 1700010M22Rik RIKEN cD N A   1 70 00 1 0M 22 g en e
2.387 Cri1 C R E B B P /E P 300 inhibitory protein  1
2.365 9430057019Rik RIKEN  cD N A   9 4 3 0 0 5 7 0 1 9  g en e
2.36 Lss lan osterol syn th a se
2.628 Rpl9 ribosom al protein L9
2.343 Bloc1s3 b io g en esis o f lyso so m e-rela ted  organ elles com plex-1,  subunit 3
2.326 T riobp TRIO an d F-actin binding protein
2.32 Rnf25 ring finger protein 25
2.307 Cpebl cytoplasm ic polyaden ylation  elem en t binding protein  1
2.304 1810037G04Rik R IKEN  cD N A   181 00 37 G 04  g en e
2.296 Tdh L-threonine d eh yd ro g en a se
2.295 Scn8a sodiu m  channel,  voltage-gated,  typ e  VIII,  alpha p o lypeptide
2.293 Insig2 insulin in du ced  g e n e  2
2.284 Psx2 placen ta specific h om eob ox  2
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2.271 2310047C04Rik R IKEN  cD N A  2 31 0 0 4 7 C 0 4  gen e.
2.255 BC027663 cD N A  seq u en c e B C 0 27 66 3
2.25 Card 10 c a sp a se  recruitm ent dom ain fam ily,  m em b er 10
2.225 Dscr6 D ow n syn dro m e critical region h om olog 6 (hum an)
2.213 Muc2 m ucin 2
2.213 Ube2d3 RIKEN  cD N A   G 430121H 02
2.208 Ube2d3 R IKEN  cD N A   13.20-3B 3
2.206 Marcks m yristoylated alanine rich protein k in a se C  su bstrate
2.201 Fbxo3 F -box only protein 3
2.193 Srr serin e ra cem a se
2.19 Trim8 tripartite m otif protein  8
2.189 D630045J12Rik A T P ase,  H + transporting,  lyso so m a l VO subunit A isoform  4
2.186 D430038012 Rik RIKEN  cD N A  D 4 3 0 0 3 8 0 1 2  g en e.
2.184 Igh M us m u scu lu s anti-D N A  au toan tibody h ea vy chain variable
2.159 T nfrsf 18 tum or n ecrosis factor recep to r superfam ily,  m em b er 18
2.158 D630042C05 Rik RIKEN  cD N A  D 6 3 0 0 4 2 C 0 5  g en e
2.157 2310057D15Rik RIKEN  cD N A  2 3 1 0 0 5 7 D 1 5  g en e
2.157 Csmd2, Gm139 CU B a n d  S u sh i m ultiple dom ain s 2
2.154 Cldn4 claudin 4
2.153 1200013B08Rik RIKEN  cD N A   1 20 0013B 08 g en e
2.153 Gm1873, Hspdl h ea t sh o ck  protein  1  (chaperonin)
2.148 Rap2ip R ap2 interacting protein
2.147 Tebp telom erase binding protein,  p 2 3
2.146 Ndp52 n u clear dom ain  10 protein 52
2.137 2810016G10Rik R IKEN  cD N A  2 8 1 0 0 1 6 G 1 0  g en e
2.13 Aatk a p o p to sis-a sso cia ted  tyrosin e kin ase
2.123 Aqp5 aquaporin 5
2.123 Edf1 en doth elial differentiation-related factor 1
2.115 Rnf14 ring finger protein  14
2.114 Gpnmb glycoprotein  (transm em bran e) n m b
2.109 D930026A11   Rik RIKEN cD N A  D 930026A 11  g en e
2.106 Dhrs7 d eh yd ro g en a se/red u cta se (S D R  fam ily) m em b er 7
2.106 V1re11 vo m eron a sal 1 receptor,  E 11
2.102 Rap1gds1 R A P 1,  G T P -G D P  dissociation  stim ulator 1
2.089 Dock2 d edica to r o f cyto-kin esis 2
2.082 Rab7l1 R A B 7,  m em b er R A S  o n co g en e fam ily-like  1
2.08 Ly6h lym p h ocyte antigen 6 com plex,  locu s H
2.076 Zfp235 zin c finger protein  2 35
2.074 D930039E07 Rik RIKEN cD N A  D 9 30 03 9E 07  g en e
2.069 D930046I15 Rik RIKEN cD N A  D 930046I15 g en e
2.068 Icam4 intercellular a dh esion  m olecu le 4,  L an dstein er-W ien er b lood group
2.06 Copbl co atom er protein com plex,  subunit b eta   1
2.059 BC021367 cD N A se q u en ce B C 0 21 36 7
2.056 D630029K19Rik RIKEN  cD N A  D 630029K 19
2.05 Spg20 sp a stic paraplegia 20,  spartin (T royer syn drom e) h om olog (hum an)
2.049 E030038G04 Rik RIKEN  cD N A E 03 0 0 3 8 G 0 4 .g en e
2.046 Nfrkb n u clear factor rela ted  to kappa B binding protein
2.043 Rps6kb2 ribosom al protein  S 6  kinase,  p olyp ep tid e 2
2.039 Cntnap2 contactin a sso cia te d  protein-like 2
2.032 Ptx3 pentaxin related  g en e
2.32 RpMO ribosom al protein  10
2.03 Man2b2 m a n n osid ase 2,  alpha B 2
2.026 A530089G01  Rik R IKEN  cD N A  A 53 00 89 G 01   g en e
2.02 Smarca5 SW I/SN F  related,  m atrix a sso cia ted ,  actin d ep en d en t regu lator o f chrom atin,
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2.016 Btg1
subfam ily a,  m em b er 5
B -cell translocation g e n e  1,  anti-proliferative
2.014 2310043N10Rik RIKEN  cD N A  2 3 1 0 0 4 3 N 1 0  g en e
2.003 D630050F13 Rik RIKEN  cD N A  D 630 05 0F 13 .g en e
2.001 Prkarla protein kinase,  cA M P  d ep en d en t regulatory,  typ e 1,  alpha
1.992 Aldob aldolase 2,  B isoform
1.99 Syk sp leen  tyrosin e kin ase
1.989 Cldn18 claudin  18
1.989 A230086K09 Rik R IKEN  cD N A  A 23 00 86 K 0 9  g e n e
1.983 Cog2 co m po n en t o f oligom eric golgi co m plex  2
1.981 Ckmtl creatin e kinase,  m itochondrial 1,  ubiquitous
1.98 Prlpc3 prolactin-like protein C  3
1.976 BC028278 cD N A  seq u en ce  B C 0 28 27 8
1.976 Gm44 g en e m o del 44,  (NCBI)
1.973 Palmd palm delphin
1.967 Kcnj11 p otassiu m  inw ardly rectifying channel,  su bfam ily J,  m em b er 11
1.966 Ywhae tryptophan 5 -m o n o o x yg en a se activation protein,  epsilon  p olyp ep tid e
1.964 Supt4h su p p resso r o f Ty 4 h om olog (S.  cerevisiae)
1.958 Xpot W 093B 05 G G T C  G en e  Trap Library G V 03C 04 M us m u scu lu s cD N A
1.956 Scyel sm all inducible cytokin e su bfam ily E,  m em b er 1
1.955 9430047F21  Rik RIKEN  cD N A  9430047F 21  g en e
1.953 Serpinb6c serin e (or cystein e) p ro tein a se inhibitor,  clad e B,  m em b er 6c
1.952 Dctn2 dynactin 2
1.947 Igvh Im m unoglobulin h ea vy chain variable
1.946 Nek6 NIMA  (n ever in m ito sis g en e a )-related e x p re sse d  k in a se 6
2.35 Rps27a ribosom al protein S 27 a
1.941 Lrrc15 leucine rich rep ea t containing 15
1.938 Gsc g o o seco id
1.935 Rgs9 regulator o f G -protein signaling 9
1.931 Zfp353 zin c finger protein 3 53
1.927 B530045E10Rik RIKEN  cD N A  B 53 00 45 E 1 0  g en e
1.923 Otopl otopetrin  1
1.918 Fez2 fasciculation a n d  elongation protein  ze ta  2 (zygin II)
1.918 Has1 hyaluronan sy n th a se l
1.917 4932412D23Rik R IK E N  cD N A  4 9 3 24 12 D 23  g en e
1.916 *gy M us m u scu lu s anti-hum an apolipoprotein A m on oclon al an tibody
1.916 Rhotl ras h om olog g en e fam ily,  m em b er T1
1.912 Clecsf9 C -type (calcium  depen d en t,  recognition dom ain) lectin,  su perfam ily m em b e r 9
1.908 Perl perio d  h om olog  1  (D rosophila)
1.906 Hadhb h yd ro xya cyl-C oen zym e A d eh yd ro g en a se
1.904 Pim1 proviral integration site  1
1.9 BC037006 cD N A seq u en ce  B C 0 37 00 6
1.898 Gzma g ran zym e A
1.897 LOC381980 sim ilar to C atech ol O -m eth yltran sferase
1.894 Dyrklb dual-specificity tyrosin e-(Y )-ph osph orylation  regu la ted  kin ase  1b
1.883 Gm1228 G 040G 03 G G T C  G en e  Trap Library G V 07C 05
1.881 Cocoacrisp C ocoacrisp
1.875 Pcdh7 protocadherin  7
1.875 Trpm2 transient recep to r p oten tial cation channel,  su bfam ily M,  m em b er 2
1.873 Sesnl sestrin   1
1.871 1110049G11 Rik RIKEN  cD N A   1110049G 11  g en e
1.866 Mdfi M yoD  fam ily inhibitor
1.865 Fcna ficolin A
1.865 Ly6c lym ph ocyte antigen  6 com plex,  locu s C
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1.86 9630015D15Rik RIKEN  cD N A  9 6 3 0 0 1 5 D 15 g en e
1.86 Rhoq ras h om olog g en e fam ily,  m em b er Q
1.86 Tusc5 tu m or su p p re sso r ca n dida te 5
1.856 D5wsu178e DNA segm en t,  C h r 5,  W ayn e S ta te U niversity 178,  e x p re sse d
1.854 Sc5d sterol-C 5< lesatu ra se (fungal E R G 3,  d elta -5 -d esa tu ra se)
1.852 Ccl4 ch em okin e (C -C  m otif) ligand 4
1.85 Ky k yph oscoliosis
1.849 Cxcl2 ch em okin e (C -X -C  m otif) ligand 2
1.849 Zfp111 zin c finger protein  111
1.844 Car4 carbonic an h yd rase 4
1.801 Cd36 C D 36 antigen
1.831 Slc12a7 solu te carrier fam ily 12,  m em b er 7
1.831 9630005I20 Rik RIKEN cD N A   9630005120  g en e
1.829 Tnfrsf5 tum or n ecrosis factor recep to r superfam ily,  m em b er 5
1.828 2410118M9Rik M us m u scu lu s cD N A  clon e IM A G E :4458730,  partial cds.
1.813 B230399E16Rik R IKEN  cD N A  B 23 03 99 E 1 6  g en e
1.812 0610007N19Rik RIKEN  cD N A  0 61 00 07 N 19  g en e
1.886 Mrpl15 m itochondrial ribosom al protein  L15
1.81 Muc 2 M ucin 2
1.809 Hoxal h om eo  box A1
1.802 Arid 5b A T  rich interactive dom ain  5B  (Mrf1 like)
1.802 Wig1 w ild-type p 5 3 -in d u ced  g en e  1
1.801 Ccpgl cell cycle p ro gression   1
1.801 Trhde thyrotropin-releasing h orm on e degradin g ecto en zym e
1.8 Ncr1 natural cytotoxicity triggering recep to r 1
1.799 Ccl20 ch em okin e (C C  m otif) ligand 20
1.786 Large like-glycosyltran sferase
1.784 2610209M04Rik RIKEN  cD N A  2610209M 04 g en e
1.782 Phc1 polyh om eotic-like  1  (D rosophila)
1.777 Commd8 CO M M  dom ain containing 8
1.771 Commd9 CO M M  dom ain containing 9
1.77 A830080H07Rik RIKEN  cD N A  A 830080H 07 g en e
1.77 Slc39a1 solu te carrier fam ily 39 (zinc transporter),  m em b er 1
1.765 Fbxo15 A 017F 06 G G T C  G en e  Trap Library G V 03C 04
1.763 Uhrfl ubiquitin-like,  containing PH D  a n d  RIN G  finger dom ains,  1
1.751 GabarapM gam m a-am in obu tyric acid (G A B A(A)) recep to r-a sso cia ted  protein-like  1
1.751 Muted m u ted
1.749 Pdcd4 pro gra m m ed  cell d eath  4
1.747 Nudtl nudix (n u cleoside d ip h osp h ate linked m o iety X )-type m otif 1
1.745 Coq7 dem eth yl-Q   7
1.741 Sfrs6 splicing factor,  arginine/serine-rich 6
1.736 Mb m yoglobin
1.735 Arpcla actin related  protein  2 /3  com plex,  subunit 1A
1.735 G630071F17 Rik RIKEN cD N A   G 6 30 07 1F 17 .g en e
1.726 Idb3 inhibitor o f D N A binding 3
1.726 Slc34a2 solu te carrier fam ily 34 (sodiu m  p h o sph a te),  m em b er 2
1.721 Grina glutam ate receptor,  ionotropic,  N -m eth yl D -a sp a ra te-a sso cia ted  protein  1
1.72 Svil supervillin
1.716 2810442l22Rik RIKEN  cD N A  2810442122 g en e
1.716 Np15 n u clear protein  15.6
1.714 Rsbnl rosbin,  round sp erm a tid  b a sic protein  1
1.711 5730421 E18Rik R IKEN  cD N A  5 7 3 0 4 2 1 E 18 g en e
1.71 1300006C06Rik R IKEN  cD N A   1 30 00 06 C 0 6  g en e
1.709 8030499P14 Rik RIKEN cD N A   8 0 3 0 4 9 9 P 1 4  g en e
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1.701 B430201L21  Rik RIKEN  cD N A  B 430201L 21  g en e
1.699 Pgaml p h o sph o glycera te m u ta se  1
1.697 Capri 11 M us m u scu lu s calpain  11  (C apn 11) m R N A ,  co m plete cds.
1.694 A430079K02. Rik RIKEN  cD N A  A 4 3 0 0 7 9 K 0 2 .g en e
1.693 F730011C10 Rik RIKEN  cD N A  F 73 00 11 C 1 0  g en e
1.681 Pdgfa pla telet d erived  grow th factor,  alpha
1.68 Sec6l1 S E C 6-like  1  (S.  cerevisiae)
1.677 Pcdhal protocadh erin  alpha  1
1.676 Egr3 early grow th resp o n se 3
1.66 Cxcl12 ch em okin e (C -X -C  m otif) ligand  12
1.651 Kdelcl KDEL (L ys-A sp-G lu-L eu) containing  1
1.644 Bloc1s1 b io g en esis o f lyso so m e-rela ted  o rgan elles com plex-1,  subunit 1
1.636 Krt2-8 keratin com plex 2,  basic,  g en e 8
1.946 Rps3a ribosom al protein S 3a
1.627 Klhl17, kelch-like  17 (D rosophila)
1.612 Axl AXL recep to r tyrosin e kin ase
1.61 Eno2 en o la se 2,  g am m a neu ron al
1.603 Zadh2 zin c binding alcoh ol d eh yd ro g en a se,  dom ain containing 2
1.591 BC013529 cD N A  se q u en ce B C 0 13 52 9
1.586 6330409N04Rik RIKEN cD N A   633 04 09 N 04  g en e
1.569 Adamts13 a disintegrin-like a n d  m eta llop rotea se,  th rom bospon din  typ e  1  m otif,  13
1.568 3930401 E15Rik RIKEN  cD N A 3 9 3 0 4 0 1 E 15 g en e
1.565 2900097C17Rik RIKEN  cD N A 2 9 0 0 0 9 7 C 1 7 g en e
Table 8.2 Genes overexpressed (>1.5 fold) in 8-cell embryos after parthenogenetic egg activation 
with CX
d Common Gene Name
nge Symbol
9.774 Cdknlc cyclin -depen den t kin ase inhibitor 1C  (P 57)
8.171 BC030336 cD N A  seq u en c e B C 030336
7.76 Slco3a1 solu te carrier organic anion tran sporter fam ily,  m em b er 3a1
6.861 Stra8 stim u lated b y retinoic acid g en e 8
6.477 Ifnarl interferon (alpha a n d  beta) recep to r 1
6.119 Bean brevican
5.908 Gadd45b grow th a rrest a n d  D N A -dam age-in du cible 45 beta
5.344 Aloxe3 arach idon ate lipo xyg en ase 3
5.12 Pcdhb9 protocadh erin  b eta   9
5.069 Oog1 o og en esin   1
5.026 Zcchc8 zin c finger,  C C H C  dom ain containing 8
4.913 Prlr, AI987712 M us m u scu lu s prolactin recep to r (Prlr),  m R N A
4.896 Dhh d esert h ed g eh o g
4.886 Ier5 im m ediate early resp o n se 5
4.752 Pdcl phosducin-like
4.608 Tcf3 transcription factor 3
4.475 Tfpi tissu e factor p a th w a y inhibitor
4.373 Brdt brom odom ain,  testis-sp ecific
4.359 Plcd4 p h o sph o lipa se C,  delta 4
4.133 Chesl ch eckpoint su p resso r 1
4.114 Eif2c4 eu karyotic translation initiation factor 2C,  4
4.109 Rps6ka6 ribosom al protein S 6  k in a se p olyp ep tid e 6
4.108 AF067063 cD N A  seq u en c e A F 067063
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4.086 Tiam2 T-cell lym ph om a invasion an d m eta sta sis 2
4.068 Fern 1c fem -1  h om olog c (C .eleg an s)
4.056 1300019C06Rik R IKEN  cD N A   1 30 00 19 C 0 6  g en e
4.054 Pycard P Y D  a n d  C A R D  dom ain  containing
3.995 Nup133 nucleoporin  133
3.94 Arg2 argin ase typ e II
3.857 Map3k9 m itogen -activated protein  kin ase kin ase kin ase 9
3.83 Itprl inositol 1,  4,  5-triph osph ate recep to r 1
3.824 Evpl envoplakin
3.771 G630049C14Rik RIKEN  cD N A   G 6 30 04 9C 14  g en e
3.761 Shmt2 serin e h ydroxym eth yl tran sfera se 2 (m itochondrial)
3.727 A430104N18Rik RIKEN  cD N A  A 43 01 04 N 18  g en e
3.706 Smadl M AD h om olog  1  (D rosophila)
3.687 Asb4 ankyrin rep ea t a n d  S O C S  box-containing protein  4
3.658 5830411E10Rik RIKEN  cD N A  5 8 3 0 4 1 1E 10 g en e
3.569 Plxncl plexin C1
3.566 9830130M13 Rik M us m u scu lu s h ypoth etical protein  9 8 3 0 1 30M 13 (9 8 3 0 1 30M 13),  m R N A
3.535 4932432N11Rik RIKEN  cD N A  4 932432N 11  g en e
3.501 2210413P12 Rik RIKEN  cD N A  2 2 1 0 4 1 3 P 1 2  g en e
3.443 E430025L02 Rik RIKEN  cD N A  E 430025L 02 g en e
3.418 Ddx26 D EAD /H  (A sp-G lu-A la-A sp/H is) box p olyp ep tid e 26
3.418 Ripk3 receptor-interacting serine-th reon in e kin ase 3
3.407 5730438N18Rik R IKEN  cD N A 5 7 3 04 38 N 18  g en e
3.392 Hic2 h yperm eth ylated in ca n cer 2
3.375 1810043M15Rik RIKEN  cD N A   1810043M 15 g en e
3.341 AA536743 e x p re sse d  seq u en ce A A 536743
3.291 Map3k5 m itogen  a ctiva ted  protein kin ase kin ase kin ase 5
3.278 D16Ertd472e D N A segm en t,  C hr 16,  E R A TO  D o i472,  e x p re sse d
3.269 Parp9 p o ly (A D P -ribose) p o lym era se fam ily,  m em b er 9
3.261 Cdc25a cell division cycle 2 5  h om olog A  (S.  cerevisiae)
3.253 Rom1 rod ou ter seg m e n t m em bran e protein  1
3.214 A230054D04Rik, W 073A 02 G G T C  G en e  Trap Library G V 03C 04 M us m u scu lu s cD N A   clon e 
W 073A 02,
3.201 E230022H04Rik R IK E N  cD N A  E 230022H 04 g en e
3.187 LOC382105 M us m u scu lu s sim ilar to RIKEN  cD N A  E 330009P 21  g en e  (L O C 382105),  m R N A
3.175 Mospdl m otile sp erm  dom ain containing  1
3.162 Pcdh8 protocadh erin  8
3.149 Snail snail h om olog  1  (D rosophila)
3.136 Dhx36 D E AH  (A sp-G lu-A la-H is) box p olyp ep tid e 36
3.123 Zfyve20 zin c finger,  F YV E  dom ain containing 20
3.12 4930555B11Rik RIKEN  cD N A  4930555B 11  g en e
3.12 C330023M02Rik RIKEN  cD N A   C 330023M 02 g en e
3.112 C230025N18 Rik RIKEN  cD N A : C 2 3 0 0 2 5 N 18
3.097 1700081L11 Rik RIKEN  cD N A
3.092 Osm oncostatin M
3.088 Cul5 cullin 5
3.068 3100002L24Rik RIKEN  cD N A 3 0 1 0 0 2 7 A 04 g en e
3.066 GdapIO gan glioside-in du ced differen tiation -associated-protein   10
3.022 Papin papilin, proteoglycan -like su lfated glycoprotein
3.019 Egr1 early grow th resp o n se  1
3.001 Zfp131 zin c finger protein   131
3 Trpm7 transient recep to r p oten tial cation channel,  su bfam ily M,  m em b er 7
2.981 Mkiaa1686 pleckstrin h om ology dom ain containing,  fam ily A  m em b er 5
2.966 4931413l07Rik RIKEN  cD N A  4931413107 g en e
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2.955 Ddit4 D N A -dam age-in du cible transcript 4
2.953 Tac4 tachykinin 4
2.951 Mize m ela n om a-derived  leu cin e zipper,  extra-n u clear factor
2.933 2610511E22Rik RIKEN  cD N A  2 6 1 0 5 1 1E 22 g en e
2.932 Pum1 pum ilio  1  (D rosophila)
2.927 Cbx1 ch rom obox h om olog  1  (D rosophila H P1  beta)
2.924 Cablesl C dk5 a n d  A bl e n zy m e su b stra te  1
2.92 1700022C02Rik RIKEN cD N A   1 70 00 22 C 0 2  g en e
2.901 Gm92 g en e m o d el 9 2 ,  (NCBI)
2.891 Kcnk4 p otassiu m  channel,  su bfam ily K,  m em b er 4
2.876 Slc38a5 solu te carrier fam ily 38,  m em b er 5
2.862 Sfrs12 splicing factor,  arginine/serine-rich  12
2.858 Lrp1 low  d en sity lipoprotein recepto r-related  protein   1
2.851 Rockl R h o-a sso ciated  coiled-coil form ing kin ase  1
2.82 EII2 elongation factor R N A  p o lym era se II2
2.815 Derl3 D eri-like dom ain fam ily,  m em b er 3
2.8 Fgfbpl fibroblast grow th factor binding protein   1
2.786 Gdf9 grow th differentiation factor 9
2.75 Tceal transcription elongation factor A (Sll)  1
2.735 B230218L05Rik R IKEN  cD N A  B 230218L 05 g en e
2.734 Ercc4 excision  repair cross-co m p lem en tin g  roden t repair deficien cy,  com plem en tation  
grou p 4
2.726 Uxs1, Gm1937 U D P -glucuronate d eca rb o x yla se  1
2.697 Arid4b A T  rich interactive dom ain 4B  (R bp1  like)
2.688 Gm443 g en e m o d el 443,  (NCBI)
2.671 Smad4 M AD h om olog 4 (D rosophila)
2.664 Ddx55 D EAD  (A sp-G lu-A la-A sp) box p o lypeptide 55
2.66 Pum2 pum ilio 2 (D rosophila)
2.632 4930447l22Rik RIKEN cD N A  4930447122 g en e
2.62 Col17a1 procollagen,  typ e XVII,  alpha  1
2.619 Eroll E R 01-like (S.  cerevisiae)
2.618 Glee glucuronyl C 5-epim era se
2.615 A230054D04 Rik, RIKEN  cD N A  A 230054D 04
2.613 Adam 10 a disintegrin a n d  m eta llop rotea se dom ain  10
2.581 A930019P04 Rik R IKEN  cD N A  A 93 00 19 P 04
2.579 Shbg se x  h orm on e binding globulin
2.576 4930500009Rik R IKEN  cD N A  4 9 3 0 5 0 0 0 0 9  g en e
2.567 B130054P17 Rik RIKEN  cD N A  B 13 00 54 P 17
2.559 Zfp68 zin c finger protein  68
2.556 Mbd3l2 m eth yl-C pG  binding dom ain protein  3-like 2
2.544 A730025A07 Rik RIKEN cD N A  A 73 00 25 A 0 7
2.542 2410146L05Rik RIKEN cD N A   2 41 01 46 L 05  g en e
2.538 B930020H05 Rik RIKEN cD N A  :B 930020H 05
2.537 Pdzrn3 PD Z dom ain containing R IN G  finger 3
2.534 Hmmr hyaluronan m ed ia ted  m otility recep to r (RH AM M )
2.532 Leprel leprecan   1
2.529 A130089123.Rik RIKEN cD N A  A 1 30089123.
2.524 4833422F06Rik RIKEN cD N A  4 83 34 22 F 0 6  g en e
2.52 4930430J02Rik RIKEN cD N A  4 9 3 04 30 J0 2  g en e
2.514 Ankrd17 ankyrin rep ea t dom ain   17
2.513 4932442K08Rik RIKEN cD N A  4 9 3 2 4 4 2 K 0 8  g en e
2.511 Wdr40a W D  rep ea t dom ain 40A
2.508 Zc3hdc5 zin c finger C C C H  typ e dom ain containing 5
2.495 Gm978 g en e m o d el 9 7 8 ,  (NCBI)
250Appendices
2.491 Aif1 allograft inflam m atory factor 1
2.491 D130064H19Rik RIKEN cD N A  D 130064H 19 g en e
2.49 Tcf19 transcription factor 19
2.481 Atxn7l3 ataxin  7-like 3
2.481 Gsdmdcl gasderm in  dom ain containing  1
2.477 Mafk v-m af m u scu loapon eu rotic fibrosarcom a o n co g en e fam ily,  protein K  (avian)
2.474 Cpa1 ca rb ox ypep tida se A1
2.469 Snrp70 U1  sm all n u clear ribonucleoprotein p olyp ep tid e A
2.462 Bcl7a B -cell C L U Iym phom a  7A
2.454 PrameW preferentially e x p re sse d  antigen  in m elan om a like 4
2.45 4933412A08Rik RIKEN cD N A  4 9 3 3 4 1 2A 08 g en e
2.447 Cd7 C D 7 antigen
2.445 1300013B24Rik RIKEN  cD N A   1 30 00 1 3B 24 g en e
2.445 9230118019 Rik RIKEN  cD N A  9 2 3 0 1 1 8 0 1 9
2.442 E030047P15 Rik RIKEN  cD N A :E 030047P 15
2.437 4930408F14Rik RIKEN  cD N A  493 04 08 F 1 4  g en e
2.437 Brd1 brom odom ain  containing  1
2.437 Cdh3 cadherin 3
2.433 Sec23a S E C 23A   (S.  cerevisiae)
2.431 AW544865 ex p re sse d  se q u e n c e  A W 54 48 65
2.429 Zfp371 zin c finger protein 371
2.421 Faf1 F a s-a sso cia ted  factor 1
2.417 Mga M A X  g en e a sso cia ted
2.414 3110048E14Rik RIKEN cD N A  311 00 48 E 1 4  g en e
2.403 1700018018Rik RIKEN  cD N A   1 7 0 0 0 1 8 0 1 8
2.399 1810055G02Rik R IKEN  cD N A  18100 55 G 02  g en e
2.399 Kif 11 kinesin fam ily m em b er 11
2.396 Gsr glutathione red u cta se  1
2.388 D130036D15.Rik RIKEN cD N A D 130036D 15.
2.385 D130020L05Rik RIKEN cD N A   1110034C 04 g en e
2.385 Mapkbpl m itogen  a ctiva ted  protein kin ase binding protein  1
2.382 Tap-1, Tapi tran sporter 1,  A TP-binding ca ssette,  su b-fam ily B (M D R/TAP)
2.376 Son S on  cell proliferation protein
2.364 Orcll origin recognition com plex,  subunit  1-like (S .cereviaiae)
2.361 Siat5 sialyltran sferase 5
2.359 Map3k6 m ito gen -activa ted  protein kin ase kin ase kin ase 6
2.359 Syngr3 syn aptogyrin  3
2.357 Nek4 NIMA  (n ever in m itosis g en e a )-related e x p re sse d  k in a se 4
2.356 4732493F09Rik RIKEN  cD N A   4732493F 09 g en e
2.355 Spg4 sp a stic paraplegia 4 h om olog (hum an)
2.351 Rnf6 ring finger protein  (C 3H 2C 3 type)  6
2.35 E130113K08Rik RIKEN  cD N A   8 43 08 70 G 24  g en e
2.34 Eya3 e y e s  a b sen t 3 h om olog (D rosophila)
2.339 4921513E08Rik RIKEN cD N A 4 9 2 1 5 1 3 E 0 8  g en e
2.339 A230106M15Rik RIKEN cD N A A 230106M 15 g en e
2.339 A930014D07Rik RIKEN  cD N A A 93 00 14 D 07  g en e
2.338 Ccr4 ch em okin e (C -C  m otif) recep to r 4
2.333 Gm179 A 012E 07 G G T C  G en e  Trap Library G V 03C 04
2.333 Spz1 sperm atog en ic Zip  1
2.332 Sap30 sin 3 a sso cia ted  p o lyp ep tid e
2.331 D930023J12Rik R IKEN  cD N A  D 9 30 02 3J 12  g en e
2.33 Latsl large tum or su p resso r
2.33 Rhced R h esu s b lo od  grou p C E  a n d  D
2.328 A930015D03Rik M us m usculus,  clon e IM A G E .5347090,  m R N A .
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2.328 Hivep2 H um an im m u n odeficien cy virus  1  en a h a n cer binding protein 2
2.317 Kcnmb4 p otassiu m  large co n du ctan ce calciu m -activated channel,  su bfam ily M,  b eta  
m em b er 4
2.314 Padi2 peptidyl arginine deim in ase,  typ e II
2.313 Stx1b2, Stx1b1 syntaxin  1B1
2.311 Klhl7 kelch-like 7 (D rosophila)
2.309 Actr2 A R P 2 actin -related protein  2 h om olog (yeast)
2.309 Tacstdl tu m o r-associa ted  calcium  sign al tran sdu cer 1
2.307 Il17rc interleukin  17 recep to r C
2.306 Ptger4 cD N A,  R IKEN  D 1 3 0 0 0 4 L 1 2 :prostaglan din  E recepto r 4 (su b type E P4),.
2.303 Dnajc7 D naJ (H sp40) hom olog,  su bfam ily C,  m em b er 7
2.301 Glell G LE1  R N A  export m ediator-like (yea st
2.3 Grsfl G -rich R N A se q u e n c e  binding factor 1
2.3 Psap prosaposin
2.294 Zdhhc16 zin c finger,  D H H C  dom ain containing  16
2.292 3830405G04Rik RIKEN  cD N A  3 83 0 4 0 5 G 0 4  g en e
2.291 D11Bwg0280e D NA segm en t,  C h r 11,  B righam  &  W om en 's G en etics 0 2 8 0 e e x p re sse d
2.291 Rgs2 regu lator o f G -protein signaling 2
2.291 Usp33 ubiquitin specific p ro tea se 33
2.281 BC055757 cD N A  se q u en ce  B C 0 55 75 7
2.274 Fgf18 fibroblast grow th factor 18
2.271 Polr2b p o lym era se (R N A )  II (DN A directed) p o lyp ep tid e B
2.269 Mllt3 m yeloid/lym ph oid or m ix ed  lin eage-leu kem ia translocation to 3 h om olog
2.268 Baz2a brom odom ain  a djacen t to zin c finger dom ain,  2A
2.261 Gga3 golgi a sso ciated,  g am m a adaptin ea r containing,  A R F  binding protein  3
2.242 Ibtk inhibitor o f Bruton agam m aglobu lin em ia tyrosin e kin ase
2.242 Zfp319 zin c finger protein 319
2.233 Hsp25, Hspbl h ea t sh o ck  protein  1
2.232 Psmdl RIKEN cD N A  4 9 3 0 4 3 8 0 0 5  g en e
2.225 Cdk7 cyclin -depen den t kin ase  7 (h om olog o fX en o p u s M 0 1 5  cdk-activatin g kin ase)
2.222 1300007B12Rik RIKEN  cD N A   1300007B 12 g en e
2.222 Ercc6 excision  repair cross-com plem en tin g roden t repair deficiency,  com plem en tation  
group 6
2.221 Gale g a la cto se-4 -ep im era se,  U D P
2.216 ArhgapHa R ho G T P a se activatin g protein  11A
2.215 AU040829 e x p re sse d  se q u e n ce  A U 040829
2.214 Cai calcium  binding protein,  intestinal
2.21 Og2x O G 2 h om eob ox  g en e
2.207 2310026L22Rik R IKEN  cD N A  231 00 26 L 22  g en e
2.206 Sitpec signaling in term ediate in  Toll path w ay-evolu tion arily co n served
2.199 A430008J24Rik RIKEN cD N A  A 43 00 08 J2 4
2.183 4632412E09Rik RIKEN cD N A  4 6 3 2 4 1 2E 09 g en e
2.183 Pank3 p an toth en ate k in a se 3
2.181 Proml prom inin  1
2.166 Prc1 protein regu lator o f cyto kin esis  1
2.166 Sca7 spin ocerebellar ataxia  7 h om olog (hum an)
2.161 1700009P03Rik RIKEN cD N A   1 70 00 09 P 03  g en e
2.16 Ptprv protein tyrosin e p h o sp h a ta se,  recep to r type,  V
2.155 AW555464 e x p ressed  se q u en c e A W 555464
2.153 Rnf166 ring finger protein   166
2.149 Magoh m ago-n ash i hom olog,  proliferation -associated (D rosophila)
2.145 Ncoa6 n u clear recep to r coactivator 6
2.14 Gyk glycerol kin ase
2.14 Hnrpa2b1 h etero g en eo u s n u clear ribonucleoprotein A 2/B 1
2.138 4732430117 Rik RIKEN  cD N A  4732430117
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2.136 Ppm 1a protein p h o sp h a ta se  1A,  m agn esiu m  d epen d en t,  alpha isoform
2.132 Falz fetal A lzh eim er antigen
2.129 5730405K23Rik RIKEN  cD N A   5 7 3 04 05 K 2 3  g en e
2.129 D730045A05Rik R IKEN  cD N A  D 7 30 04 5A 05  g en e
2.129 Edaradd E D A R  (ectodysplasin -A  recep to r)-a sso cia ted  d eath  dom ain
2.127 AU019823 ex p re sse d  se q u e n c e  A U 0 19823
2.127 Klrdl killer cell lectin-like receptor,  subfam ily D,  m em b er 1
2.126 Gpr125 G  protein -cou pled recep to r 125
2.125 Pbefl pre-B -cell colon y-en h an cin g factor 1
2.122 Padi4 p eptidyl arginine deim in ase,  typ e IV
2.12 Trub2 TruB pseu dou ridin e (psi) syn th a se hom olog 2 (E.  coli)
2.118 2310003L22Rik RIKEN cD N A   231 00 03 L 22  g en e
2.117 Polr3a p o lym era se (R N A )  III (D NA directed) p olyp ep tid e A
2.115 1810073E21Rik RIKEN  cD N A   1810073E 21 g en e
2.115 F8 coagulation factor VIII
2.115 Rtkn rhotekin
2.113 2610024G14Rik RIKEN  cD N A  2 6 1 0 0 2 4 G 1 4  g en e
2.111 Mlycd m alonyl-C oA  d eca rb o x yla se
2.108 6330503K22Rik R IKEN  cD N A   6 33 05 03 K 2 2  g en e
2.108 Zfp1 zin c finger protein   1
2.107 Almsl A lstrom  syn d ro m e  1  h om olog (hum an)
2.107 Elk4, ELK4,  m em b er o f E T S  o n co g en e fam ily
2.106 Cpt2 carnitine palm itoyltran sferase 2
2.102 E130016E03Rik W 192F 02 G G T C  G en e  Trap Library G V 04C 04
2.098 Syncrip, Snx14 sorting nexin  14
2.097 Per3 p erio d  h om olog 3 (D rosophila)
2.097 Tubb3 tubulin,  b eta  3
2.093 4930429E23Rik RIKEN  cD N A  4 93 04 29 E 2 3  g en e
2.093 Bicd2 bicau dal D h om olog 2 (D rosophila)
2.092 Spin spindlin
2.09 Crlf3 cytokin e receptor-like factor 3
2.087 Rtn4r reticulon 4 recep to r
2.085 Taf4a TAF4A R N A p o lym era se II,  TATA box binding protein (T B P )-a sso ciated  factor
2.08 4932442K0Rik RIK E N  cD N A  4 9 3 24 42 K 0  g en e
2.077 Sfrs4 splicing factor,  arginine/serine-rich 4 (S R p75)
2.076 Cstf3 clea va g e stim ulation factor,  3' pre-R N A ,  subunit 3
2.073 Rnf40 ring finger protein  40
2.07 Jag1 ja g g e d  1
2.069 Pnrcl proline-rich n u clear recep to r coactivator 1
2.066 .D230035M11Rik RIKEN cD N A   1 70 00 34 P 14  g en e
2.061 Igf2bp3 insulin-like grow th factor 2,  binding protein 3
2.06 Dhx30 DEAH  (A sp-G lu-A la-H is) box p olyp ep tid e 30
2.059 C130036G08 M us m u scu lu s h ypoth etical protein  C 13 00 36 G 08  (C 130036G 08),  m R N A
2.059 Dck deoxycytidin e kin ase
2.059 9530060I07 Rik RIKEN cD N A  9530060107
2.057 Cdo1 cystein e d io x yg en a se  1,  cytosolic
2.054 Eif2ak3 eukaryotic translation initiation factor 2 alpha kin ase 3
2.054 Fhos2, M us m u scu lu s form in-fam ity protein  F H O S2 (F H O S2),  m R N A
2.053 Inpp5b inositol p olyph o sp h a te-5 -p h o sp h a ta se B
2.052 E2f6 E2F transcription factor 6
2.047 Arpc2 actin related protein  2/3 com plex,  subunit 2
2.045 5031400M07Rik RIKEN cD N A   5 03 14 00 M 07  g en e
2.044 Rbm10 RN A binding m otif protein  10
2.041 6330505F04Rik RIKEN  cD N A   6330505F 04 g en e
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2.039 Ldh2 lactate d eh yd ro g en a se 2,  B chain
2.039 4930525M22 Rik R IKEN  cD N A  4 930525M 22
2.037 Prx periaxin
2.036 Mbtdl m bt dom ain containing  1
2.035 Fbxo17 F -box protein  17
2.035 A630051022.Rik RIKEN  cD N A  A 6 3 0 0 5 1 0 2 2 .
2.033 LOC229751 M us m u scu lu s sim ilar to A lph a-am ylase,  pan creatic p recu rsor
2.033 Prkcbpl protein kin ase C  binding protein   1
2.033 Slc38a4 solu te carrier fam ily 38,  m em b er 4
2.031 Abcb9 A T P -binding c a ssette,  su b-fam ily B (M D R/TAP),  m em b er 9
2.031 Tjp3 tight junction protein  3
2.026 Ranbp2 R A N  binding protein 2
2.022 Milt 10 m yeloid/lym ph oid o r m ix ed  lin eage-leu kem ia translocation to  10 h om olog
2.019 Rab10 R A B 10,  m em b er R A S  o n co g en e fam ily
2.019 Thrap2 thyroid h orm one recep to r a sso c ia te d  protein 2
2.018 AK129341 M us m u scu lu s  12 d a y s em b ryo  eyeb a ll cD N A,  RIKEN  :D 230007F 04.
2.018 Mertk c-m er p ro to-on co gen e tyrosin e kin ase
2.018 More m icrorchidia
2.016 Frapl F K 506 binding protein   12-rapam ycin a sso cia ted  protein  1
2.016 Nanosl n an os h om olog  1  (D rosophila)
2.015 B230113M03Rik RIKEN  cD N A  B 230113M 03 g en e
2.012 Ccnl2 cyclin L2
2.009 5033405K12Rik RIKEN  cD N A   5 03 34 05 K 1 2  g en e
2.007 Ddr1 discoidin dom ain recep to r fam ily,  m em b er 1
2.007 Prcc papillary ren al cell carcinom a (tran slocation -associated)
2.006 Grcc9 g en e rich cluster,  C 9 g en e
1.998 Mllt2h h om olog o f hum an M LLT2 unidentified g en e
1.996 Frzb frizzled-related protein
1.993 Rps27l ribosom al protein S27-like
1.992 Dph2l2 diptheria toxin resista n ce protein requ ired for diph th am ide b io syn th esis-lik e 2
1.991 Ube3a ubiquitin protein ligase E3A
1.989 4632409L19Rik RIKEN  cD N A  4 63 24 09 L 19 4g en e
1.989 Ltb lym photoxin B
1.987 1700041 C02Rik RIKEN  cD N A
1.987 D430002022Rik R IKEN  cD N A  D 4 3 0 0 0 2 0 2 2  g en e
1.987 Prdx4 peroxiredoxin  4
1.984 1300002F13Rik RIKEN  cD N A   1300002F 13 g en e
1.984 3200001 KIORik, RIKEN  cD N A  3 2 0 0 0 0 1 K 10 g en e
1.981 Serpine2 serin e (or cystein e) p ro tein ase inhibitor,  clad e E,  m em b er 2
1.979 C80587 e x p re sse d  se q u e n c e  C 80 58 7
1.977 1500031 M22Rik RIKEN cD N A   1 50 00 31 M 22 g en e
1.976 Ddx28 D EAD  (A sp-G lu-A la-A sp) box p o lypeptide 28
1.976 Eif4g1 eukaryotic translation initiation factor 4,  g am m a  1
1.97 Phactr4 p h o sp h a ta se a n d  actin regu lator 4
1.968 Snx27 sorting nexin fam ily m em b er 27
1.964 BC054822 cD N A se q u en ce B C 0 54 82 2
1.964 Lig1 ligase 1,  DNA,  A T P -d ep en d en t
1.963 1700001 K23Rik R IK E N cD N A   1 70 00 01 K 23
1.962 8030493P09Rik RIKEN cD N A   8 0 3 0 4 9 3 P 0 9  g en e
1.961 Rbm10 RN A binding m otif protein  10
1.961 Trp53inp1 transform ation related  protein  53 inducible n u clear protein  1
1.96 Cdk9 cyclin -depen den t kin ase 9 (C D C 2-related kinase)
1.959 4732495E13Rik RIKEN  cD N A  4 73 24 95 E 1 3  g en e
1.959 Dnclicl dynein,  cytoplasm ic,  light in term ediate chain  1
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1.958 1810045K06Rik R IKEN  cD N A
1.955 1700123A16Rik RIKEN  cD N A   1 70 01 23A 16 g en e
1.954 Utp14b, Acsl3 acyl-C oA  syn th eta se long-chain fam ily m em b er 3
1.952 lpo8 im portin 8
1.949 Ape a d en o m a to sis p o lyp o sis coli
1.948 Ubp1 u pstream  binding protein  1
1.947 Cdc42se2 C D C 42 sm all effector 2
1.947 Sod2 su peroxide d ism u ta se 2
1.946 Midn m idnolin
1.945 6720425G15Rik M us m u scu lu s cD N A  clon e IM AGE: 1264584, partial cds.
1.943 Sfrs2 splicing factor,  arginine/serine-rich 2 (SC -35)
1.943 Twistnb TW IST n eigh bor
1.942 Arhgap17 R ho G T P ase activatin g protein   17
1.942 Socs3 su p p resso r o f cytokin e sign alin g 3
1.941 1700003E16Rik RIKEN  cD N A  1 70 0003E 16
1.938 D5ertd585e D NA segm en t,  C h r 5,  E R A T O  D oi 585,  e x p re sse d
1.937 Mapk14 m itogen  a ctiva ted  protein k in a se  14
1.935 Col23a1 procollagen ,  typ e XXIII,  alpha  1
1.931 Gnn M us m u scu lu s cD N A  seq u en ce  B C 0 3 0 3 0 7  (B C 030307),  m R N A
1.927 Slc25a19 solu te carrier fam ily 25  (m itochondrial d eox yn u cleotide carrier),  m em b er 19
1.919 Socs2 su p p re sso r o f cytokin e signaling 2
1.916 4930572J05Rik R IK E N  cD N A  4 9 3 05 72 J0 5  g en e
1.916 Rgs17 regu lator o f G -protein signaling  17
1.916 Spred2 spro u ty protein with EVH -1  dom ain 2,  related  se q u en ce
1.914 Vrk1 vaccinia related  kin ase  1
1.913 Slc1a3 solu te carrier fam ily 1  (glial high affinity glu tam ate transporter),  m e m b e r 3
1.911 Kcna5 p o ta ssiu m  vo lta g e-g a ted  channel,  sh aker-related subfam ily,  m em b er 5
1.91 B230339M05Rik, RIKEN  cD N A  B 230339M 05 g en e
1.908 Gng7 guanine n u cleotide binding protein (G  protein),  gam m a  7 subunit
1.905 D11Ertd461e D NA segm en t,  C hr 11,  E R A T O  D oi 461,  ex p re sse d
1.905 Hiatl h ippocam pu s abu n dan t g en e transcript 1
1.901 Tmem5 tran sm em bran e protein 5
1.899 Gbp1 gu an ylate n u cleotide binding protein  1
1.899 Zfp612 zin c finger protein 612
1.897 Ube2g1 ubiquitin-conjugating en zym e E 2G   1  (U B C 7 hom olog,  C.  eleg an s)
1.896 Fut10 fu cosyltran sferase  10
1.895 B930088P06 Rik R IKEN  cD N A  B 93 00 88 P 06
1.894 2700049P18Rik RIKEN  cD N A   2 7 0 0 0 4 9 P 1 8  g en e
1.894 Fgf5 fibroblast grow th factor 5
1.894 Gadd45g grow th arrest an d D N A -dam age-in du cible 45  gam m a
1.892 Tnnc2 troponin C2,  fa st
1.889 Celsrl cadherin E G F  LAG  se v e n -p a ss G -type recep to r 1
1.888 Hccs h olocytoch rom e c  syn th eta se
1.884 Sp3 trans-acting transcription factor 3
1.883 Ccnb3 cyclin B 3
1.882 Prkcbl protein kin ase C,  b eta   1
1.881 Mum1l1 m elan om a a sso cia ted  antigen  (m u tated)  1-like  1
1.88 3010027A04Rik RIKEN  cD N A 3 0 1 0 0 2 7 A 04 g en e
1.879 5430439M09Rik RIKEN  cD N A  5430439M 09 g en e
1.876 0610012D09Rik RIKEN  cD N A  0 6 1 0 0 1 2D 09 g en e
1.874 CblM C asitas B -lineage lym phom a-like  1
1.873 Art5 A D P -ribosyltran sferase 5
1.872 4930488P06Rik RIKEN cD N A  4 9 3 0 4 8 8 P 0 6  g en e
1.872 9430077D24Rik M us m usculus,  clon e IM A G E .4507201,  m R N A .
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1.872 Rgs4 regulator o f G -protein signaling 4
1.871 Cebpb C C A A T /en h ancer binding protein (C/EBP),  b eta
1.87 V2r14, Gm 1844 vom eron asal 2,  receptor,  14
1.867 Rab35 R A B 35,  m em b er R A S  o n cog en e fam ily
1.866 Siah2 se v e n  in absen tia  2
1.865 Cstf2t clea va g e stim ulation factor, 3' pre-R N A  subunit 2,  tau
1.865 Oit1 oncoprotein in du ced  transcript 1
1.864 4933417K04Rik R IKEN  cD N A  4 9 3 3 4 1 7 K 04 g en e
1.862 Flcn folliculin
1.861 Tdrd3 tu dor dom ain containing 3
1.858 Cdc6 cell division cycle 6 h om olog (S.  cerevisiae)
1.858 Cebpz C C A A T /en h ancer binding protein  zeta
1.857 Ddx27 D EAD  (A sp-G lu-A la-A sp) box p o lypeptide 27
1.856 AI606181 e x p re sse d  se q u e n c e  A I606181
1.853 Ddx10 W 014H 09 G G T C  G en e  Trap Library G V 03C 01
1.852 LOC386163 M us m u scu lu s sim ilar to R N P  particle co m po n en t (L O C 386163),  m R N A
1.879 Kif23 kinesin fam ily m em b er 2 c
1.851 Lamp2 lyso so m a l m em bra n e glycoprotein  2
1.851 Numal n u clear m itotic a pp aratu s protein   1
1.85 4933424A10Rik RIKEN  cD N A  4 9 3 3 4 2 4 A 10  g en e
1.842 C330027C09Rik RIKEN  cD N A   C 3 3 0 0 2 7 C 0 9  g en e
1.842 Nmb n eurom edin B
1.842 Rnf34 ring finger protein  34
1.842 Zmynd19 zin c finger,  M YN D  dom ain containing  19
1.841 Psme4, p ro tea so m e (prosom e,  m acropain) activator subunit 4
1.84 Card4 c a sp a se  recru itm en t dom ain 4
1.836 Sh3bp2 SH 3-dom ain binding protein 2
1.834 Ppp1r7 protein p h o sp h a ta se  1,  regu latory (inhibitor) su bu n it 7
1.834 Tbc1d7 TBC1  dom ain fam ily,  m em b er 7
1.831 BC005537 cD N A  se q u e n ce B C 0 05 53 7
1.83 Gnpnatl M us m u scu lu s glu co sam in e-ph o sph a te N -acetyltran sferase  1  (G n p n atl),  m R N A
1.83 A630042D18 Rik RIKEN  cD N A  A 63 00 42 D 18
1.829 Tcl1 T-cell lym ph om a breakpoin t 1
1.828 4930535B03Rik RIKEN  cD N A.  4 9 3 05 35 B 0 3  g en e
1.827 Calmbpl calm odulin binding protein  1
1.827 Gtf2h1 g en era l transcription factor IIH, p o lypeptide  1
1.827 Ly75 lym p h ocyte antigen  75
1.825 Topi top o iso m era se (D N A) 1
1.824 A430078P17:Rik RIKEN cD N A  A 430078P 17:
1.823 2310004l24Rik RIKEN cD N A  2310004124 g en e
1.821 Ndrg4 N -m yc dow n stream  regu lated g en e 4
1.815 Dnajc5 D naJ (H sp40) hom olog,  su bfam ily C,  m em b er 5
1.811 A830012D13 Rik RIKEN cD N A  A 83 00 12 D 13
1.81 Ddefl d evelop m en t a n d  differentiation enhancing
1.81 Tuba4 tubulin,  alpha 4
1.808 lesbpi interferon c o n sen su s se q u en ce  binding protein  1
1.808 Pabpc4 p oly A binding protein,  cyto plasm ic 4
1.807 Dirc2 disru pted in renal carcin om a 2 (hum an)
1.804 2610041 P08Rik RIKEN cD N A  2 6 1 0 0 4 1 P 0 8  g en e
1.803 Anksl ankyrin rep ea t a n d  SA M  dom ain containing  1
1.8 4930542G03Rik RIKEN  cD N A  4 9 3 0 5 4 2 G 0 3  g en e
1.795 G630064G18Rik RIKEN  cD N A  G 6 30 06 4G 1 8  g en e
1.792 D030062I09 Rik R IKEN  cD N A  D 030062I09
1.79 2610528A15Rik RIKEN  cD N A  2 61 05 28 A 1 5  g en e
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1.789 Pim3 proviral integration site 3
1.789 Plekhm2 pleckstrin h om ology dom ain containing,  fam ily M  (with R U N  dom ain) m e m b er 2
1.786 AI642036 e x p re sse d  seq u en c e A I642036
1.786 Mapk4 m itogen -activated protein kin ase 4
1.784 Klf 16 K ruppel-like factor 16
1.779 Pols p o lym era se (DN A directed) sigm a
1.779 Rara retinoic a cid  receptor,  alpha
1.778 Jak2 Jan u s kin ase 2
1.773 Hrmt1l1 h etero g en eo u s n u clear ribonucleoprotein m eth yltran sferase-like  1  (S.  cerevisia e)
1.773 Mak10 M A K 10 hom olog,  am in o-acid N -acetyltran sferase subunit,  (S.  cerevisiae)
1.772 Kiflb kinesin fam ily m em b er 1B
1.772 Socsl S u p p resso r o f cytokin e signalling  1
1.77 Arid 1b A T  rich in teractive dom ain   1B (Sw i1  like)
1.77 Prkar2a protein kinase, cAMP dependent regulatory, type II alpha
1.768 Goraspl golgi rea sse m b ly stackin g protein  1
1.768 6530401P13 Rik R IKEN  cD N A  6 5 3 0 4 0 1 P 1 3
1.766 Ostb M us m u scu lu s organic solu te tran sporter b eta  (O stb),  m R N A
1.764 Evl E n a-vasodilator stim u lated p h osph oprotein
1.763 Hnrphl h etero g en eo u s n u clear ribonucleoprotein H1
1.762 1700021 l09Rik RIKEN  cD N A   1700021109 g en e
1.762 493040101 ORik RIKEN  cD N A  4 9 3 0 4 0 1 0 1 0  g e n e
1.761 T nfrsf 13b tum or n ecrosis factor recep to r superfam ily,  m em b er 13b
1.768 Chka choline kin ase alpha
1.757 2010110K18Rik RIKEN  cD N A   2 0 1 0 1 10K 18 g en e
1.757 Wsb2 W D  rep ea t a n d  S O C S  box-containing 2
1.755 Zfp143 zin c finger protein  143
1.753 1110020M19Rik RIKEN  cD N A   1 1 10020M 19 g en e
1.753 Bpy2ip1 RIKEN  cD N A  B py2ip1
1.753 Slc1a5 solu te carrier fam ily 1  (neutral am ino acid transporter),  m em b er 5
1.752 Zfp346 zin c finger protein  3 46
1.751 Akt3 th ym om a viral p ro to-on co gen e 3
1.751 Hnrpf h etero g en eo u s n u clear ribonucleoprotein F
1.749 2410005K20Rik RIKEN  cD N A   2 41 00 05 K 2 0  g en e
1.746 Gtf2h4 g en era l transcription factor IIH, p o lyp ep tid e 4
1.739 Dnclcl dynein,  cytoplasm ic,  light chain  1
1.737 2610024N01Rik RIKEN  cD N A  2610024N 01  g en e
1.735 A730064F23 Rik RIKEN  cD N A  A 730064F 23
1.733 Adnp a ctivity-dep en den t n eu roprotective protein
1.731 Eda ectodysplasin -A
1.731 Plk4 polo-like kin ase 4 (D rosophila)
1.726 AbccIO A TP-binding ca ssette ,  sub-fam ily C (C F TR /M R P),  m em b er 3
1.725 Pprd cD N A clon e A 03 9C 05
1.723 2810003C17Rik RIKEN cD N A  2 8 1 0 0 0 3 C 1 7  g en e
1.716 Rad21 R A D 21  h om olog (S.  p o m b e)
1.715 Slc39a6 solu te carrier fam ily 39 (m etal ion transporter),  m em b er 6
1.715 Wdr26 W D  repea t dom ain 26
1.712 Cdkn2d cyclin -depen den t k in a se inhibitor 2D  (p19,  inhibits C D K4)
1.712 C230051C19 Rik RIKEN  cD N A   C 23 00 51 C 1 9
1.71 Prkcbpl protein kin ase  C binding protein  1
1.706 Rpl17 ribosom al protein L 17
1.705 Acly A T P  citrate lya se
1.704 Kif3c kinesin fam ily m em b er 3C
1.701 7030408E01  Rik RIKEN  cD N A   7030408E 01
1.7 1110025G12Rik RIKEN cD N A   1 1 100 25 G 12  g en e
257Appendices
1.7 Nags N -acetylglu tam ate syn th a se
1.692 Phldbl pleckstrin hom ology-like dom ain,  fam ily B,  m em b er 1
1.691 Dapk2 d ea th -a sso cia ted  kin ase 2
1.691 Nfatc3 n u clear factor o f a ctiva ted  T-cells,  cytoplasm ic,  calcin eu rin -depen den t 3
1.691 Ppp4c protein p h o sp h a ta se 4,  catalytic subunit
1.683 Glisl GLIS fam ily zin c finger 1
1.678 Spata5 sp erm a to g en esis a sso cia ted  5
1.674 Nfkbia n u clear factor o f kappa light chain g en e en h an cer in B -cells inhibitor,  alpha
1.668 Myst2 M Y S T  h iston e a cetyltra n sferase 2
1.667 1300006C19Rik R IKEN  cD N A .  1 30 00 06 C 1 9  g en e
1.667 Map4k2 m itogen  a ctiva ted  protein kin ase kin ase kin ase kin ase 2
1.666 D1pas1 DNA seg m en t,  C h r 1,  P a steu r Institute  1
1.664 1810003N24Rik RIKEN cD N A   1810003N 24 g en e
1.663 Ercc4 excision repair cross-co m p lem en tin g  roden t repair deficiency,  com plem en tation  
group 4
1.661 1110015K06Rik RIKEN  cD N A   1 11 0015K 06 g en e
1.66 Rabep2 rabaptin,  R A B  G T P a se binding effector protein 2
1.655 2010009L17Rik RIKEN  cD N A   2 0 1 0 0 0 9 L 1 7  g en e
1.655 Mfi2 antigen p 9 7  (m elan om a a sso cia ted ).
1.651 8430417G17Rik RIKEN  cD N A   8 4 3 0 4 1 7 G 1 7 g e n e
1.651 Adprtl2 A D P -ribosyltran sferase (NAD+, poly(A D P -ribose) polym erase)-like 2
1.639 Oxctl 3-oxoacid C oA  tran sfera se  1
1.627 Ndufa2 NAD H  d eh yd ro g en a se (ubiquinone)  1 alpha su bcom plex,  2
1.626 Amd1 S -aden osylm eth ion in e d ecarbo xyla se  1
1.62 A930010I02 Rik M us m u scu lu s h ypoth etical protein A 930010I02 (A 9 3 0 0 10102),  m R N A
1.62 BC059842 cD N A  seq u en ce B C 059842
1.62 Pkd1 polycystic kidn ey d ise a se   1  h om olog
1.618 2810405F18Rik RIKEN  cD N A  2 81 0405F 18 g en e
1.615 Cpsf2 clea va g e a n d  polyaden ylation  specific factor 2
1.615 Lrdd leucine-rich a n d  d eath  dom ain containing
1.614 Usf2 M us m u scu lu s u pstream  transcription factor 2 (U sf2),  m R N A
1.602 Slc7a1 M us m usculus,  clon e IM A G E .3472087,  m R N A .
1.601 Cnn1 calponin  1
1.596 Casp2 c a sp a se  2
1.596 Polr3d p o lym era se (R N A )  III (DN A directed) p o lypeptide D
1.587 Hist1h4j h iston e  1,  H 4j
1.578 Ube2d2 ubiquitin-conjugating en zy m e  E 2D  2
1.572 B130043D19 Rik RIKEN  cD N A  B 130043D 19
1.566 Tubb4 tubulin,  b eta  4
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